data_2k5n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k5n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.327 0.584 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -115.92 157.95 23.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.384 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -98.02 130.08 44.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.87 162.88 24.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.34 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -110.14 138.69 46.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.046 0.45 . . . . 0.0 110.134 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.836 HD12 HG22 ' A' ' 40' ' ' ILE . 53.0 mt -79.51 114.81 20.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.206 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -113.08 -55.45 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 111.04 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 m -104.51 124.51 49.4 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -160.06 126.79 4.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.98 102.13 10.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 2.5 tmtp? -73.83 -30.38 62.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.524 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.28 -42.06 94.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 0.0 110.672 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -90.38 -51.57 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 37.43 1.41 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.417 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.554 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 36.9 p90 -148.83 167.08 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.383 0.592 . . . . 0.0 110.819 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.53 -160.27 32.21 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.062 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.91 127.86 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.687 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.4 132.51 66.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.501 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -111.71 130.18 55.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.625 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 13.3 p-10 -91.85 -170.69 2.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.47 -9.0 19.69 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.105 0.478 . . . . 0.0 110.853 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -97.2 -44.85 6.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 -100.19 2.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.356 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -166.81 -160.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.49 135.93 36.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.555 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 63.2 mtt85 -117.75 156.73 27.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.692 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -79.86 117.48 20.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.101 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.687 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.1 m-85 -113.18 156.13 23.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.406 0.622 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.564 ' HD1' HG21 ' A' ' 32' ' ' ILE . 20.0 t-80 -148.89 138.23 21.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.931 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -49.19 -30.93 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.564 HG21 ' HD1' ' A' ' 30' ' ' HIS . 14.8 tt -61.94 -30.04 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 112.011 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.7 mmtt -93.69 10.26 33.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 40' ' ' ILE . 21.7 t -108.73 132.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.751 0.31 . . . . 0.0 110.252 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.91 -23.92 33.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.418 ' HB2' HD13 ' A' ' 39' ' ' LEU . 23.0 p-10 -135.81 71.48 63.78 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 121.634 0.731 . . . . 0.0 110.149 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.42 -21.62 13.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.338 2.692 . . . . 0.0 114.34 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.4 -9.47 59.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.564 0.697 . . . . 0.0 110.107 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.434 HD12 ' HG3' ' A' ' 66' ' ' PRO . 85.0 mt -93.45 -5.87 48.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.822 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.836 HG22 HD12 ' A' ' 7' ' ' ILE . 66.5 mt -71.28 111.42 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.085 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -137.48 157.1 47.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.668 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 14.8 tmtt? -59.95 136.1 57.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.963 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.65 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 26.8 t70 74.97 4.47 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.835 176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.65 156.41 22.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.26 138.26 36.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.0 m -132.42 164.51 34.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.392 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.8 p -127.87 140.56 51.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 12.6 p90 -151.68 162.96 40.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.492 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.557 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 10.6 mm-40 -94.9 142.84 25.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.37 142.93 16.99 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.377 2.051 . . . . 0.0 113.384 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.476 HG21 ' CE2' ' A' ' 60' ' ' TYR . 14.6 t -163.08 177.36 9.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.508 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -115.74 155.13 28.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.05 0.453 . . . . 0.0 111.102 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 14.3 t-20 -132.8 168.49 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.951 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -68.23 -38.75 82.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 15.8 ptpt -91.98 -1.66 57.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.879 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.87 -133.49 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.15 155.82 17.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.1 p -148.04 170.32 18.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.763 0.316 . . . . 0.0 111.016 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -135.4 151.06 50.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.256 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' A' ' 51' ' ' THR . 24.2 m-85 -122.47 170.29 10.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.768 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . . . 48.99 58.43 5.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.974 0.796 . . . . 0.0 110.879 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 34' ' ' VAL . 27.3 t -85.47 120.4 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.765 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 127.13 47.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.223 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.2 t -80.61 151.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.919 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.64 88.31 3.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.36 0.413 . . . . 0.0 110.443 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 39' ' ' LEU . 74.2 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.216 1.944 . . . . 0.0 111.949 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 11.8 ttt -138.98 177.18 8.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' H ' ' HG2' ' A' ' 3' ' ' MET . 4.3 p-10 -106.66 141.93 37.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 112.03 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -135.39 176.74 19.91 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -122.6 139.56 53.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.615 0.708 . . . . 0.0 110.721 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 19' ' ' ILE . 53.0 mt -76.46 107.86 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.285 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -97.88 -43.0 7.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.238 0.542 . . . . 0.0 111.037 -174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 m -132.09 121.9 24.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -139.42 129.83 25.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -107.62 92.35 4.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -59.44 -49.23 78.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.043 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.05 -45.38 90.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.24 -39.65 59.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.762 -174.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.82 6.14 35.16 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.848 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.468 ' HE1' ' HG2' ' A' ' 14' ' ' LYS . 33.1 p90 -130.54 174.84 9.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.722 0.761 . . . . 0.0 110.836 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.39 -170.84 41.75 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.0 124.39 26.2 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.779 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.69 119.02 60.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.831 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 60.2 tttt -107.06 124.17 49.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.508 . . . . 0.0 110.823 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.602 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 p-10 -89.03 -176.18 5.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.884 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -107.73 5.27 26.54 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.214 0.53 . . . . 0.0 111.013 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.28 -49.86 5.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.68 -92.11 1.85 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.329 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -168.68 -168.53 0.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.657 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -74.62 135.84 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.554 0.693 . . . . 0.0 111.689 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -103.43 151.61 22.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.028 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -79.98 117.34 20.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.779 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 56.1 m-85 -111.09 155.64 22.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.631 0.729 . . . . 0.0 111.405 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.466 ' ND1' HG21 ' A' ' 32' ' ' ILE . 14.3 t-80 -139.83 131.77 27.74 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.965 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -46.87 -32.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG21 ' ND1' ' A' ' 30' ' ' HIS . 20.3 tt -62.7 -32.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.49 6.24 31.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 33.6 t -91.79 133.42 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.91 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.25 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.517 HD21 HD13 ' A' ' 39' ' ' LEU . 22.2 p-10 -145.65 72.25 13.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.676 0.75 . . . . 0.0 110.124 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' HG13 ' A' ' 40' ' ' ILE . 92.8 Cg_endo -75.34 -9.69 20.39 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.146 2.564 . . . . 0.0 112.63 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.6 -9.98 59.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.517 HD13 HD21 ' A' ' 36' ' ' ASN . 90.4 mt -109.63 2.8 20.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.192 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 37' ' ' PRO . 55.4 mt -65.4 129.36 29.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.018 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 17.2 ptpt -143.33 166.02 25.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.275 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 12.9 tmtt? -80.08 144.9 32.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.674 0.273 . . . . 0.0 110.526 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 29.6 t70 67.27 27.88 8.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.696 0.76 . . . . 0.0 110.441 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -103.72 148.69 25.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.155 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.13 137.68 32.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 64' ' ' VAL . 26.8 m -133.29 155.56 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.405 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.4 p -113.13 133.81 54.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.93 175.7 13.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.85 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.0 mt-10 -115.72 140.81 26.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.789 174.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -82.05 133.94 7.97 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.957 2.438 . . . . 0.0 113.215 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -149.58 -175.18 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.045 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -124.21 146.48 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.118 0.485 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.411 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 15.8 t-20 -101.01 -64.68 1.03 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.724 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -174.02 -65.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.738 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.8 28.43 3.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.222 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.31 173.19 29.64 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.404 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.5 mt -81.13 146.01 30.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.73 0.3 . . . . 0.0 110.367 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.4 m -144.59 168.87 19.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.163 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -144.94 154.63 42.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.574 0.226 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -135.76 179.09 6.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.7 50.53 16.89 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.982 0.801 . . . . 0.0 110.22 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.11 113.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.078 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.23 114.66 28.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.891 ' HA ' HG12 ' A' ' 46' ' ' VAL . 45.9 t -71.13 131.36 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.847 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.04 86.98 4.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 0.0 110.671 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 122.435 2.09 . . . . 0.0 111.727 179.151 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 mtt -103.28 160.77 14.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.774 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -93.36 151.93 19.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.089 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -150.91 161.27 28.98 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.412 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -111.36 132.45 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.41 . . . . 0.0 110.289 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.829 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.3 mt -67.08 112.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.446 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -101.07 -43.55 5.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 24.3 m -145.99 140.4 26.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.36 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -140.7 122.17 15.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 86.0 m-85 -110.54 88.82 2.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -55.85 -63.14 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.58 -7.48 59.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.114 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 23.7 tptm -85.22 -32.79 22.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' HIS . . . 103.71 -17.76 48.92 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.905 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -109.31 179.06 4.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.261 0.553 . . . . 0.0 111.657 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.55 171.82 44.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.289 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 98.4 m-85 -130.38 128.4 41.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.829 HG12 ' HA ' ' A' ' 7' ' ' ILE . 58.2 mt -133.11 128.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.124 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 21' ' ' ASP . 44.4 tptt -85.18 115.56 23.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.711 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.667 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.5 p-10 -92.61 -171.63 2.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -83.94 -36.84 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.704 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -89.04 -47.9 7.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -171.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.01 -101.69 2.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.08 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 9.7 t70 -163.4 -154.52 0.28 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -168.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.4 ' H ' ' CG ' ' A' ' 25' ' ' ASP . 19.4 m120 -75.24 115.92 15.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.2 0.524 . . . . 0.0 110.101 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 43.7 mtt180 -100.17 152.39 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -80.24 118.56 22.02 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 8.9 m-85 -105.02 158.18 16.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.765 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.558 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.5 t-80 -140.4 126.09 19.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.71 -38.49 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.605 HG23 ' HG2' ' A' ' 33' ' ' LYS . 20.0 tt -59.74 -30.77 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.303 0.573 . . . . 0.0 111.839 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.605 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -96.11 11.74 33.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.349 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.485 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 21.8 t -97.85 127.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.22 61.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.447 . . . . 0.0 111.101 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -133.04 69.65 78.66 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.86 -17.66 32.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.672 2.248 . . . . 0.0 112.756 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.03 -28.88 65.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.257 0.551 . . . . 0.0 110.807 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.456 HD12 ' HG3' ' A' ' 66' ' ' PRO . 90.4 mt -88.56 3.12 51.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.289 -174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.816 HG21 HD13 ' A' ' 7' ' ' ILE . 42.2 mt -74.7 112.77 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.767 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.41 165.71 18.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.237 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -69.99 134.99 48.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.119 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 t70 69.03 16.94 8.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.963 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -84.04 159.94 21.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 175.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.31 139.39 33.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.4 m -131.95 162.8 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.681 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -126.55 134.44 50.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.857 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.667 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 19.0 p90 -149.06 174.6 12.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.813 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 10.0 mm-40 -96.17 142.03 23.98 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -81.86 134.73 8.52 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.221 2.614 . . . . 0.0 112.034 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.544 HG23 ' CE2' ' A' ' 60' ' ' TYR . 13.3 t -158.58 174.07 15.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.0 0.428 . . . . 0.0 110.121 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -140.17 156.32 46.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.09 -73.51 0.64 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.067 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.66 -63.71 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.96 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -79.88 0.0 33.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.143 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.56 47.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.262 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.26 155.04 23.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 m -145.59 168.97 19.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.31 150.85 45.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.795 0.331 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' CE2' HG23 ' A' ' 51' ' ' THR . 29.6 m-85 -126.1 171.27 10.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.897 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . . . 49.99 56.22 8.23 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.988 0.805 . . . . 0.0 110.93 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -73.43 106.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.778 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.09 106.08 16.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.009 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.704 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.2 t -68.83 147.44 12.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.022 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.4 t -109.28 87.12 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.361 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 39' ' ' LEU . 71.1 Cg_endo . . . . . 0 N--CA 1.456 -0.715 0 C-N-CA 122.155 1.903 . . . . 0.0 111.813 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.8 mtm -98.73 145.79 26.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.6 p30 -108.22 161.8 14.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.286 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.71 159.72 23.29 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.798 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -108.44 133.62 52.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.783 HD11 HG23 ' A' ' 40' ' ' ILE . 47.0 mt -77.72 126.55 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.906 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -114.77 -53.09 2.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.059 0.457 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -118.44 124.52 47.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.924 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -138.6 125.29 20.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.428 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 89.3 m-85 -98.15 98.13 9.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.856 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -62.45 -36.64 83.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.26 -21.21 62.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 67.5 mmtt -102.42 -48.06 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.891 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.28 15.23 23.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.51 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 52.8 p90 -141.72 173.04 11.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.83 -166.99 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.476 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.8 129.78 30.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.762 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.4 mt -127.25 138.64 54.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.125 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -91.86 119.18 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.425 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -86.3 -173.34 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.389 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 44.0 mt-10 -79.18 -24.54 43.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.769 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -122.52 -44.14 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -169.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.58 -96.33 0.75 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.839 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -169.21 -157.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 130.09 38.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.503 0.592 . . . . 0.0 110.089 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 23.1 mtp85 -112.09 147.07 36.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.286 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.57 117.63 19.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.762 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 31.8 m-85 -111.22 150.41 29.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.902 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.464 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.0 t-160 -148.24 136.19 20.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.702 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.41 -34.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.675 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.8 tt -58.08 -34.71 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.675 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -100.74 15.38 28.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.415 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 40' ' ' ILE . 23.4 t -114.04 134.57 56.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.321 . . . . 0.0 110.28 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.31 60.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.16 78.13 53.47 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.619 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.76 -19.81 23.52 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.868 2.379 . . . . 0.0 113.956 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.56 -22.72 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -78.99 -11.45 60.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.452 0.644 . . . . 0.0 109.427 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.783 HG23 HD11 ' A' ' 7' ' ' ILE . 56.8 mt -70.97 116.08 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.424 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -156.97 169.55 24.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.637 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 13.4 tmtt? -61.08 140.26 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 36.6 t70 76.29 4.14 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.115 0.884 . . . . 0.0 111.933 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HB1' HD12 ' A' ' 7' ' ' ILE . . . -92.13 156.19 17.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.048 -0.407 . . . . 0.0 110.324 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.49 149.08 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.4 m -134.95 149.8 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.855 0.36 . . . . 0.0 110.893 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -109.63 138.03 46.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.061 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -161.48 -179.18 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.514 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 pt-20 -104.35 142.1 23.92 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.8 Cg_endo -86.88 137.05 4.48 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.113 2.542 . . . . 0.0 112.345 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.586 HG22 ' CE2' ' A' ' 60' ' ' TYR . 6.2 t -159.23 169.38 24.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -109.96 155.8 21.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.724 0.297 . . . . 0.0 110.612 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.432 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 13.8 t-20 -132.53 157.75 43.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.612 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -78.59 8.87 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.792 0.329 . . . . 0.0 111.554 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -134.14 19.17 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 0.0 110.395 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.01 -147.38 19.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.427 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.59 152.28 20.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -144.5 167.67 21.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.672 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.04 153.41 37.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.583 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CE2' HG22 ' A' ' 51' ' ' THR . 71.2 m-85 -130.23 168.29 17.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.44 55.79 8.88 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 124.058 0.849 . . . . 0.0 111.253 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 34' ' ' VAL . 23.4 t -82.75 117.49 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.168 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -122.37 119.86 32.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.564 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.9 t -68.62 142.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.03 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.4 86.4 5.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.472 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 C-N-CA 122.549 2.166 . . . . 0.0 112.204 -177.133 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.412 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 79.3 mtp -116.15 150.66 37.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.732 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -105.56 147.17 28.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.071 0.462 . . . . 0.0 110.715 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.29 161.01 26.48 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.694 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -105.6 138.38 41.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.72 105.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.717 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 p -107.53 -51.93 2.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.199 0.523 . . . . 0.0 110.524 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 20.5 m -100.81 118.83 37.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -151.0 113.32 4.6 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.924 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.558 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 99.4 m-85 -106.3 84.4 2.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.059 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 12.5 tmtt? -59.82 -30.75 69.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.164 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.62 -24.62 65.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.425 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.558 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.7 mptp? -104.4 -31.13 9.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.3 13.96 34.44 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.521 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -139.45 174.13 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.373 0.587 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.19 -162.54 31.44 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.069 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 97.7 m-85 -139.03 131.72 28.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.693 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 77.1 mt -119.09 122.07 68.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.004 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 26' ' ' ASN . 2.1 mmmp? -89.33 112.62 23.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.07 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.621 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.0 p-10 -96.65 -170.17 2.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.817 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.38 -32.09 72.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.059 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 27.1 t-20 -63.75 -31.09 72.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.385 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.75 10.32 47.08 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.667 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -107.68 168.18 9.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 17.1 p-10 -107.18 116.13 31.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.425 0.631 . . . . 0.0 110.561 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 39.6 mtt-85 -100.47 141.37 33.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.59 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -80.03 113.68 18.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.693 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 42.7 m-85 -105.62 153.64 21.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.672 0.748 . . . . 0.0 111.196 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.509 ' HD1' ' CG2' ' A' ' 32' ' ' ILE . 27.4 t-80 -147.78 140.69 24.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.989 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.07 -18.36 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.672 HG23 ' HG2' ' A' ' 33' ' ' LYS . 7.6 tp -57.29 -39.89 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 111.701 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.672 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -92.06 3.28 55.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.769 -176.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.865 HG12 HD13 ' A' ' 40' ' ' ILE . 39.6 t -100.14 126.8 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.14 -30.37 21.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.339 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.644 HD21 HD11 ' A' ' 39' ' ' LEU . 13.0 p-10 -121.21 85.32 41.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.258 0.551 . . . . 0.0 111.343 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.77 -19.47 9.79 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.092 2.528 . . . . 0.0 113.733 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.79 -23.95 36.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.541 0.686 . . . . 0.0 109.926 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.644 HD11 HD21 ' A' ' 36' ' ' ASN . 88.4 mt -86.95 -8.49 57.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.063 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.865 HD13 HG12 ' A' ' 34' ' ' VAL . 68.2 mt -65.19 107.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.377 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 73.7 mmtt -115.72 157.71 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -71.93 135.81 46.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 70.64 9.46 6.88 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.351 0.596 . . . . 0.0 111.16 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 41' ' ' LYS . . . -82.27 166.96 19.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 110.639 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.18 145.19 36.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.452 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.768 HG12 ' HA ' ' A' ' 64' ' ' VAL . 32.8 m -131.28 160.5 42.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.71 151.86 38.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.621 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 20.2 p90 -167.02 173.58 9.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.037 0.446 . . . . 0.0 111.477 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.2 mm-40 -104.96 141.12 21.9 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.266 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 21.4 Cg_endo -92.7 143.37 2.34 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.056 2.504 . . . . 0.0 113.508 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 t -152.02 151.06 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.389 174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 m -90.88 156.29 18.12 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.476 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.411 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 4.6 t-20 -136.11 173.87 11.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.49 -20.17 62.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -112.0 13.64 20.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.175 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.48 -155.75 21.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.987 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.5 mt -86.2 148.22 25.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.255 0.55 . . . . 0.0 110.687 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -145.44 169.17 18.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.731 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.24 154.37 43.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -136.23 177.05 8.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.209 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.1 42.04 31.76 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.984 0.803 . . . . 0.0 110.419 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.7 t -75.06 112.69 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -116.84 125.31 51.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.556 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.768 ' HA ' HG12 ' A' ' 46' ' ' VAL . 21.1 t -76.81 146.86 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.37 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.4 87.85 2.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 123.426 0.454 . . . . 0.0 110.434 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.3 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.582 2.188 . . . . 0.0 111.793 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -101.33 153.71 19.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.45 144.67 28.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.121 0.486 . . . . 0.0 110.451 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.3 162.76 28.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.699 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -111.03 134.05 52.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.08 0.467 . . . . 0.0 110.278 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.957 HD13 HG21 ' A' ' 40' ' ' ILE . 57.0 mt -77.66 114.98 18.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.52 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 p -108.1 -42.57 4.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -130.28 122.89 28.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.517 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 74.3 t-105 -144.32 135.4 25.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.826 0.346 . . . . 0.0 110.329 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.64 86.42 2.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.536 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -60.63 -27.65 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.499 0.666 . . . . 0.0 110.009 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.403 ' OD2' ' HE3' ' A' ' 14' ' ' LYS . 18.1 t70 -61.88 -34.03 75.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.357 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 30.9 mmtp -119.16 -21.76 7.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.98 12.28 50.24 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.821 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.411 ' HD2' ' HE1' ' A' ' 28' ' ' TYR . 25.5 m-85 -98.31 160.88 14.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -177.84 162.51 30.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.913 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -137.48 126.02 23.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.699 HD13 HG23 ' A' ' 46' ' ' VAL . 86.8 mt -120.99 129.99 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -93.9 120.88 34.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.4 p-10 -86.22 -173.67 4.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.983 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -91.1 -10.76 40.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.159 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.44 -42.91 28.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.46 44.81 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.75 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -136.2 162.18 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 0.0 110.542 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -117.86 127.11 53.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.538 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.77 146.29 50.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.235 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HD2' ' A' ' 16' ' ' PHE . 67.5 t80 -76.59 127.28 32.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.693 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 29.9 m-85 -112.97 154.7 26.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.808 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.439 ' ND1' HG22 ' A' ' 32' ' ' ILE . 10.5 t-80 -141.67 130.99 23.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.652 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -49.82 -34.12 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.616 HG21 ' HG2' ' A' ' 33' ' ' LYS . 19.2 tt -56.94 -34.22 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HG2' HG21 ' A' ' 32' ' ' ILE . 73.9 mmtt -97.45 9.2 43.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.458 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 33.3 t -97.31 130.4 46.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.63 54.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.777 HD21 HD12 ' A' ' 39' ' ' LEU . 9.3 p-10 -132.73 79.42 64.14 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.272 0.558 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 68.9 Cg_endo -74.76 -22.34 15.49 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.02 2.48 . . . . 0.0 113.518 -173.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.17 -28.14 64.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD12 HD21 ' A' ' 36' ' ' ASN . 57.1 mt -82.63 -5.48 58.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.957 HG21 HD13 ' A' ' 7' ' ' ILE . 39.0 mt -72.25 112.62 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.625 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -133.79 174.76 10.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.772 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 1.7 tmtp? -70.53 140.96 51.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 33.1 t70 74.94 6.14 4.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.575 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 7' ' ' ILE . . . -81.34 152.0 27.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.146 -0.346 . . . . 0.0 110.323 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.18 136.6 40.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 110.558 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.699 HG23 HD13 ' A' ' 19' ' ' ILE . 28.5 m -130.44 158.83 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.122 0.486 . . . . 0.0 111.046 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.6 p -118.31 135.4 54.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.378 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 16.8 p90 -143.69 164.9 29.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -173.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -98.17 142.23 24.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.591 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.55 142.89 21.12 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.292 1.994 . . . . 0.0 112.95 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.563 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 13.5 t -157.85 166.63 32.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.607 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -113.9 145.48 41.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.993 0.425 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.86 177.16 7.94 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.17 -25.76 58.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.053 0.454 . . . . 0.0 109.903 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.83 -14.41 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.939 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.01 -138.43 10.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.87 139.49 34.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -144.08 168.59 19.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.235 -174.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -138.92 149.13 44.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.865 0.364 . . . . 0.0 111.436 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.563 ' CE1' ' HB ' ' A' ' 51' ' ' THR . 16.9 p90 -134.05 -177.61 4.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.133 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.43 42.2 32.02 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.743 0.652 . . . . 0.0 110.202 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -68.1 100.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.004 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 16.6 ttmm -108.28 116.42 31.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HA ' HG11 ' A' ' 46' ' ' VAL . 50.7 t -70.88 148.49 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.133 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.2 t -104.64 87.94 2.0 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 93.2 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 C-N-CA 122.223 1.949 . . . . 0.0 111.956 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -113.83 149.22 35.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.348 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -101.46 152.12 21.13 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.943 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -151.6 177.06 29.73 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.23 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -126.9 132.14 50.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.8 ' HA ' HG12 ' A' ' 19' ' ' ILE . 62.7 mt -65.0 106.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.506 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m -95.02 -37.38 11.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.86 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -150.96 125.06 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.878 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.661 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 74.6 t-105 -143.02 131.7 22.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.4 96.2 4.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.734 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.2 -41.78 89.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -69.57 -28.03 65.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.661 ' HG2' ' HD1' ' A' ' 16' ' ' PHE . 39.6 ttmt -87.69 -38.49 15.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.936 0.398 . . . . 0.0 110.41 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 106.34 -12.78 43.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.661 ' HD1' ' HG2' ' A' ' 14' ' ' LYS . 57.6 m-85 -96.6 163.42 13.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.902 0.382 . . . . 0.0 111.356 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.76 27.27 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.117 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -139.57 131.76 28.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.8 HG12 ' HA ' ' A' ' 7' ' ' ILE . 68.0 mt -136.92 125.11 33.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.862 0.363 . . . . 0.0 110.984 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 14.1 tmtt? -86.41 125.78 33.92 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.0 p-10 -97.1 -169.51 1.87 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.833 0.825 . . . . 0.0 112.853 -169.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -77.95 -30.23 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.287 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -74.09 -36.67 64.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.741 0.305 . . . . 0.0 110.41 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.17 41.05 0.45 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.488 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.41 163.51 32.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.159 0.48 . . . . 0.0 109.943 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -110.36 115.34 29.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -101.61 153.66 19.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.417 -170.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.892 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.8 m-85 -116.65 153.93 31.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.895 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.458 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.3 t-160 -136.4 133.76 37.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.661 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 12.4 p -47.23 -31.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.3 tt -67.72 -30.15 47.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.972 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.9 mmtt -97.7 15.31 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.67 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.722 HG12 HD12 ' A' ' 40' ' ' ILE . 39.6 t -94.29 130.77 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.38 48.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.975 0.417 . . . . 0.0 110.948 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 39' ' ' LEU . 22.4 p-10 -135.21 79.22 50.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.518 0.675 . . . . 0.0 111.203 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 40' ' ' ILE . 86.0 Cg_endo -76.95 -11.1 18.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.859 2.373 . . . . 0.0 112.247 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.39 -18.97 61.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.803 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.616 ' HB3' ' HG3' ' A' ' 66' ' ' PRO . 78.7 mt -106.39 12.87 29.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.722 HD12 HG12 ' A' ' 34' ' ' VAL . 40.9 mt -82.82 126.48 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.0 112.183 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -139.18 168.38 19.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 12.7 tmtt? -78.88 139.85 38.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.443 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 66.7 m-20 73.97 13.04 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.706 0.803 . . . . 0.0 111.709 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HB1' HD12 ' A' ' 7' ' ' ILE . . . -82.57 156.72 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.594 0.235 . . . . 0.0 110.673 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.72 137.88 31.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 19' ' ' ILE . 28.6 m -136.04 160.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.775 ' HB ' ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -124.23 154.46 40.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -166.45 171.47 11.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.902 0.382 . . . . 0.0 111.542 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 26.3 mm-40 -101.17 143.33 26.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.128 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.55 148.56 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.25 1.966 . . . . 0.0 112.183 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -166.29 171.1 12.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -109.54 155.4 21.43 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 23.1 t-20 -131.17 162.46 29.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.663 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -58.94 -36.35 74.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.489 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.45 -48.7 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.706 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -141.27 3.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.119 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -86.1 149.16 25.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.557 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -151.01 169.78 20.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -135.42 151.1 50.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.556 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.1 172.23 7.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.565 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.537 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 50.01 49.5 20.21 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.946 0.778 . . . . 0.0 111.297 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.582 HG21 ' HD2' ' A' ' 29' ' ' PHE . 17.9 t -76.95 109.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.001 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.775 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -109.15 128.76 55.28 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 ' HA ' HG11 ' A' ' 46' ' ' VAL . 28.5 t -84.93 143.93 10.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.398 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -114.3 85.12 10.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 39' ' ' LEU . 87.0 Cg_endo . . . . . 0 N--CA 1.447 -1.242 0 C-N-CA 123.094 2.529 . . . . 0.0 112.208 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.426 ' HE3' ' HB2' ' A' ' 3' ' ' MET . 3.4 mpp? -109.53 177.29 4.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.895 0.379 . . . . 0.0 110.946 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.85 151.43 25.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.936 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.63 165.44 23.79 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.973 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -112.37 135.35 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.909 HD11 HG21 ' A' ' 40' ' ' ILE . 51.8 mt -82.29 121.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 p -106.89 -53.45 2.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.998 0.428 . . . . 0.0 111.228 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.1 m -124.55 127.32 47.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.078 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -142.09 135.53 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.986 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.49 102.56 9.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.03 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.649 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.85 -49.0 64.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.829 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -70.92 -46.46 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.57 19.57 9.71 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.8 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.68 170.73 15.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.924 0.862 . . . . 0.0 110.661 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.41 -170.52 41.33 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.267 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -133.25 131.81 40.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.744 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.6 mt -131.26 131.17 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -100.74 120.63 40.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.663 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.8 p30 -109.6 -164.84 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.144 0.497 . . . . 0.0 111.543 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.84 -10.25 59.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.128 -171.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.29 -28.05 69.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.326 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.95 8.02 55.86 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.195 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -129.77 163.78 25.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.51 ' H ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -93.65 137.27 33.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 110.574 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.576 ' HG2' ' HB3' ' A' ' 57' ' ' LEU . 35.2 mtt85 -111.29 150.2 29.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.666 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -89.23 123.42 33.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.688 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 63.7 m-85 -116.74 155.64 28.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.315 0.579 . . . . 0.0 111.808 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG21 ' A' ' 32' ' ' ILE . 11.4 t-160 -136.49 135.17 38.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.666 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.96 -29.67 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.491 HG21 ' ND1' ' A' ' 30' ' ' HIS . 18.1 tt -63.76 -31.31 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.21 -9.01 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.667 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.853 HG12 HD13 ' A' ' 40' ' ' ILE . 39.6 t -91.17 134.29 30.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.261 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.36 -24.22 19.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.178 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.67 ' HB2' HG22 ' A' ' 64' ' ' VAL . 3.2 m-20 -122.38 65.49 23.13 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.849 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.04 -30.55 13.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.015 1.81 . . . . 0.0 113.656 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.13 -18.27 34.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.428 0.633 . . . . 0.0 110.152 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 87.4 mt -90.9 -8.68 48.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.909 HG21 HD11 ' A' ' 7' ' ' ILE . 54.3 mt -61.03 119.56 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.621 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -126.84 173.25 9.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -83.47 136.02 34.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 66.83 13.85 9.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.484 0.659 . . . . 0.0 111.001 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.13 156.4 17.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.671 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.7 137.65 39.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 64' ' ' VAL . 19.7 m -126.48 157.3 37.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.86 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 0.0 110.52 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.663 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 7.8 p90 -158.9 176.69 12.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.288 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.1 pm0 -111.47 143.36 28.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.1 Cg_exo -77.1 154.07 32.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.283 2.655 . . . . 0.0 113.507 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -166.89 179.4 5.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.036 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 p -118.66 146.31 44.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.874 0.369 . . . . 0.0 110.447 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.551 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 2.3 t-20 -105.88 25.87 10.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 25.2 t-20 71.36 -56.18 0.64 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.833 -174.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.7 -39.04 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.099 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.24 -156.51 12.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.109 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 84.2 mt -84.82 134.77 34.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.959 0.409 . . . . 0.0 111.125 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 7.6 m -147.92 168.74 21.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.593 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . . . -144.08 163.85 32.36 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.739 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.38 179.5 6.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.378 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.63 41.28 31.22 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 124.124 0.89 . . . . 0.0 110.508 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG11 ' HD2' ' A' ' 48' ' ' PHE . 22.0 t -76.77 107.61 8.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.301 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -109.05 127.73 54.36 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.965 175.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 36' ' ' ASN . 82.3 t -65.78 149.95 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.695 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.51 86.02 1.29 Allowed Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 88.1 Cg_endo . . . . . 0 N--CA 1.447 -1.233 0 C-N-CA 122.806 2.337 . . . . 0.0 112.58 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.15 157.86 20.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.491 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -96.97 147.53 23.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.922 0.391 . . . . 0.0 110.054 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.686 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.86 165.49 28.05 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.762 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 m -120.37 135.0 55.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.089 0.471 . . . . 0.0 109.843 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.93 HD13 HG23 ' A' ' 40' ' ' ILE . 51.0 mt -76.58 117.24 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.585 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -101.47 -46.57 4.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 110.93 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -124.14 123.13 39.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -132.06 116.06 16.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.038 0.447 . . . . 0.0 110.695 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.483 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 81.1 m-85 -105.19 90.35 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.5 -38.97 82.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.722 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.99 -25.71 56.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.263 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HB2' ' CB ' ' A' ' 11' ' ' PHE . 41.0 mmtm -83.73 -38.2 21.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.39 45.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.921 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 54.8 p90 -144.13 176.61 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.809 0.337 . . . . 0.0 110.849 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.78 -168.41 29.87 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.297 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -138.29 130.65 28.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.784 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.1 mt -122.54 130.65 74.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 21' ' ' ASP . 13.3 tmtt? -104.58 118.09 35.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.686 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.6 p-10 -86.57 -178.78 6.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.943 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -93.39 -2.29 54.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.011 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -112.08 -54.06 2.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.819 0.343 . . . . 0.0 111.106 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.09 -99.16 2.07 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.194 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -158.85 -159.2 0.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.54 129.93 37.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.256 0.55 . . . . 0.0 110.621 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.585 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 69.1 mtt180 -108.32 151.6 25.76 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -77.95 124.42 27.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.063 0.459 . . . . 0.0 110.251 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 49.4 m-85 -120.51 148.0 44.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.496 0.665 . . . . 0.0 110.246 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -148.83 143.72 26.49 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.785 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG21 ' CB ' ' A' ' 37' ' ' PRO . 11.1 p -49.09 -25.52 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.715 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.6 tt -65.35 -33.61 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.715 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -106.7 -1.1 23.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.875 HG11 HD12 ' A' ' 40' ' ' ILE . 46.4 t -99.25 126.29 52.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.41 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.81 74.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.554 HD21 ' HB ' ' A' ' 64' ' ' VAL . 37.1 m-20 -118.36 76.4 12.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.977 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' CB ' HG21 ' A' ' 31' ' ' VAL . 63.0 Cg_endo -75.77 -24.07 11.99 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.109 1.872 . . . . 0.0 112.439 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.92 -13.64 57.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.394 0.616 . . . . 0.0 110.594 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -103.13 3.91 36.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.739 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.93 HG23 HD13 ' A' ' 7' ' ' ILE . 62.9 mt -72.47 115.88 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.4 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 30.8 mmtp -120.3 154.06 35.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.619 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -71.2 132.31 44.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.31 24.23 7.44 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.793 0.683 . . . . 0.0 111.647 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -95.67 157.98 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.969 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.85 139.7 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 111.09 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 64' ' ' VAL . 15.4 m -137.6 166.5 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.187 0.518 . . . . 0.0 110.967 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.1 p -131.5 134.99 46.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.634 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 10.2 p90 -156.31 164.75 37.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.982 0.42 . . . . 0.0 111.475 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.65 144.09 29.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.631 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 147.23 32.35 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.763 2.309 . . . . 0.0 113.918 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 60' ' ' TYR . 15.1 t -154.21 139.83 17.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.736 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 p -89.13 126.79 35.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.236 0.541 . . . . 0.0 111.528 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.432 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 14.2 t-20 -86.91 167.65 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.947 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.42 -34.54 61.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.556 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -99.96 -57.48 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.357 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.69 -148.22 4.8 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.488 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.73 140.87 30.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.007 0.432 . . . . 0.0 111.112 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -149.14 168.98 21.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.61 152.17 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 52.9 p90 -124.67 172.96 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.532 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.554 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . 45.81 52.12 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 124.347 1.029 . . . . 0.0 110.828 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.81 111.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.402 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -97.19 119.06 34.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.723 ' HA ' HG11 ' A' ' 46' ' ' VAL . 95.7 t -70.63 148.21 10.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.68 89.52 2.3 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 123.304 0.378 . . . . 0.0 110.936 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.512 0 C-N-CA 122.316 2.01 . . . . 0.0 111.908 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.445 ' HB1' ' OE2' ' A' ' 49' ' ' GLU . . . . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -112.37 169.76 8.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.973 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.67 152.45 20.48 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.925 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 m -100.13 135.83 40.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.033 0.444 . . . . 0.0 110.705 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 40' ' ' ILE . 55.2 mt -82.47 116.41 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.781 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -103.53 -51.35 3.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 30.2 m -119.52 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 58.9 t-105 -150.74 122.18 7.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 0.0 110.904 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -130.48 87.42 2.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.611 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.35 -37.82 78.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.21 -35.03 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.842 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HE2' ' HE1' ' A' ' 16' ' ' PHE . 54.0 mtpt -90.16 -14.48 33.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.627 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.01 -4.19 62.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.199 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' HIS . 53.5 p90 -132.75 173.58 11.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.643 0.721 . . . . 0.0 111.996 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -165.28 177.82 40.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.229 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 94.0 m-85 -139.07 130.18 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.758 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 85.4 mt -136.94 135.1 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.653 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.4 tmtp? -112.53 117.65 32.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.855 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.6 p-10 -97.84 174.96 6.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -94.89 2.01 55.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.35 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.603 ' HB2' ' HG2' ' A' ' 3' ' ' MET . 7.2 t30 -105.88 -50.29 3.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.59 -87.99 2.03 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.359 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -171.24 -164.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 50.6 t-20 -82.23 122.69 28.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 43.8 mtt-85 -112.22 153.89 26.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.794 0.33 . . . . 0.0 111.041 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -80.12 121.34 25.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.758 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.1 m-85 -110.13 159.57 17.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.599 ' HD1' HG22 ' A' ' 32' ' ' ILE . 10.7 t-80 -148.54 147.03 28.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.14 -10.47 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 111.407 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.599 HG22 ' HD1' ' A' ' 30' ' ' HIS . 8.9 tt -82.84 -19.49 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.565 0.698 . . . . 0.0 110.462 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -103.14 -3.49 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.657 -173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.799 HG12 HD12 ' A' ' 40' ' ' ILE . 25.6 t -104.71 139.4 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.84 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.71 -31.34 19.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.318 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.765 HD21 HD11 ' A' ' 39' ' ' LEU . 21.7 p-10 -132.69 77.51 69.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.393 0.616 . . . . 0.0 110.65 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.2 -19.0 13.87 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.863 2.376 . . . . 0.0 113.817 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.31 -0.83 57.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.995 0.426 . . . . 0.0 111.053 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.765 HD11 HD21 ' A' ' 36' ' ' ASN . 69.6 mt -102.85 0.59 32.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.657 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.799 HD12 HG12 ' A' ' 34' ' ' VAL . 58.0 mt -80.96 109.11 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.805 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -117.67 155.62 29.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.3 tmtt? -74.42 141.51 45.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 59.3 m-20 75.48 19.82 2.05 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.522 0.729 . . . . 0.0 111.442 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -103.25 165.88 10.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.235 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.45 137.61 45.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.284 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 64' ' ' VAL . 18.3 m -128.35 164.27 30.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.104 0.478 . . . . 0.0 111.484 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 p -124.36 136.86 54.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.593 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.653 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 14.4 p90 -156.2 170.08 23.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.122 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.445 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 23.8 mm-40 -93.28 140.58 23.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -84.0 135.39 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.221 2.614 . . . . 0.0 113.1 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.589 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 11.9 t -151.48 -174.45 4.84 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.543 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -126.37 -177.9 4.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.228 0.537 . . . . 0.0 110.79 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.601 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 7.7 t-20 -145.89 -170.99 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.8 -27.2 26.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.006 0.432 . . . . 0.0 109.963 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -108.38 1.74 21.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.067 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.8 31.83 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.482 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.4 mt -87.52 159.02 18.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.189 0.495 . . . . 0.0 110.518 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.601 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.5 m -147.69 169.01 20.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.205 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.19 151.01 47.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 26.9 p90 -133.0 170.66 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.399 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.73 47.8 23.89 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.152 0.907 . . . . 0.0 110.175 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.18 120.59 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.104 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -123.0 127.35 48.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.271 174.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.843 ' HA ' HG12 ' A' ' 46' ' ' VAL . 19.2 t -67.24 154.55 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.123 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.79 84.12 5.15 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 121.07 0.462 . . . . 0.0 111.29 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 58.2 Cg_endo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 123.35 2.7 . . . . 0.0 112.213 172.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.6 mtm -111.13 167.54 10.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.208 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -112.97 152.38 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.38 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.76 172.92 30.42 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.826 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -117.6 136.35 53.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 0.0 110.242 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.712 HD12 HG23 ' A' ' 40' ' ' ILE . 46.8 mt -79.88 114.45 20.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.664 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 p -102.76 -43.3 5.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.179 0.514 . . . . 0.0 110.795 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.7 m -127.21 126.01 42.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.252 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -145.22 128.1 16.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.668 0.27 . . . . 0.0 111.039 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.61 98.16 5.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.3 176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.69 -37.31 86.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.95 -42.6 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.364 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 50.7 tptt -95.7 -49.82 5.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.618 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.47 13.48 12.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.952 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 74.6 m-85 -125.69 164.36 20.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.675 0.274 . . . . 0.0 110.328 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.35 170.47 41.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.86 129.04 37.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.698 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.1 mt -128.53 130.3 69.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.367 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -89.36 123.04 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.4 p30 -91.08 175.26 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.486 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -96.48 24.98 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.53 -48.88 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.514 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.18 -71.09 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.401 -0.905 . . . . 0.0 113.986 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.38 -154.3 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.027 0.414 . . . . 0.0 110.071 -170.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -88.03 152.93 21.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 53.1 mtt-85 -124.69 147.41 48.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -86.96 113.83 23.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.93 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.698 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 34.7 m-85 -105.48 150.13 25.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.657 0.741 . . . . 0.0 111.956 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG21 ' A' ' 32' ' ' ILE . 2.7 t-80 -128.45 130.61 47.83 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.084 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 37' ' ' PRO . 11.1 p -47.29 -31.95 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.491 HG21 ' ND1' ' A' ' 30' ' ' HIS . 13.5 tt -75.32 -21.41 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.58 -174.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.39 1.2 57.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.117 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 21.9 t -96.67 143.12 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.28 -42.81 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.368 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -127.69 75.67 77.69 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.189 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 91.8 Cg_endo -81.17 -17.29 9.29 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.959 2.439 . . . . 0.0 113.865 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -89.92 -8.76 51.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.474 0.654 . . . . 0.0 109.871 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.1 1.29 52.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.625 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.712 HG23 HD12 ' A' ' 7' ' ' ILE . 51.1 mt -68.38 127.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.919 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.636 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 7.8 mtpm? -121.06 157.72 29.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.559 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -80.94 139.65 35.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.67 56.52 1.54 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.809 0.814 . . . . 0.0 109.276 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.6 36.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.18 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.96 140.12 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -134.88 162.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -127.5 139.84 52.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 9.7 p90 -156.47 170.63 21.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.414 . . . . 0.0 111.917 -172.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 62.5 mm-40 -85.4 142.56 37.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 5.5 Cg_exo -78.93 133.96 11.53 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.505 2.136 . . . . 0.0 111.287 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.58 HG21 ' CE2' ' A' ' 60' ' ' TYR . 9.5 t -165.94 152.09 9.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -129.56 145.97 51.42 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.03 -69.85 0.78 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -175.33 -54.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.362 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.79 17.69 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.703 -175.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.49 171.76 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.333 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.84 155.93 37.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -148.03 169.14 20.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.803 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -148.92 143.14 26.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.468 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.58 ' CE2' HG21 ' A' ' 51' ' ' THR . 22.8 m-85 -122.07 168.49 11.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.98 37.97 26.76 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.626 0.579 . . . . 0.0 110.79 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.514 ' HB ' HG13 ' A' ' 34' ' ' VAL . 18.4 t -67.86 114.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.158 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -115.95 117.85 31.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.587 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG11 ' A' ' 46' ' ' VAL . 20.9 t -79.98 146.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.487 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -111.56 86.24 6.69 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.2 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 C-N-CA 123.079 2.519 . . . . 0.0 111.852 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.28 153.81 17.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.1 p-10 -107.88 139.92 41.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 110.759 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.31 166.4 23.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.442 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 p -109.67 137.8 46.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.039 0.447 . . . . 0.0 111.315 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.459 HD12 HG12 ' A' ' 19' ' ' ILE . 21.5 mm -63.83 115.87 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.474 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.437 ' O ' ' HE3' ' A' ' 42' ' ' LYS . 29.3 p -110.59 -47.13 3.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.123 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -122.5 125.76 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.98 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -156.04 133.27 10.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.708 0.289 . . . . 0.0 110.578 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.627 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 86.4 m-85 -123.47 115.68 21.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.29 -51.87 61.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.966 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.43 -8.36 59.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 111.268 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 11' ' ' PHE . 70.2 mmtt -85.73 -39.88 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.863 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.13 9.21 65.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.045 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 41.1 p90 -135.47 169.13 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.043 0.422 . . . . 0.0 110.732 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.17 -170.93 41.73 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.112 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -136.58 134.91 37.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.621 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 90.8 mt -126.68 129.75 71.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.276 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -92.27 117.58 30.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.627 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 4.9 p-10 -102.43 -173.37 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 111.797 -173.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 40.9 mt-10 -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.073 -174.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -70.0 -25.62 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.981 0.419 . . . . 0.0 110.23 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.59 -18.49 9.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.568 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 -163.13 0.86 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.38 0.59 . . . . 0.0 110.13 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -121.62 147.91 45.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' CZ ' HD12 ' A' ' 57' ' ' LEU . 8.2 mpt_? -111.52 146.89 36.5 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.202 170.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -85.68 120.83 27.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 53.9 m-85 -109.87 154.85 22.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.414 0.626 . . . . 0.0 111.672 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -144.8 134.86 23.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.093 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.39 -27.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -64.68 -25.72 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.606 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.5 mmtt -101.52 11.64 38.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.161 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.714 HG13 HD13 ' A' ' 40' ' ' ILE . 61.1 t -97.95 127.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.077 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.82 -30.53 32.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.558 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.646 HD21 HD13 ' A' ' 39' ' ' LEU . 13.8 p-10 -142.06 81.4 14.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.177 0.513 . . . . 0.0 111.602 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.1 -19.04 23.31 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.739 2.293 . . . . 0.0 112.948 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.55 -23.31 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.352 0.596 . . . . 0.0 110.617 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.646 HD13 HD21 ' A' ' 36' ' ' ASN . 81.2 mt -101.89 9.68 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.091 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.714 HD13 HG13 ' A' ' 34' ' ' VAL . 51.2 mt -81.41 118.49 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.86 159.7 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 8' ' ' THR . 85.0 tttt -78.16 146.12 35.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 t70 72.42 3.76 4.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.56 156.32 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.222 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.78 139.15 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.571 HG23 HD11 ' A' ' 19' ' ' ILE . 32.9 m -128.53 148.6 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.224 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -110.86 134.6 52.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.012 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.627 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.6 p90 -147.79 167.45 24.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.956 0.408 . . . . 0.0 111.609 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 54.2 mm-40 -92.36 142.51 26.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.613 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -82.95 133.92 6.9 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.783 2.322 . . . . 0.0 112.301 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.3 t -152.96 161.38 42.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -101.64 147.61 26.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.291 0.567 . . . . 0.0 111.205 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -113.95 156.88 23.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.729 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -55.35 -33.72 63.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 111.461 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -101.8 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.596 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.0 -135.95 2.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.115 -172.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.439 HD12 ' CZ ' ' A' ' 27' ' ' ARG . 91.7 mt -102.59 151.33 22.46 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.696 0.284 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -145.55 167.49 22.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 111.003 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -140.93 148.89 41.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.553 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -117.84 170.97 8.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.206 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 46.95 53.72 10.13 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.095 0.872 . . . . 0.0 111.37 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 36.5 t -70.95 100.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.1 0.476 . . . . 0.0 110.234 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -118.24 117.09 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.119 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.579 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 21.8 t -69.66 151.58 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.819 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.7 t -103.34 88.26 1.61 Allowed Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.1 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 123.329 2.686 . . . . 0.0 113.215 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -97.74 157.12 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.0 111.163 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.65 130.37 42.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.234 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.95 171.89 23.92 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.077 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -132.77 139.66 47.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.1 mt -76.85 106.01 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.079 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -95.69 -61.45 1.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.986 0.422 . . . . 0.0 110.603 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -98.76 118.22 35.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.337 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -140.68 127.36 20.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.878 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -116.87 89.77 3.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.352 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.1 -34.32 77.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.641 0.734 . . . . 0.0 110.092 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.39 -21.74 64.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.511 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.887 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.89 -45.7 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.225 -0.297 . . . . 0.0 111.302 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.29 1.3 20.39 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.555 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.553 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 56.0 p90 -140.4 175.57 9.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.09 0.445 . . . . 0.0 110.889 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.98 -161.32 26.41 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.115 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -137.37 129.72 29.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.092 0.473 . . . . 0.0 109.792 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.72 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.0 mt -116.66 131.07 70.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 13.9 tttp -106.07 130.67 53.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.83 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.9 p30 -92.76 175.92 6.63 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.74 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -100.76 16.97 23.25 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.535 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -114.84 -43.91 3.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.045 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.11 -80.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.09 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 11.8 t70 -161.23 -160.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 3.6 p-10 -99.24 154.21 18.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.616 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.35 163.64 20.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -178.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.76 128.7 34.27 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.72 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 58.5 m-85 -127.43 157.24 40.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.333 0.587 . . . . 0.0 111.193 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.78 ' HD1' HG23 ' A' ' 32' ' ' ILE . 54.7 t-80 -148.25 150.03 32.95 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.98 27.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.523 0.678 . . . . 0.0 112.793 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.78 HG23 ' HD1' ' A' ' 30' ' ' HIS . 15.8 tt -118.35 -32.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.514 -0.741 . . . . 0.0 110.902 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 32' ' ' ILE . 34.5 mmtp -95.21 5.27 52.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 110.902 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 36' ' ' ASN . 45.3 t -94.14 129.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.388 176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 -15.46 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.551 ' HB2' HG22 ' A' ' 64' ' ' VAL . 5.4 m-20 -122.08 65.66 21.35 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.981 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.3 -11.93 20.94 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.057 1.838 . . . . 0.0 111.772 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -84.57 -17.89 37.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.22 12.47 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.674 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.8 mt -75.19 134.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -161.18 170.62 19.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.168 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.613 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 8.3 tmtm? -74.69 137.88 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.758 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.613 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 7.5 t70 69.98 13.15 7.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.367 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.76 143.81 35.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.301 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 138.68 32.51 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 64' ' ' VAL . 20.5 m -138.4 163.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.23 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -128.02 134.23 49.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.215 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.71 172.36 16.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.31 141.73 24.99 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.74 160.27 6.27 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.815 2.343 . . . . 0.0 113.833 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.799 ' HB ' ' HE2' ' A' ' 60' ' ' TYR . 14.5 t -164.64 -179.46 5.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.747 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.419 ' C ' HD21 ' A' ' 53' ' ' ASN . 3.4 m -134.62 148.29 50.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.114 0.483 . . . . 0.0 110.052 175.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.419 HD21 ' C ' ' A' ' 52' ' ' THR . 0.9 OUTLIER -123.49 -179.91 4.51 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -72.25 -28.06 62.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.285 0.565 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 52.1 mmtt -74.39 -42.81 58.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.338 175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.88 -153.56 23.59 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.597 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.576 HD11 HH12 ' A' ' 27' ' ' ARG . 68.7 mt -73.54 134.49 43.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 5.5 m -143.65 167.87 21.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.944 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.56 160.9 40.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.942 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.799 ' HE2' ' HB ' ' A' ' 51' ' ' THR . 29.0 p90 -141.1 175.31 9.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.44 48.78 21.89 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.07 0.856 . . . . 0.0 110.706 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.444 ' HB ' HG11 ' A' ' 34' ' ' VAL . 14.5 t -83.6 111.84 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.317 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.14 126.76 51.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.827 0.346 . . . . 0.0 110.097 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.731 ' HA ' HG11 ' A' ' 46' ' ' VAL . 81.7 t -70.26 144.26 13.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.257 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -110.64 85.28 4.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.736 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 9.9 Cg_endo . . . . . 0 N--CA 1.451 -1.007 0 C-N-CA 123.069 2.513 . . . . 0.0 111.705 174.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ttm -147.94 165.94 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.371 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.53 146.68 46.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.349 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.27 162.28 27.22 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.22 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.42 ' C ' HG22 ' A' ' 19' ' ' ILE . 9.0 m -114.1 134.78 54.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 40' ' ' ILE . 55.6 mt -73.81 121.14 24.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.704 -174.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -117.17 -56.1 2.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -117.65 122.73 44.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.042 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -140.79 114.37 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.944 0.402 . . . . 0.0 110.454 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 87.8 m-85 -89.61 83.18 6.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.844 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.54 -42.34 95.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.553 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -84.9 -47.8 9.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.343 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.91 8.91 8.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.314 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -138.35 172.51 12.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.316 0.558 . . . . 0.0 110.648 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.02 -171.22 38.21 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -137.37 129.35 29.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.763 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 66.1 mt -123.84 132.13 71.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.04 117.16 20.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.422 . . . . 0.0 110.617 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.655 ' HB3' ' H ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -77.05 -168.52 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.93 0.871 . . . . 0.0 111.732 -174.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.59 -15.78 53.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.755 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.655 ' H ' ' HB3' ' A' ' 21' ' ' ASP . 46.9 m-80 -76.67 -14.63 59.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.644 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.44 -31.82 7.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.201 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.9 -175.55 2.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -109.46 147.94 32.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -171.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 49.3 mtt-85 -97.91 160.47 14.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.476 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.66 106.13 16.72 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 35.3 m-85 -96.97 154.94 17.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.282 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.754 ' HD1' HG21 ' A' ' 32' ' ' ILE . 25.4 t-80 -149.12 133.48 17.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.561 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.68 -36.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.754 HG21 ' HD1' ' A' ' 30' ' ' HIS . 17.6 tt -61.26 -26.72 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.153 0.502 . . . . 0.0 111.939 -175.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.5 mmtt -104.88 9.16 34.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.384 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 HD13 ' A' ' 40' ' ' ILE . 39.3 t -106.61 127.63 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.89 70.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.184 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -134.71 71.95 69.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.056 0.455 . . . . 0.0 111.427 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.39 -20.39 27.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.578 2.185 . . . . 0.0 112.657 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -80.88 -16.23 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.618 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.69 3.82 53.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.05 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.904 HG23 HD13 ' A' ' 7' ' ' ILE . 52.9 mt -73.9 110.07 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.381 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -117.64 -176.81 3.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.243 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -87.81 147.75 25.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.564 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.99 9.39 6.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.92 0.763 . . . . 0.0 111.104 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HB2' HD11 ' A' ' 7' ' ' ILE . . . -90.3 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.48 151.88 20.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.342 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.2 m -129.94 164.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.433 0.635 . . . . 0.0 111.461 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -127.11 134.9 50.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.887 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.52 174.72 14.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.357 . . . . 0.0 111.667 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.82 142.01 23.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.257 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -86.81 138.88 5.31 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 167.79 27.8 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 131.86 41.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.22 24.14 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.51 -43.57 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.894 0.878 . . . . 0.0 111.811 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.92 -32.56 73.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.699 0.285 . . . . 0.0 110.777 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.74 -176.54 44.06 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.283 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.1 mt -79.09 138.16 37.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 2.0 p -151.13 169.05 22.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.122 0.487 . . . . 0.0 111.305 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 27' ' ' ARG . . . -143.35 148.41 36.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -131.79 175.11 9.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.76 32.63 22.4 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 124.016 0.822 . . . . 0.0 109.861 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.77 114.98 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.325 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -116.47 119.97 37.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.683 ' HA ' HG12 ' A' ' 46' ' ' VAL . 43.0 t -72.73 151.14 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.749 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.57 87.52 1.79 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.807 0.337 . . . . 0.0 110.235 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.3 Cg_endo . . . . . 0 N--CA 1.457 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 111.726 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.278 0.561 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' THR . 35.0 ttm -115.44 167.89 10.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.8 p-10 -127.93 141.18 51.61 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.056 0.455 . . . . 0.0 111.156 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -144.98 177.77 23.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.394 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 19' ' ' ILE . 6.6 m -122.92 135.27 54.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.8 0.333 . . . . 0.0 110.107 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.954 HD12 HG21 ' A' ' 40' ' ' ILE . 56.4 mt -74.28 122.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -114.27 -58.14 2.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 17.3 m -114.88 129.72 56.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.082 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.452 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 76.5 t-105 -152.89 130.14 11.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.42 97.47 5.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.87 -42.54 98.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.424 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.02 -43.64 70.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.764 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 16' ' ' PHE . 8.2 mmpt? -66.79 -39.77 87.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.82 -3.94 57.55 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.079 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.572 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 64.9 m-85 -95.48 156.81 16.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.421 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -163.51 157.31 29.45 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.0 m-85 -136.23 126.66 26.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.752 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 80.6 mt -134.07 133.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -102.95 129.02 49.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.704 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.5 p-10 -89.68 179.26 6.06 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.517 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.67 -8.53 58.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.75 -43.76 5.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.65 -98.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.103 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.2 -178.99 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.612 -0.346 . . . . 0.0 110.249 -164.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.91 122.87 20.74 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.322 0.582 . . . . 0.0 110.544 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -108.4 151.65 25.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.8 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -77.88 122.29 25.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.375 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.752 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 17.2 m-85 -112.55 153.21 27.86 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.318 0.58 . . . . 0.0 110.283 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.522 ' ND1' HG23 ' A' ' 32' ' ' ILE . 3.7 t-80 -133.92 131.04 38.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.843 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 14.7 p -49.7 -26.72 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.522 HG23 ' ND1' ' A' ' 30' ' ' HIS . 12.3 tt -79.16 -20.37 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.459 0.647 . . . . 0.0 111.377 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 32' ' ' ILE . 66.2 mmtt -102.69 10.77 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.013 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.72 HG11 HD13 ' A' ' 40' ' ' ILE . 34.6 t -101.66 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.643 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.11 -33.82 72.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.542 HD21 HD11 ' A' ' 39' ' ' LEU . 12.6 p-10 -141.75 74.63 22.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.076 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 40' ' ' ILE . 70.5 Cg_endo -75.02 -16.98 19.87 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.787 2.325 . . . . 0.0 112.983 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.28 -22.61 57.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.298 0.57 . . . . 0.0 110.434 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.542 HD11 HD21 ' A' ' 36' ' ' ASN . 92.3 mt -97.93 5.17 49.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.439 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.954 HG21 HD12 ' A' ' 7' ' ' ILE . 33.0 mt -73.02 120.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.089 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -135.75 164.89 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.472 173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.608 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 2.4 tmtp? -68.98 142.53 54.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.608 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 30.6 t70 75.72 4.63 3.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.901 0.75 . . . . 0.0 111.38 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.646 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -81.38 147.29 29.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.14 -0.35 . . . . 0.0 110.233 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 140.67 29.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.614 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.6 m -132.28 151.15 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 3' ' ' MET . 11.5 p -118.91 135.23 54.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.804 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.4 p90 -154.1 173.18 16.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 0.0 111.76 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -99.83 142.89 25.45 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.635 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.29 143.99 12.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.468 2.112 . . . . 0.0 112.691 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 60' ' ' TYR . 11.6 t -165.12 176.46 8.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.292 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -113.35 143.75 43.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.146 0.498 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -100.89 16.7 24.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.753 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 73.59 -47.19 0.65 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -107.3 26.14 10.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.863 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.15 -171.21 34.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.951 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 145.78 25.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -148.03 169.98 18.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.811 0.339 . . . . 0.0 111.037 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.77 149.73 52.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.96 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' A' ' 51' ' ' THR . 27.6 m-85 -114.37 172.37 7.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.96 41.27 26.91 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.973 0.795 . . . . 0.0 111.79 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 20.8 t -68.15 103.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.103 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -107.12 117.29 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.931 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.612 HG21 HG12 ' A' ' 40' ' ' ILE . 22.3 t -87.67 140.17 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -176.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.23 88.44 2.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.108 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.573 -175.41 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.836 0.35 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.5 ' HE3' ' HB2' ' A' ' 22' ' ' GLU . 77.2 mtp -113.21 158.26 20.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 4.4 p-10 -106.11 140.47 39.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.232 0.539 . . . . 0.0 111.181 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.58 170.43 23.93 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.35 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -117.94 134.97 54.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.14 0.495 . . . . 0.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.82 HD11 HG21 ' A' ' 40' ' ' ILE . 48.2 mt -77.79 120.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.391 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -107.74 -52.11 2.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 m -121.36 127.72 51.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.455 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -138.67 117.61 12.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.763 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 93.4 m-85 -90.76 88.37 7.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.3 -33.05 74.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.123 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.17 -31.66 72.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.79 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.763 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -92.46 -60.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.029 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.64 14.16 3.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.668 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.27 172.55 12.52 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.527 -0.396 . . . . 0.0 110.197 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.19 -163.27 24.91 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.505 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.547 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 85.2 m-85 -141.4 132.84 26.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.753 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 74.4 mt -130.87 139.43 51.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.301 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -100.1 118.71 37.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.522 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 6.8 p-10 -102.22 -171.9 2.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.318 0.58 . . . . 0.0 111.288 -176.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HB2' ' HE3' ' A' ' 3' ' ' MET . 44.8 mt-10 -66.28 -23.34 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.449 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -70.53 -13.34 62.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.855 0.359 . . . . 0.0 110.992 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.97 24.75 40.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.787 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -127.3 -177.47 4.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 18' ' ' PHE . 28.3 t-20 -127.54 120.67 28.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 51.0 mtt-85 -105.17 153.43 21.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.205 -172.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -80.44 115.97 20.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.739 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.753 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 23.9 m-85 -107.42 152.92 23.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.457 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.2 t-160 -150.47 138.45 20.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.231 -175.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.71 -31.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.572 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.1 tt -63.42 -27.63 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.051 0.453 . . . . 0.0 111.943 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.3 mmtt -102.28 7.25 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.502 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.685 HG11 HD12 ' A' ' 40' ' ' ILE . 21.8 t -106.66 130.45 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.774 0.321 . . . . 0.0 110.198 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.07 -35.17 59.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -137.99 70.57 49.42 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.399 0.619 . . . . 0.0 111.026 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HA ' HG13 ' A' ' 40' ' ' ILE . 73.0 Cg_endo -74.16 -10.71 22.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.003 2.469 . . . . 0.0 112.236 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.37 -25.04 63.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.31 8.61 40.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.016 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.82 HG21 HD11 ' A' ' 7' ' ' ILE . 43.8 mt -75.72 124.0 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.228 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.549 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 15.3 ptpt -144.63 163.74 33.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.158 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 1.4 tmtp? -72.73 140.56 47.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.524 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 35.1 t70 75.1 18.79 2.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.859 0.725 . . . . 0.0 110.89 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -100.93 149.38 23.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.23 137.5 32.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.237 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.986 HG11 ' HA ' ' A' ' 64' ' ' VAL . 15.9 m -132.6 147.59 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.874 0.369 . . . . 0.0 111.097 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.5 p -111.28 135.26 52.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.738 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 6.3 p90 -156.18 172.66 18.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 29.6 mm-40 -96.72 141.86 23.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_endo -89.02 136.38 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.847 2.365 . . . . 0.0 112.164 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.522 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 14.2 t -153.06 -177.0 6.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.036 0.446 . . . . 0.0 110.133 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -128.21 142.34 51.2 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.546 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 8.8 t-20 -105.8 170.05 8.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.54 -33.41 73.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.853 0.358 . . . . 0.0 110.732 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -119.56 26.76 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.82 176.17 22.71 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.687 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 57' ' ' LEU . 4.0 mp -79.28 143.7 35.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.834 0.317 . . . . 0.0 110.171 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p -151.76 170.22 20.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.222 0.534 . . . . 0.0 111.386 -172.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -136.7 148.51 47.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.162 175.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.522 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 29.6 p90 -130.3 177.38 7.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.71 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.1 35.5 26.4 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.004 0.815 . . . . 0.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . 26.1 t -67.46 112.24 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.356 -174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.57 117.22 30.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.504 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.986 ' HA ' HG11 ' A' ' 46' ' ' VAL . 41.7 t -70.67 137.38 24.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.347 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.3 85.71 16.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.659 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 5.9 Cg_exo . . . . . 0 C--N 1.343 0.286 0 C-N-CA 123.276 2.65 . . . . 0.0 111.67 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.716 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 72.5 mtp -105.71 159.22 16.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.185 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.77 142.43 31.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.428 0.633 . . . . 0.0 111.12 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -138.46 167.39 25.02 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.046 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -110.64 137.87 47.76 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.135 0.493 . . . . 0.0 110.734 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 40' ' ' ILE . 58.2 mt -79.19 117.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.714 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.5 p -108.68 -43.55 4.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.25 0.548 . . . . 0.0 111.227 -175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.5 m -136.55 122.14 19.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.766 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.58 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 71.0 t-105 -139.54 130.78 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.623 0.249 . . . . 0.0 110.58 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.54 90.59 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.96 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.58 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.6 tmtt? -67.08 -26.36 66.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.47 -20.72 36.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.081 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -97.07 -44.67 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.578 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.72 -2.82 10.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.511 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 40.0 p90 -148.42 177.89 9.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.568 0.684 . . . . 0.0 111.646 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.15 -164.05 28.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.242 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.93 131.25 42.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.1 mt -130.17 129.94 65.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -103.47 124.33 48.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.476 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 9.4 p-10 -95.34 -175.98 3.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.029 0.442 . . . . 0.0 110.687 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.2 -7.46 51.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.522 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.716 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 5.7 t-20 -95.84 -58.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.682 0.277 . . . . 0.0 111.213 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.69 -92.19 2.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.678 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -164.33 -154.31 0.24 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -72.81 135.79 45.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 109.785 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 42.2 mtt180 -114.34 148.9 36.86 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.666 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -85.16 115.86 23.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.783 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 51.2 m-85 -109.94 161.8 15.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.71 138.52 24.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.63 -28.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -61.68 -26.85 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 111.794 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HG2' HG23 ' A' ' 32' ' ' ILE . 33.9 mmtp -99.93 7.39 44.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.589 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 40' ' ' ILE . 29.0 t -100.8 123.92 54.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.19 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.291 -176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.713 HD21 HD13 ' A' ' 39' ' ' LEU . 12.2 p-10 -134.27 78.25 58.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.359 0.6 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.18 -19.66 13.38 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.966 2.444 . . . . 0.0 114.195 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.54 -2.95 58.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.067 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.713 HD13 HD21 ' A' ' 36' ' ' ASN . 59.8 mt -99.08 -1.71 38.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.145 0.498 . . . . 0.0 109.855 174.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.695 HG21 HD13 ' A' ' 7' ' ' ILE . 52.7 mt -71.74 122.59 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.443 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.32 165.25 17.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.881 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -78.4 148.28 33.73 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.082 0.468 . . . . 0.0 111.613 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 61.52 26.73 16.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.172 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 165.01 11.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.702 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.51 138.83 39.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 111.141 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 64' ' ' VAL . 27.3 m -131.54 152.11 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -110.97 134.73 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.993 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 9.1 p90 -151.95 165.6 34.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.017 0.437 . . . . 0.0 111.469 -175.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.24 141.32 24.9 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -88.66 139.34 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.313 2.675 . . . . 0.0 113.488 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -150.55 173.82 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 151.7 48.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.96 0.41 . . . . 0.0 110.84 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.47 177.31 7.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -74.97 -11.5 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -95.18 -2.83 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.4 -140.41 12.26 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.794 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.31 144.57 27.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.213 0.53 . . . . 0.0 110.71 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -143.61 168.79 19.05 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -149.44 168.05 24.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.697 0.284 . . . . 0.0 111.291 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -148.72 -179.96 7.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.64 41.57 28.23 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.785 0.678 . . . . 0.0 110.521 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.6 t -70.23 101.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.364 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 19.4 ttmm -101.68 114.27 28.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.593 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.721 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.3 t -77.57 134.85 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.903 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.71 86.11 5.43 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 85.2 Cg_endo . . . . . 0 N--CA 1.451 -0.973 0 C-N-CA 123.053 2.502 . . . . 0.0 113.396 -174.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.656 ' HE2' ' HB3' ' A' ' 23' ' ' ASN . 60.7 mtp -115.34 154.18 29.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.549 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -118.08 139.96 50.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -146.5 176.58 25.34 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.869 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -116.6 140.13 49.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.426 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.3 mt -79.14 116.76 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.189 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -108.77 -63.27 1.36 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 m -102.91 129.05 49.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.29 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -147.03 135.01 21.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.759 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.447 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 89.2 m-85 -126.27 113.12 16.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.301 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' C ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -60.86 -64.07 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 -176.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.68 -17.02 61.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.336 -170.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 6.7 mmpt? -81.28 -35.62 30.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.944 173.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.26 15.16 62.84 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.266 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 43.9 p90 -145.34 175.39 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.478 -0.425 . . . . 0.0 110.605 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.63 -167.96 34.05 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.571 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.76 125.37 28.38 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.731 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.2 mt -120.85 129.2 75.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.865 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -107.45 126.49 52.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.216 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.621 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 5.0 p-10 -96.05 175.45 6.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.791 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -103.3 13.82 32.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.656 ' HB3' ' HE2' ' A' ' 3' ' ' MET . 8.2 t30 -107.09 -47.51 3.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.453 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.35 -83.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.34 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -169.15 -164.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -82.83 131.29 35.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -124.64 150.37 46.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 111.237 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -78.48 127.1 31.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.547 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.7 m-85 -120.62 156.56 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.656 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.637 ' ND1' HG21 ' A' ' 32' ' ' ILE . 11.4 t-80 -141.39 141.22 33.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.08 -31.26 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.637 HG21 ' ND1' ' A' ' 30' ' ' HIS . 18.2 tt -70.98 -21.26 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.672 0.749 . . . . 0.0 110.631 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.7 -11.52 59.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.058 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.846 HG12 HD12 ' A' ' 40' ' ' ILE . 23.3 t -91.11 138.44 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.31 -36.13 22.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.619 HD21 HD12 ' A' ' 39' ' ' LEU . 10.6 p-10 -129.25 85.35 59.71 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.772 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.7 -31.63 5.22 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.742 2.961 . . . . 0.0 112.692 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.93 -25.47 68.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.619 HD12 HD21 ' A' ' 36' ' ' ASN . 87.9 mt -95.77 5.25 51.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.612 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.846 HD12 HG12 ' A' ' 34' ' ' VAL . 36.2 mt -75.66 124.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.141 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 18.0 ptpt -143.68 164.57 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.165 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -78.92 151.42 31.72 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.27 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 71.68 4.04 4.89 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.432 1.083 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -85.09 158.45 20.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.757 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.17 136.0 39.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 64' ' ' VAL . 29.0 m -132.25 156.08 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -117.59 135.16 54.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.097 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.621 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.5 p90 -151.6 177.03 10.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.612 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -121.93 144.7 41.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.0 145.94 32.03 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.993 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -150.09 152.78 35.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -91.01 150.7 21.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.223 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.466 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 4.8 t-20 -127.15 159.18 35.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -70.35 -32.75 70.59 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.902 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 50.7 pttt -101.93 6.43 41.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -154.28 25.25 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.145 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.61 146.45 27.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.808 0.337 . . . . 0.0 110.461 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.9 p -145.07 169.41 18.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.09 0.471 . . . . 0.0 111.581 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HB1' ' CZ ' ' A' ' 29' ' ' PHE . . . -141.95 154.14 44.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.599 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -132.12 -175.93 3.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.21 50.52 18.84 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.005 0.816 . . . . 0.0 111.136 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.681 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -72.86 104.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.949 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -103.62 111.83 24.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.89 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.671 ' HA ' HG12 ' A' ' 46' ' ' VAL . 59.0 t -72.58 142.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.881 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -105.13 88.42 2.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.1 Cg_exo . . . . . 0 N--CA 1.458 -0.616 0 C-N-CA 122.363 2.042 . . . . 0.0 111.069 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.62 150.52 28.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.98 158.2 16.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.574 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -152.19 172.51 31.44 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 176.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.2 m -122.18 130.88 53.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.864 0.332 . . . . 0.0 110.196 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.838 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.5 mt -67.7 105.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.304 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -95.4 -36.29 11.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.886 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 31.7 m -144.87 136.97 25.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -145.59 126.02 14.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.042 0.448 . . . . 0.0 111.368 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -119.87 95.53 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.84 -41.0 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.96 -37.09 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.081 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.697 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 18.6 tptm -86.26 -30.4 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 92.02 5.59 65.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.542 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.697 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 84.1 m-85 -119.21 162.36 18.81 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.669 -0.313 . . . . 0.0 110.604 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.23 173.12 39.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.223 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.9 m-85 -131.05 131.41 44.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.838 HG12 ' HA ' ' A' ' 7' ' ' ILE . 82.2 mt -136.4 130.56 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.98 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -91.73 139.52 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.6 p-10 -115.87 -164.65 0.97 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.388 0.613 . . . . 0.0 111.88 -171.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -62.97 -32.28 73.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.566 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.25 -33.81 75.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 26.71 9.19 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.099 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -135.15 177.53 7.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' H ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -96.07 139.89 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.106 0.479 . . . . 0.0 110.383 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.518 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 52.9 mtt-85 -118.2 138.99 51.94 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.47 119.54 25.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.556 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.809 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 66.3 m-85 -111.66 160.17 17.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.625 0.726 . . . . 0.0 112.099 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.53 ' ND1' HG23 ' A' ' 32' ' ' ILE . 15.6 t-160 -141.75 142.31 33.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.984 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -48.94 -34.39 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.53 HG23 ' ND1' ' A' ' 30' ' ' HIS . 18.4 tt -62.54 -25.38 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.565 0.697 . . . . 0.0 111.363 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.756 ' HG3' ' HA ' ' A' ' 60' ' ' TYR . 7.6 mptt -77.52 -22.48 51.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.241 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 40' ' ' ILE . 23.9 t -93.8 134.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.606 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.03 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.65 HD21 HD13 ' A' ' 39' ' ' LEU . 14.8 p-10 -127.88 77.04 76.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.095 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 -23.47 18.12 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.9 2.4 . . . . 0.0 113.273 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.1 -29.11 68.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.459 0.647 . . . . 0.0 111.074 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 36' ' ' ASN . 81.3 mt -92.8 4.97 52.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.36 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.699 HG21 HD12 ' A' ' 7' ' ' ILE . 40.0 mt -69.93 110.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.974 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.58 158.09 25.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.986 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 144.71 33.44 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.148 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.43 11.02 8.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.517 0.675 . . . . 0.0 110.551 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.59 154.76 19.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.8 143.37 26.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 64' ' ' VAL . 28.5 m -134.32 164.14 35.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.408 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.25 153.58 45.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -167.77 177.07 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 41.1 mt-10 -110.46 142.78 26.76 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.4 Cg_endo -84.97 142.47 8.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.214 2.609 . . . . 0.0 113.219 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 t -144.86 162.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -104.19 149.46 25.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.943 0.402 . . . . 0.0 110.73 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 6.3 t-20 -139.68 154.79 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -66.95 -31.35 71.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -82.4 -18.09 43.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.85 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.04 -163.26 31.33 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.648 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.05 140.53 47.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.069 0.435 . . . . 0.0 110.407 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.4 p -135.0 167.22 21.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.82 0.343 . . . . 0.0 110.691 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -149.95 159.31 44.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.756 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 43.2 p90 -143.87 -178.61 6.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 123.31 0.381 . . . . 0.0 110.005 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.29 39.4 30.19 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.701 0.626 . . . . 0.0 110.249 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.74 119.03 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.403 -172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.0 127.05 55.43 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.775 ' HA ' HG13 ' A' ' 46' ' ' VAL . 27.9 t -77.87 142.63 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.214 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.7 86.81 3.13 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.397 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 94.2 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 122.726 2.284 . . . . 0.0 112.5 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -118.5 164.21 15.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.136 0.494 . . . . 0.0 111.199 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -115.01 152.76 31.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.468 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.22 -178.5 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.514 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -125.47 136.71 53.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.165 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.814 HD11 HG23 ' A' ' 40' ' ' ILE . 44.0 mt -77.11 115.63 19.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.263 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -104.28 -40.32 6.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.166 0.507 . . . . 0.0 111.431 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 m -136.97 114.77 11.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.451 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.656 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 75.9 t-105 -130.62 136.48 48.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.057 0.455 . . . . 0.0 111.493 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.35 97.12 5.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.656 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.1 tmtp? -67.75 -33.09 74.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 110.005 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.32 -35.7 81.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.034 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.905 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.5 mmpt? -88.9 -30.09 19.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.37 9.58 57.77 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 48.6 p90 -144.39 174.65 10.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.964 0.412 . . . . 0.0 111.026 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.66 -172.63 37.86 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.069 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -134.78 126.84 29.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.725 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 79.3 mt -123.64 131.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.887 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 20' ' ' LYS . 13.7 mmmm -90.57 119.84 31.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.506 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.98 177.42 7.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.491 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -81.2 -5.98 58.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.335 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.34 -35.03 18.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.234 0.54 . . . . 0.0 109.563 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.76 22.65 2.69 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.017 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -108.03 164.09 12.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.397 0.598 . . . . 0.0 110.485 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -116.89 115.62 25.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -111.11 148.66 32.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.712 -172.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -81.52 122.13 27.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.7 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 30.7 m-85 -111.72 154.85 24.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.531 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.635 ' HD1' HG21 ' A' ' 32' ' ' ILE . 17.4 t-80 -141.32 133.12 27.35 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.14 -29.7 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.635 HG21 ' HD1' ' A' ' 30' ' ' HIS . 19.1 tt -67.06 -29.33 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.276 0.56 . . . . 0.0 111.225 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -82.3 -4.32 56.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.204 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 40' ' ' ILE . 22.0 t -95.84 133.31 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.173 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.27 -42.78 22.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -125.43 73.88 68.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' HG13 ' A' ' 40' ' ' ILE . 56.0 Cg_endo -70.65 -15.86 33.79 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.548 2.166 . . . . 0.0 112.262 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.93 -10.63 60.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.603 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 66' ' ' PRO . 95.6 mt -108.22 7.97 27.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.814 HG23 HD11 ' A' ' 7' ' ' ILE . 50.7 mt -78.67 114.75 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.39 0.614 . . . . 0.0 111.63 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 48.9 mtpt -124.29 167.78 13.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.59 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.99 135.25 34.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.49 21.56 2.28 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 0.0 109.795 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 41' ' ' LYS . . . -98.81 146.58 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.413 177.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.62 29.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.197 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 19' ' ' ILE . 23.6 m -136.56 156.0 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.7 p -121.71 135.18 54.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.761 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.59 179.98 7.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.613 0.244 . . . . 0.0 110.924 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.5 pt-20 -125.83 142.88 43.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 171.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_exo -74.41 145.4 33.86 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.059 2.506 . . . . 0.0 113.481 -174.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 58' ' ' SER . 9.0 t -139.17 156.95 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -113.63 127.26 55.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.431 0.634 . . . . 0.0 112.111 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -108.38 161.22 15.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.596 171.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -71.45 -13.43 61.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.099 0.476 . . . . 0.0 110.309 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.78 -19.95 25.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.108 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.08 -162.31 31.27 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.969 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -85.47 138.01 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 111.057 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.549 ' HB2' HG22 ' A' ' 51' ' ' THR . 5.4 m -137.89 169.64 17.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.337 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -139.94 152.78 46.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.731 0.301 . . . . 0.0 110.679 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.474 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 1.6 p90 -139.67 -179.22 5.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.221 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.25 48.31 22.38 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.921 0.763 . . . . 0.0 110.041 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 24.9 t -75.9 112.67 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -113.49 109.89 19.39 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.001 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.654 ' HA ' HG13 ' A' ' 46' ' ' VAL . 56.1 t -66.45 152.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.08 88.7 2.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.558 ' HB3' HD13 ' A' ' 39' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.727 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . 68.9 113.54 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 124.035 0.835 . . . . 0.0 111.459 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -115.92 157.95 23.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.384 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -98.02 130.08 44.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.87 162.88 24.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.34 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -110.14 138.69 46.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.046 0.45 . . . . 0.0 110.134 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.836 HD12 HG22 ' A' ' 40' ' ' ILE . 53.0 mt -79.51 114.81 20.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.206 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -113.08 -55.45 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 111.04 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 m -104.51 124.51 49.4 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -160.06 126.79 4.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.98 102.13 10.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 2.5 tmtp? -73.83 -30.38 62.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.524 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.28 -42.06 94.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 0.0 110.672 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -90.38 -51.57 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 37.43 1.41 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.417 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.554 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 36.9 p90 -148.83 167.08 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.383 0.592 . . . . 0.0 110.819 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.53 -160.27 32.21 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.062 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.91 127.86 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.687 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.4 132.51 66.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.501 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -111.71 130.18 55.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.625 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 13.3 p-10 -91.85 -170.69 2.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.47 -9.0 19.69 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.105 0.478 . . . . 0.0 110.853 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -97.2 -44.85 6.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 -100.19 2.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.356 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -166.81 -160.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.49 135.93 36.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.555 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 63.2 mtt85 -117.75 156.73 27.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.692 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -79.86 117.48 20.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.101 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.687 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.1 m-85 -113.18 156.13 23.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.406 0.622 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.564 ' HD1' HG21 ' A' ' 32' ' ' ILE . 20.0 t-80 -148.89 138.23 21.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.931 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -49.19 -30.93 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.564 HG21 ' HD1' ' A' ' 30' ' ' HIS . 14.8 tt -61.94 -30.04 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 112.011 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.7 mmtt -93.69 10.26 33.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 40' ' ' ILE . 21.7 t -108.73 132.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.751 0.31 . . . . 0.0 110.252 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.91 -23.92 33.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.418 ' HB2' HD13 ' A' ' 39' ' ' LEU . 23.0 p-10 -135.81 71.48 63.78 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 121.634 0.731 . . . . 0.0 110.149 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.42 -21.62 13.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.338 2.692 . . . . 0.0 114.34 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.4 -9.47 59.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.564 0.697 . . . . 0.0 110.107 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.434 HD12 ' HG3' ' A' ' 66' ' ' PRO . 85.0 mt -93.45 -5.87 48.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.822 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.836 HG22 HD12 ' A' ' 7' ' ' ILE . 66.5 mt -71.28 111.42 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.085 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -137.48 157.1 47.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.668 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 14.8 tmtt? -59.95 136.1 57.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.963 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.65 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 26.8 t70 74.97 4.47 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.835 176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.65 156.41 22.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.26 138.26 36.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.0 m -132.42 164.51 34.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.392 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.8 p -127.87 140.56 51.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 12.6 p90 -151.68 162.96 40.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.492 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.557 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 10.6 mm-40 -94.9 142.84 25.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.37 142.93 16.99 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.377 2.051 . . . . 0.0 113.384 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.476 HG21 ' CE2' ' A' ' 60' ' ' TYR . 14.6 t -163.08 177.36 9.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.508 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -115.74 155.13 28.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.05 0.453 . . . . 0.0 111.102 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 14.3 t-20 -132.8 168.49 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.951 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -68.23 -38.75 82.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 15.8 ptpt -91.98 -1.66 57.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.879 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.87 -133.49 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.15 155.82 17.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.1 p -148.04 170.32 18.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.763 0.316 . . . . 0.0 111.016 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -135.4 151.06 50.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.256 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' A' ' 51' ' ' THR . 24.2 m-85 -122.47 170.29 10.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.768 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . . . 48.99 58.43 5.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.974 0.796 . . . . 0.0 110.879 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 34' ' ' VAL . 27.3 t -85.47 120.4 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.765 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 127.13 47.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.223 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.2 t -80.61 151.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.919 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.64 88.31 3.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.36 0.413 . . . . 0.0 110.443 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 39' ' ' LEU . 74.2 Cg_endo -75.31 143.76 28.49 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.216 1.944 . . . . 0.0 111.949 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.0 -7.97 59.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.62 163.32 35.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -125.0 89.59 3.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.028 0.442 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -109.13 144.44 37.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.285 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -77.42 133.86 38.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.092 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -134.57 92.98 2.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.437 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -160.61 137.72 9.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.953 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.76 177.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.56 126.59 33.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.239 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 11.8 ttt -138.98 177.18 8.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' H ' ' HG2' ' A' ' 3' ' ' MET . 4.3 p-10 -106.66 141.93 37.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 112.03 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -135.39 176.74 19.91 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -122.6 139.56 53.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.615 0.708 . . . . 0.0 110.721 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 19' ' ' ILE . 53.0 mt -76.46 107.86 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.285 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -97.88 -43.0 7.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.238 0.542 . . . . 0.0 111.037 -174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 m -132.09 121.9 24.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -139.42 129.83 25.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -107.62 92.35 4.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -59.44 -49.23 78.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.043 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.05 -45.38 90.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.24 -39.65 59.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.762 -174.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.82 6.14 35.16 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.848 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.468 ' HE1' ' HG2' ' A' ' 14' ' ' LYS . 33.1 p90 -130.54 174.84 9.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.722 0.761 . . . . 0.0 110.836 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.39 -170.84 41.75 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.0 124.39 26.2 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.779 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.69 119.02 60.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.831 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 60.2 tttt -107.06 124.17 49.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.508 . . . . 0.0 110.823 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.602 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 p-10 -89.03 -176.18 5.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.884 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -107.73 5.27 26.54 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.214 0.53 . . . . 0.0 111.013 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.28 -49.86 5.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.68 -92.11 1.85 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.329 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -168.68 -168.53 0.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.657 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -74.62 135.84 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.554 0.693 . . . . 0.0 111.689 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -103.43 151.61 22.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.028 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -79.98 117.34 20.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.779 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 56.1 m-85 -111.09 155.64 22.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.631 0.729 . . . . 0.0 111.405 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.466 ' ND1' HG21 ' A' ' 32' ' ' ILE . 14.3 t-80 -139.83 131.77 27.74 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.965 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -46.87 -32.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG21 ' ND1' ' A' ' 30' ' ' HIS . 20.3 tt -62.7 -32.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.49 6.24 31.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 33.6 t -91.79 133.42 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.91 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.25 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.517 HD21 HD13 ' A' ' 39' ' ' LEU . 22.2 p-10 -145.65 72.25 13.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.676 0.75 . . . . 0.0 110.124 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' HG13 ' A' ' 40' ' ' ILE . 92.8 Cg_endo -75.34 -9.69 20.39 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.146 2.564 . . . . 0.0 112.63 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.6 -9.98 59.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD13 HD21 ' A' ' 36' ' ' ASN . 90.4 mt -109.63 2.8 20.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.192 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 37' ' ' PRO . 55.4 mt -65.4 129.36 29.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.018 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 17.2 ptpt -143.33 166.02 25.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.275 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 12.9 tmtt? -80.08 144.9 32.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.674 0.273 . . . . 0.0 110.526 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 29.6 t70 67.27 27.88 8.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.696 0.76 . . . . 0.0 110.441 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -103.72 148.69 25.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.155 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.13 137.68 32.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 64' ' ' VAL . 26.8 m -133.29 155.56 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.405 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.4 p -113.13 133.81 54.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.93 175.7 13.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.85 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.0 mt-10 -115.72 140.81 26.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.789 174.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -82.05 133.94 7.97 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.957 2.438 . . . . 0.0 113.215 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -149.58 -175.18 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.045 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -124.21 146.48 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.118 0.485 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.411 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 15.8 t-20 -101.01 -64.68 1.03 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.724 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -174.02 -65.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.738 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.8 28.43 3.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.222 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.31 173.19 29.64 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.404 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.5 mt -81.13 146.01 30.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.73 0.3 . . . . 0.0 110.367 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.4 m -144.59 168.87 19.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.163 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -144.94 154.63 42.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.574 0.226 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -135.76 179.09 6.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.7 50.53 16.89 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.982 0.801 . . . . 0.0 110.22 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.11 113.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.078 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.23 114.66 28.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.891 ' HA ' HG12 ' A' ' 46' ' ' VAL . 45.9 t -71.13 131.36 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.847 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.04 86.98 4.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 0.0 110.671 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.79 157.85 27.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.435 2.09 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.0 mt -91.61 16.5 10.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.222 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 64.87 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.4 m80 42.86 -99.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.533 0.733 . . . . 0.0 112.587 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.6 m80 61.4 26.21 16.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -71.86 -25.12 61.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -106.81 101.25 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.523 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -114.42 -7.58 12.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.45 0.643 . . . . 0.0 109.335 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.4 p80 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.926 175.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.87 116.61 14.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.984 0.421 . . . . 0.0 110.854 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 mtt -103.28 160.77 14.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.774 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -93.36 151.93 19.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.089 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -150.91 161.27 28.98 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.412 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -111.36 132.45 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.41 . . . . 0.0 110.289 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.829 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.3 mt -67.08 112.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.446 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -101.07 -43.55 5.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 24.3 m -145.99 140.4 26.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.36 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -140.7 122.17 15.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 86.0 m-85 -110.54 88.82 2.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -55.85 -63.14 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.58 -7.48 59.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.114 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 23.7 tptm -85.22 -32.79 22.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' HIS . . . 103.71 -17.76 48.92 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.905 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -109.31 179.06 4.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.261 0.553 . . . . 0.0 111.657 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.55 171.82 44.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.289 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 98.4 m-85 -130.38 128.4 41.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.829 HG12 ' HA ' ' A' ' 7' ' ' ILE . 58.2 mt -133.11 128.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.124 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 21' ' ' ASP . 44.4 tptt -85.18 115.56 23.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.711 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.667 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.5 p-10 -92.61 -171.63 2.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -83.94 -36.84 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.704 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -89.04 -47.9 7.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -171.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.01 -101.69 2.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.08 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 9.7 t70 -163.4 -154.52 0.28 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -168.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.4 ' H ' ' CG ' ' A' ' 25' ' ' ASP . 19.4 m120 -75.24 115.92 15.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.2 0.524 . . . . 0.0 110.101 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 43.7 mtt180 -100.17 152.39 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -80.24 118.56 22.02 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 8.9 m-85 -105.02 158.18 16.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.765 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.558 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.5 t-80 -140.4 126.09 19.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.71 -38.49 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.605 HG23 ' HG2' ' A' ' 33' ' ' LYS . 20.0 tt -59.74 -30.77 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.303 0.573 . . . . 0.0 111.839 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.605 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -96.11 11.74 33.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.349 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.485 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 21.8 t -97.85 127.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.22 61.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.447 . . . . 0.0 111.101 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -133.04 69.65 78.66 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.86 -17.66 32.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.672 2.248 . . . . 0.0 112.756 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.03 -28.88 65.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.257 0.551 . . . . 0.0 110.807 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.456 HD12 ' HG3' ' A' ' 66' ' ' PRO . 90.4 mt -88.56 3.12 51.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.289 -174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.816 HG21 HD13 ' A' ' 7' ' ' ILE . 42.2 mt -74.7 112.77 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.767 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.41 165.71 18.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.237 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -69.99 134.99 48.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.119 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 t70 69.03 16.94 8.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.963 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -84.04 159.94 21.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 175.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.31 139.39 33.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.4 m -131.95 162.8 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.681 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -126.55 134.44 50.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.857 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.667 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 19.0 p90 -149.06 174.6 12.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.813 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 10.0 mm-40 -96.17 142.03 23.98 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -81.86 134.73 8.52 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.221 2.614 . . . . 0.0 112.034 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.544 HG23 ' CE2' ' A' ' 60' ' ' TYR . 13.3 t -158.58 174.07 15.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.0 0.428 . . . . 0.0 110.121 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -140.17 156.32 46.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.09 -73.51 0.64 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.067 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.66 -63.71 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.96 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -79.88 0.0 33.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.143 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.56 47.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.262 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.26 155.04 23.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 m -145.59 168.97 19.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.31 150.85 45.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.795 0.331 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' CE2' HG23 ' A' ' 51' ' ' THR . 29.6 m-85 -126.1 171.27 10.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.897 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . . . 49.99 56.22 8.23 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.988 0.805 . . . . 0.0 110.93 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -73.43 106.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.778 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.09 106.08 16.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.009 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.704 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.2 t -68.83 147.44 12.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.022 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.4 t -109.28 87.12 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.361 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 39' ' ' LEU . 71.1 Cg_endo -79.12 139.48 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.155 1.903 . . . . 0.0 111.813 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.735 ' H ' HD21 ' A' ' 67' ' ' LEU . 2.4 pt? -92.73 -9.49 40.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.349 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.19 122.94 49.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -83.71 -40.33 19.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.991 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -88.06 129.8 35.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -146.08 135.85 23.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.213 0.53 . . . . 0.0 111.691 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -170.54 161.81 7.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -84.61 112.2 20.22 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.8 m80 . . . . . 0 C--O 1.25 1.126 0 O-C-N 123.989 0.806 . . . . 0.0 111.4 177.117 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.73 -178.23 0.22 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.703 0.627 . . . . 0.0 110.531 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.8 mtm -98.73 145.79 26.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.6 p30 -108.22 161.8 14.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.286 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.71 159.72 23.29 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.798 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -108.44 133.62 52.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.783 HD11 HG23 ' A' ' 40' ' ' ILE . 47.0 mt -77.72 126.55 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.906 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -114.77 -53.09 2.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.059 0.457 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -118.44 124.52 47.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.924 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -138.6 125.29 20.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.428 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 89.3 m-85 -98.15 98.13 9.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.856 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -62.45 -36.64 83.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.26 -21.21 62.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 67.5 mmtt -102.42 -48.06 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.891 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.28 15.23 23.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.51 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 52.8 p90 -141.72 173.04 11.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.83 -166.99 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.476 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.8 129.78 30.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.762 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.4 mt -127.25 138.64 54.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.125 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -91.86 119.18 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.425 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -86.3 -173.34 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.389 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 44.0 mt-10 -79.18 -24.54 43.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.769 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -122.52 -44.14 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -169.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.58 -96.33 0.75 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.839 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -169.21 -157.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 130.09 38.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.503 0.592 . . . . 0.0 110.089 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 23.1 mtp85 -112.09 147.07 36.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.286 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.57 117.63 19.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.762 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 31.8 m-85 -111.22 150.41 29.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.902 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.464 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.0 t-160 -148.24 136.19 20.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.702 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.41 -34.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.675 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.8 tt -58.08 -34.71 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.675 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -100.74 15.38 28.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.415 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 40' ' ' ILE . 23.4 t -114.04 134.57 56.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.321 . . . . 0.0 110.28 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.31 60.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.16 78.13 53.47 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.619 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.76 -19.81 23.52 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.868 2.379 . . . . 0.0 113.956 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.56 -22.72 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -78.99 -11.45 60.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.452 0.644 . . . . 0.0 109.427 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.783 HG23 HD11 ' A' ' 7' ' ' ILE . 56.8 mt -70.97 116.08 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.424 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -156.97 169.55 24.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.637 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 13.4 tmtt? -61.08 140.26 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 36.6 t70 76.29 4.14 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.115 0.884 . . . . 0.0 111.933 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HB1' HD12 ' A' ' 7' ' ' ILE . . . -92.13 156.19 17.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.048 -0.407 . . . . 0.0 110.324 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.49 149.08 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.4 m -134.95 149.8 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.855 0.36 . . . . 0.0 110.893 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -109.63 138.03 46.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.061 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -161.48 -179.18 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.514 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 pt-20 -104.35 142.1 23.92 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.8 Cg_endo -86.88 137.05 4.48 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.113 2.542 . . . . 0.0 112.345 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.586 HG22 ' CE2' ' A' ' 60' ' ' TYR . 6.2 t -159.23 169.38 24.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -109.96 155.8 21.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.724 0.297 . . . . 0.0 110.612 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 13.8 t-20 -132.53 157.75 43.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.612 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -78.59 8.87 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.792 0.329 . . . . 0.0 111.554 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -134.14 19.17 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 0.0 110.395 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.01 -147.38 19.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.427 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.59 152.28 20.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -144.5 167.67 21.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.672 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.04 153.41 37.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.583 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CE2' HG22 ' A' ' 51' ' ' THR . 71.2 m-85 -130.23 168.29 17.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.44 55.79 8.88 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 124.058 0.849 . . . . 0.0 111.253 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 34' ' ' VAL . 23.4 t -82.75 117.49 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.168 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -122.37 119.86 32.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.564 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.9 t -68.62 142.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.03 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.4 86.4 5.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.472 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.586 ' HB2' HD12 ' A' ' 67' ' ' LEU . 92.3 Cg_endo -83.13 174.15 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.549 2.166 . . . . 0.0 112.204 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 66' ' ' PRO . 6.5 mp 59.35 24.81 13.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.292 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -55.83 -54.74 40.87 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -119.04 147.15 44.42 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 164.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -71.8 144.61 49.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.045 0.45 . . . . 0.0 111.057 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -101.05 -46.86 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.469 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 61.61 -93.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.99 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 179.52 -67.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.4 t60 . . . . . 0 C--O 1.245 0.853 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.493 168.693 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.79 114.35 21.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.412 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 79.3 mtp -116.15 150.66 37.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.732 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -105.56 147.17 28.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.071 0.462 . . . . 0.0 110.715 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.29 161.01 26.48 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.694 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -105.6 138.38 41.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.72 105.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.717 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 p -107.53 -51.93 2.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.199 0.523 . . . . 0.0 110.524 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 20.5 m -100.81 118.83 37.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -151.0 113.32 4.6 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.924 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.558 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 99.4 m-85 -106.3 84.4 2.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.059 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 12.5 tmtt? -59.82 -30.75 69.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.164 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.62 -24.62 65.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.425 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.558 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.7 mptp? -104.4 -31.13 9.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.3 13.96 34.44 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.521 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -139.45 174.13 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.373 0.587 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.19 -162.54 31.44 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.069 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 97.7 m-85 -139.03 131.72 28.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.693 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 77.1 mt -119.09 122.07 68.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.004 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 26' ' ' ASN . 2.1 mmmp? -89.33 112.62 23.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.07 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.621 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.0 p-10 -96.65 -170.17 2.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.817 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.38 -32.09 72.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.059 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 27.1 t-20 -63.75 -31.09 72.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.385 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.75 10.32 47.08 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.667 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -107.68 168.18 9.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.415 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 17.1 p-10 -107.18 116.13 31.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.425 0.631 . . . . 0.0 110.561 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 39.6 mtt-85 -100.47 141.37 33.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.59 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -80.03 113.68 18.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.693 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 42.7 m-85 -105.62 153.64 21.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.672 0.748 . . . . 0.0 111.196 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.509 ' HD1' ' CG2' ' A' ' 32' ' ' ILE . 27.4 t-80 -147.78 140.69 24.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.989 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.07 -18.36 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.672 HG23 ' HG2' ' A' ' 33' ' ' LYS . 7.6 tp -57.29 -39.89 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 111.701 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.672 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -92.06 3.28 55.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.769 -176.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.865 HG12 HD13 ' A' ' 40' ' ' ILE . 39.6 t -100.14 126.8 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.14 -30.37 21.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.339 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.644 HD21 HD11 ' A' ' 39' ' ' LEU . 13.0 p-10 -121.21 85.32 41.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.258 0.551 . . . . 0.0 111.343 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.77 -19.47 9.79 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.092 2.528 . . . . 0.0 113.733 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.79 -23.95 36.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.541 0.686 . . . . 0.0 109.926 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.644 HD11 HD21 ' A' ' 36' ' ' ASN . 88.4 mt -86.95 -8.49 57.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.063 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.865 HD13 HG12 ' A' ' 34' ' ' VAL . 68.2 mt -65.19 107.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.377 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 73.7 mmtt -115.72 157.71 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -71.93 135.81 46.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 70.64 9.46 6.88 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.351 0.596 . . . . 0.0 111.16 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 41' ' ' LYS . . . -82.27 166.96 19.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 110.639 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.18 145.19 36.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.452 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.768 HG12 ' HA ' ' A' ' 64' ' ' VAL . 32.8 m -131.28 160.5 42.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.71 151.86 38.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.621 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 20.2 p90 -167.02 173.58 9.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.037 0.446 . . . . 0.0 111.477 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.2 mm-40 -104.96 141.12 21.9 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.266 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 21.4 Cg_endo -92.7 143.37 2.34 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.056 2.504 . . . . 0.0 113.508 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 t -152.02 151.06 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.389 174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 m -90.88 156.29 18.12 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.476 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.411 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 4.6 t-20 -136.11 173.87 11.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.49 -20.17 62.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -112.0 13.64 20.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.175 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.48 -155.75 21.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.987 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.5 mt -86.2 148.22 25.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.255 0.55 . . . . 0.0 110.687 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -145.44 169.17 18.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.731 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.24 154.37 43.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -136.23 177.05 8.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.209 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.1 42.04 31.76 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.984 0.803 . . . . 0.0 110.419 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.7 t -75.06 112.69 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -116.84 125.31 51.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.556 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.768 ' HA ' HG12 ' A' ' 46' ' ' VAL . 21.1 t -76.81 146.86 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.37 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.4 87.85 2.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 123.426 0.454 . . . . 0.0 110.434 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.3 Cg_endo -72.67 172.23 15.62 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.582 2.188 . . . . 0.0 111.793 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.7 mt 70.2 -54.41 0.62 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.406 0.682 . . . . 0.0 111.945 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.6 -52.66 54.29 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.032 0.533 . . . . 0.0 109.87 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -122.15 86.59 2.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 109.599 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -96.02 141.61 29.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.93 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -141.65 149.25 40.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.979 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -132.75 160.97 35.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.278 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -90.72 110.58 21.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.912 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.353 -176.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.01 17.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.344 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -101.33 153.71 19.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.45 144.67 28.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.121 0.486 . . . . 0.0 110.451 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.3 162.76 28.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.699 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -111.03 134.05 52.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.08 0.467 . . . . 0.0 110.278 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.957 HD13 HG21 ' A' ' 40' ' ' ILE . 57.0 mt -77.66 114.98 18.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.52 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 p -108.1 -42.57 4.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -130.28 122.89 28.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.517 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 74.3 t-105 -144.32 135.4 25.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.826 0.346 . . . . 0.0 110.329 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.64 86.42 2.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.536 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -60.63 -27.65 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.499 0.666 . . . . 0.0 110.009 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.403 ' OD2' ' HE3' ' A' ' 14' ' ' LYS . 18.1 t70 -61.88 -34.03 75.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.357 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 30.9 mmtp -119.16 -21.76 7.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.98 12.28 50.24 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.821 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.411 ' HD2' ' HE1' ' A' ' 28' ' ' TYR . 25.5 m-85 -98.31 160.88 14.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -177.84 162.51 30.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.913 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -137.48 126.02 23.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.699 HD13 HG23 ' A' ' 46' ' ' VAL . 86.8 mt -120.99 129.99 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -93.9 120.88 34.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.4 p-10 -86.22 -173.67 4.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.983 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -91.1 -10.76 40.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.159 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.44 -42.91 28.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.46 44.81 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.75 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -136.2 162.18 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 0.0 110.542 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -117.86 127.11 53.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.538 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.77 146.29 50.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.235 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HD2' ' A' ' 16' ' ' PHE . 67.5 t80 -76.59 127.28 32.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.693 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 29.9 m-85 -112.97 154.7 26.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.808 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.439 ' ND1' HG22 ' A' ' 32' ' ' ILE . 10.5 t-80 -141.67 130.99 23.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.652 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -49.82 -34.12 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.616 HG21 ' HG2' ' A' ' 33' ' ' LYS . 19.2 tt -56.94 -34.22 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HG2' HG21 ' A' ' 32' ' ' ILE . 73.9 mmtt -97.45 9.2 43.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.458 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 33.3 t -97.31 130.4 46.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.63 54.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.777 HD21 HD12 ' A' ' 39' ' ' LEU . 9.3 p-10 -132.73 79.42 64.14 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.272 0.558 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 68.9 Cg_endo -74.76 -22.34 15.49 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.02 2.48 . . . . 0.0 113.518 -173.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.17 -28.14 64.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD12 HD21 ' A' ' 36' ' ' ASN . 57.1 mt -82.63 -5.48 58.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.957 HG21 HD13 ' A' ' 7' ' ' ILE . 39.0 mt -72.25 112.62 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.625 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -133.79 174.76 10.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.772 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 1.7 tmtp? -70.53 140.96 51.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 33.1 t70 74.94 6.14 4.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.575 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 7' ' ' ILE . . . -81.34 152.0 27.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.146 -0.346 . . . . 0.0 110.323 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.18 136.6 40.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 110.558 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.699 HG23 HD13 ' A' ' 19' ' ' ILE . 28.5 m -130.44 158.83 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.122 0.486 . . . . 0.0 111.046 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.6 p -118.31 135.4 54.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.378 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 16.8 p90 -143.69 164.9 29.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -173.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -98.17 142.23 24.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.591 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.55 142.89 21.12 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.292 1.994 . . . . 0.0 112.95 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.563 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 13.5 t -157.85 166.63 32.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.607 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -113.9 145.48 41.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.993 0.425 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.86 177.16 7.94 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.17 -25.76 58.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.053 0.454 . . . . 0.0 109.903 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.83 -14.41 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.939 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.01 -138.43 10.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.87 139.49 34.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -144.08 168.59 19.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.235 -174.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -138.92 149.13 44.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.865 0.364 . . . . 0.0 111.436 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.563 ' CE1' ' HB ' ' A' ' 51' ' ' THR . 16.9 p90 -134.05 -177.61 4.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.133 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.43 42.2 32.02 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.743 0.652 . . . . 0.0 110.202 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -68.1 100.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.004 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 16.6 ttmm -108.28 116.42 31.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HA ' HG11 ' A' ' 46' ' ' VAL . 50.7 t -70.88 148.49 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.133 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.2 t -104.64 87.94 2.0 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 93.2 Cg_endo -82.3 145.06 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.223 1.949 . . . . 0.0 111.956 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' H ' HD21 ' A' ' 67' ' ' LEU . 2.3 pt? -60.23 -24.13 64.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.695 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -162.69 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -131.06 -54.86 1.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.904 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t60 70.37 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 O-C-N 124.193 0.933 . . . . 0.0 110.313 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -64.35 134.7 55.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 0.0 111.124 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.1 135.52 38.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -170.99 151.36 3.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 110.887 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.589 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.8 114.35 4.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -113.83 149.22 35.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.348 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -101.46 152.12 21.13 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.943 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -151.6 177.06 29.73 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.23 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -126.9 132.14 50.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.8 ' HA ' HG12 ' A' ' 19' ' ' ILE . 62.7 mt -65.0 106.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.506 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m -95.02 -37.38 11.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.86 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -150.96 125.06 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.878 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.661 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 74.6 t-105 -143.02 131.7 22.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.4 96.2 4.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.734 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.2 -41.78 89.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -69.57 -28.03 65.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.661 ' HG2' ' HD1' ' A' ' 16' ' ' PHE . 39.6 ttmt -87.69 -38.49 15.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.936 0.398 . . . . 0.0 110.41 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 106.34 -12.78 43.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.661 ' HD1' ' HG2' ' A' ' 14' ' ' LYS . 57.6 m-85 -96.6 163.42 13.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.902 0.382 . . . . 0.0 111.356 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.76 27.27 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.117 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -139.57 131.76 28.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.8 HG12 ' HA ' ' A' ' 7' ' ' ILE . 68.0 mt -136.92 125.11 33.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.862 0.363 . . . . 0.0 110.984 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 14.1 tmtt? -86.41 125.78 33.92 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.0 p-10 -97.1 -169.51 1.87 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.833 0.825 . . . . 0.0 112.853 -169.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -77.95 -30.23 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.287 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -74.09 -36.67 64.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.741 0.305 . . . . 0.0 110.41 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.17 41.05 0.45 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.488 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.41 163.51 32.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.159 0.48 . . . . 0.0 109.943 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -110.36 115.34 29.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -101.61 153.66 19.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.417 -170.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.892 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.8 m-85 -116.65 153.93 31.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.895 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.458 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.3 t-160 -136.4 133.76 37.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.661 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 12.4 p -47.23 -31.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.3 tt -67.72 -30.15 47.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.972 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.9 mmtt -97.7 15.31 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.67 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.722 HG12 HD12 ' A' ' 40' ' ' ILE . 39.6 t -94.29 130.77 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.38 48.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.975 0.417 . . . . 0.0 110.948 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 39' ' ' LEU . 22.4 p-10 -135.21 79.22 50.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.518 0.675 . . . . 0.0 111.203 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 40' ' ' ILE . 86.0 Cg_endo -76.95 -11.1 18.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.859 2.373 . . . . 0.0 112.247 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.39 -18.97 61.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.803 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.616 ' HB3' ' HG3' ' A' ' 66' ' ' PRO . 78.7 mt -106.39 12.87 29.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.722 HD12 HG12 ' A' ' 34' ' ' VAL . 40.9 mt -82.82 126.48 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.0 112.183 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -139.18 168.38 19.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 12.7 tmtt? -78.88 139.85 38.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 66.7 m-20 73.97 13.04 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.706 0.803 . . . . 0.0 111.709 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HB1' HD12 ' A' ' 7' ' ' ILE . . . -82.57 156.72 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.594 0.235 . . . . 0.0 110.673 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.72 137.88 31.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 19' ' ' ILE . 28.6 m -136.04 160.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.775 ' HB ' ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -124.23 154.46 40.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -166.45 171.47 11.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.902 0.382 . . . . 0.0 111.542 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 26.3 mm-40 -101.17 143.33 26.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.128 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.55 148.56 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.25 1.966 . . . . 0.0 112.183 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -166.29 171.1 12.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -109.54 155.4 21.43 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 23.1 t-20 -131.17 162.46 29.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.663 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -58.94 -36.35 74.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.489 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.45 -48.7 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.706 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -141.27 3.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.119 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -86.1 149.16 25.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.557 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -151.01 169.78 20.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -135.42 151.1 50.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.556 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.1 172.23 7.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.565 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.537 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 50.01 49.5 20.21 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.946 0.778 . . . . 0.0 111.297 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.582 HG21 ' HD2' ' A' ' 29' ' ' PHE . 17.9 t -76.95 109.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.001 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.775 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -109.15 128.76 55.28 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 ' HA ' HG11 ' A' ' 46' ' ' VAL . 28.5 t -84.93 143.93 10.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.398 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -114.3 85.12 10.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 39' ' ' LEU . 87.0 Cg_endo -96.93 164.12 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.094 2.529 . . . . 0.0 112.208 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.743 ' H ' HD21 ' A' ' 67' ' ' LEU . 2.3 pt? -91.23 3.09 55.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.17 0.509 . . . . 0.0 109.989 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 70' ' ' HIS . 12.3 tp10 -90.22 -88.46 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.543 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.6 t60 55.8 28.12 11.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.655 0.74 . . . . 0.0 109.134 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.486 ' HB3' ' OE2' ' A' ' 68' ' ' GLU . 29.8 t-80 -120.82 13.25 11.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.573 -169.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 70' ' ' HIS . 34.0 m80 70.83 152.36 0.11 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.839 -175.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -132.71 127.65 35.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.108 0.48 . . . . 0.0 109.877 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -83.77 102.38 12.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.902 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.589 -177.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.771 0.32 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.58 124.02 49.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.426 ' HE3' ' HB2' ' A' ' 3' ' ' MET . 3.4 mpp? -109.53 177.29 4.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.895 0.379 . . . . 0.0 110.946 -176.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.85 151.43 25.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.936 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.63 165.44 23.79 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.973 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -112.37 135.35 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.909 HD11 HG21 ' A' ' 40' ' ' ILE . 51.8 mt -82.29 121.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 p -106.89 -53.45 2.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.998 0.428 . . . . 0.0 111.228 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.1 m -124.55 127.32 47.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.078 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -142.09 135.53 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.986 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.49 102.56 9.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.03 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.649 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.85 -49.0 64.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.829 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -70.92 -46.46 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.57 19.57 9.71 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.8 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.68 170.73 15.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.924 0.862 . . . . 0.0 110.661 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.41 -170.52 41.33 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.267 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -133.25 131.81 40.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.744 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.6 mt -131.26 131.17 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -100.74 120.63 40.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.663 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.8 p30 -109.6 -164.84 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.144 0.497 . . . . 0.0 111.543 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.84 -10.25 59.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.128 -171.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.29 -28.05 69.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.326 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.95 8.02 55.86 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.195 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -129.77 163.78 25.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' H ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -93.65 137.27 33.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 110.574 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.576 ' HG2' ' HB3' ' A' ' 57' ' ' LEU . 35.2 mtt85 -111.29 150.2 29.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.666 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -89.23 123.42 33.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.688 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 63.7 m-85 -116.74 155.64 28.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.315 0.579 . . . . 0.0 111.808 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG21 ' A' ' 32' ' ' ILE . 11.4 t-160 -136.49 135.17 38.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.666 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.96 -29.67 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.491 HG21 ' ND1' ' A' ' 30' ' ' HIS . 18.1 tt -63.76 -31.31 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.21 -9.01 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.667 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.853 HG12 HD13 ' A' ' 40' ' ' ILE . 39.6 t -91.17 134.29 30.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.261 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.36 -24.22 19.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.178 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.67 ' HB2' HG22 ' A' ' 64' ' ' VAL . 3.2 m-20 -122.38 65.49 23.13 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.849 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.04 -30.55 13.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.015 1.81 . . . . 0.0 113.656 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.13 -18.27 34.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.428 0.633 . . . . 0.0 110.152 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 87.4 mt -90.9 -8.68 48.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.909 HG21 HD11 ' A' ' 7' ' ' ILE . 54.3 mt -61.03 119.56 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.621 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -126.84 173.25 9.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -83.47 136.02 34.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 66.83 13.85 9.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.484 0.659 . . . . 0.0 111.001 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.13 156.4 17.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.671 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.7 137.65 39.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 64' ' ' VAL . 19.7 m -126.48 157.3 37.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.86 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 0.0 110.52 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.663 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 7.8 p90 -158.9 176.69 12.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.288 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.1 pm0 -111.47 143.36 28.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.1 Cg_exo -77.1 154.07 32.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.283 2.655 . . . . 0.0 113.507 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -166.89 179.4 5.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.036 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 p -118.66 146.31 44.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.874 0.369 . . . . 0.0 110.447 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.551 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 2.3 t-20 -105.88 25.87 10.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 25.2 t-20 71.36 -56.18 0.64 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.833 -174.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.7 -39.04 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.099 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.24 -156.51 12.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.109 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 84.2 mt -84.82 134.77 34.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.959 0.409 . . . . 0.0 111.125 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 7.6 m -147.92 168.74 21.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.593 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . . . -144.08 163.85 32.36 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.739 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.38 179.5 6.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.378 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.63 41.28 31.22 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 124.124 0.89 . . . . 0.0 110.508 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG11 ' HD2' ' A' ' 48' ' ' PHE . 22.0 t -76.77 107.61 8.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.301 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -109.05 127.73 54.36 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.965 175.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 36' ' ' ASN . 82.3 t -65.78 149.95 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.695 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.51 86.02 1.29 Allowed Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 88.1 Cg_endo -92.94 159.55 2.7 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.806 2.337 . . . . 0.0 112.58 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -90.49 -26.97 19.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HG2' ' H ' ' A' ' 70' ' ' HIS . 31.0 tt0 -135.73 128.73 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.941 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -68.29 -19.22 64.68 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.455 0.169 . . . . 0.0 111.044 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 54.3 m-70 65.91 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.956 0.785 . . . . 0.0 111.176 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -57.35 105.84 0.27 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.123 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.76 139.39 30.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 -173.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -84.39 -74.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.0 m170 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.326 171.492 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.09 129.16 38.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.246 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.15 157.86 20.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.491 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -96.97 147.53 23.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.922 0.391 . . . . 0.0 110.054 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.686 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.86 165.49 28.05 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.762 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 m -120.37 135.0 55.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.089 0.471 . . . . 0.0 109.843 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.93 HD13 HG23 ' A' ' 40' ' ' ILE . 51.0 mt -76.58 117.24 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.585 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -101.47 -46.57 4.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 110.93 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -124.14 123.13 39.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -132.06 116.06 16.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.038 0.447 . . . . 0.0 110.695 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.483 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 81.1 m-85 -105.19 90.35 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.5 -38.97 82.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.722 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.99 -25.71 56.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.263 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HB2' ' CB ' ' A' ' 11' ' ' PHE . 41.0 mmtm -83.73 -38.2 21.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.39 45.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.921 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 54.8 p90 -144.13 176.61 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.809 0.337 . . . . 0.0 110.849 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.78 -168.41 29.87 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.297 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -138.29 130.65 28.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.784 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.1 mt -122.54 130.65 74.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 21' ' ' ASP . 13.3 tmtt? -104.58 118.09 35.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.686 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.6 p-10 -86.57 -178.78 6.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.943 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -93.39 -2.29 54.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.011 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -112.08 -54.06 2.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.819 0.343 . . . . 0.0 111.106 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.09 -99.16 2.07 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.194 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -158.85 -159.2 0.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.54 129.93 37.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.256 0.55 . . . . 0.0 110.621 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.585 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 69.1 mtt180 -108.32 151.6 25.76 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -77.95 124.42 27.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.063 0.459 . . . . 0.0 110.251 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 49.4 m-85 -120.51 148.0 44.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.496 0.665 . . . . 0.0 110.246 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -148.83 143.72 26.49 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.785 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG21 ' CB ' ' A' ' 37' ' ' PRO . 11.1 p -49.09 -25.52 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.715 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.6 tt -65.35 -33.61 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.715 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -106.7 -1.1 23.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.875 HG11 HD12 ' A' ' 40' ' ' ILE . 46.4 t -99.25 126.29 52.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.41 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.81 74.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.554 HD21 ' HB ' ' A' ' 64' ' ' VAL . 37.1 m-20 -118.36 76.4 12.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.977 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' CB ' HG21 ' A' ' 31' ' ' VAL . 63.0 Cg_endo -75.77 -24.07 11.99 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.109 1.872 . . . . 0.0 112.439 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.92 -13.64 57.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.394 0.616 . . . . 0.0 110.594 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -103.13 3.91 36.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.739 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.93 HG23 HD13 ' A' ' 7' ' ' ILE . 62.9 mt -72.47 115.88 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.4 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 30.8 mmtp -120.3 154.06 35.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.619 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -71.2 132.31 44.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.31 24.23 7.44 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.793 0.683 . . . . 0.0 111.647 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -95.67 157.98 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.969 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.85 139.7 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 111.09 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 64' ' ' VAL . 15.4 m -137.6 166.5 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.187 0.518 . . . . 0.0 110.967 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.1 p -131.5 134.99 46.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.634 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 10.2 p90 -156.31 164.75 37.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.982 0.42 . . . . 0.0 111.475 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.65 144.09 29.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.631 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 147.23 32.35 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.763 2.309 . . . . 0.0 113.918 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 60' ' ' TYR . 15.1 t -154.21 139.83 17.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.736 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 p -89.13 126.79 35.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.236 0.541 . . . . 0.0 111.528 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 14.2 t-20 -86.91 167.65 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.947 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.42 -34.54 61.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.556 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -99.96 -57.48 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.357 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.69 -148.22 4.8 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.488 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.73 140.87 30.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.007 0.432 . . . . 0.0 111.112 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -149.14 168.98 21.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.61 152.17 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 52.9 p90 -124.67 172.96 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.532 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.554 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . 45.81 52.12 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 124.347 1.029 . . . . 0.0 110.828 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.9 t -76.81 111.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.402 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -97.19 119.06 34.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.723 ' HA ' HG11 ' A' ' 46' ' ' VAL . 95.7 t -70.63 148.21 10.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.68 89.52 2.3 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 123.304 0.378 . . . . 0.0 110.936 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 56.0 Cg_endo -69.29 135.04 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.316 2.01 . . . . 0.0 111.908 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.93 -21.73 40.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.179 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.1 133.7 39.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.858 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -90.95 124.13 34.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 71' ' ' HIS . 28.0 t60 -127.42 -24.8 3.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 70' ' ' HIS . 13.8 m-70 67.01 -167.57 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -134.85 -34.54 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.139 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -133.15 -69.52 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.681 174.522 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 23.4 ttt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.935 0.398 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.445 ' HB1' ' OE2' ' A' ' 49' ' ' GLU . . . -70.14 117.48 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.442 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -112.37 169.76 8.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.973 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.67 152.45 20.48 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.925 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 m -100.13 135.83 40.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.033 0.444 . . . . 0.0 110.705 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.796 HD13 HG22 ' A' ' 40' ' ' ILE . 55.2 mt -82.47 116.41 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.781 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -103.53 -51.35 3.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 30.2 m -119.52 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 58.9 t-105 -150.74 122.18 7.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 0.0 110.904 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -130.48 87.42 2.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.611 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.35 -37.82 78.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.21 -35.03 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.842 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HE2' ' HE1' ' A' ' 16' ' ' PHE . 54.0 mtpt -90.16 -14.48 33.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.627 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.01 -4.19 62.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.199 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' HIS . 53.5 p90 -132.75 173.58 11.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.643 0.721 . . . . 0.0 111.996 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -165.28 177.82 40.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.229 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 94.0 m-85 -139.07 130.18 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.758 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 85.4 mt -136.94 135.1 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.653 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.4 tmtp? -112.53 117.65 32.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.855 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.6 p-10 -97.84 174.96 6.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -94.89 2.01 55.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.35 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.603 ' HB2' ' HG2' ' A' ' 3' ' ' MET . 7.2 t30 -105.88 -50.29 3.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.59 -87.99 2.03 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.359 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -171.24 -164.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 50.6 t-20 -82.23 122.69 28.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 43.8 mtt-85 -112.22 153.89 26.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.794 0.33 . . . . 0.0 111.041 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -80.12 121.34 25.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.758 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.1 m-85 -110.13 159.57 17.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.599 ' HD1' HG22 ' A' ' 32' ' ' ILE . 10.7 t-80 -148.54 147.03 28.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.14 -10.47 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 111.407 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.599 HG22 ' HD1' ' A' ' 30' ' ' HIS . 8.9 tt -82.84 -19.49 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.565 0.698 . . . . 0.0 110.462 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -103.14 -3.49 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.657 -173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.799 HG12 HD12 ' A' ' 40' ' ' ILE . 25.6 t -104.71 139.4 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.84 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.71 -31.34 19.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.318 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.765 HD21 HD11 ' A' ' 39' ' ' LEU . 21.7 p-10 -132.69 77.51 69.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.393 0.616 . . . . 0.0 110.65 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.2 -19.0 13.87 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.863 2.376 . . . . 0.0 113.817 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.31 -0.83 57.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.995 0.426 . . . . 0.0 111.053 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.765 HD11 HD21 ' A' ' 36' ' ' ASN . 69.6 mt -102.85 0.59 32.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.657 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.799 HD12 HG12 ' A' ' 34' ' ' VAL . 58.0 mt -80.96 109.11 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.805 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -117.67 155.62 29.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.3 tmtt? -74.42 141.51 45.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 59.3 m-20 75.48 19.82 2.05 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.522 0.729 . . . . 0.0 111.442 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -103.25 165.88 10.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.235 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.45 137.61 45.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.284 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 64' ' ' VAL . 18.3 m -128.35 164.27 30.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.104 0.478 . . . . 0.0 111.484 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 p -124.36 136.86 54.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.593 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.653 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 14.4 p90 -156.2 170.08 23.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.122 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.445 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 23.8 mm-40 -93.28 140.58 23.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 3.7 Cg_exo -84.0 135.39 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.221 2.614 . . . . 0.0 113.1 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.589 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 11.9 t -151.48 -174.45 4.84 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.543 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -126.37 -177.9 4.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.228 0.537 . . . . 0.0 110.79 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.601 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 7.7 t-20 -145.89 -170.99 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.8 -27.2 26.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.006 0.432 . . . . 0.0 109.963 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -108.38 1.74 21.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.067 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.8 31.83 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.482 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.4 mt -87.52 159.02 18.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.189 0.495 . . . . 0.0 110.518 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.601 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.5 m -147.69 169.01 20.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.205 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.19 151.01 47.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 26.9 p90 -133.0 170.66 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.399 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.73 47.8 23.89 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.152 0.907 . . . . 0.0 110.175 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.18 120.59 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.104 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -123.0 127.35 48.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.271 174.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.843 ' HA ' HG12 ' A' ' 46' ' ' VAL . 19.2 t -67.24 154.55 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.123 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.79 84.12 5.15 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 121.07 0.462 . . . . 0.0 111.29 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 58.2 Cg_endo -100.95 146.53 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.35 2.7 . . . . 0.0 112.213 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.711 ' H ' HD21 ' A' ' 67' ' ' LEU . 1.3 pt? -96.33 52.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.857 0.837 . . . . 0.0 110.283 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -147.4 120.42 8.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.297 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -91.97 123.9 35.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.188 0.518 . . . . 0.0 111.704 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -86.47 105.06 16.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -49.52 134.38 19.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.012 0.435 . . . . 0.0 110.925 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -106.18 146.42 30.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.179 -168.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -120.88 -33.31 3.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 164.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 . . . . . 0 C--O 1.245 0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.729 173.885 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.69 129.94 43.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 112.062 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.6 mtm -111.13 167.54 10.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.208 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -112.97 152.38 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.38 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.76 172.92 30.42 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.826 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -117.6 136.35 53.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 0.0 110.242 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.712 HD12 HG23 ' A' ' 40' ' ' ILE . 46.8 mt -79.88 114.45 20.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.664 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 p -102.76 -43.3 5.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.179 0.514 . . . . 0.0 110.795 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.7 m -127.21 126.01 42.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.252 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -145.22 128.1 16.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.668 0.27 . . . . 0.0 111.039 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.61 98.16 5.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.3 176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.69 -37.31 86.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.95 -42.6 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.364 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 50.7 tptt -95.7 -49.82 5.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.618 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.47 13.48 12.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.952 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 74.6 m-85 -125.69 164.36 20.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.675 0.274 . . . . 0.0 110.328 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.35 170.47 41.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.86 129.04 37.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.698 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.1 mt -128.53 130.3 69.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.367 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -89.36 123.04 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.4 p30 -91.08 175.26 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.486 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -96.48 24.98 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.53 -48.88 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.514 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.18 -71.09 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.401 -0.905 . . . . 0.0 113.986 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.38 -154.3 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.027 0.414 . . . . 0.0 110.071 -170.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -88.03 152.93 21.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 53.1 mtt-85 -124.69 147.41 48.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -86.96 113.83 23.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.93 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.698 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 34.7 m-85 -105.48 150.13 25.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.657 0.741 . . . . 0.0 111.956 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG21 ' A' ' 32' ' ' ILE . 2.7 t-80 -128.45 130.61 47.83 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.084 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 37' ' ' PRO . 11.1 p -47.29 -31.95 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.491 HG21 ' ND1' ' A' ' 30' ' ' HIS . 13.5 tt -75.32 -21.41 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.58 -174.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.39 1.2 57.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.117 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 21.9 t -96.67 143.12 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.28 -42.81 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.368 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -127.69 75.67 77.69 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.189 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 91.8 Cg_endo -81.17 -17.29 9.29 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.959 2.439 . . . . 0.0 113.865 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -89.92 -8.76 51.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.474 0.654 . . . . 0.0 109.871 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.1 1.29 52.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.625 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.712 HG23 HD12 ' A' ' 7' ' ' ILE . 51.1 mt -68.38 127.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.919 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.636 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 7.8 mtpm? -121.06 157.72 29.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.559 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -80.94 139.65 35.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.67 56.52 1.54 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.809 0.814 . . . . 0.0 109.276 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.6 36.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.18 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.96 140.12 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -134.88 162.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -127.5 139.84 52.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 9.7 p90 -156.47 170.63 21.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.414 . . . . 0.0 111.917 -172.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 62.5 mm-40 -85.4 142.56 37.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 5.5 Cg_exo -78.93 133.96 11.53 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.505 2.136 . . . . 0.0 111.287 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.58 HG21 ' CE2' ' A' ' 60' ' ' TYR . 9.5 t -165.94 152.09 9.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -129.56 145.97 51.42 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.03 -69.85 0.78 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -175.33 -54.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.362 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.79 17.69 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.703 -175.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.49 171.76 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.333 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.84 155.93 37.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -148.03 169.14 20.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.803 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -148.92 143.14 26.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.468 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.58 ' CE2' HG21 ' A' ' 51' ' ' THR . 22.8 m-85 -122.07 168.49 11.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.98 37.97 26.76 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.626 0.579 . . . . 0.0 110.79 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.514 ' HB ' HG13 ' A' ' 34' ' ' VAL . 18.4 t -67.86 114.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.158 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -115.95 117.85 31.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.587 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG11 ' A' ' 46' ' ' VAL . 20.9 t -79.98 146.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.487 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -111.56 86.24 6.69 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.2 Cg_endo -85.53 131.33 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.079 2.519 . . . . 0.0 111.852 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.73 ' H ' HD21 ' A' ' 67' ' ' LEU . 1.3 pt? -86.03 70.59 10.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.809 0.814 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -126.99 134.02 50.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.7 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -96.72 125.51 41.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.992 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -80.36 70.24 6.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.581 0.705 . . . . 0.0 109.667 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -139.37 130.93 27.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.266 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.78 127.85 30.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -107.15 -13.99 15.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.775 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.3 t60 . . . . . 0 C--O 1.246 0.896 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.346 177.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.956 0.407 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.13 114.43 23.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.28 153.81 17.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.1 p-10 -107.88 139.92 41.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 110.759 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.31 166.4 23.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.442 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 p -109.67 137.8 46.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.039 0.447 . . . . 0.0 111.315 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 HD12 HG12 ' A' ' 19' ' ' ILE . 21.5 mm -63.83 115.87 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.474 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.437 ' O ' ' HE3' ' A' ' 42' ' ' LYS . 29.3 p -110.59 -47.13 3.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.123 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -122.5 125.76 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.98 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -156.04 133.27 10.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.708 0.289 . . . . 0.0 110.578 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.627 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 86.4 m-85 -123.47 115.68 21.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.29 -51.87 61.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.966 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.43 -8.36 59.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 111.268 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 11' ' ' PHE . 70.2 mmtt -85.73 -39.88 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.863 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.13 9.21 65.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.045 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 41.1 p90 -135.47 169.13 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.043 0.422 . . . . 0.0 110.732 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.17 -170.93 41.73 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.112 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -136.58 134.91 37.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.621 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 90.8 mt -126.68 129.75 71.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.276 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -92.27 117.58 30.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.627 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 4.9 p-10 -102.43 -173.37 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 111.797 -173.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 40.9 mt-10 -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.073 -174.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -70.0 -25.62 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.981 0.419 . . . . 0.0 110.23 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.59 -18.49 9.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.568 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 -163.13 0.86 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.38 0.59 . . . . 0.0 110.13 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -121.62 147.91 45.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' CZ ' HD12 ' A' ' 57' ' ' LEU . 8.2 mpt_? -111.52 146.89 36.5 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.202 170.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -85.68 120.83 27.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 53.9 m-85 -109.87 154.85 22.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.414 0.626 . . . . 0.0 111.672 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -144.8 134.86 23.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.093 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.39 -27.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -64.68 -25.72 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.606 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.5 mmtt -101.52 11.64 38.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.161 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.714 HG13 HD13 ' A' ' 40' ' ' ILE . 61.1 t -97.95 127.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.077 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.82 -30.53 32.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.558 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.646 HD21 HD13 ' A' ' 39' ' ' LEU . 13.8 p-10 -142.06 81.4 14.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.177 0.513 . . . . 0.0 111.602 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.1 -19.04 23.31 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.739 2.293 . . . . 0.0 112.948 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.55 -23.31 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.352 0.596 . . . . 0.0 110.617 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.646 HD13 HD21 ' A' ' 36' ' ' ASN . 81.2 mt -101.89 9.68 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.091 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.714 HD13 HG13 ' A' ' 34' ' ' VAL . 51.2 mt -81.41 118.49 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.86 159.7 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 8' ' ' THR . 85.0 tttt -78.16 146.12 35.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 t70 72.42 3.76 4.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.56 156.32 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.222 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.78 139.15 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.571 HG23 HD11 ' A' ' 19' ' ' ILE . 32.9 m -128.53 148.6 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.224 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -110.86 134.6 52.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.012 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.627 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.6 p90 -147.79 167.45 24.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.956 0.408 . . . . 0.0 111.609 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 54.2 mm-40 -92.36 142.51 26.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.613 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -82.95 133.92 6.9 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.783 2.322 . . . . 0.0 112.301 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.3 t -152.96 161.38 42.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -101.64 147.61 26.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.291 0.567 . . . . 0.0 111.205 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -113.95 156.88 23.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.729 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -55.35 -33.72 63.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 111.461 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -101.8 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.596 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.0 -135.95 2.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.115 -172.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.439 HD12 ' CZ ' ' A' ' 27' ' ' ARG . 91.7 mt -102.59 151.33 22.46 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.696 0.284 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -145.55 167.49 22.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 111.003 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . . . -140.93 148.89 41.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.553 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -117.84 170.97 8.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.206 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 46.95 53.72 10.13 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.095 0.872 . . . . 0.0 111.37 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 36.5 t -70.95 100.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.1 0.476 . . . . 0.0 110.234 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -118.24 117.09 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.119 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.579 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 21.8 t -69.66 151.58 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.819 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.7 t -103.34 88.26 1.61 Allowed Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.1 Cg_endo -81.93 140.09 11.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.329 2.686 . . . . 0.0 113.215 -170.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.774 HD22 ' H ' ' A' ' 67' ' ' LEU . 2.1 pt? -84.56 -12.07 54.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.803 174.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 70' ' ' HIS . 11.9 tp10 -108.98 151.95 25.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.429 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 82.9 m-70 -80.72 -15.9 55.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.502 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 81.6 t60 72.85 -70.56 0.16 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.389 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.4 m80 66.03 163.19 0.16 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.034 0.533 . . . . 0.0 110.693 -174.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 m170 59.65 -164.0 0.22 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.089 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -114.72 -59.08 2.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.301 177.126 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 1' ' ' MET . 47.7 ttm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.204 0.526 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.77 114.18 28.01 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -97.74 157.12 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.0 111.163 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.65 130.37 42.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.234 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.95 171.89 23.92 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.077 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -132.77 139.66 47.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.1 mt -76.85 106.01 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.079 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -95.69 -61.45 1.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.986 0.422 . . . . 0.0 110.603 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -98.76 118.22 35.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.337 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -140.68 127.36 20.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.878 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -116.87 89.77 3.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.352 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.1 -34.32 77.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.641 0.734 . . . . 0.0 110.092 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.39 -21.74 64.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.511 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.887 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.89 -45.7 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.225 -0.297 . . . . 0.0 111.302 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.29 1.3 20.39 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.555 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.553 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 56.0 p90 -140.4 175.57 9.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.09 0.445 . . . . 0.0 110.889 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.98 -161.32 26.41 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.115 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -137.37 129.72 29.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.092 0.473 . . . . 0.0 109.792 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.72 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.0 mt -116.66 131.07 70.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 13.9 tttp -106.07 130.67 53.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.83 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.9 p30 -92.76 175.92 6.63 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.74 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -100.76 16.97 23.25 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.535 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -114.84 -43.91 3.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.045 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.11 -80.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.09 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 11.8 t70 -161.23 -160.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 3.6 p-10 -99.24 154.21 18.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.616 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.35 163.64 20.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -178.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.76 128.7 34.27 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.72 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 58.5 m-85 -127.43 157.24 40.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.333 0.587 . . . . 0.0 111.193 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.78 ' HD1' HG23 ' A' ' 32' ' ' ILE . 54.7 t-80 -148.25 150.03 32.95 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.98 27.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.523 0.678 . . . . 0.0 112.793 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.78 HG23 ' HD1' ' A' ' 30' ' ' HIS . 15.8 tt -118.35 -32.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.514 -0.741 . . . . 0.0 110.902 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HG2' HG22 ' A' ' 32' ' ' ILE . 34.5 mmtp -95.21 5.27 52.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 110.902 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 36' ' ' ASN . 45.3 t -94.14 129.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.388 176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 -15.46 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.551 ' HB2' HG22 ' A' ' 64' ' ' VAL . 5.4 m-20 -122.08 65.66 21.35 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.981 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.3 -11.93 20.94 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.057 1.838 . . . . 0.0 111.772 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -84.57 -17.89 37.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.22 12.47 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.674 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.8 mt -75.19 134.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -161.18 170.62 19.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.168 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.613 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 8.3 tmtm? -74.69 137.88 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.758 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.613 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 7.5 t70 69.98 13.15 7.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.367 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.76 143.81 35.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.301 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 138.68 32.51 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 64' ' ' VAL . 20.5 m -138.4 163.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.23 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -128.02 134.23 49.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.215 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.71 172.36 16.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.31 141.73 24.99 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.74 160.27 6.27 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.815 2.343 . . . . 0.0 113.833 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.799 ' HB ' ' HE2' ' A' ' 60' ' ' TYR . 14.5 t -164.64 -179.46 5.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.747 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.419 ' C ' HD21 ' A' ' 53' ' ' ASN . 3.4 m -134.62 148.29 50.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.114 0.483 . . . . 0.0 110.052 175.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.419 HD21 ' C ' ' A' ' 52' ' ' THR . 0.9 OUTLIER -123.49 -179.91 4.51 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -72.25 -28.06 62.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.285 0.565 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 52.1 mmtt -74.39 -42.81 58.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.338 175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.88 -153.56 23.59 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.597 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD11 HH12 ' A' ' 27' ' ' ARG . 68.7 mt -73.54 134.49 43.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 5.5 m -143.65 167.87 21.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.944 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.56 160.9 40.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.942 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.799 ' HE2' ' HB ' ' A' ' 51' ' ' THR . 29.0 p90 -141.1 175.31 9.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.44 48.78 21.89 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.07 0.856 . . . . 0.0 110.706 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 ' HB ' HG11 ' A' ' 34' ' ' VAL . 14.5 t -83.6 111.84 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.317 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.14 126.76 51.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.827 0.346 . . . . 0.0 110.097 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.731 ' HA ' HG11 ' A' ' 46' ' ' VAL . 81.7 t -70.26 144.26 13.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.257 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -110.64 85.28 4.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.736 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 9.9 Cg_endo -91.48 136.85 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.069 2.513 . . . . 0.0 111.705 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.62 17.5 3.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.256 0.55 . . . . 0.0 110.698 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -103.4 -69.45 0.8 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.027 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 63.38 83.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.886 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -140.03 -71.47 0.38 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.083 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 64.02 104.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.754 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -74.75 160.85 30.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -134.16 153.16 52.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.747 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.1 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.614 173.331 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.38 -163.59 0.26 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.529 0.518 . . . . 0.0 109.833 -173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ttm -147.94 165.94 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.371 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.53 146.68 46.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.349 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.27 162.28 27.22 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.22 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.42 ' C ' HG22 ' A' ' 19' ' ' ILE . 9.0 m -114.1 134.78 54.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 40' ' ' ILE . 55.6 mt -73.81 121.14 24.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.704 -174.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -117.17 -56.1 2.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -117.65 122.73 44.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.042 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -140.79 114.37 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.944 0.402 . . . . 0.0 110.454 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 87.8 m-85 -89.61 83.18 6.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.844 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.54 -42.34 95.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.553 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -84.9 -47.8 9.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.343 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.91 8.91 8.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.314 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -138.35 172.51 12.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.316 0.558 . . . . 0.0 110.648 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.02 -171.22 38.21 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -137.37 129.35 29.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.763 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 66.1 mt -123.84 132.13 71.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.04 117.16 20.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.422 . . . . 0.0 110.617 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.655 ' HB3' ' H ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -77.05 -168.52 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.93 0.871 . . . . 0.0 111.732 -174.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.59 -15.78 53.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.755 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.655 ' H ' ' HB3' ' A' ' 21' ' ' ASP . 46.9 m-80 -76.67 -14.63 59.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.644 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.44 -31.82 7.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.201 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.9 -175.55 2.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -109.46 147.94 32.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -171.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 49.3 mtt-85 -97.91 160.47 14.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.476 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.66 106.13 16.72 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 35.3 m-85 -96.97 154.94 17.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.282 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.754 ' HD1' HG21 ' A' ' 32' ' ' ILE . 25.4 t-80 -149.12 133.48 17.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.561 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.68 -36.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.754 HG21 ' HD1' ' A' ' 30' ' ' HIS . 17.6 tt -61.26 -26.72 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.153 0.502 . . . . 0.0 111.939 -175.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.5 mmtt -104.88 9.16 34.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.384 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 HD13 ' A' ' 40' ' ' ILE . 39.3 t -106.61 127.63 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.89 70.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.184 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -134.71 71.95 69.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.056 0.455 . . . . 0.0 111.427 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.39 -20.39 27.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.578 2.185 . . . . 0.0 112.657 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -80.88 -16.23 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.618 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.69 3.82 53.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.05 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.904 HG23 HD13 ' A' ' 7' ' ' ILE . 52.9 mt -73.9 110.07 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.381 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -117.64 -176.81 3.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.243 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -87.81 147.75 25.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.564 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.99 9.39 6.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.92 0.763 . . . . 0.0 111.104 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HB2' HD11 ' A' ' 7' ' ' ILE . . . -90.3 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.48 151.88 20.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.342 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.2 m -129.94 164.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.433 0.635 . . . . 0.0 111.461 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -127.11 134.9 50.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.887 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.52 174.72 14.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.357 . . . . 0.0 111.667 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.82 142.01 23.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.257 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -86.81 138.88 5.31 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 167.79 27.8 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 131.86 41.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.22 24.14 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.51 -43.57 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.894 0.878 . . . . 0.0 111.811 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.92 -32.56 73.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.699 0.285 . . . . 0.0 110.777 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.74 -176.54 44.06 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.283 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.1 mt -79.09 138.16 37.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 2.0 p -151.13 169.05 22.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.122 0.487 . . . . 0.0 111.305 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB2' ' HD2' ' A' ' 27' ' ' ARG . . . -143.35 148.41 36.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -131.79 175.11 9.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.76 32.63 22.4 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 124.016 0.822 . . . . 0.0 109.861 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.77 114.98 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.325 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -116.47 119.97 37.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.683 ' HA ' HG12 ' A' ' 46' ' ' VAL . 43.0 t -72.73 151.14 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.749 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.57 87.52 1.79 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.807 0.337 . . . . 0.0 110.235 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.3 Cg_endo -82.26 131.86 6.86 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 111.726 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.29 -70.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.232 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 128.14 21.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -146.74 70.03 1.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.383 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -56.18 124.07 16.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.434 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.4 121.09 17.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.875 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.48 85.18 7.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -99.27 37.31 1.58 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.545 0.688 . . . . 0.0 109.603 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.933 -178.304 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.4 114.23 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.866 0.729 . . . . 0.0 111.635 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' THR . 35.0 ttm -115.44 167.89 10.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.8 p-10 -127.93 141.18 51.61 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.056 0.455 . . . . 0.0 111.156 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -144.98 177.77 23.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.394 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 19' ' ' ILE . 6.6 m -122.92 135.27 54.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.8 0.333 . . . . 0.0 110.107 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.954 HD12 HG21 ' A' ' 40' ' ' ILE . 56.4 mt -74.28 122.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -114.27 -58.14 2.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 17.3 m -114.88 129.72 56.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.082 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.452 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 76.5 t-105 -152.89 130.14 11.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.42 97.47 5.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.87 -42.54 98.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.424 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.02 -43.64 70.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.764 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 16' ' ' PHE . 8.2 mmpt? -66.79 -39.77 87.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.82 -3.94 57.55 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.079 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.572 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 64.9 m-85 -95.48 156.81 16.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.421 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -163.51 157.31 29.45 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.0 m-85 -136.23 126.66 26.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.752 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 80.6 mt -134.07 133.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -102.95 129.02 49.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.704 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.5 p-10 -89.68 179.26 6.06 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.517 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.67 -8.53 58.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.75 -43.76 5.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.65 -98.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.103 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.2 -178.99 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.612 -0.346 . . . . 0.0 110.249 -164.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.91 122.87 20.74 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.322 0.582 . . . . 0.0 110.544 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -108.4 151.65 25.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.8 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -77.88 122.29 25.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.375 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.752 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 17.2 m-85 -112.55 153.21 27.86 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.318 0.58 . . . . 0.0 110.283 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.522 ' ND1' HG23 ' A' ' 32' ' ' ILE . 3.7 t-80 -133.92 131.04 38.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.843 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 14.7 p -49.7 -26.72 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.522 HG23 ' ND1' ' A' ' 30' ' ' HIS . 12.3 tt -79.16 -20.37 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.459 0.647 . . . . 0.0 111.377 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 32' ' ' ILE . 66.2 mmtt -102.69 10.77 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.013 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.72 HG11 HD13 ' A' ' 40' ' ' ILE . 34.6 t -101.66 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.643 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.11 -33.82 72.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.542 HD21 HD11 ' A' ' 39' ' ' LEU . 12.6 p-10 -141.75 74.63 22.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.076 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 40' ' ' ILE . 70.5 Cg_endo -75.02 -16.98 19.87 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.787 2.325 . . . . 0.0 112.983 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.28 -22.61 57.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.298 0.57 . . . . 0.0 110.434 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.542 HD11 HD21 ' A' ' 36' ' ' ASN . 92.3 mt -97.93 5.17 49.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.439 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.954 HG21 HD12 ' A' ' 7' ' ' ILE . 33.0 mt -73.02 120.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.089 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -135.75 164.89 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.472 173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.608 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 2.4 tmtp? -68.98 142.53 54.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.608 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 30.6 t70 75.72 4.63 3.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.901 0.75 . . . . 0.0 111.38 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.646 ' HB1' HD13 ' A' ' 7' ' ' ILE . . . -81.38 147.29 29.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.14 -0.35 . . . . 0.0 110.233 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 140.67 29.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.614 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.6 m -132.28 151.15 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 3' ' ' MET . 11.5 p -118.91 135.23 54.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.804 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.4 p90 -154.1 173.18 16.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 0.0 111.76 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -99.83 142.89 25.45 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.635 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.29 143.99 12.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.468 2.112 . . . . 0.0 112.691 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 60' ' ' TYR . 11.6 t -165.12 176.46 8.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.292 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -113.35 143.75 43.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.146 0.498 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -100.89 16.7 24.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.753 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 73.59 -47.19 0.65 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -107.3 26.14 10.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.863 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.15 -171.21 34.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.951 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 145.78 25.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -148.03 169.98 18.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.811 0.339 . . . . 0.0 111.037 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.77 149.73 52.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.96 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' A' ' 51' ' ' THR . 27.6 m-85 -114.37 172.37 7.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.96 41.27 26.91 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.973 0.795 . . . . 0.0 111.79 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 20.8 t -68.15 103.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.103 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -107.12 117.29 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.931 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.612 HG21 HG12 ' A' ' 40' ' ' ILE . 22.3 t -87.67 140.17 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -176.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.23 88.44 2.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.108 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.92 162.17 39.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.573 -175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.603 ' H ' HD21 ' A' ' 67' ' ' LEU . 2.3 pt? -68.17 -25.57 65.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.009 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -162.39 151.19 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -85.86 80.79 8.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.239 0.542 . . . . 0.0 109.668 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -79.13 136.02 37.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.387 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -78.45 134.11 37.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.384 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -136.89 97.89 3.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -112.59 -3.64 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.53 172.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.79 124.26 21.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.5 ' HE3' ' HB2' ' A' ' 22' ' ' GLU . 77.2 mtp -113.21 158.26 20.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 4.4 p-10 -106.11 140.47 39.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.232 0.539 . . . . 0.0 111.181 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.58 170.43 23.93 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.35 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -117.94 134.97 54.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.14 0.495 . . . . 0.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.82 HD11 HG21 ' A' ' 40' ' ' ILE . 48.2 mt -77.79 120.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.391 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -107.74 -52.11 2.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 m -121.36 127.72 51.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.455 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -138.67 117.61 12.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.763 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 93.4 m-85 -90.76 88.37 7.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.3 -33.05 74.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.123 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.17 -31.66 72.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.79 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.763 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -92.46 -60.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.029 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.64 14.16 3.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.668 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.27 172.55 12.52 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.527 -0.396 . . . . 0.0 110.197 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.19 -163.27 24.91 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.505 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.547 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 85.2 m-85 -141.4 132.84 26.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.753 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 74.4 mt -130.87 139.43 51.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.301 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -100.1 118.71 37.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.522 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 6.8 p-10 -102.22 -171.9 2.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.318 0.58 . . . . 0.0 111.288 -176.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HB2' ' HE3' ' A' ' 3' ' ' MET . 44.8 mt-10 -66.28 -23.34 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.449 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -70.53 -13.34 62.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.855 0.359 . . . . 0.0 110.992 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.97 24.75 40.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.787 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -127.3 -177.47 4.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 18' ' ' PHE . 28.3 t-20 -127.54 120.67 28.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 51.0 mtt-85 -105.17 153.43 21.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.205 -172.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -80.44 115.97 20.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.739 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.753 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 23.9 m-85 -107.42 152.92 23.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.457 ' ND1' HG21 ' A' ' 32' ' ' ILE . 12.2 t-160 -150.47 138.45 20.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.231 -175.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.71 -31.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.572 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.1 tt -63.42 -27.63 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.051 0.453 . . . . 0.0 111.943 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.3 mmtt -102.28 7.25 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.502 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.685 HG11 HD12 ' A' ' 40' ' ' ILE . 21.8 t -106.66 130.45 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.774 0.321 . . . . 0.0 110.198 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.07 -35.17 59.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -137.99 70.57 49.42 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.399 0.619 . . . . 0.0 111.026 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HA ' HG13 ' A' ' 40' ' ' ILE . 73.0 Cg_endo -74.16 -10.71 22.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.003 2.469 . . . . 0.0 112.236 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.37 -25.04 63.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.31 8.61 40.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.016 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.82 HG21 HD11 ' A' ' 7' ' ' ILE . 43.8 mt -75.72 124.0 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.228 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.549 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 15.3 ptpt -144.63 163.74 33.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.158 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 1.4 tmtp? -72.73 140.56 47.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 35.1 t70 75.1 18.79 2.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.859 0.725 . . . . 0.0 110.89 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -100.93 149.38 23.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.23 137.5 32.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.237 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.986 HG11 ' HA ' ' A' ' 64' ' ' VAL . 15.9 m -132.6 147.59 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.874 0.369 . . . . 0.0 111.097 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.5 p -111.28 135.26 52.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.738 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 6.3 p90 -156.18 172.66 18.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 29.6 mm-40 -96.72 141.86 23.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_endo -89.02 136.38 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.847 2.365 . . . . 0.0 112.164 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.522 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 14.2 t -153.06 -177.0 6.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.036 0.446 . . . . 0.0 110.133 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -128.21 142.34 51.2 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.546 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 8.8 t-20 -105.8 170.05 8.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.54 -33.41 73.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.853 0.358 . . . . 0.0 110.732 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -119.56 26.76 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.82 176.17 22.71 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.687 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 57' ' ' LEU . 4.0 mp -79.28 143.7 35.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.834 0.317 . . . . 0.0 110.171 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p -151.76 170.22 20.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.222 0.534 . . . . 0.0 111.386 -172.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -136.7 148.51 47.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.162 175.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.522 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 29.6 p90 -130.3 177.38 7.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.71 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.1 35.5 26.4 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.004 0.815 . . . . 0.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . 26.1 t -67.46 112.24 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.356 -174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.57 117.22 30.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.504 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.986 ' HA ' HG11 ' A' ' 46' ' ' VAL . 41.7 t -70.67 137.38 24.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.347 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.3 85.71 16.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.659 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 5.9 Cg_exo -79.56 -169.99 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.276 2.65 . . . . 0.0 111.67 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.08 -33.14 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.487 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.563 ' HG2' ' H ' ' A' ' 69' ' ' HIS . 27.2 tt0 -137.54 168.57 19.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.563 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 35.8 t-80 -66.39 -23.42 66.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.698 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 66.73 102.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.88 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -66.94 107.58 2.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.376 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.23 157.05 16.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.867 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -81.25 124.07 29.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.366 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.142 175.666 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.49 114.85 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.255 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.716 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 72.5 mtp -105.71 159.22 16.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.185 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.77 142.43 31.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.428 0.633 . . . . 0.0 111.12 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -138.46 167.39 25.02 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.046 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -110.64 137.87 47.76 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.135 0.493 . . . . 0.0 110.734 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 40' ' ' ILE . 58.2 mt -79.19 117.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.714 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.5 p -108.68 -43.55 4.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.25 0.548 . . . . 0.0 111.227 -175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.5 m -136.55 122.14 19.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.766 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.58 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 71.0 t-105 -139.54 130.78 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.623 0.249 . . . . 0.0 110.58 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.54 90.59 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.96 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.58 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.6 tmtt? -67.08 -26.36 66.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.47 -20.72 36.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.081 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -97.07 -44.67 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.578 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.72 -2.82 10.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.511 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 40.0 p90 -148.42 177.89 9.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.568 0.684 . . . . 0.0 111.646 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.15 -164.05 28.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.242 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.93 131.25 42.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.1 mt -130.17 129.94 65.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -103.47 124.33 48.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.476 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 9.4 p-10 -95.34 -175.98 3.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.029 0.442 . . . . 0.0 110.687 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.2 -7.46 51.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.522 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.716 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 5.7 t-20 -95.84 -58.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.682 0.277 . . . . 0.0 111.213 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.69 -92.19 2.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.678 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -164.33 -154.31 0.24 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -72.81 135.79 45.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 109.785 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 42.2 mtt180 -114.34 148.9 36.86 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.666 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -85.16 115.86 23.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.783 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 51.2 m-85 -109.94 161.8 15.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.71 138.52 24.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.63 -28.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -61.68 -26.85 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 111.794 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HG2' HG23 ' A' ' 32' ' ' ILE . 33.9 mmtp -99.93 7.39 44.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.589 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 40' ' ' ILE . 29.0 t -100.8 123.92 54.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.19 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.291 -176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.713 HD21 HD13 ' A' ' 39' ' ' LEU . 12.2 p-10 -134.27 78.25 58.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.359 0.6 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.18 -19.66 13.38 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.966 2.444 . . . . 0.0 114.195 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.54 -2.95 58.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.067 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.713 HD13 HD21 ' A' ' 36' ' ' ASN . 59.8 mt -99.08 -1.71 38.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.145 0.498 . . . . 0.0 109.855 174.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.695 HG21 HD13 ' A' ' 7' ' ' ILE . 52.7 mt -71.74 122.59 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.443 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.32 165.25 17.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.881 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -78.4 148.28 33.73 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.082 0.468 . . . . 0.0 111.613 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 61.52 26.73 16.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.172 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 165.01 11.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.702 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.51 138.83 39.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 111.141 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 64' ' ' VAL . 27.3 m -131.54 152.11 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -110.97 134.73 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.993 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 9.1 p90 -151.95 165.6 34.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.017 0.437 . . . . 0.0 111.469 -175.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.24 141.32 24.9 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -88.66 139.34 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.313 2.675 . . . . 0.0 113.488 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -150.55 173.82 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 151.7 48.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.96 0.41 . . . . 0.0 110.84 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.47 177.31 7.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -74.97 -11.5 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -95.18 -2.83 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.4 -140.41 12.26 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.794 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.31 144.57 27.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.213 0.53 . . . . 0.0 110.71 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -143.61 168.79 19.05 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -149.44 168.05 24.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.697 0.284 . . . . 0.0 111.291 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -148.72 -179.96 7.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.64 41.57 28.23 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.785 0.678 . . . . 0.0 110.521 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.6 t -70.23 101.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.364 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 19.4 ttmm -101.68 114.27 28.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.593 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.721 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.3 t -77.57 134.85 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.903 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.71 86.11 5.43 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 85.2 Cg_endo -93.37 -169.27 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.053 2.502 . . . . 0.0 113.396 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.07 84.97 2.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.287 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -51.19 125.78 14.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.021 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -128.83 128.97 44.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -59.93 133.52 56.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.722 -171.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.86 135.71 41.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.125 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -74.93 135.88 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.986 0.422 . . . . 0.0 110.706 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -115.65 67.33 0.7 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.73 0.776 . . . . 0.0 110.438 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 33.3 m80 . . . . . 0 C--O 1.247 0.96 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.912 176.709 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.08 16.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.096 0.474 . . . . 0.0 110.808 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.656 ' HE2' ' HB3' ' A' ' 23' ' ' ASN . 60.7 mtp -115.34 154.18 29.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.549 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -118.08 139.96 50.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -146.5 176.58 25.34 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.869 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -116.6 140.13 49.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.426 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.3 mt -79.14 116.76 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.189 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -108.77 -63.27 1.36 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 m -102.91 129.05 49.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.29 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -147.03 135.01 21.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.759 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.447 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 89.2 m-85 -126.27 113.12 16.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.301 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' C ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -60.86 -64.07 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 -176.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.68 -17.02 61.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.336 -170.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 6.7 mmpt? -81.28 -35.62 30.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.944 173.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.26 15.16 62.84 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.266 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 43.9 p90 -145.34 175.39 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.478 -0.425 . . . . 0.0 110.605 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.63 -167.96 34.05 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.571 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.76 125.37 28.38 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.731 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.2 mt -120.85 129.2 75.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.865 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -107.45 126.49 52.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.216 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.621 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 5.0 p-10 -96.05 175.45 6.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.791 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -103.3 13.82 32.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.656 ' HB3' ' HE2' ' A' ' 3' ' ' MET . 8.2 t30 -107.09 -47.51 3.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.453 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.35 -83.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.34 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -169.15 -164.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -82.83 131.29 35.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -124.64 150.37 46.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 111.237 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -78.48 127.1 31.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.547 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.7 m-85 -120.62 156.56 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.656 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.637 ' ND1' HG21 ' A' ' 32' ' ' ILE . 11.4 t-80 -141.39 141.22 33.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.08 -31.26 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.637 HG21 ' ND1' ' A' ' 30' ' ' HIS . 18.2 tt -70.98 -21.26 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.672 0.749 . . . . 0.0 110.631 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.7 -11.52 59.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.058 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.846 HG12 HD12 ' A' ' 40' ' ' ILE . 23.3 t -91.11 138.44 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.31 -36.13 22.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.619 HD21 HD12 ' A' ' 39' ' ' LEU . 10.6 p-10 -129.25 85.35 59.71 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.772 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.7 -31.63 5.22 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.742 2.961 . . . . 0.0 112.692 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.93 -25.47 68.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.619 HD12 HD21 ' A' ' 36' ' ' ASN . 87.9 mt -95.77 5.25 51.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.612 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.846 HD12 HG12 ' A' ' 34' ' ' VAL . 36.2 mt -75.66 124.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.141 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 18.0 ptpt -143.68 164.57 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.165 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -78.92 151.42 31.72 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.27 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 71.68 4.04 4.89 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.432 1.083 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -85.09 158.45 20.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.757 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.17 136.0 39.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 64' ' ' VAL . 29.0 m -132.25 156.08 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -117.59 135.16 54.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.097 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.621 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.5 p90 -151.6 177.03 10.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.612 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -121.93 144.7 41.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.0 145.94 32.03 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.993 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -150.09 152.78 35.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -91.01 150.7 21.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.223 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.466 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 4.8 t-20 -127.15 159.18 35.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -70.35 -32.75 70.59 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.902 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 50.7 pttt -101.93 6.43 41.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -154.28 25.25 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.145 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.61 146.45 27.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.808 0.337 . . . . 0.0 110.461 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.9 p -145.07 169.41 18.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.09 0.471 . . . . 0.0 111.581 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HB1' ' CZ ' ' A' ' 29' ' ' PHE . . . -141.95 154.14 44.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.599 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -132.12 -175.93 3.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.21 50.52 18.84 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.005 0.816 . . . . 0.0 111.136 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.681 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -72.86 104.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.949 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -103.62 111.83 24.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.89 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.671 ' HA ' HG12 ' A' ' 46' ' ' VAL . 59.0 t -72.58 142.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.881 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -105.13 88.42 2.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.1 Cg_exo -74.96 123.74 8.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.363 2.042 . . . . 0.0 111.069 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.65 -61.23 1.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.008 0.432 . . . . 0.0 110.504 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -116.48 153.8 31.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.411 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.14 126.11 32.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 72' ' ' HIS . 26.7 t-80 -82.14 56.23 3.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.871 0.367 . . . . 0.0 111.613 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 69.75 -30.75 0.2 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.743 0.817 . . . . 0.0 112.559 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 70' ' ' HIS . 86.5 t60 -70.25 99.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.525 . . . . 0.0 109.735 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -112.13 148.98 32.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.354 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.361 177.211 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.675 0.274 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.13 118.51 30.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.62 150.52 28.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.98 158.2 16.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.574 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -152.19 172.51 31.44 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 176.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.2 m -122.18 130.88 53.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.864 0.332 . . . . 0.0 110.196 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.838 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.5 mt -67.7 105.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.304 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -95.4 -36.29 11.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.886 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 31.7 m -144.87 136.97 25.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -145.59 126.02 14.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.042 0.448 . . . . 0.0 111.368 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -119.87 95.53 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.84 -41.0 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.96 -37.09 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.081 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.697 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 18.6 tptm -86.26 -30.4 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 92.02 5.59 65.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.542 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.697 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 84.1 m-85 -119.21 162.36 18.81 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.669 -0.313 . . . . 0.0 110.604 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.23 173.12 39.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.223 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.9 m-85 -131.05 131.41 44.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.838 HG12 ' HA ' ' A' ' 7' ' ' ILE . 82.2 mt -136.4 130.56 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.98 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -91.73 139.52 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.6 p-10 -115.87 -164.65 0.97 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.388 0.613 . . . . 0.0 111.88 -171.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -62.97 -32.28 73.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.566 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.25 -33.81 75.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 26.71 9.19 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.099 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -135.15 177.53 7.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' H ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -96.07 139.89 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.106 0.479 . . . . 0.0 110.383 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.518 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 52.9 mtt-85 -118.2 138.99 51.94 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.47 119.54 25.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.556 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.809 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 66.3 m-85 -111.66 160.17 17.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.625 0.726 . . . . 0.0 112.099 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.53 ' ND1' HG23 ' A' ' 32' ' ' ILE . 15.6 t-160 -141.75 142.31 33.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.984 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -48.94 -34.39 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.53 HG23 ' ND1' ' A' ' 30' ' ' HIS . 18.4 tt -62.54 -25.38 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.565 0.697 . . . . 0.0 111.363 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.756 ' HG3' ' HA ' ' A' ' 60' ' ' TYR . 7.6 mptt -77.52 -22.48 51.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.241 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 40' ' ' ILE . 23.9 t -93.8 134.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.606 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.03 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.65 HD21 HD13 ' A' ' 39' ' ' LEU . 14.8 p-10 -127.88 77.04 76.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.095 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 -23.47 18.12 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.9 2.4 . . . . 0.0 113.273 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.1 -29.11 68.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.459 0.647 . . . . 0.0 111.074 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 36' ' ' ASN . 81.3 mt -92.8 4.97 52.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.36 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.699 HG21 HD12 ' A' ' 7' ' ' ILE . 40.0 mt -69.93 110.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.974 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.58 158.09 25.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.986 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 144.71 33.44 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.148 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.43 11.02 8.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.517 0.675 . . . . 0.0 110.551 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.59 154.76 19.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.8 143.37 26.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 64' ' ' VAL . 28.5 m -134.32 164.14 35.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.408 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.25 153.58 45.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -167.77 177.07 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 41.1 mt-10 -110.46 142.78 26.76 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.4 Cg_endo -84.97 142.47 8.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.214 2.609 . . . . 0.0 113.219 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 t -144.86 162.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -104.19 149.46 25.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.943 0.402 . . . . 0.0 110.73 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 6.3 t-20 -139.68 154.79 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -66.95 -31.35 71.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -82.4 -18.09 43.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.85 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.04 -163.26 31.33 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.648 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.05 140.53 47.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.069 0.435 . . . . 0.0 110.407 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.4 p -135.0 167.22 21.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.82 0.343 . . . . 0.0 110.691 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB1' ' CE2' ' A' ' 29' ' ' PHE . . . -149.95 159.31 44.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.756 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 43.2 p90 -143.87 -178.61 6.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 123.31 0.381 . . . . 0.0 110.005 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.29 39.4 30.19 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.701 0.626 . . . . 0.0 110.249 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.74 119.03 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.403 -172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.0 127.05 55.43 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.775 ' HA ' HG13 ' A' ' 46' ' ' VAL . 27.9 t -77.87 142.63 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.214 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.7 86.81 3.13 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.397 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 94.2 Cg_endo -84.41 168.67 11.42 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.726 2.284 . . . . 0.0 112.5 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.855 ' H ' HD21 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -65.1 -65.89 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.573 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.799 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 1.5 tm-20 -162.41 105.56 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -145.91 121.06 10.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.157 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -63.95 146.6 53.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.61 177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -60.56 119.1 7.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -74.53 136.47 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.769 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -69.73 -40.68 76.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 C--O 1.242 0.695 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.492 169.029 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.701 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 10.2 tpt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.701 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -55.96 127.74 31.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 110.766 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -118.5 164.21 15.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.136 0.494 . . . . 0.0 111.199 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -115.01 152.76 31.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.468 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.22 -178.5 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.514 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -125.47 136.71 53.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.165 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.814 HD11 HG23 ' A' ' 40' ' ' ILE . 44.0 mt -77.11 115.63 19.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.263 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -104.28 -40.32 6.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.166 0.507 . . . . 0.0 111.431 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 m -136.97 114.77 11.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.451 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.656 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 75.9 t-105 -130.62 136.48 48.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.057 0.455 . . . . 0.0 111.493 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.35 97.12 5.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.656 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.1 tmtp? -67.75 -33.09 74.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 110.005 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.32 -35.7 81.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.034 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.905 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.5 mmpt? -88.9 -30.09 19.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.37 9.58 57.77 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 48.6 p90 -144.39 174.65 10.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.964 0.412 . . . . 0.0 111.026 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.66 -172.63 37.86 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.069 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -134.78 126.84 29.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.725 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 79.3 mt -123.64 131.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.887 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 20' ' ' LYS . 13.7 mmmm -90.57 119.84 31.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.506 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.98 177.42 7.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.491 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -81.2 -5.98 58.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.335 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.34 -35.03 18.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.234 0.54 . . . . 0.0 109.563 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.76 22.65 2.69 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.017 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -108.03 164.09 12.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.397 0.598 . . . . 0.0 110.485 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -116.89 115.62 25.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -111.11 148.66 32.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.712 -172.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -81.52 122.13 27.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.7 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 30.7 m-85 -111.72 154.85 24.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.531 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.635 ' HD1' HG21 ' A' ' 32' ' ' ILE . 17.4 t-80 -141.32 133.12 27.35 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.14 -29.7 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.635 HG21 ' HD1' ' A' ' 30' ' ' HIS . 19.1 tt -67.06 -29.33 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.276 0.56 . . . . 0.0 111.225 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -82.3 -4.32 56.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.204 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 40' ' ' ILE . 22.0 t -95.84 133.31 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.173 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.27 -42.78 22.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -125.43 73.88 68.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' HG13 ' A' ' 40' ' ' ILE . 56.0 Cg_endo -70.65 -15.86 33.79 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.548 2.166 . . . . 0.0 112.262 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.93 -10.63 60.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.603 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 66' ' ' PRO . 95.6 mt -108.22 7.97 27.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.814 HG23 HD11 ' A' ' 7' ' ' ILE . 50.7 mt -78.67 114.75 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.39 0.614 . . . . 0.0 111.63 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 48.9 mtpt -124.29 167.78 13.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.59 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.99 135.25 34.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.49 21.56 2.28 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 0.0 109.795 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 41' ' ' LYS . . . -98.81 146.58 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.413 177.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.62 29.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.197 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 19' ' ' ILE . 23.6 m -136.56 156.0 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.7 p -121.71 135.18 54.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.761 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.59 179.98 7.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.613 0.244 . . . . 0.0 110.924 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.5 pt-20 -125.83 142.88 43.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 171.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_exo -74.41 145.4 33.86 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.059 2.506 . . . . 0.0 113.481 -174.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 58' ' ' SER . 9.0 t -139.17 156.95 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -113.63 127.26 55.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.431 0.634 . . . . 0.0 112.111 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -108.38 161.22 15.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.596 171.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -71.45 -13.43 61.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.099 0.476 . . . . 0.0 110.309 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.78 -19.95 25.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.108 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.08 -162.31 31.27 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.969 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -85.47 138.01 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 111.057 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.549 ' HB2' HG22 ' A' ' 51' ' ' THR . 5.4 m -137.89 169.64 17.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.337 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . . . -139.94 152.78 46.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.731 0.301 . . . . 0.0 110.679 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.474 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 1.6 p90 -139.67 -179.22 5.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.221 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.25 48.31 22.38 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.921 0.763 . . . . 0.0 110.041 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 24.9 t -75.9 112.67 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -113.49 109.89 19.39 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.001 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.654 ' HA ' HG13 ' A' ' 46' ' ' VAL . 56.1 t -66.45 152.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.08 88.7 2.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.558 ' HB3' HD13 ' A' ' 39' ' ' LEU . 35.9 Cg_endo -64.71 148.49 90.22 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.727 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.654 ' H ' HD21 ' A' ' 67' ' ' LEU . 1.7 pt? -61.33 -25.16 66.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.214 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -148.68 -71.39 0.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.931 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -151.86 -56.65 0.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.479 . . . . 0.0 110.308 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -160.42 136.15 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -61.91 -38.2 87.49 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.192 -172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.449 ' O ' ' HB3' ' A' ' 73' ' ' HIS . 44.3 t-80 76.8 161.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.806 0.691 . . . . 0.0 111.339 169.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 72' ' ' HIS . 48.6 t-80 83.86 101.88 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.169 174.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 . . . . . 0 C--O 1.246 0.899 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.48 171.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.327 0.584 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -115.92 157.95 23.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.384 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -98.02 130.08 44.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.87 162.88 24.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.34 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -110.14 138.69 46.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.046 0.45 . . . . 0.0 110.134 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.863 HD13 HG23 ' A' ' 40' ' ' ILE . 53.0 mt -79.51 114.81 20.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.206 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -113.08 -55.45 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 111.04 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 m -104.51 124.51 49.4 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -160.06 126.79 4.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.98 102.13 10.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 2.5 tmtp? -73.83 -30.38 62.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.524 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.28 -42.06 94.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 0.0 110.672 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -90.38 -51.57 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 37.43 1.41 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.417 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 36.9 p90 -148.83 167.08 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.383 0.592 . . . . 0.0 110.819 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.53 -160.27 32.21 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.062 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.91 127.86 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.695 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.4 132.51 66.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.501 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -111.71 130.18 55.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 13.3 p-10 -91.85 -170.69 2.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.47 -9.0 19.69 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.105 0.478 . . . . 0.0 110.853 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -97.2 -44.85 6.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 -100.19 2.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.356 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -166.81 -160.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.49 135.93 36.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.555 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 63.2 mtt85 -117.75 156.73 27.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.692 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -79.86 117.48 20.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.101 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.695 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.1 m-85 -113.18 156.13 23.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.406 0.622 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 20.0 t-80 -148.89 138.23 21.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.931 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -49.19 -30.93 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' HG2' ' A' ' 33' ' ' LYS . 14.8 tt -61.94 -30.04 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 112.011 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.7 mmtt -93.69 10.26 33.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.739 HG11 HD11 ' A' ' 40' ' ' ILE . 21.7 t -108.73 132.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.751 0.31 . . . . 0.0 110.252 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.91 -23.92 33.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.435 ' HB2' HD12 ' A' ' 39' ' ' LEU . 23.0 p-10 -135.81 71.48 63.78 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 121.634 0.731 . . . . 0.0 110.149 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.42 -21.62 13.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.338 2.692 . . . . 0.0 114.34 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.4 -9.47 59.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.564 0.697 . . . . 0.0 110.107 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 36' ' ' ASN . 85.0 mt -93.45 -5.87 48.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.822 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.863 HG23 HD13 ' A' ' 7' ' ' ILE . 66.5 mt -71.28 111.42 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.085 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -137.48 157.1 47.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.668 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.681 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 14.8 tmtt? -59.95 136.1 57.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.963 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.681 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 26.8 t70 74.97 4.47 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.835 176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.65 156.41 22.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.26 138.26 36.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.0 m -132.42 164.51 34.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.392 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.8 p -127.87 140.56 51.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 12.6 p90 -151.68 162.96 40.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.492 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.6 mm-40 -94.9 142.84 25.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.37 142.93 16.99 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.377 2.051 . . . . 0.0 113.384 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.485 HG21 ' CE2' ' A' ' 60' ' ' TYR . 14.6 t -163.08 177.36 9.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.508 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -115.74 155.13 28.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.05 0.453 . . . . 0.0 111.102 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.658 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 14.3 t-20 -132.8 168.49 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.951 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -68.23 -38.75 82.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 15.8 ptpt -91.98 -1.66 57.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.879 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.87 -133.49 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.15 155.82 17.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.1 p -148.04 170.32 18.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.763 0.316 . . . . 0.0 111.016 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -135.4 151.06 50.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.256 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 51' ' ' THR . 24.2 m-85 -122.47 170.29 10.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.768 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.599 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 48.99 58.43 5.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.974 0.796 . . . . 0.0 110.879 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 34' ' ' VAL . 27.3 t -85.47 120.4 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.765 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -123.99 127.13 47.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.223 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.2 t -80.61 151.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.919 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.64 88.31 3.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.36 0.413 . . . . 0.0 110.443 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 39' ' ' LEU . 74.2 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.216 1.944 . . . . 0.0 111.949 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.457 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 11.8 ttt -138.98 177.18 8.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' H ' ' HG2' ' A' ' 3' ' ' MET . 4.3 p-10 -106.66 141.93 37.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 112.03 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -135.39 176.74 19.91 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -122.6 139.56 53.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.615 0.708 . . . . 0.0 110.721 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 19' ' ' ILE . 53.0 mt -76.46 107.86 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.285 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -97.88 -43.0 7.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.238 0.542 . . . . 0.0 111.037 -174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 m -132.09 121.9 24.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -139.42 129.83 25.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -107.62 92.35 4.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -59.44 -49.23 78.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.043 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.05 -45.38 90.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HG2' ' HE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -75.24 -39.65 59.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.762 -174.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.82 6.14 35.16 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.848 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.492 ' HE1' ' HG2' ' A' ' 14' ' ' LYS . 33.1 p90 -130.54 174.84 9.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.722 0.761 . . . . 0.0 110.836 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.39 -170.84 41.75 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.0 124.39 26.2 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.791 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.69 119.02 60.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.831 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 60.2 tttt -107.06 124.17 49.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.508 . . . . 0.0 110.823 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 p-10 -89.03 -176.18 5.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.884 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -107.73 5.27 26.54 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.214 0.53 . . . . 0.0 111.013 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.28 -49.86 5.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.68 -92.11 1.85 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.329 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -168.68 -168.53 0.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.669 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -74.62 135.84 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.554 0.693 . . . . 0.0 111.689 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -103.43 151.61 22.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.028 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -79.98 117.34 20.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 56.1 m-85 -111.09 155.64 22.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.631 0.729 . . . . 0.0 111.405 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.481 ' ND1' HG22 ' A' ' 32' ' ' ILE . 14.3 t-80 -139.83 131.77 27.74 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.965 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -46.87 -32.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' ND1' ' A' ' 30' ' ' HIS . 20.3 tt -62.7 -32.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.49 6.24 31.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 40' ' ' ILE . 33.6 t -91.79 133.42 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.91 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.25 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.566 HD22 HD12 ' A' ' 39' ' ' LEU . 22.2 p-10 -145.65 72.25 13.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.676 0.75 . . . . 0.0 110.124 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.568 ' HA ' HG13 ' A' ' 40' ' ' ILE . 92.8 Cg_endo -75.34 -9.69 20.39 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.146 2.564 . . . . 0.0 112.63 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.6 -9.98 59.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.566 HD12 HD22 ' A' ' 36' ' ' ASN . 90.4 mt -109.63 2.8 20.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.192 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 37' ' ' PRO . 55.4 mt -65.4 129.36 29.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.018 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 17.2 ptpt -143.33 166.02 25.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.275 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 12.9 tmtt? -80.08 144.9 32.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.674 0.273 . . . . 0.0 110.526 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 29.6 t70 67.27 27.88 8.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.696 0.76 . . . . 0.0 110.441 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -103.72 148.69 25.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.155 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.13 137.68 32.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 64' ' ' VAL . 26.8 m -133.29 155.56 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.405 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.4 p -113.13 133.81 54.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.93 175.7 13.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.85 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.0 mt-10 -115.72 140.81 26.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.789 174.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -82.05 133.94 7.97 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.957 2.438 . . . . 0.0 113.215 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -149.58 -175.18 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.045 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -124.21 146.48 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.118 0.485 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.435 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 15.8 t-20 -101.01 -64.68 1.03 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.724 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -174.02 -65.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.738 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.8 28.43 3.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.222 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.31 173.19 29.64 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.404 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.5 mt -81.13 146.01 30.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.73 0.3 . . . . 0.0 110.367 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.4 m -144.59 168.87 19.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.163 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.94 154.63 42.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.574 0.226 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -135.76 179.09 6.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.7 50.53 16.89 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.982 0.801 . . . . 0.0 110.22 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.11 113.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.078 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.23 114.66 28.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.914 ' HA ' HG12 ' A' ' 46' ' ' VAL . 45.9 t -71.13 131.36 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.847 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.04 86.98 4.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 0.0 110.671 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 122.435 2.09 . . . . 0.0 111.727 179.151 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 mtt -103.28 160.77 14.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.774 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -93.36 151.93 19.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.089 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -150.91 161.27 28.98 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.412 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -111.36 132.45 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.41 . . . . 0.0 110.289 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.85 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.3 mt -67.08 112.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.446 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HE2' ' A' ' 42' ' ' LYS . 3.2 m -101.07 -43.55 5.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -174.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -145.99 140.4 26.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.36 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -140.7 122.17 15.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 86.0 m-85 -110.54 88.82 2.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -55.85 -63.14 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.58 -7.48 59.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.114 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 23.7 tptm -85.22 -32.79 22.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' HIS . . . 103.71 -17.76 48.92 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.905 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -109.31 179.06 4.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.261 0.553 . . . . 0.0 111.657 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.55 171.82 44.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.289 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.38 128.4 41.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 7' ' ' ILE . 58.2 mt -133.11 128.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.124 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' ASP . 44.4 tptt -85.18 115.56 23.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.711 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.683 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.5 p-10 -92.61 -171.63 2.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -83.94 -36.84 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.704 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -89.04 -47.9 7.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -171.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.01 -101.69 2.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.08 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -163.4 -154.52 0.28 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.24 115.92 15.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.2 0.524 . . . . 0.0 110.101 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 43.7 mtt180 -100.17 152.39 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -80.24 118.56 22.02 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.78 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 8.9 m-85 -105.02 158.18 16.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.765 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.561 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.5 t-80 -140.4 126.09 19.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.71 -38.49 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.616 HG23 ' HG2' ' A' ' 33' ' ' LYS . 20.0 tt -59.74 -30.77 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.303 0.573 . . . . 0.0 111.839 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -96.11 11.74 33.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.349 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.509 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 21.8 t -97.85 127.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.22 61.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.447 . . . . 0.0 111.101 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -133.04 69.65 78.66 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.86 -17.66 32.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.672 2.248 . . . . 0.0 112.756 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.03 -28.88 65.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.257 0.551 . . . . 0.0 110.807 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' A' ' 66' ' ' PRO . 90.4 mt -88.56 3.12 51.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.289 -174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.838 HG23 HD13 ' A' ' 7' ' ' ILE . 42.2 mt -74.7 112.77 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.767 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.41 165.71 18.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.237 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 8' ' ' THR . 5.2 tptm -69.99 134.99 48.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.119 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 t70 69.03 16.94 8.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.963 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -84.04 159.94 21.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.31 139.39 33.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.4 m -131.95 162.8 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.681 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -126.55 134.44 50.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.857 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.683 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 19.0 p90 -149.06 174.6 12.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.813 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.684 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.0 mm-40 -96.17 142.03 23.98 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -81.86 134.73 8.52 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.221 2.614 . . . . 0.0 112.034 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 60' ' ' TYR . 13.3 t -158.58 174.07 15.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.0 0.428 . . . . 0.0 110.121 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -140.17 156.32 46.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.09 -73.51 0.64 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.067 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.66 -63.71 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.96 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -79.88 0.0 33.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.143 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.56 47.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.262 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.26 155.04 23.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 m -145.59 168.97 19.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.31 150.85 45.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.795 0.331 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.556 ' CE2' HG21 ' A' ' 51' ' ' THR . 29.6 m-85 -126.1 171.27 10.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.897 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.684 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 49.99 56.22 8.23 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.988 0.805 . . . . 0.0 110.93 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -73.43 106.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.778 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.09 106.08 16.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.009 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.724 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.2 t -68.83 147.44 12.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.022 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.4 t -109.28 87.12 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.361 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.1 Cg_endo . . . . . 0 N--CA 1.456 -0.715 0 C-N-CA 122.155 1.903 . . . . 0.0 111.813 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.8 mtm -98.73 145.79 26.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.6 p30 -108.22 161.8 14.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.286 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.71 159.72 23.29 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.798 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -108.44 133.62 52.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.756 HD13 HG23 ' A' ' 40' ' ' ILE . 47.0 mt -77.72 126.55 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.906 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -114.77 -53.09 2.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.059 0.457 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -118.44 124.52 47.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.924 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -138.6 125.29 20.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 89.3 m-85 -98.15 98.13 9.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.856 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -62.45 -36.64 83.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.26 -21.21 62.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 67.5 mmtt -102.42 -48.06 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.891 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.28 15.23 23.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.51 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 52.8 p90 -141.72 173.04 11.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.83 -166.99 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.476 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.8 129.78 30.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.4 mt -127.25 138.64 54.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.125 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -91.86 119.18 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.425 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -86.3 -173.34 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.389 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 44.0 mt-10 -79.18 -24.54 43.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.769 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -122.52 -44.14 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -169.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.58 -96.33 0.75 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.839 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -169.21 -157.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 130.09 38.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.503 0.592 . . . . 0.0 110.089 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 23.1 mtp85 -112.09 147.07 36.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.286 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.57 117.63 19.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 31.8 m-85 -111.22 150.41 29.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.902 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.438 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.0 t-160 -148.24 136.19 20.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.702 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.41 -34.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.698 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.8 tt -58.08 -34.71 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.698 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -100.74 15.38 28.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.415 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 40' ' ' ILE . 23.4 t -114.04 134.57 56.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.321 . . . . 0.0 110.28 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.31 60.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.16 78.13 53.47 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.619 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.76 -19.81 23.52 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.868 2.379 . . . . 0.0 113.956 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.56 -22.72 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -78.99 -11.45 60.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.452 0.644 . . . . 0.0 109.427 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 7' ' ' ILE . 56.8 mt -70.97 116.08 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.424 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -156.97 169.55 24.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.637 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 13.4 tmtt? -61.08 140.26 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 36.6 t70 76.29 4.14 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.115 0.884 . . . . 0.0 111.933 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -92.13 156.19 17.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.048 -0.407 . . . . 0.0 110.324 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.49 149.08 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.4 m -134.95 149.8 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.855 0.36 . . . . 0.0 110.893 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -109.63 138.03 46.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.061 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -161.48 -179.18 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.514 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 pt-20 -104.35 142.1 23.92 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.8 Cg_endo -86.88 137.05 4.48 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.113 2.542 . . . . 0.0 112.345 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 60' ' ' TYR . 6.2 t -159.23 169.38 24.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -109.96 155.8 21.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.724 0.297 . . . . 0.0 110.612 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 13.8 t-20 -132.53 157.75 43.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.612 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -78.59 8.87 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.792 0.329 . . . . 0.0 111.554 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -134.14 19.17 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 0.0 110.395 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.01 -147.38 19.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.427 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.59 152.28 20.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -144.5 167.67 21.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.672 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.04 153.41 37.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.583 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.603 ' CE2' HG21 ' A' ' 51' ' ' THR . 71.2 m-85 -130.23 168.29 17.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.44 55.79 8.88 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 124.058 0.849 . . . . 0.0 111.253 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 34' ' ' VAL . 23.4 t -82.75 117.49 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.168 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -122.37 119.86 32.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.9 t -68.62 142.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.03 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.4 86.4 5.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.472 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 C-N-CA 122.549 2.166 . . . . 0.0 112.204 -177.133 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 79.3 mtp -116.15 150.66 37.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.732 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -105.56 147.17 28.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.071 0.462 . . . . 0.0 110.715 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.29 161.01 26.48 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.694 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -105.6 138.38 41.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.72 105.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.717 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 p -107.53 -51.93 2.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.199 0.523 . . . . 0.0 110.524 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 20.5 m -100.81 118.83 37.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -151.0 113.32 4.6 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.924 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.584 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 99.4 m-85 -106.3 84.4 2.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.059 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 12.5 tmtt? -59.82 -30.75 69.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.164 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.62 -24.62 65.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.425 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.7 mptp? -104.4 -31.13 9.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.3 13.96 34.44 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.521 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -139.45 174.13 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.373 0.587 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.19 -162.54 31.44 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.069 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 97.7 m-85 -139.03 131.72 28.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 77.1 mt -119.09 122.07 68.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.004 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 26' ' ' ASN . 2.1 mmmp? -89.33 112.62 23.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.07 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.0 p-10 -96.65 -170.17 2.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.817 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.38 -32.09 72.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.059 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 27.1 t-20 -63.75 -31.09 72.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.385 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.75 10.32 47.08 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.667 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -107.68 168.18 9.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 17.1 p-10 -107.18 116.13 31.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.425 0.631 . . . . 0.0 110.561 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 39.6 mtt-85 -100.47 141.37 33.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.59 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -80.03 113.68 18.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 42.7 m-85 -105.62 153.64 21.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.672 0.748 . . . . 0.0 111.196 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -147.78 140.69 24.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.989 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.07 -18.36 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.676 HG23 ' HG2' ' A' ' 33' ' ' LYS . 7.6 tp -57.29 -39.89 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 111.701 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.676 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -92.06 3.28 55.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.769 -176.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -100.14 126.8 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.14 -30.37 21.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.339 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 HD12 ' A' ' 39' ' ' LEU . 13.0 p-10 -121.21 85.32 41.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.258 0.551 . . . . 0.0 111.343 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.77 -19.47 9.79 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.092 2.528 . . . . 0.0 113.733 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.79 -23.95 36.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.541 0.686 . . . . 0.0 109.926 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 36' ' ' ASN . 88.4 mt -86.95 -8.49 57.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.063 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.869 HD11 HG11 ' A' ' 34' ' ' VAL . 68.2 mt -65.19 107.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.377 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 73.7 mmtt -115.72 157.71 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -71.93 135.81 46.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 70.64 9.46 6.88 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.351 0.596 . . . . 0.0 111.16 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -82.27 166.96 19.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 110.639 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.18 145.19 36.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.452 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 64' ' ' VAL . 32.8 m -131.28 160.5 42.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.71 151.86 38.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.639 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 20.2 p90 -167.02 173.58 9.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.037 0.446 . . . . 0.0 111.477 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.2 mm-40 -104.96 141.12 21.9 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.266 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 21.4 Cg_endo -92.7 143.37 2.34 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.056 2.504 . . . . 0.0 113.508 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 t -152.02 151.06 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.389 174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 m -90.88 156.29 18.12 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.476 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 4.6 t-20 -136.11 173.87 11.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.49 -20.17 62.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -112.0 13.64 20.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.175 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.48 -155.75 21.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.987 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.5 mt -86.2 148.22 25.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.255 0.55 . . . . 0.0 110.687 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -145.44 169.17 18.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.731 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.24 154.37 43.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 49' ' ' GLU . 32.4 p90 -136.23 177.05 8.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.209 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.1 42.04 31.76 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.984 0.803 . . . . 0.0 110.419 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.7 t -75.06 112.69 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -116.84 125.31 51.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.556 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 46' ' ' VAL . 21.1 t -76.81 146.86 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.37 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.4 87.85 2.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 123.426 0.454 . . . . 0.0 110.434 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.3 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.582 2.188 . . . . 0.0 111.793 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -101.33 153.71 19.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.45 144.67 28.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.121 0.486 . . . . 0.0 110.451 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.3 162.76 28.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.699 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -111.03 134.05 52.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.08 0.467 . . . . 0.0 110.278 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 40' ' ' ILE . 57.0 mt -77.66 114.98 18.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.52 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 p -108.1 -42.57 4.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -130.28 122.89 28.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 74.3 t-105 -144.32 135.4 25.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.826 0.346 . . . . 0.0 110.329 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.64 86.42 2.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.536 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -60.63 -27.65 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.499 0.666 . . . . 0.0 110.009 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HE3' ' A' ' 14' ' ' LYS . 18.1 t70 -61.88 -34.03 75.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.357 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 30.9 mmtp -119.16 -21.76 7.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.98 12.28 50.24 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.821 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.411 ' HD2' ' HE1' ' A' ' 28' ' ' TYR . 25.5 m-85 -98.31 160.88 14.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -177.84 162.51 30.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.913 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -137.48 126.02 23.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.722 HD13 HG21 ' A' ' 46' ' ' VAL . 86.8 mt -120.99 129.99 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -93.9 120.88 34.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.4 p-10 -86.22 -173.67 4.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.983 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -91.1 -10.76 40.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.159 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.44 -42.91 28.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.46 44.81 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.75 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -136.2 162.18 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 0.0 110.542 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -117.86 127.11 53.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.538 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.77 146.29 50.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.235 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HD2' ' A' ' 16' ' ' PHE . 67.5 t80 -76.59 127.28 32.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 29.9 m-85 -112.97 154.7 26.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.808 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG22 ' A' ' 32' ' ' ILE . 10.5 t-80 -141.67 130.99 23.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.652 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -49.82 -34.12 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.62 HG23 ' HG2' ' A' ' 33' ' ' LYS . 19.2 tt -56.94 -34.22 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.9 mmtt -97.45 9.2 43.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.458 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.557 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 33.3 t -97.31 130.4 46.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.63 54.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.845 HD22 HD12 ' A' ' 39' ' ' LEU . 9.3 p-10 -132.73 79.42 64.14 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.272 0.558 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 68.9 Cg_endo -74.76 -22.34 15.49 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.02 2.48 . . . . 0.0 113.518 -173.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.17 -28.14 64.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 HD22 ' A' ' 36' ' ' ASN . 57.1 mt -82.63 -5.48 58.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.974 HG23 HD13 ' A' ' 7' ' ' ILE . 39.0 mt -72.25 112.62 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.625 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -133.79 174.76 10.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.772 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 1.7 tmtp? -70.53 140.96 51.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.536 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 33.1 t70 74.94 6.14 4.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.575 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.34 152.0 27.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.146 -0.346 . . . . 0.0 110.323 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.18 136.6 40.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 110.558 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.722 HG21 HD13 ' A' ' 19' ' ' ILE . 28.5 m -130.44 158.83 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.122 0.486 . . . . 0.0 111.046 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.6 p -118.31 135.4 54.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.378 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.465 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 16.8 p90 -143.69 164.9 29.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -173.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -98.17 142.23 24.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.591 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.55 142.89 21.12 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.292 1.994 . . . . 0.0 112.95 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 13.5 t -157.85 166.63 32.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.607 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -113.9 145.48 41.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.993 0.425 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.86 177.16 7.94 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.17 -25.76 58.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.053 0.454 . . . . 0.0 109.903 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.83 -14.41 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.939 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.01 -138.43 10.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.87 139.49 34.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -144.08 168.59 19.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.235 -174.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.92 149.13 44.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.865 0.364 . . . . 0.0 111.436 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 51' ' ' THR . 16.9 p90 -134.05 -177.61 4.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.133 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.43 42.2 32.02 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.743 0.652 . . . . 0.0 110.202 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -68.1 100.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.004 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.542 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 16.6 ttmm -108.28 116.42 31.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.635 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.7 t -70.88 148.49 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.133 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.2 t -104.64 87.94 2.0 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 93.2 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 C-N-CA 122.223 1.949 . . . . 0.0 111.956 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -113.83 149.22 35.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.348 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -101.46 152.12 21.13 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.943 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -151.6 177.06 29.73 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.23 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' ILE . 3.2 m -126.9 132.14 50.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.828 ' HA ' HG12 ' A' ' 19' ' ' ILE . 62.7 mt -65.0 106.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.506 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m -95.02 -37.38 11.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.86 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -150.96 125.06 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.878 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.648 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 74.6 t-105 -143.02 131.7 22.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.4 96.2 4.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.734 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.2 -41.78 89.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -69.57 -28.03 65.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.667 ' HG2' ' HD1' ' A' ' 16' ' ' PHE . 39.6 ttmt -87.69 -38.49 15.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.936 0.398 . . . . 0.0 110.41 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 106.34 -12.78 43.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.667 ' HD1' ' HG2' ' A' ' 14' ' ' LYS . 57.6 m-85 -96.6 163.42 13.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.902 0.382 . . . . 0.0 111.356 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.76 27.27 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.117 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -139.57 131.76 28.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.828 HG12 ' HA ' ' A' ' 7' ' ' ILE . 68.0 mt -136.92 125.11 33.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.862 0.363 . . . . 0.0 110.984 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 14.1 tmtt? -86.41 125.78 33.92 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.0 p-10 -97.1 -169.51 1.87 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.833 0.825 . . . . 0.0 112.853 -169.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -77.95 -30.23 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.287 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -74.09 -36.67 64.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.741 0.305 . . . . 0.0 110.41 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.17 41.05 0.45 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.488 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.41 163.51 32.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.159 0.48 . . . . 0.0 109.943 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -110.36 115.34 29.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -101.61 153.66 19.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.417 -170.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.892 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.8 m-85 -116.65 153.93 31.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.895 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.3 t-160 -136.4 133.76 37.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.648 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 12.4 p -47.23 -31.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.3 tt -67.72 -30.15 47.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.972 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.9 mmtt -97.7 15.31 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.67 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -94.29 130.77 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.38 48.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.975 0.417 . . . . 0.0 110.948 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.499 HD22 HD12 ' A' ' 39' ' ' LEU . 22.4 p-10 -135.21 79.22 50.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.518 0.675 . . . . 0.0 111.203 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HA ' HG13 ' A' ' 40' ' ' ILE . 86.0 Cg_endo -76.95 -11.1 18.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.859 2.373 . . . . 0.0 112.247 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.39 -18.97 61.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.803 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB3' ' HG3' ' A' ' 66' ' ' PRO . 78.7 mt -106.39 12.87 29.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 34' ' ' VAL . 40.9 mt -82.82 126.48 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.0 112.183 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -139.18 168.38 19.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 12.7 tmtt? -78.88 139.85 38.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 66.7 m-20 73.97 13.04 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.706 0.803 . . . . 0.0 111.709 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -82.57 156.72 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.594 0.235 . . . . 0.0 110.673 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.72 137.88 31.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 19' ' ' ILE . 28.6 m -136.04 160.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.801 ' HB ' ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -124.23 154.46 40.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 p90 -166.45 171.47 11.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.902 0.382 . . . . 0.0 111.542 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 26.3 mm-40 -101.17 143.33 26.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.128 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.55 148.56 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.25 1.966 . . . . 0.0 112.183 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -166.29 171.1 12.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -109.54 155.4 21.43 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.572 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 23.1 t-20 -131.17 162.46 29.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.663 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -58.94 -36.35 74.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.489 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.45 -48.7 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.706 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -141.27 3.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.119 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -86.1 149.16 25.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -151.01 169.78 20.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -135.42 151.1 50.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.556 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.1 172.23 7.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.565 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 50.01 49.5 20.21 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.946 0.778 . . . . 0.0 111.297 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.585 HG21 ' HD2' ' A' ' 29' ' ' PHE . 17.9 t -76.95 109.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.001 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.801 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -109.15 128.76 55.28 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 46' ' ' VAL . 28.5 t -84.93 143.93 10.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.398 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -114.3 85.12 10.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.654 ' HG3' ' HB3' ' A' ' 39' ' ' LEU . 87.0 Cg_endo . . . . . 0 N--CA 1.447 -1.242 0 C-N-CA 123.094 2.529 . . . . 0.0 112.208 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -109.53 177.29 4.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.895 0.379 . . . . 0.0 110.946 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.85 151.43 25.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.936 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.63 165.44 23.79 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.973 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -112.37 135.35 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.921 HD13 HG23 ' A' ' 40' ' ' ILE . 51.8 mt -82.29 121.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 p -106.89 -53.45 2.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.998 0.428 . . . . 0.0 111.228 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.1 m -124.55 127.32 47.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.078 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -142.09 135.53 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.986 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.49 102.56 9.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.03 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.649 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.85 -49.0 64.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.829 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -70.92 -46.46 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.57 19.57 9.71 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.8 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.68 170.73 15.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.924 0.862 . . . . 0.0 110.661 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.41 -170.52 41.33 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.267 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -133.25 131.81 40.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.755 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.6 mt -131.26 131.17 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -100.74 120.63 40.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.8 p30 -109.6 -164.84 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.144 0.497 . . . . 0.0 111.543 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.84 -10.25 59.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.128 -171.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.29 -28.05 69.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.326 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.95 8.02 55.86 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.195 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -129.77 163.78 25.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -93.65 137.27 33.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 110.574 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' HB3' ' A' ' 57' ' ' LEU . 35.2 mtt85 -111.29 150.2 29.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.666 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -89.23 123.42 33.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.688 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.755 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 63.7 m-85 -116.74 155.64 28.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.315 0.579 . . . . 0.0 111.808 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.48 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-160 -136.49 135.17 38.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.666 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.96 -29.67 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.48 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.1 tt -63.76 -31.31 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.21 -9.01 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.667 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.872 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -91.17 134.29 30.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.261 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.36 -24.22 19.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.178 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.709 ' HB2' HG23 ' A' ' 64' ' ' VAL . 3.2 m-20 -122.38 65.49 23.13 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.849 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.04 -30.55 13.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.015 1.81 . . . . 0.0 113.656 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.13 -18.27 34.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.428 0.633 . . . . 0.0 110.152 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 87.4 mt -90.9 -8.68 48.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.921 HG23 HD13 ' A' ' 7' ' ' ILE . 54.3 mt -61.03 119.56 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.621 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -126.84 173.25 9.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -83.47 136.02 34.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 66.83 13.85 9.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.484 0.659 . . . . 0.0 111.001 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.13 156.4 17.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.671 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.7 137.65 39.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 64' ' ' VAL . 19.7 m -126.48 157.3 37.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.86 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 0.0 110.52 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.674 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 7.8 p90 -158.9 176.69 12.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.288 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.1 pm0 -111.47 143.36 28.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.1 Cg_exo -77.1 154.07 32.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.283 2.655 . . . . 0.0 113.507 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -166.89 179.4 5.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.036 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 57' ' ' LEU . 8.2 p -118.66 146.31 44.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.874 0.369 . . . . 0.0 110.447 175.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.568 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 46.4 t30 -105.88 25.87 10.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 25.2 t-20 71.36 -56.18 0.64 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.833 -174.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.7 -39.04 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.099 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.24 -156.51 12.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.109 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 84.2 mt -84.82 134.77 34.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.959 0.409 . . . . 0.0 111.125 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 7.6 m -147.92 168.74 21.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.593 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -144.08 163.85 32.36 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.739 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.38 179.5 6.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.378 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.63 41.28 31.22 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 124.124 0.89 . . . . 0.0 110.508 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 48' ' ' PHE . 22.0 t -76.77 107.61 8.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.301 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -109.05 127.73 54.36 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.965 175.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 36' ' ' ASN . 82.3 t -65.78 149.95 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.695 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.51 86.02 1.29 Allowed Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 88.1 Cg_endo . . . . . 0 N--CA 1.447 -1.233 0 C-N-CA 122.806 2.337 . . . . 0.0 112.58 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.15 157.86 20.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.491 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -96.97 147.53 23.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.922 0.391 . . . . 0.0 110.054 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.714 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.86 165.49 28.05 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.762 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 m -120.37 135.0 55.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.089 0.471 . . . . 0.0 109.843 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.953 HD13 HG23 ' A' ' 40' ' ' ILE . 51.0 mt -76.58 117.24 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.585 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -101.47 -46.57 4.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 110.93 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -124.14 123.13 39.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -132.06 116.06 16.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.038 0.447 . . . . 0.0 110.695 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 81.1 m-85 -105.19 90.35 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.5 -38.97 82.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.722 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.99 -25.71 56.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.263 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 11' ' ' PHE . 41.0 mmtm -83.73 -38.2 21.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.39 45.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.921 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 54.8 p90 -144.13 176.61 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.809 0.337 . . . . 0.0 110.849 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.78 -168.41 29.87 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.297 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -138.29 130.65 28.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.1 mt -122.54 130.65 74.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 21' ' ' ASP . 13.3 tmtt? -104.58 118.09 35.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.6 p-10 -86.57 -178.78 6.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.943 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -93.39 -2.29 54.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.011 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -112.08 -54.06 2.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.819 0.343 . . . . 0.0 111.106 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.09 -99.16 2.07 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.194 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -158.85 -159.2 0.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.54 129.93 37.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.256 0.55 . . . . 0.0 110.621 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 69.1 mtt180 -108.32 151.6 25.76 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -77.95 124.42 27.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.063 0.459 . . . . 0.0 110.251 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 49.4 m-85 -120.51 148.0 44.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.496 0.665 . . . . 0.0 110.246 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -148.83 143.72 26.49 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.785 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' CB ' ' A' ' 37' ' ' PRO . 11.1 p -49.09 -25.52 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.731 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.6 tt -65.35 -33.61 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -106.7 -1.1 23.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 40' ' ' ILE . 46.4 t -99.25 126.29 52.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.41 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.81 74.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 64' ' ' VAL . 7.9 m120 -118.36 76.4 12.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.977 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' CB ' HG23 ' A' ' 31' ' ' VAL . 63.0 Cg_endo -75.77 -24.07 11.99 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.109 1.872 . . . . 0.0 112.439 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.92 -13.64 57.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.394 0.616 . . . . 0.0 110.594 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 79.9 mt -103.13 3.91 36.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.739 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.953 HG23 HD13 ' A' ' 7' ' ' ILE . 62.9 mt -72.47 115.88 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.4 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 30.8 mmtp -120.3 154.06 35.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.619 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -71.2 132.31 44.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.31 24.23 7.44 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.793 0.683 . . . . 0.0 111.647 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -95.67 157.98 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.969 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.85 139.7 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 111.09 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.4 m -137.6 166.5 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.187 0.518 . . . . 0.0 110.967 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.1 p -131.5 134.99 46.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.634 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 10.2 p90 -156.31 164.75 37.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.982 0.42 . . . . 0.0 111.475 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.65 144.09 29.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.631 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 147.23 32.35 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.763 2.309 . . . . 0.0 113.918 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.453 ' HB ' ' CD1' ' A' ' 60' ' ' TYR . 15.1 t -154.21 139.83 17.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.736 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 p -89.13 126.79 35.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.236 0.541 . . . . 0.0 111.528 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 14.2 t-20 -86.91 167.65 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.947 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.42 -34.54 61.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.556 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -99.96 -57.48 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.357 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.69 -148.22 4.8 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.488 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.73 140.87 30.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.007 0.432 . . . . 0.0 111.112 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -149.14 168.98 21.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.61 152.17 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 52.9 p90 -124.67 172.96 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.532 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . 45.81 52.12 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 124.347 1.029 . . . . 0.0 110.828 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' HD2' ' A' ' 29' ' ' PHE . 20.9 t -76.81 111.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.402 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -97.19 119.06 34.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 95.7 t -70.63 148.21 10.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.68 89.52 2.3 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 123.304 0.378 . . . . 0.0 110.936 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.512 0 C-N-CA 122.316 2.01 . . . . 0.0 111.908 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . . . . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.637 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -112.37 169.76 8.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.973 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.67 152.45 20.48 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.925 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 m -100.13 135.83 40.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.033 0.444 . . . . 0.0 110.705 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.794 HD13 HG23 ' A' ' 40' ' ' ILE . 55.2 mt -82.47 116.41 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.781 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -103.53 -51.35 3.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 30.2 m -119.52 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.466 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 58.9 t-105 -150.74 122.18 7.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 0.0 110.904 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -130.48 87.42 2.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.611 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.35 -37.82 78.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.21 -35.03 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.842 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HE2' ' HE1' ' A' ' 16' ' ' PHE . 54.0 mtpt -90.16 -14.48 33.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.627 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.01 -4.19 62.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.199 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' HIS . 53.5 p90 -132.75 173.58 11.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.643 0.721 . . . . 0.0 111.996 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.466 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -165.28 177.82 40.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.229 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 94.0 m-85 -139.07 130.18 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.768 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 85.4 mt -136.94 135.1 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.653 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.4 tmtp? -112.53 117.65 32.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.855 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.662 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.6 p-10 -97.84 174.96 6.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -94.89 2.01 55.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.35 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 3' ' ' MET . 7.2 t30 -105.88 -50.29 3.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.59 -87.99 2.03 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.359 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -171.24 -164.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 50.6 t-20 -82.23 122.69 28.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 43.8 mtt-85 -112.22 153.89 26.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.794 0.33 . . . . 0.0 111.041 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -80.12 121.34 25.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.768 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.1 m-85 -110.13 159.57 17.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.578 ' HB3' HG22 ' A' ' 32' ' ' ILE . 10.7 t-80 -148.54 147.03 28.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.14 -10.47 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 111.407 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 30' ' ' HIS . 8.9 tt -82.84 -19.49 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.565 0.698 . . . . 0.0 110.462 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 32' ' ' ILE . 12.3 mptt -103.14 -3.49 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.657 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG11 HD11 ' A' ' 40' ' ' ILE . 25.6 t -104.71 139.4 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.84 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.71 -31.34 19.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.318 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.8 HD22 HD12 ' A' ' 39' ' ' LEU . 21.7 p-10 -132.69 77.51 69.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.393 0.616 . . . . 0.0 110.65 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.2 -19.0 13.87 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.863 2.376 . . . . 0.0 113.817 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.31 -0.83 57.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.995 0.426 . . . . 0.0 111.053 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 HD22 ' A' ' 36' ' ' ASN . 69.6 mt -102.85 0.59 32.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.657 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.798 HD11 HG11 ' A' ' 34' ' ' VAL . 58.0 mt -80.96 109.11 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.805 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -117.67 155.62 29.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.3 tmtt? -74.42 141.51 45.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 59.3 m-20 75.48 19.82 2.05 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.522 0.729 . . . . 0.0 111.442 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -103.25 165.88 10.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.235 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.45 137.61 45.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.284 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 64' ' ' VAL . 18.3 m -128.35 164.27 30.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.104 0.478 . . . . 0.0 111.484 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 p -124.36 136.86 54.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.593 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 14.4 p90 -156.2 170.08 23.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.122 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 23.8 mm-40 -93.28 140.58 23.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -84.0 135.39 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.221 2.614 . . . . 0.0 113.1 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.6 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 11.9 t -151.48 -174.45 4.84 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.543 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 12.6 t -126.37 -177.9 4.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.228 0.537 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.616 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 7.7 t-20 -145.89 -170.99 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.8 -27.2 26.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.006 0.432 . . . . 0.0 109.963 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -108.38 1.74 21.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.067 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.8 31.83 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.482 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 71.4 mt -87.52 159.02 18.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.189 0.495 . . . . 0.0 110.518 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.616 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.5 m -147.69 169.01 20.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.205 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.19 151.01 47.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.6 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 26.9 p90 -133.0 170.66 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.399 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.73 47.8 23.89 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.152 0.907 . . . . 0.0 110.175 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.18 120.59 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.104 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 127.35 48.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.271 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.858 ' HA ' HG12 ' A' ' 46' ' ' VAL . 19.2 t -67.24 154.55 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.123 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.79 84.12 5.15 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 121.07 0.462 . . . . 0.0 111.29 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 58.2 Cg_endo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 123.35 2.7 . . . . 0.0 112.213 172.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.6 mtm -111.13 167.54 10.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.208 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -112.97 152.38 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.38 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.76 172.92 30.42 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.826 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -117.6 136.35 53.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 0.0 110.242 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 40' ' ' ILE . 46.8 mt -79.88 114.45 20.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.664 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 p -102.76 -43.3 5.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.179 0.514 . . . . 0.0 110.795 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.7 m -127.21 126.01 42.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.252 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -145.22 128.1 16.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.668 0.27 . . . . 0.0 111.039 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.61 98.16 5.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.3 176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.69 -37.31 86.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.95 -42.6 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.364 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 50.7 tptt -95.7 -49.82 5.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.618 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.47 13.48 12.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.952 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 74.6 m-85 -125.69 164.36 20.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.675 0.274 . . . . 0.0 110.328 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.35 170.47 41.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.86 129.04 37.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.1 mt -128.53 130.3 69.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.367 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -89.36 123.04 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.4 p30 -91.08 175.26 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.486 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -96.48 24.98 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.53 -48.88 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.514 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.18 -71.09 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.401 -0.905 . . . . 0.0 113.986 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.38 -154.3 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.027 0.414 . . . . 0.0 110.071 -170.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -88.03 152.93 21.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 53.1 mtt-85 -124.69 147.41 48.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -86.96 113.83 23.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.93 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 34.7 m-85 -105.48 150.13 25.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.657 0.741 . . . . 0.0 111.956 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' ND1' HG22 ' A' ' 32' ' ' ILE . 2.7 t-80 -128.45 130.61 47.83 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.084 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 37' ' ' PRO . 11.1 p -47.29 -31.95 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' ND1' ' A' ' 30' ' ' HIS . 13.5 tt -75.32 -21.41 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.58 -174.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.39 1.2 57.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.117 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 21.9 t -96.67 143.12 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.28 -42.81 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.368 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 39' ' ' LEU . 13.9 p-10 -127.69 75.67 77.69 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.189 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 91.8 Cg_endo -81.17 -17.29 9.29 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.959 2.439 . . . . 0.0 113.865 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -89.92 -8.76 51.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.474 0.654 . . . . 0.0 109.871 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 36' ' ' ASN . 87.3 mt -96.1 1.29 52.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.625 177.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 7' ' ' ILE . 51.1 mt -68.38 127.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.919 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -121.06 157.72 29.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.559 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -80.94 139.65 35.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.67 56.52 1.54 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.809 0.814 . . . . 0.0 109.276 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.6 36.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.18 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.96 140.12 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -134.88 162.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -127.5 139.84 52.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 9.7 p90 -156.47 170.63 21.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.414 . . . . 0.0 111.917 -172.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 62.5 mm-40 -85.4 142.56 37.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 5.5 Cg_exo -78.93 133.96 11.53 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.505 2.136 . . . . 0.0 111.287 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 60' ' ' TYR . 9.5 t -165.94 152.09 9.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -129.56 145.97 51.42 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.03 -69.85 0.78 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -175.33 -54.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.362 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.79 17.69 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.703 -175.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.49 171.76 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.333 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.84 155.93 37.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -148.03 169.14 20.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.803 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -148.92 143.14 26.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.468 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 51' ' ' THR . 22.8 m-85 -122.07 168.49 11.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.98 37.97 26.76 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.626 0.579 . . . . 0.0 110.79 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' HG13 ' A' ' 34' ' ' VAL . 18.4 t -67.86 114.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.158 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -115.95 117.85 31.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.587 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.9 t -79.98 146.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.487 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -111.56 86.24 6.69 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.2 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 C-N-CA 123.079 2.519 . . . . 0.0 111.852 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.28 153.81 17.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.1 p-10 -107.88 139.92 41.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 110.759 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.31 166.4 23.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.442 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 p -109.67 137.8 46.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.039 0.447 . . . . 0.0 111.315 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 HD13 HG12 ' A' ' 19' ' ' ILE . 21.5 mm -63.83 115.87 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.474 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.452 ' O ' ' HE3' ' A' ' 42' ' ' LYS . 29.3 p -110.59 -47.13 3.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.123 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -122.5 125.76 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.98 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -156.04 133.27 10.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.708 0.289 . . . . 0.0 110.578 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 86.4 m-85 -123.47 115.68 21.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.29 -51.87 61.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.966 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.43 -8.36 59.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 111.268 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 11' ' ' PHE . 70.2 mmtt -85.73 -39.88 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.863 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.13 9.21 65.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.045 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 41.1 p90 -135.47 169.13 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.043 0.422 . . . . 0.0 110.732 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.17 -170.93 41.73 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.112 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -136.58 134.91 37.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.629 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 90.8 mt -126.68 129.75 71.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.276 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -92.27 117.58 30.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.645 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 4.9 p-10 -102.43 -173.37 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 111.797 -173.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 40.9 mt-10 -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.073 -174.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -70.0 -25.62 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.981 0.419 . . . . 0.0 110.23 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.59 -18.49 9.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.568 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 -163.13 0.86 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.38 0.59 . . . . 0.0 110.13 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -121.62 147.91 45.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CZ ' HD13 ' A' ' 57' ' ' LEU . 8.2 mpt_? -111.52 146.89 36.5 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.202 170.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -85.68 120.83 27.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 53.9 m-85 -109.87 154.85 22.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.414 0.626 . . . . 0.0 111.672 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -144.8 134.86 23.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.093 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.39 -27.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.513 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -64.68 -25.72 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.606 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.5 mmtt -101.52 11.64 38.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.161 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 40' ' ' ILE . 61.1 t -97.95 127.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.077 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.82 -30.53 32.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.558 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.658 HD22 HD12 ' A' ' 39' ' ' LEU . 13.8 p-10 -142.06 81.4 14.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.177 0.513 . . . . 0.0 111.602 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.1 -19.04 23.31 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.739 2.293 . . . . 0.0 112.948 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.55 -23.31 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.352 0.596 . . . . 0.0 110.617 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.658 HD12 HD22 ' A' ' 36' ' ' ASN . 81.2 mt -101.89 9.68 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.091 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.712 HD11 HG11 ' A' ' 34' ' ' VAL . 51.2 mt -81.41 118.49 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.86 159.7 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 8' ' ' THR . 85.0 tttt -78.16 146.12 35.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 t70 72.42 3.76 4.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.56 156.32 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.222 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' GLY . . . -97.78 139.15 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 19' ' ' ILE . 32.9 m -128.53 148.6 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.224 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -110.86 134.6 52.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.012 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.6 p90 -147.79 167.45 24.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.956 0.408 . . . . 0.0 111.609 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 54.2 mm-40 -92.36 142.51 26.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.613 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -82.95 133.92 6.9 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.783 2.322 . . . . 0.0 112.301 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.3 t -152.96 161.38 42.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -101.64 147.61 26.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.291 0.567 . . . . 0.0 111.205 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -113.95 156.88 23.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.729 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -55.35 -33.72 63.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 111.461 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -101.8 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.596 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.0 -135.95 2.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.115 -172.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.45 HD13 ' CZ ' ' A' ' 27' ' ' ARG . 91.7 mt -102.59 151.33 22.46 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.696 0.284 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -145.55 167.49 22.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 111.003 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -140.93 148.89 41.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.553 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -117.84 170.97 8.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.206 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 46.95 53.72 10.13 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.095 0.872 . . . . 0.0 111.37 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 36.5 t -70.95 100.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.1 0.476 . . . . 0.0 110.234 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 34.3 ttmt -118.24 117.09 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.119 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.581 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 21.8 t -69.66 151.58 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.819 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.7 t -103.34 88.26 1.61 Allowed Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.1 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 123.329 2.686 . . . . 0.0 113.215 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -97.74 157.12 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.0 111.163 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.65 130.37 42.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.234 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.95 171.89 23.92 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.077 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -132.77 139.66 47.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.48 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.1 mt -76.85 106.01 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.079 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -95.69 -61.45 1.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.986 0.422 . . . . 0.0 110.603 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -98.76 118.22 35.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.337 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -140.68 127.36 20.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.878 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -116.87 89.77 3.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.352 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.1 -34.32 77.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.641 0.734 . . . . 0.0 110.092 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.39 -21.74 64.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.511 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.898 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.89 -45.7 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.225 -0.297 . . . . 0.0 111.302 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.29 1.3 20.39 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.555 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.565 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 56.0 p90 -140.4 175.57 9.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.09 0.445 . . . . 0.0 110.889 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.98 -161.32 26.41 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.115 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -137.37 129.72 29.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.092 0.473 . . . . 0.0 109.792 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.727 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.0 mt -116.66 131.07 70.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 13.9 tttp -106.07 130.67 53.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.83 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.9 p30 -92.76 175.92 6.63 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.74 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -100.76 16.97 23.25 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.535 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -114.84 -43.91 3.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.045 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.11 -80.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.09 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 11.8 t70 -161.23 -160.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 3.6 p-10 -99.24 154.21 18.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.35 163.64 20.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -178.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.76 128.7 34.27 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.727 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 58.5 m-85 -127.43 157.24 40.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.333 0.587 . . . . 0.0 111.193 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.565 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 54.7 t-80 -148.25 150.03 32.95 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.98 27.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.523 0.678 . . . . 0.0 112.793 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.446 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.8 tt -118.35 -32.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.514 -0.741 . . . . 0.0 110.902 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 32' ' ' ILE . 34.5 mmtp -95.21 5.27 52.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 110.902 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 36' ' ' ASN . 45.3 t -94.14 129.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.388 176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 -15.46 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 64' ' ' VAL . 5.4 m-20 -122.08 65.66 21.35 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.981 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 71.9 Cg_endo -75.3 -11.93 20.94 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.057 1.838 . . . . 0.0 111.772 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -84.57 -17.89 37.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.22 12.47 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.674 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.8 mt -75.19 134.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -161.18 170.62 19.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.168 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 8.3 tmtm? -74.69 137.88 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.758 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 7.5 t70 69.98 13.15 7.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.367 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.76 143.81 35.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.301 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 138.68 32.51 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 64' ' ' VAL . 20.5 m -138.4 163.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.23 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -128.02 134.23 49.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.215 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.71 172.36 16.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.31 141.73 24.99 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.74 160.27 6.27 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.815 2.343 . . . . 0.0 113.833 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.803 ' HB ' ' HE2' ' A' ' 60' ' ' TYR . 14.5 t -164.64 -179.46 5.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.747 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -134.62 148.29 50.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.114 0.483 . . . . 0.0 110.052 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.49 -179.91 4.51 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -72.25 -28.06 62.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.285 0.565 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 52.1 mmtt -74.39 -42.81 58.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.338 175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.88 -153.56 23.59 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.597 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD13 HH12 ' A' ' 27' ' ' ARG . 68.7 mt -73.54 134.49 43.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 5.5 m -143.65 167.87 21.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.944 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.56 160.9 40.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.942 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.803 ' HE2' ' HB ' ' A' ' 51' ' ' THR . 29.0 p90 -141.1 175.31 9.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.44 48.78 21.89 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.07 0.856 . . . . 0.0 110.706 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' HG13 ' A' ' 34' ' ' VAL . 14.5 t -83.6 111.84 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.317 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.14 126.76 51.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.827 0.346 . . . . 0.0 110.097 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 46' ' ' VAL . 81.7 t -70.26 144.26 13.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.257 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -110.64 85.28 4.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.736 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 9.9 Cg_endo . . . . . 0 N--CA 1.451 -1.007 0 C-N-CA 123.069 2.513 . . . . 0.0 111.705 174.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ttm -147.94 165.94 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.371 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.53 146.68 46.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.349 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.27 162.28 27.22 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.22 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' HG23 ' A' ' 19' ' ' ILE . 9.0 m -114.1 134.78 54.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.927 HD13 HG23 ' A' ' 40' ' ' ILE . 55.6 mt -73.81 121.14 24.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.704 -174.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -117.17 -56.1 2.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -117.65 122.73 44.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.042 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -140.79 114.37 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.944 0.402 . . . . 0.0 110.454 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 87.8 m-85 -89.61 83.18 6.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.844 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.54 -42.34 95.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.553 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -84.9 -47.8 9.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.343 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.91 8.91 8.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.314 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -138.35 172.51 12.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.316 0.558 . . . . 0.0 110.648 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.02 -171.22 38.21 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -137.37 129.35 29.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 66.1 mt -123.84 132.13 71.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.04 117.16 20.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.422 . . . . 0.0 110.617 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HB3' ' H ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -77.05 -168.52 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.93 0.871 . . . . 0.0 111.732 -174.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.59 -15.78 53.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.755 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.714 ' H ' ' HB3' ' A' ' 21' ' ' ASP . 46.9 m-80 -76.67 -14.63 59.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.644 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.44 -31.82 7.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.201 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.9 -175.55 2.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -109.46 147.94 32.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -171.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.631 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 49.3 mtt-85 -97.91 160.47 14.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.476 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.66 106.13 16.72 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 35.3 m-85 -96.97 154.94 17.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.282 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 32' ' ' ILE . 25.4 t-80 -149.12 133.48 17.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.561 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.68 -36.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.611 HG23 ' HG2' ' A' ' 33' ' ' LYS . 17.6 tt -61.26 -26.72 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.153 0.502 . . . . 0.0 111.939 -175.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.5 mmtt -104.88 9.16 34.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.384 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 40' ' ' ILE . 39.3 t -106.61 127.63 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.89 70.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.184 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -134.71 71.95 69.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.056 0.455 . . . . 0.0 111.427 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.39 -20.39 27.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.578 2.185 . . . . 0.0 112.657 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -80.88 -16.23 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.618 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.69 3.82 53.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.05 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.927 HG23 HD13 ' A' ' 7' ' ' ILE . 52.9 mt -73.9 110.07 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.381 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -117.64 -176.81 3.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.243 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -87.81 147.75 25.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.564 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.99 9.39 6.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.92 0.763 . . . . 0.0 111.104 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -90.3 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.48 151.88 20.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.342 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.2 m -129.94 164.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.433 0.635 . . . . 0.0 111.461 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -127.11 134.9 50.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.887 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.52 174.72 14.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.357 . . . . 0.0 111.667 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.82 142.01 23.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.257 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -86.81 138.88 5.31 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 167.79 27.8 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 131.86 41.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.22 24.14 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.51 -43.57 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.894 0.878 . . . . 0.0 111.811 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.92 -32.56 73.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.699 0.285 . . . . 0.0 110.777 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.74 -176.54 44.06 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.283 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.1 mt -79.09 138.16 37.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.435 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 2.0 p -151.13 169.05 22.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.122 0.487 . . . . 0.0 111.305 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HB2' ' HD2' ' A' ' 27' ' ' ARG . . . -143.35 148.41 36.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -131.79 175.11 9.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.76 32.63 22.4 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 124.016 0.822 . . . . 0.0 109.861 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.77 114.98 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.325 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -116.47 119.97 37.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' HG12 ' A' ' 46' ' ' VAL . 43.0 t -72.73 151.14 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.749 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.57 87.52 1.79 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.807 0.337 . . . . 0.0 110.235 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.3 Cg_endo . . . . . 0 N--CA 1.457 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 111.726 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.278 0.561 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 35.0 ttm -115.44 167.89 10.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.8 p-10 -127.93 141.18 51.61 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.056 0.455 . . . . 0.0 111.156 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -144.98 177.77 23.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.394 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 19' ' ' ILE . 6.6 m -122.92 135.27 54.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.8 0.333 . . . . 0.0 110.107 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.954 HD13 HG23 ' A' ' 40' ' ' ILE . 56.4 mt -74.28 122.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -114.27 -58.14 2.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 17.3 m -114.88 129.72 56.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.082 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.436 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 76.5 t-105 -152.89 130.14 11.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.42 97.47 5.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.87 -42.54 98.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.424 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.02 -43.64 70.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.764 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 16' ' ' PHE . 8.2 mmpt? -66.79 -39.77 87.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.82 -3.94 57.55 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.079 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.593 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 64.9 m-85 -95.48 156.81 16.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -163.51 157.31 29.45 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.0 m-85 -136.23 126.66 26.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 80.6 mt -134.07 133.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -102.95 129.02 49.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.5 p-10 -89.68 179.26 6.06 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.517 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.67 -8.53 58.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.75 -43.76 5.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.65 -98.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.103 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.2 -178.99 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.612 -0.346 . . . . 0.0 110.249 -164.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.91 122.87 20.74 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.322 0.582 . . . . 0.0 110.544 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -108.4 151.65 25.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.8 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -77.88 122.29 25.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.375 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 17.2 m-85 -112.55 153.21 27.86 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.318 0.58 . . . . 0.0 110.283 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 32' ' ' ILE . 3.7 t-80 -133.92 131.04 38.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.843 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 14.7 p -49.7 -26.72 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG22 ' ND1' ' A' ' 30' ' ' HIS . 12.3 tt -79.16 -20.37 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.459 0.647 . . . . 0.0 111.377 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' A' ' 32' ' ' ILE . 66.2 mmtt -102.69 10.77 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.013 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 34.6 t -101.66 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.643 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.11 -33.82 72.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.559 HD22 HD12 ' A' ' 39' ' ' LEU . 12.6 p-10 -141.75 74.63 22.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.076 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HA ' HG13 ' A' ' 40' ' ' ILE . 70.5 Cg_endo -75.02 -16.98 19.87 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.787 2.325 . . . . 0.0 112.983 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.28 -22.61 57.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.298 0.57 . . . . 0.0 110.434 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.559 HD12 HD22 ' A' ' 36' ' ' ASN . 92.3 mt -97.93 5.17 49.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.439 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 7' ' ' ILE . 33.0 mt -73.02 120.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.089 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -135.75 164.89 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.472 173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.616 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 2.4 tmtp? -68.98 142.53 54.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 30.6 t70 75.72 4.63 3.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.901 0.75 . . . . 0.0 111.38 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.38 147.29 29.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.14 -0.35 . . . . 0.0 110.233 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 140.67 29.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.614 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.6 m -132.28 151.15 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' MET . 11.5 p -118.91 135.23 54.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.804 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.564 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.4 p90 -154.1 173.18 16.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 0.0 111.76 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -99.83 142.89 25.45 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.635 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.29 143.99 12.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.468 2.112 . . . . 0.0 112.691 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 60' ' ' TYR . 11.6 t -165.12 176.46 8.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.292 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -113.35 143.75 43.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.146 0.498 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -100.89 16.7 24.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.753 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 73.59 -47.19 0.65 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -107.3 26.14 10.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.863 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.15 -171.21 34.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.951 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 145.78 25.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -148.03 169.98 18.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.811 0.339 . . . . 0.0 111.037 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.77 149.73 52.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.96 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 51' ' ' THR . 27.6 m-85 -114.37 172.37 7.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.96 41.27 26.91 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.973 0.795 . . . . 0.0 111.79 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 20.8 t -68.15 103.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.103 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -107.12 117.29 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.931 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 40' ' ' ILE . 22.3 t -87.67 140.17 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -176.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.23 88.44 2.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.108 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.573 -175.41 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.836 0.35 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.492 ' HE1' ' HB2' ' A' ' 22' ' ' GLU . 77.2 mtp -113.21 158.26 20.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 4.4 p-10 -106.11 140.47 39.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.232 0.539 . . . . 0.0 111.181 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.58 170.43 23.93 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.35 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -117.94 134.97 54.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.14 0.495 . . . . 0.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 40' ' ' ILE . 48.2 mt -77.79 120.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.391 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -107.74 -52.11 2.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 m -121.36 127.72 51.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.455 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -138.67 117.61 12.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.787 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 93.4 m-85 -90.76 88.37 7.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.3 -33.05 74.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.123 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.17 -31.66 72.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.79 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.787 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -92.46 -60.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.029 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.64 14.16 3.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.668 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.27 172.55 12.52 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.527 -0.396 . . . . 0.0 110.197 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.19 -163.27 24.91 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.505 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.55 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 85.2 m-85 -141.4 132.84 26.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 74.4 mt -130.87 139.43 51.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.301 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HE3' ' HA2' ' A' ' 24' ' ' GLY . 1.2 tmtp? -100.1 118.71 37.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.522 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 6.8 p-10 -102.22 -171.9 2.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.318 0.58 . . . . 0.0 111.288 -176.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 44.8 mt-10 -66.28 -23.34 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.449 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -70.53 -13.34 62.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.855 0.359 . . . . 0.0 110.992 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 20' ' ' LYS . . . 85.97 24.75 40.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.787 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -127.3 -177.47 4.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 18' ' ' PHE . 28.3 t-20 -127.54 120.67 28.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 51.0 mtt-85 -105.17 153.43 21.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.205 -172.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -80.44 115.97 20.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.739 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 23.9 m-85 -107.42 152.92 23.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.2 t-160 -150.47 138.45 20.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.231 -175.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.71 -31.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.1 tt -63.42 -27.63 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.051 0.453 . . . . 0.0 111.943 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.3 mmtt -102.28 7.25 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.502 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 40' ' ' ILE . 21.8 t -106.66 130.45 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.774 0.321 . . . . 0.0 110.198 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.07 -35.17 59.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -137.99 70.57 49.42 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.399 0.619 . . . . 0.0 111.026 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HA ' HG13 ' A' ' 40' ' ' ILE . 73.0 Cg_endo -74.16 -10.71 22.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.003 2.469 . . . . 0.0 112.236 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.37 -25.04 63.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.31 8.61 40.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.016 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 7' ' ' ILE . 43.8 mt -75.72 124.0 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.228 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.556 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 15.3 ptpt -144.63 163.74 33.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.158 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 1.4 tmtp? -72.73 140.56 47.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 35.1 t70 75.1 18.79 2.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.859 0.725 . . . . 0.0 110.89 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -100.93 149.38 23.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.23 137.5 32.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.237 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.9 m -132.6 147.59 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.874 0.369 . . . . 0.0 111.097 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.5 p -111.28 135.26 52.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.738 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 6.3 p90 -156.18 172.66 18.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 29.6 mm-40 -96.72 141.86 23.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_endo -89.02 136.38 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.847 2.365 . . . . 0.0 112.164 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.526 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 14.2 t -153.06 -177.0 6.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.036 0.446 . . . . 0.0 110.133 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -128.21 142.34 51.2 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 8.8 t-20 -105.8 170.05 8.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.54 -33.41 73.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.853 0.358 . . . . 0.0 110.732 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -119.56 26.76 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.82 176.17 22.71 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.687 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 57' ' ' LEU . 4.0 mp -79.28 143.7 35.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.834 0.317 . . . . 0.0 110.171 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p -151.76 170.22 20.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.222 0.534 . . . . 0.0 111.386 -172.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -136.7 148.51 47.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.162 175.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.526 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 29.6 p90 -130.3 177.38 7.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.71 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.1 35.5 26.4 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.004 0.815 . . . . 0.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . 26.1 t -67.46 112.24 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.356 -174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.57 117.22 30.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.504 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 46' ' ' VAL . 41.7 t -70.67 137.38 24.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.347 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.3 85.71 16.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.659 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 5.9 Cg_exo . . . . . 0 C--N 1.343 0.286 0 C-N-CA 123.276 2.65 . . . . 0.0 111.67 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.5 mtp -105.71 159.22 16.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.185 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.77 142.43 31.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.428 0.633 . . . . 0.0 111.12 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -138.46 167.39 25.02 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.046 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -110.64 137.87 47.76 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.135 0.493 . . . . 0.0 110.734 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 HG23 ' A' ' 40' ' ' ILE . 58.2 mt -79.19 117.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.714 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.5 p -108.68 -43.55 4.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.25 0.548 . . . . 0.0 111.227 -175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.5 m -136.55 122.14 19.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.766 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 71.0 t-105 -139.54 130.78 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.623 0.249 . . . . 0.0 110.58 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.54 90.59 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.96 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.631 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.6 tmtt? -67.08 -26.36 66.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.47 -20.72 36.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.081 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -97.07 -44.67 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.578 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.72 -2.82 10.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.511 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 40.0 p90 -148.42 177.89 9.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.568 0.684 . . . . 0.0 111.646 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.15 -164.05 28.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.242 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.93 131.25 42.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.1 mt -130.17 129.94 65.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -103.47 124.33 48.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.507 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 9.4 p-10 -95.34 -175.98 3.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.029 0.442 . . . . 0.0 110.687 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.2 -7.46 51.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.522 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . 5.7 t-20 -95.84 -58.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.682 0.277 . . . . 0.0 111.213 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.69 -92.19 2.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.678 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -164.33 -154.31 0.24 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -72.81 135.79 45.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 109.785 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 42.2 mtt180 -114.34 148.9 36.86 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.666 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -85.16 115.86 23.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 51.2 m-85 -109.94 161.8 15.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.71 138.52 24.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.63 -28.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -61.68 -26.85 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 111.794 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 32' ' ' ILE . 33.9 mmtp -99.93 7.39 44.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.589 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 40' ' ' ILE . 29.0 t -100.8 123.92 54.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.19 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.291 -176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.754 HD22 HD12 ' A' ' 39' ' ' LEU . 12.2 p-10 -134.27 78.25 58.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.359 0.6 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.18 -19.66 13.38 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.966 2.444 . . . . 0.0 114.195 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.54 -2.95 58.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.067 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.754 HD12 HD22 ' A' ' 36' ' ' ASN . 59.8 mt -99.08 -1.71 38.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.145 0.498 . . . . 0.0 109.855 174.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.702 HG23 HD13 ' A' ' 7' ' ' ILE . 52.7 mt -71.74 122.59 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.443 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.32 165.25 17.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.881 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -78.4 148.28 33.73 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.082 0.468 . . . . 0.0 111.613 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 61.52 26.73 16.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.172 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 165.01 11.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.702 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.51 138.83 39.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 111.141 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 64' ' ' VAL . 27.3 m -131.54 152.11 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -110.97 134.73 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.993 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 9.1 p90 -151.95 165.6 34.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.017 0.437 . . . . 0.0 111.469 -175.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.24 141.32 24.9 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -88.66 139.34 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.313 2.675 . . . . 0.0 113.488 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -150.55 173.82 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 151.7 48.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.96 0.41 . . . . 0.0 110.84 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.47 177.31 7.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -74.97 -11.5 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -95.18 -2.83 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.4 -140.41 12.26 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.794 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.31 144.57 27.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.213 0.53 . . . . 0.0 110.71 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -143.61 168.79 19.05 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.44 168.05 24.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.697 0.284 . . . . 0.0 111.291 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -148.72 -179.96 7.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.64 41.57 28.23 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.785 0.678 . . . . 0.0 110.521 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.6 t -70.23 101.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.364 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 19.4 ttmm -101.68 114.27 28.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.593 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.3 t -77.57 134.85 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.903 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.71 86.11 5.43 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 85.2 Cg_endo . . . . . 0 N--CA 1.451 -0.973 0 C-N-CA 123.053 2.502 . . . . 0.0 113.396 -174.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.429 ' HE3' ' HB3' ' A' ' 23' ' ' ASN . 60.7 mtp -115.34 154.18 29.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.549 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -118.08 139.96 50.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -146.5 176.58 25.34 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.869 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -116.6 140.13 49.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.3 mt -79.14 116.76 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.189 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -108.77 -63.27 1.36 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 m -102.91 129.05 49.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.29 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -147.03 135.01 21.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.759 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 89.2 m-85 -126.27 113.12 16.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.301 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -60.86 -64.07 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 -176.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.68 -17.02 61.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.336 -170.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 6.7 mmpt? -81.28 -35.62 30.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.944 173.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.26 15.16 62.84 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.266 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 43.9 p90 -145.34 175.39 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.478 -0.425 . . . . 0.0 110.605 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.63 -167.96 34.05 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.571 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.76 125.37 28.38 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.739 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.2 mt -120.85 129.2 75.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.865 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -107.45 126.49 52.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.216 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.631 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 5.0 p-10 -96.05 175.45 6.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.791 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -103.3 13.82 32.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB3' ' HE3' ' A' ' 3' ' ' MET . 8.2 t30 -107.09 -47.51 3.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.453 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.35 -83.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.34 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -169.15 -164.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -82.83 131.29 35.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -124.64 150.37 46.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 111.237 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -78.48 127.1 31.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.547 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.7 m-85 -120.62 156.56 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.656 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-80 -141.39 141.22 33.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.08 -31.26 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.627 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.2 tt -70.98 -21.26 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.672 0.749 . . . . 0.0 110.631 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.7 -11.52 59.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.058 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.868 HG11 HD11 ' A' ' 40' ' ' ILE . 23.3 t -91.11 138.44 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.31 -36.13 22.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.673 HD22 HD12 ' A' ' 39' ' ' LEU . 10.6 p-10 -129.25 85.35 59.71 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.772 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.7 -31.63 5.22 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.742 2.961 . . . . 0.0 112.692 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.93 -25.47 68.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.673 HD12 HD22 ' A' ' 36' ' ' ASN . 87.9 mt -95.77 5.25 51.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.612 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.868 HD11 HG11 ' A' ' 34' ' ' VAL . 36.2 mt -75.66 124.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.141 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 18.0 ptpt -143.68 164.57 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.165 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -78.92 151.42 31.72 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.27 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 71.68 4.04 4.89 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.432 1.083 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.485 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -85.09 158.45 20.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.757 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.17 136.0 39.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 64' ' ' VAL . 29.0 m -132.25 156.08 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -117.59 135.16 54.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.097 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.5 p90 -151.6 177.03 10.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.612 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -121.93 144.7 41.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.0 145.94 32.03 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.993 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -150.09 152.78 35.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -91.01 150.7 21.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.223 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 4.8 t-20 -127.15 159.18 35.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -70.35 -32.75 70.59 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.902 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 50.7 pttt -101.93 6.43 41.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -154.28 25.25 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.145 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.61 146.45 27.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.808 0.337 . . . . 0.0 110.461 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.9 p -145.07 169.41 18.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.09 0.471 . . . . 0.0 111.581 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -141.95 154.14 44.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.599 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -132.12 -175.93 3.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.21 50.52 18.84 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.005 0.816 . . . . 0.0 111.136 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -72.86 104.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.949 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -103.62 111.83 24.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.89 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HA ' HG12 ' A' ' 46' ' ' VAL . 59.0 t -72.58 142.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.881 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -105.13 88.42 2.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.1 Cg_exo . . . . . 0 N--CA 1.458 -0.616 0 C-N-CA 122.363 2.042 . . . . 0.0 111.069 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.62 150.52 28.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.98 158.2 16.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.574 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -152.19 172.51 31.44 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 176.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.2 m -122.18 130.88 53.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.864 0.332 . . . . 0.0 110.196 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.866 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.5 mt -67.7 105.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.304 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -95.4 -36.29 11.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.886 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 31.7 m -144.87 136.97 25.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -145.59 126.02 14.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.042 0.448 . . . . 0.0 111.368 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -119.87 95.53 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.84 -41.0 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.96 -37.09 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.081 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.724 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 18.6 tptm -86.26 -30.4 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.02 5.59 65.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.542 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.724 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 84.1 m-85 -119.21 162.36 18.81 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.669 -0.313 . . . . 0.0 110.604 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.23 173.12 39.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.223 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.9 m-85 -131.05 131.41 44.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.866 HG12 ' HA ' ' A' ' 7' ' ' ILE . 82.2 mt -136.4 130.56 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.98 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -91.73 139.52 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.6 p-10 -115.87 -164.65 0.97 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.388 0.613 . . . . 0.0 111.88 -171.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -62.97 -32.28 73.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.566 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.25 -33.81 75.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 26.71 9.19 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.099 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t70 -135.15 177.53 7.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -96.07 139.89 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.106 0.479 . . . . 0.0 110.383 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 52.9 mtt-85 -118.2 138.99 51.94 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.47 119.54 25.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.556 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.817 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 66.3 m-85 -111.66 160.17 17.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.625 0.726 . . . . 0.0 112.099 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CD2' HG22 ' A' ' 32' ' ' ILE . 4.4 t60 -141.75 142.31 33.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.984 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -48.94 -34.39 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.698 HG22 ' CD2' ' A' ' 30' ' ' HIS . 18.4 tt -62.54 -25.38 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.565 0.697 . . . . 0.0 111.363 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.785 ' HG3' ' HA ' ' A' ' 60' ' ' TYR . 7.6 mptt -77.52 -22.48 51.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.241 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 23.9 t -93.8 134.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.606 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.03 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.675 HD22 HD12 ' A' ' 39' ' ' LEU . 14.8 p-10 -127.88 77.04 76.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.095 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 40' ' ' ILE . 59.9 Cg_endo -73.12 -23.47 18.12 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.9 2.4 . . . . 0.0 113.273 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.1 -29.11 68.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.459 0.647 . . . . 0.0 111.074 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.675 HD12 HD22 ' A' ' 36' ' ' ASN . 81.3 mt -92.8 4.97 52.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.36 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 7' ' ' ILE . 40.0 mt -69.93 110.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.974 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.58 158.09 25.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.986 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 144.71 33.44 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.148 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.43 11.02 8.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.517 0.675 . . . . 0.0 110.551 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.59 154.76 19.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.8 143.37 26.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.794 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.5 m -134.32 164.14 35.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.408 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.25 153.58 45.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -167.77 177.07 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 41.1 mt-10 -110.46 142.78 26.76 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.4 Cg_endo -84.97 142.47 8.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.214 2.609 . . . . 0.0 113.219 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 t -144.86 162.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -104.19 149.46 25.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.943 0.402 . . . . 0.0 110.73 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 6.3 t-20 -139.68 154.79 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -66.95 -31.35 71.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -82.4 -18.09 43.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.85 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.04 -163.26 31.33 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.648 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' ASP . 83.9 mt -73.05 140.53 47.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.069 0.435 . . . . 0.0 110.407 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.4 p -135.0 167.22 21.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.82 0.343 . . . . 0.0 110.691 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.95 159.31 44.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.785 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 43.2 p90 -143.87 -178.61 6.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 123.31 0.381 . . . . 0.0 110.005 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.29 39.4 30.19 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.701 0.626 . . . . 0.0 110.249 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -78.74 119.03 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.403 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.0 127.05 55.43 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.794 ' HA ' HG12 ' A' ' 46' ' ' VAL . 27.9 t -77.87 142.63 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.214 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.7 86.81 3.13 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.397 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 94.2 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 122.726 2.284 . . . . 0.0 112.5 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -118.5 164.21 15.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.136 0.494 . . . . 0.0 111.199 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -115.01 152.76 31.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.468 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.22 -178.5 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.514 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -125.47 136.71 53.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.165 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.821 HD13 HG23 ' A' ' 40' ' ' ILE . 44.0 mt -77.11 115.63 19.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.263 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -104.28 -40.32 6.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.166 0.507 . . . . 0.0 111.431 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 m -136.97 114.77 11.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.451 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.702 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 75.9 t-105 -130.62 136.48 48.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.057 0.455 . . . . 0.0 111.493 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.35 97.12 5.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.702 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.1 tmtp? -67.75 -33.09 74.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 110.005 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.32 -35.7 81.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.034 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.927 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.5 mmpt? -88.9 -30.09 19.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.37 9.58 57.77 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 48.6 p90 -144.39 174.65 10.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.964 0.412 . . . . 0.0 111.026 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.66 -172.63 37.86 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.069 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -134.78 126.84 29.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.734 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 79.3 mt -123.64 131.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.887 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.57 119.84 31.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.506 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.98 177.42 7.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.491 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -81.2 -5.98 58.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.335 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.34 -35.03 18.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.234 0.54 . . . . 0.0 109.563 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.76 22.65 2.69 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.017 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -108.03 164.09 12.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.397 0.598 . . . . 0.0 110.485 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -116.89 115.62 25.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -111.11 148.66 32.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.712 -172.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -81.52 122.13 27.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.7 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 30.7 m-85 -111.72 154.85 24.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.531 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.576 ' ND1' HG22 ' A' ' 32' ' ' ILE . 17.4 t-80 -141.32 133.12 27.35 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.14 -29.7 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.576 HG22 ' ND1' ' A' ' 30' ' ' HIS . 19.1 tt -67.06 -29.33 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.276 0.56 . . . . 0.0 111.225 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -82.3 -4.32 56.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.204 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 40' ' ' ILE . 22.0 t -95.84 133.31 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.173 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.27 -42.78 22.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -125.43 73.88 68.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 40' ' ' ILE . 56.0 Cg_endo -70.65 -15.86 33.79 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.548 2.166 . . . . 0.0 112.262 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.93 -10.63 60.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.603 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 66' ' ' PRO . 95.6 mt -108.22 7.97 27.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.821 HG23 HD13 ' A' ' 7' ' ' ILE . 50.7 mt -78.67 114.75 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.39 0.614 . . . . 0.0 111.63 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 48.9 mtpt -124.29 167.78 13.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.59 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.99 135.25 34.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.49 21.56 2.28 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 0.0 109.795 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -98.81 146.58 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.413 177.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.62 29.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.197 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.701 HG21 HD13 ' A' ' 19' ' ' ILE . 23.6 m -136.56 156.0 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.7 p -121.71 135.18 54.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.761 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.59 179.98 7.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.613 0.244 . . . . 0.0 110.924 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.5 pt-20 -125.83 142.88 43.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 171.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_exo -74.41 145.4 33.86 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.059 2.506 . . . . 0.0 113.481 -174.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 58' ' ' SER . 9.0 t -139.17 156.95 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -113.63 127.26 55.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.431 0.634 . . . . 0.0 112.111 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -108.38 161.22 15.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.596 171.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -71.45 -13.43 61.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.099 0.476 . . . . 0.0 110.309 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.78 -19.95 25.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.108 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.08 -162.31 31.27 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.969 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -85.47 138.01 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 111.057 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 51' ' ' THR . 5.4 m -137.89 169.64 17.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.337 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -139.94 152.78 46.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.731 0.301 . . . . 0.0 110.679 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 1.6 p90 -139.67 -179.22 5.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.221 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.25 48.31 22.38 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.921 0.763 . . . . 0.0 110.041 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 24.9 t -75.9 112.67 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 39.6 mtmt -113.49 109.89 19.39 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.001 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.666 ' HA ' HG12 ' A' ' 46' ' ' VAL . 56.1 t -66.45 152.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.08 88.7 2.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 39' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.727 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . 68.9 113.54 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 124.035 0.835 . . . . 0.0 111.459 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -115.92 157.95 23.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.384 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -98.02 130.08 44.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.87 162.88 24.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.34 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -110.14 138.69 46.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.046 0.45 . . . . 0.0 110.134 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.863 HD13 HG23 ' A' ' 40' ' ' ILE . 53.0 mt -79.51 114.81 20.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.206 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -113.08 -55.45 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 111.04 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 m -104.51 124.51 49.4 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -160.06 126.79 4.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.98 102.13 10.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 2.5 tmtp? -73.83 -30.38 62.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.524 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.28 -42.06 94.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 0.0 110.672 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -90.38 -51.57 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 37.43 1.41 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.417 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 36.9 p90 -148.83 167.08 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.383 0.592 . . . . 0.0 110.819 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.53 -160.27 32.21 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.062 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.91 127.86 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.695 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.4 132.51 66.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.501 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -111.71 130.18 55.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 13.3 p-10 -91.85 -170.69 2.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.47 -9.0 19.69 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.105 0.478 . . . . 0.0 110.853 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -97.2 -44.85 6.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 -100.19 2.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.356 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -166.81 -160.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.49 135.93 36.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.555 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 63.2 mtt85 -117.75 156.73 27.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.692 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -79.86 117.48 20.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.101 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.695 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.1 m-85 -113.18 156.13 23.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.406 0.622 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 20.0 t-80 -148.89 138.23 21.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.931 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -49.19 -30.93 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' HG2' ' A' ' 33' ' ' LYS . 14.8 tt -61.94 -30.04 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 112.011 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.7 mmtt -93.69 10.26 33.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.739 HG11 HD11 ' A' ' 40' ' ' ILE . 21.7 t -108.73 132.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.751 0.31 . . . . 0.0 110.252 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.91 -23.92 33.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.435 ' HB2' HD12 ' A' ' 39' ' ' LEU . 23.0 p-10 -135.81 71.48 63.78 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 121.634 0.731 . . . . 0.0 110.149 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.42 -21.62 13.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.338 2.692 . . . . 0.0 114.34 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.4 -9.47 59.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.564 0.697 . . . . 0.0 110.107 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 36' ' ' ASN . 85.0 mt -93.45 -5.87 48.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.822 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.863 HG23 HD13 ' A' ' 7' ' ' ILE . 66.5 mt -71.28 111.42 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.085 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -137.48 157.1 47.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.668 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.681 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 14.8 tmtt? -59.95 136.1 57.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.963 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.681 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 26.8 t70 74.97 4.47 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.835 176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.65 156.41 22.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.26 138.26 36.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.0 m -132.42 164.51 34.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.392 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.8 p -127.87 140.56 51.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 12.6 p90 -151.68 162.96 40.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.492 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.6 mm-40 -94.9 142.84 25.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.37 142.93 16.99 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.377 2.051 . . . . 0.0 113.384 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.485 HG21 ' CE2' ' A' ' 60' ' ' TYR . 14.6 t -163.08 177.36 9.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.508 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -115.74 155.13 28.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.05 0.453 . . . . 0.0 111.102 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.658 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 14.3 t-20 -132.8 168.49 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.951 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -68.23 -38.75 82.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 15.8 ptpt -91.98 -1.66 57.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.879 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.87 -133.49 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.15 155.82 17.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.1 p -148.04 170.32 18.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.763 0.316 . . . . 0.0 111.016 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -135.4 151.06 50.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.256 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 51' ' ' THR . 24.2 m-85 -122.47 170.29 10.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.768 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.599 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 48.99 58.43 5.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.974 0.796 . . . . 0.0 110.879 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 34' ' ' VAL . 27.3 t -85.47 120.4 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.765 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -123.99 127.13 47.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.223 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.2 t -80.61 151.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.919 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.64 88.31 3.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.36 0.413 . . . . 0.0 110.443 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 39' ' ' LEU . 74.2 Cg_endo -75.31 143.76 28.49 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.216 1.944 . . . . 0.0 111.949 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.0 -7.97 59.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.62 163.32 35.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -125.0 89.59 3.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.028 0.442 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -109.13 144.44 37.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.285 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -77.42 133.86 38.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.092 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -134.57 92.98 2.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.437 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -160.61 137.72 9.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.953 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.76 177.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.56 126.59 33.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.239 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.457 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 11.8 ttt -138.98 177.18 8.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' H ' ' HG2' ' A' ' 3' ' ' MET . 4.3 p-10 -106.66 141.93 37.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 112.03 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -135.39 176.74 19.91 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -122.6 139.56 53.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.615 0.708 . . . . 0.0 110.721 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 19' ' ' ILE . 53.0 mt -76.46 107.86 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.285 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -97.88 -43.0 7.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.238 0.542 . . . . 0.0 111.037 -174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 m -132.09 121.9 24.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -139.42 129.83 25.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -107.62 92.35 4.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -59.44 -49.23 78.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.043 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.05 -45.38 90.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HG2' ' HE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -75.24 -39.65 59.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.762 -174.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.82 6.14 35.16 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.848 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.492 ' HE1' ' HG2' ' A' ' 14' ' ' LYS . 33.1 p90 -130.54 174.84 9.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.722 0.761 . . . . 0.0 110.836 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.39 -170.84 41.75 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.0 124.39 26.2 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.791 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.69 119.02 60.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.831 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 60.2 tttt -107.06 124.17 49.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.508 . . . . 0.0 110.823 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 p-10 -89.03 -176.18 5.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.884 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -107.73 5.27 26.54 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.214 0.53 . . . . 0.0 111.013 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.28 -49.86 5.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.68 -92.11 1.85 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.329 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -168.68 -168.53 0.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.669 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -74.62 135.84 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.554 0.693 . . . . 0.0 111.689 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -103.43 151.61 22.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.028 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -79.98 117.34 20.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 56.1 m-85 -111.09 155.64 22.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.631 0.729 . . . . 0.0 111.405 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.481 ' ND1' HG22 ' A' ' 32' ' ' ILE . 14.3 t-80 -139.83 131.77 27.74 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.965 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -46.87 -32.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' ND1' ' A' ' 30' ' ' HIS . 20.3 tt -62.7 -32.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.49 6.24 31.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 40' ' ' ILE . 33.6 t -91.79 133.42 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.91 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.25 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.566 HD22 HD12 ' A' ' 39' ' ' LEU . 22.2 p-10 -145.65 72.25 13.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.676 0.75 . . . . 0.0 110.124 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.568 ' HA ' HG13 ' A' ' 40' ' ' ILE . 92.8 Cg_endo -75.34 -9.69 20.39 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.146 2.564 . . . . 0.0 112.63 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.6 -9.98 59.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.566 HD12 HD22 ' A' ' 36' ' ' ASN . 90.4 mt -109.63 2.8 20.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.192 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 37' ' ' PRO . 55.4 mt -65.4 129.36 29.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.018 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 17.2 ptpt -143.33 166.02 25.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.275 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 12.9 tmtt? -80.08 144.9 32.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.674 0.273 . . . . 0.0 110.526 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 29.6 t70 67.27 27.88 8.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.696 0.76 . . . . 0.0 110.441 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -103.72 148.69 25.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.155 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.13 137.68 32.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 64' ' ' VAL . 26.8 m -133.29 155.56 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.405 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.4 p -113.13 133.81 54.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.93 175.7 13.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.85 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.0 mt-10 -115.72 140.81 26.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.789 174.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -82.05 133.94 7.97 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.957 2.438 . . . . 0.0 113.215 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -149.58 -175.18 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.045 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -124.21 146.48 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.118 0.485 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.435 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 15.8 t-20 -101.01 -64.68 1.03 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.724 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -174.02 -65.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.738 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.8 28.43 3.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.222 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.31 173.19 29.64 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.404 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.5 mt -81.13 146.01 30.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.73 0.3 . . . . 0.0 110.367 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.4 m -144.59 168.87 19.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.163 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.94 154.63 42.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.574 0.226 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -135.76 179.09 6.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.7 50.53 16.89 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.982 0.801 . . . . 0.0 110.22 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.11 113.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.078 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.23 114.66 28.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.914 ' HA ' HG12 ' A' ' 46' ' ' VAL . 45.9 t -71.13 131.36 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.847 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.04 86.98 4.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 0.0 110.671 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.79 157.85 27.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.435 2.09 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.0 mt -91.61 16.5 10.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.222 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 64.87 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.4 m80 42.86 -99.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.533 0.733 . . . . 0.0 112.587 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.6 m80 61.4 26.21 16.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -71.86 -25.12 61.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -106.81 101.25 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.523 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -114.42 -7.58 12.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.45 0.643 . . . . 0.0 109.335 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.4 p80 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.926 175.341 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.87 116.61 14.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.984 0.421 . . . . 0.0 110.854 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 mtt -103.28 160.77 14.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.774 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -93.36 151.93 19.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.089 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -150.91 161.27 28.98 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.412 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -111.36 132.45 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.41 . . . . 0.0 110.289 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.85 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.3 mt -67.08 112.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.446 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HE2' ' A' ' 42' ' ' LYS . 3.2 m -101.07 -43.55 5.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -174.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -145.99 140.4 26.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.36 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -140.7 122.17 15.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 86.0 m-85 -110.54 88.82 2.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -55.85 -63.14 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.58 -7.48 59.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.114 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 23.7 tptm -85.22 -32.79 22.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' HIS . . . 103.71 -17.76 48.92 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.905 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -109.31 179.06 4.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.261 0.553 . . . . 0.0 111.657 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.55 171.82 44.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.289 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.38 128.4 41.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 7' ' ' ILE . 58.2 mt -133.11 128.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.124 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' ASP . 44.4 tptt -85.18 115.56 23.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.711 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.683 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.5 p-10 -92.61 -171.63 2.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -83.94 -36.84 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.704 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -89.04 -47.9 7.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -171.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.01 -101.69 2.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.08 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -163.4 -154.52 0.28 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.24 115.92 15.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.2 0.524 . . . . 0.0 110.101 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 43.7 mtt180 -100.17 152.39 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -80.24 118.56 22.02 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.78 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 8.9 m-85 -105.02 158.18 16.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.765 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.561 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.5 t-80 -140.4 126.09 19.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.71 -38.49 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.616 HG23 ' HG2' ' A' ' 33' ' ' LYS . 20.0 tt -59.74 -30.77 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.303 0.573 . . . . 0.0 111.839 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -96.11 11.74 33.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.349 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 21.8 t -97.85 127.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.22 61.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.447 . . . . 0.0 111.101 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -133.04 69.65 78.66 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.86 -17.66 32.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.672 2.248 . . . . 0.0 112.756 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.03 -28.88 65.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.257 0.551 . . . . 0.0 110.807 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' A' ' 66' ' ' PRO . 90.4 mt -88.56 3.12 51.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.289 -174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.838 HG23 HD13 ' A' ' 7' ' ' ILE . 42.2 mt -74.7 112.77 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.767 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.41 165.71 18.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.237 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 8' ' ' THR . 5.2 tptm -69.99 134.99 48.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.119 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 t70 69.03 16.94 8.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.963 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -84.04 159.94 21.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.31 139.39 33.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.4 m -131.95 162.8 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.681 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -126.55 134.44 50.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.857 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.683 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 19.0 p90 -149.06 174.6 12.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.813 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.684 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.0 mm-40 -96.17 142.03 23.98 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -81.86 134.73 8.52 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.221 2.614 . . . . 0.0 112.034 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 60' ' ' TYR . 13.3 t -158.58 174.07 15.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.0 0.428 . . . . 0.0 110.121 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -140.17 156.32 46.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.09 -73.51 0.64 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.067 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.66 -63.71 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.96 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -79.88 0.0 33.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.143 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.56 47.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.262 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.26 155.04 23.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 m -145.59 168.97 19.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.31 150.85 45.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.795 0.331 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.556 ' CE2' HG21 ' A' ' 51' ' ' THR . 29.6 m-85 -126.1 171.27 10.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.897 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.684 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 49.99 56.22 8.23 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.988 0.805 . . . . 0.0 110.93 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -73.43 106.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.778 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.09 106.08 16.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.009 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.724 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.2 t -68.83 147.44 12.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.022 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.4 t -109.28 87.12 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.361 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.1 Cg_endo -79.12 139.48 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.155 1.903 . . . . 0.0 111.813 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.4 pt? -92.73 -9.49 40.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.349 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.19 122.94 49.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -83.71 -40.33 19.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.991 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -88.06 129.8 35.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -146.08 135.85 23.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.213 0.53 . . . . 0.0 111.691 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -170.54 161.81 7.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -84.61 112.2 20.22 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.8 m80 . . . . . 0 C--O 1.25 1.126 0 O-C-N 123.989 0.806 . . . . 0.0 111.4 177.117 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.73 -178.23 0.22 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.703 0.627 . . . . 0.0 110.531 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.8 mtm -98.73 145.79 26.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.6 p30 -108.22 161.8 14.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.286 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.71 159.72 23.29 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.798 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -108.44 133.62 52.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.756 HD13 HG23 ' A' ' 40' ' ' ILE . 47.0 mt -77.72 126.55 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.906 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -114.77 -53.09 2.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.059 0.457 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -118.44 124.52 47.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.924 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -138.6 125.29 20.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 89.3 m-85 -98.15 98.13 9.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.856 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -62.45 -36.64 83.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.26 -21.21 62.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 67.5 mmtt -102.42 -48.06 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.891 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.28 15.23 23.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.51 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 52.8 p90 -141.72 173.04 11.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.83 -166.99 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.476 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.8 129.78 30.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.4 mt -127.25 138.64 54.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.125 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -91.86 119.18 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.425 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -86.3 -173.34 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.389 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 44.0 mt-10 -79.18 -24.54 43.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.769 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -122.52 -44.14 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -169.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.58 -96.33 0.75 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.839 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -169.21 -157.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 130.09 38.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.503 0.592 . . . . 0.0 110.089 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 23.1 mtp85 -112.09 147.07 36.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.286 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.57 117.63 19.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 31.8 m-85 -111.22 150.41 29.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.902 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.0 t-160 -148.24 136.19 20.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.702 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.41 -34.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.698 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.8 tt -58.08 -34.71 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.698 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -100.74 15.38 28.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.415 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 40' ' ' ILE . 23.4 t -114.04 134.57 56.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.321 . . . . 0.0 110.28 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.31 60.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.16 78.13 53.47 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.619 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.76 -19.81 23.52 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.868 2.379 . . . . 0.0 113.956 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.56 -22.72 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -78.99 -11.45 60.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.452 0.644 . . . . 0.0 109.427 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 7' ' ' ILE . 56.8 mt -70.97 116.08 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.424 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -156.97 169.55 24.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.637 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 13.4 tmtt? -61.08 140.26 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 36.6 t70 76.29 4.14 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.115 0.884 . . . . 0.0 111.933 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -92.13 156.19 17.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.048 -0.407 . . . . 0.0 110.324 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.49 149.08 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.4 m -134.95 149.8 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.855 0.36 . . . . 0.0 110.893 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -109.63 138.03 46.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.061 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -161.48 -179.18 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.514 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 pt-20 -104.35 142.1 23.92 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.8 Cg_endo -86.88 137.05 4.48 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.113 2.542 . . . . 0.0 112.345 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 60' ' ' TYR . 6.2 t -159.23 169.38 24.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -109.96 155.8 21.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.724 0.297 . . . . 0.0 110.612 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 13.8 t-20 -132.53 157.75 43.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.612 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -78.59 8.87 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.792 0.329 . . . . 0.0 111.554 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -134.14 19.17 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 0.0 110.395 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.01 -147.38 19.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.427 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.59 152.28 20.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -144.5 167.67 21.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.672 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.04 153.41 37.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.583 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.603 ' CE2' HG21 ' A' ' 51' ' ' THR . 71.2 m-85 -130.23 168.29 17.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.44 55.79 8.88 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 124.058 0.849 . . . . 0.0 111.253 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 34' ' ' VAL . 23.4 t -82.75 117.49 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.168 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -122.37 119.86 32.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.9 t -68.62 142.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.03 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.4 86.4 5.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.472 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.586 ' HB2' HD12 ' A' ' 67' ' ' LEU . 92.3 Cg_endo -83.13 174.15 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.549 2.166 . . . . 0.0 112.204 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 66' ' ' PRO . 6.5 mp 59.35 24.81 13.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.292 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -55.83 -54.74 40.87 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -119.04 147.15 44.42 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 164.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -71.8 144.61 49.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.045 0.45 . . . . 0.0 111.057 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -101.05 -46.86 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.469 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 61.61 -93.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.99 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 179.52 -67.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.4 t60 . . . . . 0 C--O 1.245 0.853 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.493 168.693 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 49.6 ttm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.79 114.35 21.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 79.3 mtp -116.15 150.66 37.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.732 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -105.56 147.17 28.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.071 0.462 . . . . 0.0 110.715 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.29 161.01 26.48 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.694 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -105.6 138.38 41.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.72 105.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.717 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 p -107.53 -51.93 2.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.199 0.523 . . . . 0.0 110.524 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 20.5 m -100.81 118.83 37.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -151.0 113.32 4.6 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.924 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.584 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 99.4 m-85 -106.3 84.4 2.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.059 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 12.5 tmtt? -59.82 -30.75 69.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.164 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.62 -24.62 65.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.425 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.7 mptp? -104.4 -31.13 9.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.3 13.96 34.44 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.521 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -139.45 174.13 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.373 0.587 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.19 -162.54 31.44 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.069 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 97.7 m-85 -139.03 131.72 28.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 77.1 mt -119.09 122.07 68.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.004 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 26' ' ' ASN . 2.1 mmmp? -89.33 112.62 23.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.07 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.0 p-10 -96.65 -170.17 2.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.817 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.38 -32.09 72.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.059 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 27.1 t-20 -63.75 -31.09 72.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.385 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.75 10.32 47.08 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.667 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -107.68 168.18 9.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 17.1 p-10 -107.18 116.13 31.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.425 0.631 . . . . 0.0 110.561 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 39.6 mtt-85 -100.47 141.37 33.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.59 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -80.03 113.68 18.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 42.7 m-85 -105.62 153.64 21.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.672 0.748 . . . . 0.0 111.196 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -147.78 140.69 24.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.989 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.07 -18.36 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.676 HG23 ' HG2' ' A' ' 33' ' ' LYS . 7.6 tp -57.29 -39.89 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 111.701 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.676 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -92.06 3.28 55.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.769 -176.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -100.14 126.8 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.14 -30.37 21.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.339 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 HD12 ' A' ' 39' ' ' LEU . 13.0 p-10 -121.21 85.32 41.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.258 0.551 . . . . 0.0 111.343 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.77 -19.47 9.79 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.092 2.528 . . . . 0.0 113.733 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.79 -23.95 36.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.541 0.686 . . . . 0.0 109.926 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 36' ' ' ASN . 88.4 mt -86.95 -8.49 57.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.063 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.869 HD11 HG11 ' A' ' 34' ' ' VAL . 68.2 mt -65.19 107.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.377 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 73.7 mmtt -115.72 157.71 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -71.93 135.81 46.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 70.64 9.46 6.88 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.351 0.596 . . . . 0.0 111.16 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -82.27 166.96 19.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 110.639 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.18 145.19 36.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.452 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 64' ' ' VAL . 32.8 m -131.28 160.5 42.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.71 151.86 38.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.639 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 20.2 p90 -167.02 173.58 9.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.037 0.446 . . . . 0.0 111.477 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.2 mm-40 -104.96 141.12 21.9 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.266 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 21.4 Cg_endo -92.7 143.37 2.34 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.056 2.504 . . . . 0.0 113.508 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 t -152.02 151.06 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.389 174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 m -90.88 156.29 18.12 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.476 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 4.6 t-20 -136.11 173.87 11.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.49 -20.17 62.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -112.0 13.64 20.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.175 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.48 -155.75 21.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.987 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.5 mt -86.2 148.22 25.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.255 0.55 . . . . 0.0 110.687 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -145.44 169.17 18.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.731 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.24 154.37 43.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 49' ' ' GLU . 32.4 p90 -136.23 177.05 8.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.209 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.1 42.04 31.76 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.984 0.803 . . . . 0.0 110.419 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.7 t -75.06 112.69 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -116.84 125.31 51.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.556 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 46' ' ' VAL . 21.1 t -76.81 146.86 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.37 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.4 87.85 2.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 123.426 0.454 . . . . 0.0 110.434 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.3 Cg_endo -72.67 172.23 15.62 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.582 2.188 . . . . 0.0 111.793 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.7 mt 70.2 -54.41 0.62 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.406 0.682 . . . . 0.0 111.945 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.6 -52.66 54.29 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.032 0.533 . . . . 0.0 109.87 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -122.15 86.59 2.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 109.599 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -96.02 141.61 29.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.93 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -141.65 149.25 40.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.979 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -132.75 160.97 35.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.278 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -90.72 110.58 21.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.912 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.353 -176.834 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.01 17.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.344 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -101.33 153.71 19.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.45 144.67 28.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.121 0.486 . . . . 0.0 110.451 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.3 162.76 28.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.699 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -111.03 134.05 52.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.08 0.467 . . . . 0.0 110.278 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 40' ' ' ILE . 57.0 mt -77.66 114.98 18.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.52 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 p -108.1 -42.57 4.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -130.28 122.89 28.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 74.3 t-105 -144.32 135.4 25.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.826 0.346 . . . . 0.0 110.329 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.64 86.42 2.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.536 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -60.63 -27.65 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.499 0.666 . . . . 0.0 110.009 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HE3' ' A' ' 14' ' ' LYS . 18.1 t70 -61.88 -34.03 75.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.357 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 30.9 mmtp -119.16 -21.76 7.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.98 12.28 50.24 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.821 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.411 ' HD2' ' HE1' ' A' ' 28' ' ' TYR . 25.5 m-85 -98.31 160.88 14.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -177.84 162.51 30.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.913 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -137.48 126.02 23.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.722 HD13 HG21 ' A' ' 46' ' ' VAL . 86.8 mt -120.99 129.99 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -93.9 120.88 34.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.4 p-10 -86.22 -173.67 4.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.983 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -91.1 -10.76 40.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.159 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.44 -42.91 28.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.46 44.81 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.75 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -136.2 162.18 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 0.0 110.542 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -117.86 127.11 53.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.538 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.77 146.29 50.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.235 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HD2' ' A' ' 16' ' ' PHE . 67.5 t80 -76.59 127.28 32.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 29.9 m-85 -112.97 154.7 26.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.808 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG22 ' A' ' 32' ' ' ILE . 10.5 t-80 -141.67 130.99 23.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.652 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -49.82 -34.12 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.62 HG23 ' HG2' ' A' ' 33' ' ' LYS . 19.2 tt -56.94 -34.22 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.9 mmtt -97.45 9.2 43.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.458 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.557 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 33.3 t -97.31 130.4 46.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.63 54.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.845 HD22 HD12 ' A' ' 39' ' ' LEU . 9.3 p-10 -132.73 79.42 64.14 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.272 0.558 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 68.9 Cg_endo -74.76 -22.34 15.49 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.02 2.48 . . . . 0.0 113.518 -173.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.17 -28.14 64.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 HD22 ' A' ' 36' ' ' ASN . 57.1 mt -82.63 -5.48 58.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.974 HG23 HD13 ' A' ' 7' ' ' ILE . 39.0 mt -72.25 112.62 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.625 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -133.79 174.76 10.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.772 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 1.7 tmtp? -70.53 140.96 51.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.536 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 33.1 t70 74.94 6.14 4.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.575 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.34 152.0 27.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.146 -0.346 . . . . 0.0 110.323 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.18 136.6 40.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 110.558 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.722 HG21 HD13 ' A' ' 19' ' ' ILE . 28.5 m -130.44 158.83 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.122 0.486 . . . . 0.0 111.046 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.6 p -118.31 135.4 54.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.378 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.465 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 16.8 p90 -143.69 164.9 29.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -173.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -98.17 142.23 24.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.591 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.55 142.89 21.12 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.292 1.994 . . . . 0.0 112.95 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 13.5 t -157.85 166.63 32.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.607 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -113.9 145.48 41.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.993 0.425 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.86 177.16 7.94 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.17 -25.76 58.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.053 0.454 . . . . 0.0 109.903 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.83 -14.41 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.939 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.01 -138.43 10.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.87 139.49 34.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -144.08 168.59 19.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.235 -174.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.92 149.13 44.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.865 0.364 . . . . 0.0 111.436 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 51' ' ' THR . 16.9 p90 -134.05 -177.61 4.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.133 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.43 42.2 32.02 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.743 0.652 . . . . 0.0 110.202 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -68.1 100.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.004 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.542 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 16.6 ttmm -108.28 116.42 31.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.635 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.7 t -70.88 148.49 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.133 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.2 t -104.64 87.94 2.0 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 93.2 Cg_endo -82.3 145.06 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.223 1.949 . . . . 0.0 111.956 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.3 pt? -60.23 -24.13 64.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.695 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -162.69 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -131.06 -54.86 1.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.904 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t60 70.37 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 O-C-N 124.193 0.933 . . . . 0.0 110.313 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -64.35 134.7 55.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 0.0 111.124 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.1 135.52 38.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -170.99 151.36 3.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 110.887 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.589 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.8 114.35 4.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -113.83 149.22 35.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.348 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -101.46 152.12 21.13 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.943 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -151.6 177.06 29.73 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.23 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' ILE . 3.2 m -126.9 132.14 50.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.828 ' HA ' HG12 ' A' ' 19' ' ' ILE . 62.7 mt -65.0 106.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.506 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m -95.02 -37.38 11.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.86 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -150.96 125.06 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.878 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.648 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 74.6 t-105 -143.02 131.7 22.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.4 96.2 4.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.734 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.2 -41.78 89.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -69.57 -28.03 65.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.667 ' HG2' ' HD1' ' A' ' 16' ' ' PHE . 39.6 ttmt -87.69 -38.49 15.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.936 0.398 . . . . 0.0 110.41 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 106.34 -12.78 43.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.667 ' HD1' ' HG2' ' A' ' 14' ' ' LYS . 57.6 m-85 -96.6 163.42 13.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.902 0.382 . . . . 0.0 111.356 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.76 27.27 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.117 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -139.57 131.76 28.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.828 HG12 ' HA ' ' A' ' 7' ' ' ILE . 68.0 mt -136.92 125.11 33.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.862 0.363 . . . . 0.0 110.984 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 14.1 tmtt? -86.41 125.78 33.92 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.0 p-10 -97.1 -169.51 1.87 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.833 0.825 . . . . 0.0 112.853 -169.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -77.95 -30.23 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.287 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -74.09 -36.67 64.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.741 0.305 . . . . 0.0 110.41 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.17 41.05 0.45 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.488 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.41 163.51 32.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.159 0.48 . . . . 0.0 109.943 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -110.36 115.34 29.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -101.61 153.66 19.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.417 -170.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.892 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.8 m-85 -116.65 153.93 31.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.895 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.3 t-160 -136.4 133.76 37.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.648 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 12.4 p -47.23 -31.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.3 tt -67.72 -30.15 47.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.972 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.9 mmtt -97.7 15.31 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.67 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -94.29 130.77 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.38 48.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.975 0.417 . . . . 0.0 110.948 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.499 HD22 HD12 ' A' ' 39' ' ' LEU . 22.4 p-10 -135.21 79.22 50.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.518 0.675 . . . . 0.0 111.203 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HA ' HG13 ' A' ' 40' ' ' ILE . 86.0 Cg_endo -76.95 -11.1 18.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.859 2.373 . . . . 0.0 112.247 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.39 -18.97 61.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.803 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB3' ' HG3' ' A' ' 66' ' ' PRO . 78.7 mt -106.39 12.87 29.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 34' ' ' VAL . 40.9 mt -82.82 126.48 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.0 112.183 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -139.18 168.38 19.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 12.7 tmtt? -78.88 139.85 38.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 66.7 m-20 73.97 13.04 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.706 0.803 . . . . 0.0 111.709 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -82.57 156.72 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.594 0.235 . . . . 0.0 110.673 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.72 137.88 31.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 19' ' ' ILE . 28.6 m -136.04 160.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.801 ' HB ' ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -124.23 154.46 40.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 p90 -166.45 171.47 11.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.902 0.382 . . . . 0.0 111.542 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 26.3 mm-40 -101.17 143.33 26.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.128 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.55 148.56 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.25 1.966 . . . . 0.0 112.183 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -166.29 171.1 12.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -109.54 155.4 21.43 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.572 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 23.1 t-20 -131.17 162.46 29.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.663 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -58.94 -36.35 74.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.489 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.45 -48.7 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.706 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -141.27 3.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.119 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -86.1 149.16 25.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -151.01 169.78 20.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -135.42 151.1 50.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.556 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.1 172.23 7.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.565 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 50.01 49.5 20.21 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.946 0.778 . . . . 0.0 111.297 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.585 HG21 ' HD2' ' A' ' 29' ' ' PHE . 17.9 t -76.95 109.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.001 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.801 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -109.15 128.76 55.28 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 46' ' ' VAL . 28.5 t -84.93 143.93 10.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.398 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -114.3 85.12 10.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.654 ' HG3' ' HB3' ' A' ' 39' ' ' LEU . 87.0 Cg_endo -96.93 164.12 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.094 2.529 . . . . 0.0 112.208 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.804 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.3 pt? -91.23 3.09 55.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.17 0.509 . . . . 0.0 109.989 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 70' ' ' HIS . 12.3 tp10 -90.22 -88.46 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.543 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.418 ' H ' ' HB3' ' A' ' 68' ' ' GLU . 23.2 t-80 55.8 28.12 11.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.655 0.74 . . . . 0.0 109.134 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.521 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 29.8 t-80 -120.82 13.25 11.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.573 -169.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 70' ' ' HIS . 34.0 m80 70.83 152.36 0.11 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.839 -175.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -132.71 127.65 35.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.108 0.48 . . . . 0.0 109.877 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -83.77 102.38 12.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.902 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.589 -177.866 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.771 0.32 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.58 124.02 49.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -109.53 177.29 4.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.895 0.379 . . . . 0.0 110.946 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.85 151.43 25.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.936 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.63 165.44 23.79 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.973 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -112.37 135.35 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.921 HD13 HG23 ' A' ' 40' ' ' ILE . 51.8 mt -82.29 121.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 p -106.89 -53.45 2.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.998 0.428 . . . . 0.0 111.228 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.1 m -124.55 127.32 47.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.078 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -142.09 135.53 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.986 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.49 102.56 9.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.03 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.649 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.85 -49.0 64.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.829 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -70.92 -46.46 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.57 19.57 9.71 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.8 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.68 170.73 15.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.924 0.862 . . . . 0.0 110.661 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.41 -170.52 41.33 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.267 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -133.25 131.81 40.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.755 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.6 mt -131.26 131.17 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -100.74 120.63 40.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.8 p30 -109.6 -164.84 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.144 0.497 . . . . 0.0 111.543 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.84 -10.25 59.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.128 -171.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.29 -28.05 69.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.326 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.95 8.02 55.86 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.195 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -129.77 163.78 25.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -93.65 137.27 33.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 110.574 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' HB3' ' A' ' 57' ' ' LEU . 35.2 mtt85 -111.29 150.2 29.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.666 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -89.23 123.42 33.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.688 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.755 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 63.7 m-85 -116.74 155.64 28.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.315 0.579 . . . . 0.0 111.808 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.48 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-160 -136.49 135.17 38.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.666 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.96 -29.67 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.1 tt -63.76 -31.31 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.21 -9.01 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.667 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.872 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -91.17 134.29 30.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.261 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.36 -24.22 19.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.178 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.709 ' HB2' HG23 ' A' ' 64' ' ' VAL . 3.2 m-20 -122.38 65.49 23.13 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.849 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.04 -30.55 13.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.015 1.81 . . . . 0.0 113.656 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.13 -18.27 34.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.428 0.633 . . . . 0.0 110.152 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 87.4 mt -90.9 -8.68 48.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.921 HG23 HD13 ' A' ' 7' ' ' ILE . 54.3 mt -61.03 119.56 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.621 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -126.84 173.25 9.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -83.47 136.02 34.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 66.83 13.85 9.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.484 0.659 . . . . 0.0 111.001 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.13 156.4 17.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.671 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.7 137.65 39.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 64' ' ' VAL . 19.7 m -126.48 157.3 37.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.86 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 0.0 110.52 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.674 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 7.8 p90 -158.9 176.69 12.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.288 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.1 pm0 -111.47 143.36 28.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.1 Cg_exo -77.1 154.07 32.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.283 2.655 . . . . 0.0 113.507 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -166.89 179.4 5.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.036 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 57' ' ' LEU . 8.2 p -118.66 146.31 44.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.874 0.369 . . . . 0.0 110.447 175.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.568 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 46.4 t30 -105.88 25.87 10.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 25.2 t-20 71.36 -56.18 0.64 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.833 -174.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.7 -39.04 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.099 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.24 -156.51 12.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.109 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 84.2 mt -84.82 134.77 34.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.959 0.409 . . . . 0.0 111.125 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 7.6 m -147.92 168.74 21.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.593 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -144.08 163.85 32.36 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.739 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.38 179.5 6.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.378 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.63 41.28 31.22 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 124.124 0.89 . . . . 0.0 110.508 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 48' ' ' PHE . 22.0 t -76.77 107.61 8.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.301 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -109.05 127.73 54.36 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.965 175.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 36' ' ' ASN . 82.3 t -65.78 149.95 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.695 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.51 86.02 1.29 Allowed Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 88.1 Cg_endo -92.94 159.55 2.7 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.806 2.337 . . . . 0.0 112.58 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -90.49 -26.97 19.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.624 ' HG2' ' H ' ' A' ' 70' ' ' HIS . 31.0 tt0 -135.73 128.73 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.941 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -68.29 -19.22 64.68 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.455 0.169 . . . . 0.0 111.044 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.624 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 54.3 m-70 65.91 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.956 0.785 . . . . 0.0 111.176 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -57.35 105.84 0.27 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.123 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.76 139.39 30.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 -173.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -84.39 -74.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.0 m170 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.326 171.492 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.09 129.16 38.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.246 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.15 157.86 20.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.491 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -96.97 147.53 23.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.922 0.391 . . . . 0.0 110.054 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.714 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.86 165.49 28.05 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.762 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 m -120.37 135.0 55.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.089 0.471 . . . . 0.0 109.843 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.953 HD13 HG23 ' A' ' 40' ' ' ILE . 51.0 mt -76.58 117.24 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.585 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -101.47 -46.57 4.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 110.93 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -124.14 123.13 39.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -132.06 116.06 16.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.038 0.447 . . . . 0.0 110.695 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 81.1 m-85 -105.19 90.35 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.5 -38.97 82.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.722 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.99 -25.71 56.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.263 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 11' ' ' PHE . 41.0 mmtm -83.73 -38.2 21.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.39 45.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.921 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 54.8 p90 -144.13 176.61 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.809 0.337 . . . . 0.0 110.849 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.78 -168.41 29.87 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.297 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -138.29 130.65 28.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.1 mt -122.54 130.65 74.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 21' ' ' ASP . 13.3 tmtt? -104.58 118.09 35.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.6 p-10 -86.57 -178.78 6.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.943 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -93.39 -2.29 54.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.011 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -112.08 -54.06 2.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.819 0.343 . . . . 0.0 111.106 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.09 -99.16 2.07 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.194 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -158.85 -159.2 0.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.54 129.93 37.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.256 0.55 . . . . 0.0 110.621 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 69.1 mtt180 -108.32 151.6 25.76 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -77.95 124.42 27.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.063 0.459 . . . . 0.0 110.251 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 49.4 m-85 -120.51 148.0 44.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.496 0.665 . . . . 0.0 110.246 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -148.83 143.72 26.49 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.785 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' CB ' ' A' ' 37' ' ' PRO . 11.1 p -49.09 -25.52 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.731 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.6 tt -65.35 -33.61 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -106.7 -1.1 23.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 40' ' ' ILE . 46.4 t -99.25 126.29 52.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.41 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.81 74.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 64' ' ' VAL . 7.9 m120 -118.36 76.4 12.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.977 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' CB ' HG23 ' A' ' 31' ' ' VAL . 63.0 Cg_endo -75.77 -24.07 11.99 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.109 1.872 . . . . 0.0 112.439 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.92 -13.64 57.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.394 0.616 . . . . 0.0 110.594 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 79.9 mt -103.13 3.91 36.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.739 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.953 HG23 HD13 ' A' ' 7' ' ' ILE . 62.9 mt -72.47 115.88 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.4 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 30.8 mmtp -120.3 154.06 35.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.619 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -71.2 132.31 44.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.31 24.23 7.44 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.793 0.683 . . . . 0.0 111.647 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -95.67 157.98 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.969 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.85 139.7 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 111.09 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.4 m -137.6 166.5 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.187 0.518 . . . . 0.0 110.967 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.1 p -131.5 134.99 46.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.634 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 10.2 p90 -156.31 164.75 37.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.982 0.42 . . . . 0.0 111.475 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.65 144.09 29.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.631 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 147.23 32.35 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.763 2.309 . . . . 0.0 113.918 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.453 ' HB ' ' CD1' ' A' ' 60' ' ' TYR . 15.1 t -154.21 139.83 17.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.736 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 p -89.13 126.79 35.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.236 0.541 . . . . 0.0 111.528 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 14.2 t-20 -86.91 167.65 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.947 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.42 -34.54 61.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.556 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -99.96 -57.48 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.357 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.69 -148.22 4.8 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.488 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.73 140.87 30.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.007 0.432 . . . . 0.0 111.112 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -149.14 168.98 21.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.61 152.17 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 52.9 p90 -124.67 172.96 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.532 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . 45.81 52.12 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 124.347 1.029 . . . . 0.0 110.828 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' HD2' ' A' ' 29' ' ' PHE . 20.9 t -76.81 111.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.402 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -97.19 119.06 34.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 95.7 t -70.63 148.21 10.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.68 89.52 2.3 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 123.304 0.378 . . . . 0.0 110.936 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 56.0 Cg_endo -69.29 135.04 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.316 2.01 . . . . 0.0 111.908 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.93 -21.73 40.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.179 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.1 133.7 39.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.858 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -90.95 124.13 34.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 71' ' ' HIS . 28.0 t60 -127.42 -24.8 3.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' HIS . 13.8 m-70 67.01 -167.57 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -134.85 -34.54 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.139 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -133.15 -69.52 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.681 174.522 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.561 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 23.4 ttt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.935 0.398 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . . . -70.14 117.48 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.442 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.637 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -112.37 169.76 8.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.973 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.67 152.45 20.48 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.925 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 m -100.13 135.83 40.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.033 0.444 . . . . 0.0 110.705 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.794 HD13 HG23 ' A' ' 40' ' ' ILE . 55.2 mt -82.47 116.41 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.781 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -103.53 -51.35 3.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 30.2 m -119.52 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.466 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 58.9 t-105 -150.74 122.18 7.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 0.0 110.904 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -130.48 87.42 2.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.611 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.35 -37.82 78.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.21 -35.03 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.842 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HE2' ' HE1' ' A' ' 16' ' ' PHE . 54.0 mtpt -90.16 -14.48 33.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.627 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.01 -4.19 62.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.199 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' HIS . 53.5 p90 -132.75 173.58 11.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.643 0.721 . . . . 0.0 111.996 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.466 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -165.28 177.82 40.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.229 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 94.0 m-85 -139.07 130.18 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.768 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 85.4 mt -136.94 135.1 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.653 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.4 tmtp? -112.53 117.65 32.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.855 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.662 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.6 p-10 -97.84 174.96 6.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -94.89 2.01 55.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.35 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 3' ' ' MET . 7.2 t30 -105.88 -50.29 3.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.59 -87.99 2.03 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.359 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -171.24 -164.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 50.6 t-20 -82.23 122.69 28.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 43.8 mtt-85 -112.22 153.89 26.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.794 0.33 . . . . 0.0 111.041 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -80.12 121.34 25.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.768 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.1 m-85 -110.13 159.57 17.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.578 ' HB3' HG22 ' A' ' 32' ' ' ILE . 10.7 t-80 -148.54 147.03 28.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.14 -10.47 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 111.407 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 30' ' ' HIS . 8.9 tt -82.84 -19.49 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.565 0.698 . . . . 0.0 110.462 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 32' ' ' ILE . 12.3 mptt -103.14 -3.49 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.657 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG11 HD11 ' A' ' 40' ' ' ILE . 25.6 t -104.71 139.4 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.84 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.71 -31.34 19.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.318 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.8 HD22 HD12 ' A' ' 39' ' ' LEU . 21.7 p-10 -132.69 77.51 69.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.393 0.616 . . . . 0.0 110.65 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.2 -19.0 13.87 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.863 2.376 . . . . 0.0 113.817 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.31 -0.83 57.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.995 0.426 . . . . 0.0 111.053 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 HD22 ' A' ' 36' ' ' ASN . 69.6 mt -102.85 0.59 32.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.657 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.798 HD11 HG11 ' A' ' 34' ' ' VAL . 58.0 mt -80.96 109.11 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.805 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -117.67 155.62 29.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.3 tmtt? -74.42 141.51 45.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 59.3 m-20 75.48 19.82 2.05 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.522 0.729 . . . . 0.0 111.442 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -103.25 165.88 10.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.235 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.45 137.61 45.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.284 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 64' ' ' VAL . 18.3 m -128.35 164.27 30.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.104 0.478 . . . . 0.0 111.484 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 p -124.36 136.86 54.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.593 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 14.4 p90 -156.2 170.08 23.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.122 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 23.8 mm-40 -93.28 140.58 23.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 3.7 Cg_exo -84.0 135.39 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.221 2.614 . . . . 0.0 113.1 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.6 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 11.9 t -151.48 -174.45 4.84 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.543 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 12.6 t -126.37 -177.9 4.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.228 0.537 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.616 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 7.7 t-20 -145.89 -170.99 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.8 -27.2 26.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.006 0.432 . . . . 0.0 109.963 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -108.38 1.74 21.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.067 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.8 31.83 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.482 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 71.4 mt -87.52 159.02 18.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.189 0.495 . . . . 0.0 110.518 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.616 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.5 m -147.69 169.01 20.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.205 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.19 151.01 47.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.6 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 26.9 p90 -133.0 170.66 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.399 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.73 47.8 23.89 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.152 0.907 . . . . 0.0 110.175 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.18 120.59 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.104 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 127.35 48.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.271 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.858 ' HA ' HG12 ' A' ' 46' ' ' VAL . 19.2 t -67.24 154.55 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.123 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.79 84.12 5.15 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 121.07 0.462 . . . . 0.0 111.29 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 58.2 Cg_endo -100.95 146.53 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.35 2.7 . . . . 0.0 112.213 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.784 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.3 pt? -96.33 52.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.857 0.837 . . . . 0.0 110.283 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -147.4 120.42 8.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.297 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -91.97 123.9 35.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.188 0.518 . . . . 0.0 111.704 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -86.47 105.06 16.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -49.52 134.38 19.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.012 0.435 . . . . 0.0 110.925 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -106.18 146.42 30.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.179 -168.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -120.88 -33.31 3.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 164.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 . . . . . 0 C--O 1.245 0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.729 173.885 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.69 129.94 43.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 112.062 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.6 mtm -111.13 167.54 10.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.208 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -112.97 152.38 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.38 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.76 172.92 30.42 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.826 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -117.6 136.35 53.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 0.0 110.242 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 40' ' ' ILE . 46.8 mt -79.88 114.45 20.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.664 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 p -102.76 -43.3 5.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.179 0.514 . . . . 0.0 110.795 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.7 m -127.21 126.01 42.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.252 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -145.22 128.1 16.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.668 0.27 . . . . 0.0 111.039 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.61 98.16 5.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.3 176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.69 -37.31 86.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.95 -42.6 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.364 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 50.7 tptt -95.7 -49.82 5.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.618 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.47 13.48 12.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.952 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 74.6 m-85 -125.69 164.36 20.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.675 0.274 . . . . 0.0 110.328 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.35 170.47 41.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.86 129.04 37.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.1 mt -128.53 130.3 69.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.367 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -89.36 123.04 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.4 p30 -91.08 175.26 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.486 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -96.48 24.98 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.53 -48.88 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.514 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.18 -71.09 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.401 -0.905 . . . . 0.0 113.986 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.38 -154.3 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.027 0.414 . . . . 0.0 110.071 -170.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -88.03 152.93 21.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 53.1 mtt-85 -124.69 147.41 48.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -86.96 113.83 23.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.93 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 34.7 m-85 -105.48 150.13 25.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.657 0.741 . . . . 0.0 111.956 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' ND1' HG22 ' A' ' 32' ' ' ILE . 2.7 t-80 -128.45 130.61 47.83 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.084 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 37' ' ' PRO . 11.1 p -47.29 -31.95 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' ND1' ' A' ' 30' ' ' HIS . 13.5 tt -75.32 -21.41 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.58 -174.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.39 1.2 57.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.117 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 21.9 t -96.67 143.12 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.28 -42.81 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.368 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 39' ' ' LEU . 13.9 p-10 -127.69 75.67 77.69 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.189 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 91.8 Cg_endo -81.17 -17.29 9.29 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.959 2.439 . . . . 0.0 113.865 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -89.92 -8.76 51.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.474 0.654 . . . . 0.0 109.871 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 36' ' ' ASN . 87.3 mt -96.1 1.29 52.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.625 177.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 7' ' ' ILE . 51.1 mt -68.38 127.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.919 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -121.06 157.72 29.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.559 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -80.94 139.65 35.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.67 56.52 1.54 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.809 0.814 . . . . 0.0 109.276 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.6 36.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.18 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.96 140.12 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -134.88 162.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -127.5 139.84 52.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 9.7 p90 -156.47 170.63 21.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.414 . . . . 0.0 111.917 -172.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 62.5 mm-40 -85.4 142.56 37.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 5.5 Cg_exo -78.93 133.96 11.53 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.505 2.136 . . . . 0.0 111.287 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 60' ' ' TYR . 9.5 t -165.94 152.09 9.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -129.56 145.97 51.42 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.03 -69.85 0.78 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -175.33 -54.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.362 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.79 17.69 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.703 -175.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.49 171.76 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.333 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.84 155.93 37.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -148.03 169.14 20.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.803 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -148.92 143.14 26.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.468 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 51' ' ' THR . 22.8 m-85 -122.07 168.49 11.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.98 37.97 26.76 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.626 0.579 . . . . 0.0 110.79 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' HG13 ' A' ' 34' ' ' VAL . 18.4 t -67.86 114.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.158 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -115.95 117.85 31.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.587 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.9 t -79.98 146.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.487 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -111.56 86.24 6.69 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.2 Cg_endo -85.53 131.33 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.079 2.519 . . . . 0.0 111.852 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.3 pt? -86.03 70.59 10.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.809 0.814 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -126.99 134.02 50.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.7 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -96.72 125.51 41.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.992 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -80.36 70.24 6.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.581 0.705 . . . . 0.0 109.667 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -139.37 130.93 27.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.266 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.78 127.85 30.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -107.15 -13.99 15.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.775 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.3 t60 . . . . . 0 C--O 1.246 0.896 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.346 177.854 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.956 0.407 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.13 114.43 23.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.28 153.81 17.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.1 p-10 -107.88 139.92 41.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 110.759 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.31 166.4 23.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.442 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 p -109.67 137.8 46.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.039 0.447 . . . . 0.0 111.315 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 HD13 HG12 ' A' ' 19' ' ' ILE . 21.5 mm -63.83 115.87 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.474 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.452 ' O ' ' HE3' ' A' ' 42' ' ' LYS . 29.3 p -110.59 -47.13 3.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.123 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -122.5 125.76 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.98 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -156.04 133.27 10.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.708 0.289 . . . . 0.0 110.578 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 86.4 m-85 -123.47 115.68 21.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.29 -51.87 61.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.966 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.43 -8.36 59.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 111.268 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 11' ' ' PHE . 70.2 mmtt -85.73 -39.88 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.863 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.13 9.21 65.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.045 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 41.1 p90 -135.47 169.13 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.043 0.422 . . . . 0.0 110.732 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.17 -170.93 41.73 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.112 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -136.58 134.91 37.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.629 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 90.8 mt -126.68 129.75 71.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.276 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -92.27 117.58 30.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.645 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 4.9 p-10 -102.43 -173.37 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 111.797 -173.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 40.9 mt-10 -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.073 -174.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -70.0 -25.62 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.981 0.419 . . . . 0.0 110.23 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.59 -18.49 9.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.568 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 -163.13 0.86 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.38 0.59 . . . . 0.0 110.13 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -121.62 147.91 45.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CZ ' HD13 ' A' ' 57' ' ' LEU . 8.2 mpt_? -111.52 146.89 36.5 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.202 170.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -85.68 120.83 27.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 53.9 m-85 -109.87 154.85 22.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.414 0.626 . . . . 0.0 111.672 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -144.8 134.86 23.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.093 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.39 -27.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.513 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -64.68 -25.72 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.606 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.5 mmtt -101.52 11.64 38.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.161 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 40' ' ' ILE . 61.1 t -97.95 127.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.077 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.82 -30.53 32.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.558 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.658 HD22 HD12 ' A' ' 39' ' ' LEU . 13.8 p-10 -142.06 81.4 14.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.177 0.513 . . . . 0.0 111.602 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.1 -19.04 23.31 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.739 2.293 . . . . 0.0 112.948 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.55 -23.31 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.352 0.596 . . . . 0.0 110.617 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.658 HD12 HD22 ' A' ' 36' ' ' ASN . 81.2 mt -101.89 9.68 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.091 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.712 HD11 HG11 ' A' ' 34' ' ' VAL . 51.2 mt -81.41 118.49 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.86 159.7 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 8' ' ' THR . 85.0 tttt -78.16 146.12 35.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 t70 72.42 3.76 4.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.56 156.32 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.222 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' GLY . . . -97.78 139.15 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 19' ' ' ILE . 32.9 m -128.53 148.6 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.224 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -110.86 134.6 52.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.012 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.6 p90 -147.79 167.45 24.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.956 0.408 . . . . 0.0 111.609 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 54.2 mm-40 -92.36 142.51 26.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.613 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -82.95 133.92 6.9 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.783 2.322 . . . . 0.0 112.301 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.3 t -152.96 161.38 42.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -101.64 147.61 26.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.291 0.567 . . . . 0.0 111.205 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -113.95 156.88 23.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.729 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -55.35 -33.72 63.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 111.461 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -101.8 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.596 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.0 -135.95 2.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.115 -172.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.45 HD13 ' CZ ' ' A' ' 27' ' ' ARG . 91.7 mt -102.59 151.33 22.46 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.696 0.284 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -145.55 167.49 22.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 111.003 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -140.93 148.89 41.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.553 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -117.84 170.97 8.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.206 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 46.95 53.72 10.13 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.095 0.872 . . . . 0.0 111.37 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 36.5 t -70.95 100.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.1 0.476 . . . . 0.0 110.234 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 34.3 ttmt -118.24 117.09 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.119 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.581 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 21.8 t -69.66 151.58 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.819 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.7 t -103.34 88.26 1.61 Allowed Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.1 Cg_endo -81.93 140.09 11.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.329 2.686 . . . . 0.0 113.215 -170.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.1 pt? -84.56 -12.07 54.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.803 174.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.555 ' HG3' ' H ' ' A' ' 70' ' ' HIS . 11.9 tp10 -108.98 151.95 25.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.429 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 82.9 m-70 -80.72 -15.9 55.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.555 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 81.6 t60 72.85 -70.56 0.16 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.389 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.4 m80 66.03 163.19 0.16 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.034 0.533 . . . . 0.0 110.693 -174.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 m170 59.65 -164.0 0.22 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.089 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -114.72 -59.08 2.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.301 177.126 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HG2' ' A' ' 1' ' ' MET . 47.7 ttm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.204 0.526 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.77 114.18 28.01 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -97.74 157.12 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.0 111.163 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.65 130.37 42.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.234 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.95 171.89 23.92 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.077 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -132.77 139.66 47.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.48 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.1 mt -76.85 106.01 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.079 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -95.69 -61.45 1.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.986 0.422 . . . . 0.0 110.603 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -98.76 118.22 35.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.337 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -140.68 127.36 20.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.878 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -116.87 89.77 3.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.352 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.1 -34.32 77.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.641 0.734 . . . . 0.0 110.092 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.39 -21.74 64.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.511 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.898 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.89 -45.7 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.225 -0.297 . . . . 0.0 111.302 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.29 1.3 20.39 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.555 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.565 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 56.0 p90 -140.4 175.57 9.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.09 0.445 . . . . 0.0 110.889 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.98 -161.32 26.41 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.115 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -137.37 129.72 29.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.092 0.473 . . . . 0.0 109.792 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.727 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.0 mt -116.66 131.07 70.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 13.9 tttp -106.07 130.67 53.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.83 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.9 p30 -92.76 175.92 6.63 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.74 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -100.76 16.97 23.25 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.535 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -114.84 -43.91 3.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.045 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.11 -80.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.09 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 11.8 t70 -161.23 -160.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 3.6 p-10 -99.24 154.21 18.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.35 163.64 20.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -178.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.76 128.7 34.27 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.727 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 58.5 m-85 -127.43 157.24 40.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.333 0.587 . . . . 0.0 111.193 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.565 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 54.7 t-80 -148.25 150.03 32.95 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.98 27.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.523 0.678 . . . . 0.0 112.793 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.446 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.8 tt -118.35 -32.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.514 -0.741 . . . . 0.0 110.902 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 32' ' ' ILE . 34.5 mmtp -95.21 5.27 52.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 110.902 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 36' ' ' ASN . 45.3 t -94.14 129.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.388 176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 -15.46 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 64' ' ' VAL . 5.4 m-20 -122.08 65.66 21.35 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.981 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 71.9 Cg_endo -75.3 -11.93 20.94 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.057 1.838 . . . . 0.0 111.772 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -84.57 -17.89 37.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.22 12.47 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.674 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.8 mt -75.19 134.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -161.18 170.62 19.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.168 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 8.3 tmtm? -74.69 137.88 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.758 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 7.5 t70 69.98 13.15 7.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.367 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.76 143.81 35.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.301 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 138.68 32.51 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 64' ' ' VAL . 20.5 m -138.4 163.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.23 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -128.02 134.23 49.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.215 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.71 172.36 16.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.31 141.73 24.99 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.74 160.27 6.27 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.815 2.343 . . . . 0.0 113.833 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.803 ' HB ' ' HE2' ' A' ' 60' ' ' TYR . 14.5 t -164.64 -179.46 5.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.747 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -134.62 148.29 50.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.114 0.483 . . . . 0.0 110.052 175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.49 -179.91 4.51 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -72.25 -28.06 62.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.285 0.565 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 52.1 mmtt -74.39 -42.81 58.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.338 175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.88 -153.56 23.59 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.597 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD13 HH12 ' A' ' 27' ' ' ARG . 68.7 mt -73.54 134.49 43.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 5.5 m -143.65 167.87 21.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.944 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.56 160.9 40.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.942 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.803 ' HE2' ' HB ' ' A' ' 51' ' ' THR . 29.0 p90 -141.1 175.31 9.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.44 48.78 21.89 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.07 0.856 . . . . 0.0 110.706 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' HG13 ' A' ' 34' ' ' VAL . 14.5 t -83.6 111.84 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.317 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.14 126.76 51.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.827 0.346 . . . . 0.0 110.097 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 46' ' ' VAL . 81.7 t -70.26 144.26 13.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.257 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -110.64 85.28 4.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.736 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 9.9 Cg_endo -91.48 136.85 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.069 2.513 . . . . 0.0 111.705 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.62 17.5 3.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.256 0.55 . . . . 0.0 110.698 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -103.4 -69.45 0.8 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.027 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 63.38 83.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.886 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -140.03 -71.47 0.38 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.083 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 64.02 104.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.754 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -74.75 160.85 30.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -134.16 153.16 52.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.747 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.1 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.614 173.331 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.38 -163.59 0.26 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.529 0.518 . . . . 0.0 109.833 -173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ttm -147.94 165.94 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.371 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.53 146.68 46.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.349 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.27 162.28 27.22 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.22 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' HG23 ' A' ' 19' ' ' ILE . 9.0 m -114.1 134.78 54.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.927 HD13 HG23 ' A' ' 40' ' ' ILE . 55.6 mt -73.81 121.14 24.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.704 -174.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -117.17 -56.1 2.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -117.65 122.73 44.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.042 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -140.79 114.37 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.944 0.402 . . . . 0.0 110.454 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 87.8 m-85 -89.61 83.18 6.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.844 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.54 -42.34 95.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.553 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -84.9 -47.8 9.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.343 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.91 8.91 8.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.314 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -138.35 172.51 12.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.316 0.558 . . . . 0.0 110.648 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.02 -171.22 38.21 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -137.37 129.35 29.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 66.1 mt -123.84 132.13 71.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.04 117.16 20.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.422 . . . . 0.0 110.617 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HB3' ' H ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -77.05 -168.52 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.93 0.871 . . . . 0.0 111.732 -174.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.59 -15.78 53.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.755 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.714 ' H ' ' HB3' ' A' ' 21' ' ' ASP . 46.9 m-80 -76.67 -14.63 59.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.644 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.44 -31.82 7.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.201 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.9 -175.55 2.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -109.46 147.94 32.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -171.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.631 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 49.3 mtt-85 -97.91 160.47 14.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.476 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.66 106.13 16.72 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 35.3 m-85 -96.97 154.94 17.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.282 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 32' ' ' ILE . 25.4 t-80 -149.12 133.48 17.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.561 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.68 -36.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.611 HG23 ' HG2' ' A' ' 33' ' ' LYS . 17.6 tt -61.26 -26.72 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.153 0.502 . . . . 0.0 111.939 -175.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.5 mmtt -104.88 9.16 34.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.384 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 40' ' ' ILE . 39.3 t -106.61 127.63 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.89 70.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.184 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -134.71 71.95 69.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.056 0.455 . . . . 0.0 111.427 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.39 -20.39 27.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.578 2.185 . . . . 0.0 112.657 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -80.88 -16.23 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.618 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.69 3.82 53.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.05 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.927 HG23 HD13 ' A' ' 7' ' ' ILE . 52.9 mt -73.9 110.07 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.381 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -117.64 -176.81 3.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.243 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -87.81 147.75 25.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.564 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.99 9.39 6.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.92 0.763 . . . . 0.0 111.104 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -90.3 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.48 151.88 20.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.342 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.2 m -129.94 164.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.433 0.635 . . . . 0.0 111.461 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -127.11 134.9 50.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.887 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.52 174.72 14.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.357 . . . . 0.0 111.667 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.82 142.01 23.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.257 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -86.81 138.88 5.31 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 167.79 27.8 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 131.86 41.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.22 24.14 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.51 -43.57 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.894 0.878 . . . . 0.0 111.811 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.92 -32.56 73.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.699 0.285 . . . . 0.0 110.777 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.74 -176.54 44.06 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.283 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.1 mt -79.09 138.16 37.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.435 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 2.0 p -151.13 169.05 22.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.122 0.487 . . . . 0.0 111.305 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HB2' ' HD2' ' A' ' 27' ' ' ARG . . . -143.35 148.41 36.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -131.79 175.11 9.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.76 32.63 22.4 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 124.016 0.822 . . . . 0.0 109.861 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.77 114.98 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.325 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -116.47 119.97 37.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' HG12 ' A' ' 46' ' ' VAL . 43.0 t -72.73 151.14 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.749 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.57 87.52 1.79 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.807 0.337 . . . . 0.0 110.235 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.3 Cg_endo -82.26 131.86 6.86 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 111.726 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.29 -70.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.232 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 128.14 21.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -146.74 70.03 1.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.383 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -56.18 124.07 16.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.434 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.4 121.09 17.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.875 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.48 85.18 7.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -99.27 37.31 1.58 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.545 0.688 . . . . 0.0 109.603 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.933 -178.304 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.4 114.23 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.866 0.729 . . . . 0.0 111.635 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 35.0 ttm -115.44 167.89 10.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.8 p-10 -127.93 141.18 51.61 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.056 0.455 . . . . 0.0 111.156 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -144.98 177.77 23.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.394 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 19' ' ' ILE . 6.6 m -122.92 135.27 54.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.8 0.333 . . . . 0.0 110.107 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.954 HD13 HG23 ' A' ' 40' ' ' ILE . 56.4 mt -74.28 122.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -114.27 -58.14 2.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 17.3 m -114.88 129.72 56.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.082 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.436 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 76.5 t-105 -152.89 130.14 11.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.42 97.47 5.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.87 -42.54 98.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.424 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.02 -43.64 70.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.764 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 16' ' ' PHE . 8.2 mmpt? -66.79 -39.77 87.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.82 -3.94 57.55 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.079 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.593 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 64.9 m-85 -95.48 156.81 16.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -163.51 157.31 29.45 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.0 m-85 -136.23 126.66 26.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 80.6 mt -134.07 133.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -102.95 129.02 49.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.5 p-10 -89.68 179.26 6.06 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.517 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.67 -8.53 58.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.75 -43.76 5.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.65 -98.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.103 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.2 -178.99 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.612 -0.346 . . . . 0.0 110.249 -164.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.91 122.87 20.74 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.322 0.582 . . . . 0.0 110.544 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -108.4 151.65 25.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.8 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -77.88 122.29 25.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.375 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 17.2 m-85 -112.55 153.21 27.86 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.318 0.58 . . . . 0.0 110.283 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 32' ' ' ILE . 3.7 t-80 -133.92 131.04 38.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.843 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 14.7 p -49.7 -26.72 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG22 ' ND1' ' A' ' 30' ' ' HIS . 12.3 tt -79.16 -20.37 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.459 0.647 . . . . 0.0 111.377 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' A' ' 32' ' ' ILE . 66.2 mmtt -102.69 10.77 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.013 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 34.6 t -101.66 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.643 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.11 -33.82 72.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.559 HD22 HD12 ' A' ' 39' ' ' LEU . 12.6 p-10 -141.75 74.63 22.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.076 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HA ' HG13 ' A' ' 40' ' ' ILE . 70.5 Cg_endo -75.02 -16.98 19.87 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.787 2.325 . . . . 0.0 112.983 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.28 -22.61 57.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.298 0.57 . . . . 0.0 110.434 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.559 HD12 HD22 ' A' ' 36' ' ' ASN . 92.3 mt -97.93 5.17 49.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.439 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 7' ' ' ILE . 33.0 mt -73.02 120.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.089 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -135.75 164.89 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.472 173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.616 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 2.4 tmtp? -68.98 142.53 54.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 30.6 t70 75.72 4.63 3.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.901 0.75 . . . . 0.0 111.38 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.38 147.29 29.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.14 -0.35 . . . . 0.0 110.233 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 140.67 29.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.614 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.6 m -132.28 151.15 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' MET . 11.5 p -118.91 135.23 54.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.804 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.564 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.4 p90 -154.1 173.18 16.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 0.0 111.76 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -99.83 142.89 25.45 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.635 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.29 143.99 12.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.468 2.112 . . . . 0.0 112.691 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 60' ' ' TYR . 11.6 t -165.12 176.46 8.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.292 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -113.35 143.75 43.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.146 0.498 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -100.89 16.7 24.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.753 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 73.59 -47.19 0.65 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -107.3 26.14 10.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.863 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.15 -171.21 34.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.951 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 145.78 25.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -148.03 169.98 18.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.811 0.339 . . . . 0.0 111.037 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.77 149.73 52.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.96 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 51' ' ' THR . 27.6 m-85 -114.37 172.37 7.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.96 41.27 26.91 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.973 0.795 . . . . 0.0 111.79 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 20.8 t -68.15 103.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.103 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -107.12 117.29 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.931 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 40' ' ' ILE . 22.3 t -87.67 140.17 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -176.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.23 88.44 2.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.108 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.92 162.17 39.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.573 -175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.3 pt? -68.17 -25.57 65.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.009 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -162.39 151.19 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -85.86 80.79 8.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.239 0.542 . . . . 0.0 109.668 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -79.13 136.02 37.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.387 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -78.45 134.11 37.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.384 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -136.89 97.89 3.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -112.59 -3.64 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.53 172.714 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.79 124.26 21.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.492 ' HE1' ' HB2' ' A' ' 22' ' ' GLU . 77.2 mtp -113.21 158.26 20.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 4.4 p-10 -106.11 140.47 39.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.232 0.539 . . . . 0.0 111.181 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.58 170.43 23.93 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.35 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -117.94 134.97 54.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.14 0.495 . . . . 0.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 40' ' ' ILE . 48.2 mt -77.79 120.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.391 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -107.74 -52.11 2.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 m -121.36 127.72 51.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.455 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -138.67 117.61 12.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.787 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 93.4 m-85 -90.76 88.37 7.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.3 -33.05 74.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.123 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.17 -31.66 72.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.79 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.787 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -92.46 -60.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.029 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.64 14.16 3.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.668 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.27 172.55 12.52 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.527 -0.396 . . . . 0.0 110.197 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.19 -163.27 24.91 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.505 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.55 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 85.2 m-85 -141.4 132.84 26.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 74.4 mt -130.87 139.43 51.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.301 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HE3' ' HA2' ' A' ' 24' ' ' GLY . 1.2 tmtp? -100.1 118.71 37.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.522 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 6.8 p-10 -102.22 -171.9 2.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.318 0.58 . . . . 0.0 111.288 -176.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 44.8 mt-10 -66.28 -23.34 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.449 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -70.53 -13.34 62.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.855 0.359 . . . . 0.0 110.992 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 20' ' ' LYS . . . 85.97 24.75 40.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.787 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -127.3 -177.47 4.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 18' ' ' PHE . 28.3 t-20 -127.54 120.67 28.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 51.0 mtt-85 -105.17 153.43 21.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.205 -172.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -80.44 115.97 20.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.739 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 23.9 m-85 -107.42 152.92 23.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.2 t-160 -150.47 138.45 20.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.231 -175.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.71 -31.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.1 tt -63.42 -27.63 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.051 0.453 . . . . 0.0 111.943 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.3 mmtt -102.28 7.25 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.502 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 40' ' ' ILE . 21.8 t -106.66 130.45 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.774 0.321 . . . . 0.0 110.198 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.07 -35.17 59.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -137.99 70.57 49.42 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.399 0.619 . . . . 0.0 111.026 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HA ' HG13 ' A' ' 40' ' ' ILE . 73.0 Cg_endo -74.16 -10.71 22.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.003 2.469 . . . . 0.0 112.236 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.37 -25.04 63.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.31 8.61 40.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.016 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 7' ' ' ILE . 43.8 mt -75.72 124.0 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.228 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.556 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 15.3 ptpt -144.63 163.74 33.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.158 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 1.4 tmtp? -72.73 140.56 47.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.557 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 35.1 t70 75.1 18.79 2.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.859 0.725 . . . . 0.0 110.89 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -100.93 149.38 23.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.23 137.5 32.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.237 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.9 m -132.6 147.59 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.874 0.369 . . . . 0.0 111.097 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.5 p -111.28 135.26 52.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.738 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 6.3 p90 -156.18 172.66 18.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 29.6 mm-40 -96.72 141.86 23.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_endo -89.02 136.38 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.847 2.365 . . . . 0.0 112.164 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.526 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 14.2 t -153.06 -177.0 6.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.036 0.446 . . . . 0.0 110.133 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -128.21 142.34 51.2 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 8.8 t-20 -105.8 170.05 8.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.54 -33.41 73.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.853 0.358 . . . . 0.0 110.732 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -119.56 26.76 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.82 176.17 22.71 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.687 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 57' ' ' LEU . 4.0 mp -79.28 143.7 35.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.834 0.317 . . . . 0.0 110.171 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p -151.76 170.22 20.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.222 0.534 . . . . 0.0 111.386 -172.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -136.7 148.51 47.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.162 175.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.526 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 29.6 p90 -130.3 177.38 7.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.71 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.1 35.5 26.4 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.004 0.815 . . . . 0.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . 26.1 t -67.46 112.24 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.356 -174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.57 117.22 30.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.504 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 46' ' ' VAL . 41.7 t -70.67 137.38 24.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.347 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.3 85.71 16.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.659 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 5.9 Cg_exo -79.56 -169.99 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.276 2.65 . . . . 0.0 111.67 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.08 -33.14 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.487 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 69' ' ' HIS . 27.2 tt0 -137.54 168.57 19.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 35.8 t-80 -66.39 -23.42 66.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.698 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 66.73 102.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.88 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -66.94 107.58 2.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.376 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.23 157.05 16.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.867 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -81.25 124.07 29.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.366 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.2 p80 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.142 175.666 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.49 114.85 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.255 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.5 mtp -105.71 159.22 16.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.185 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.77 142.43 31.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.428 0.633 . . . . 0.0 111.12 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -138.46 167.39 25.02 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.046 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -110.64 137.87 47.76 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.135 0.493 . . . . 0.0 110.734 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 HG23 ' A' ' 40' ' ' ILE . 58.2 mt -79.19 117.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.714 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.5 p -108.68 -43.55 4.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.25 0.548 . . . . 0.0 111.227 -175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.5 m -136.55 122.14 19.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.766 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 71.0 t-105 -139.54 130.78 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.623 0.249 . . . . 0.0 110.58 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.54 90.59 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.96 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.631 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.6 tmtt? -67.08 -26.36 66.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.47 -20.72 36.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.081 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -97.07 -44.67 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.578 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.72 -2.82 10.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.511 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 40.0 p90 -148.42 177.89 9.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.568 0.684 . . . . 0.0 111.646 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.15 -164.05 28.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.242 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.93 131.25 42.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.1 mt -130.17 129.94 65.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -103.47 124.33 48.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.507 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 9.4 p-10 -95.34 -175.98 3.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.029 0.442 . . . . 0.0 110.687 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.2 -7.46 51.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.522 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . 5.7 t-20 -95.84 -58.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.682 0.277 . . . . 0.0 111.213 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.69 -92.19 2.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.678 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -164.33 -154.31 0.24 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -72.81 135.79 45.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 109.785 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 42.2 mtt180 -114.34 148.9 36.86 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.666 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -85.16 115.86 23.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 51.2 m-85 -109.94 161.8 15.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.71 138.52 24.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.63 -28.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -61.68 -26.85 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 111.794 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 32' ' ' ILE . 33.9 mmtp -99.93 7.39 44.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.589 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 40' ' ' ILE . 29.0 t -100.8 123.92 54.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.19 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.291 -176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.754 HD22 HD12 ' A' ' 39' ' ' LEU . 12.2 p-10 -134.27 78.25 58.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.359 0.6 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.18 -19.66 13.38 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.966 2.444 . . . . 0.0 114.195 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.54 -2.95 58.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.067 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.754 HD12 HD22 ' A' ' 36' ' ' ASN . 59.8 mt -99.08 -1.71 38.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.145 0.498 . . . . 0.0 109.855 174.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.702 HG23 HD13 ' A' ' 7' ' ' ILE . 52.7 mt -71.74 122.59 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.443 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.32 165.25 17.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.881 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -78.4 148.28 33.73 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.082 0.468 . . . . 0.0 111.613 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 61.52 26.73 16.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.172 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 165.01 11.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.702 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.51 138.83 39.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 111.141 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 64' ' ' VAL . 27.3 m -131.54 152.11 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -110.97 134.73 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.993 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 9.1 p90 -151.95 165.6 34.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.017 0.437 . . . . 0.0 111.469 -175.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.24 141.32 24.9 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -88.66 139.34 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.313 2.675 . . . . 0.0 113.488 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -150.55 173.82 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 151.7 48.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.96 0.41 . . . . 0.0 110.84 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.47 177.31 7.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -74.97 -11.5 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -95.18 -2.83 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.4 -140.41 12.26 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.794 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.31 144.57 27.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.213 0.53 . . . . 0.0 110.71 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -143.61 168.79 19.05 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.44 168.05 24.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.697 0.284 . . . . 0.0 111.291 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -148.72 -179.96 7.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.64 41.57 28.23 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.785 0.678 . . . . 0.0 110.521 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.6 t -70.23 101.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.364 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 19.4 ttmm -101.68 114.27 28.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.593 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.3 t -77.57 134.85 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.903 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.71 86.11 5.43 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 85.2 Cg_endo -93.37 -169.27 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.053 2.502 . . . . 0.0 113.396 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.07 84.97 2.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.287 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -51.19 125.78 14.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.021 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -128.83 128.97 44.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -59.93 133.52 56.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.722 -171.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.86 135.71 41.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.125 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -74.93 135.88 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.986 0.422 . . . . 0.0 110.706 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -115.65 67.33 0.7 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.73 0.776 . . . . 0.0 110.438 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 33.3 m80 . . . . . 0 C--O 1.247 0.96 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.912 176.709 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.08 16.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.096 0.474 . . . . 0.0 110.808 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.429 ' HE3' ' HB3' ' A' ' 23' ' ' ASN . 60.7 mtp -115.34 154.18 29.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.549 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -118.08 139.96 50.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -146.5 176.58 25.34 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.869 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -116.6 140.13 49.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.3 mt -79.14 116.76 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.189 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -108.77 -63.27 1.36 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 m -102.91 129.05 49.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.29 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -147.03 135.01 21.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.759 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 89.2 m-85 -126.27 113.12 16.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.301 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -60.86 -64.07 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 -176.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.68 -17.02 61.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.336 -170.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 6.7 mmpt? -81.28 -35.62 30.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.944 173.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.26 15.16 62.84 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.266 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 43.9 p90 -145.34 175.39 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.478 -0.425 . . . . 0.0 110.605 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.63 -167.96 34.05 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.571 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.76 125.37 28.38 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.739 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.2 mt -120.85 129.2 75.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.865 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -107.45 126.49 52.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.216 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.631 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 5.0 p-10 -96.05 175.45 6.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.791 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -103.3 13.82 32.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB3' ' HE3' ' A' ' 3' ' ' MET . 8.2 t30 -107.09 -47.51 3.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.453 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.35 -83.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.34 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -169.15 -164.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -82.83 131.29 35.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -124.64 150.37 46.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 111.237 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -78.48 127.1 31.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.547 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.7 m-85 -120.62 156.56 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.656 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-80 -141.39 141.22 33.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.08 -31.26 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.627 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.2 tt -70.98 -21.26 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.672 0.749 . . . . 0.0 110.631 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.7 -11.52 59.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.058 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.868 HG11 HD11 ' A' ' 40' ' ' ILE . 23.3 t -91.11 138.44 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.31 -36.13 22.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.673 HD22 HD12 ' A' ' 39' ' ' LEU . 10.6 p-10 -129.25 85.35 59.71 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.772 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.7 -31.63 5.22 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.742 2.961 . . . . 0.0 112.692 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.93 -25.47 68.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.673 HD12 HD22 ' A' ' 36' ' ' ASN . 87.9 mt -95.77 5.25 51.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.612 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.868 HD11 HG11 ' A' ' 34' ' ' VAL . 36.2 mt -75.66 124.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.141 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 18.0 ptpt -143.68 164.57 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.165 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -78.92 151.42 31.72 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.27 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 71.68 4.04 4.89 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.432 1.083 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.485 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -85.09 158.45 20.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.757 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.17 136.0 39.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 64' ' ' VAL . 29.0 m -132.25 156.08 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -117.59 135.16 54.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.097 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.5 p90 -151.6 177.03 10.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.612 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -121.93 144.7 41.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.0 145.94 32.03 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.993 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -150.09 152.78 35.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -91.01 150.7 21.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.223 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 4.8 t-20 -127.15 159.18 35.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -70.35 -32.75 70.59 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.902 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 50.7 pttt -101.93 6.43 41.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -154.28 25.25 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.145 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.61 146.45 27.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.808 0.337 . . . . 0.0 110.461 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.9 p -145.07 169.41 18.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.09 0.471 . . . . 0.0 111.581 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -141.95 154.14 44.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.599 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -132.12 -175.93 3.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.21 50.52 18.84 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.005 0.816 . . . . 0.0 111.136 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -72.86 104.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.949 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -103.62 111.83 24.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.89 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HA ' HG12 ' A' ' 46' ' ' VAL . 59.0 t -72.58 142.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.881 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -105.13 88.42 2.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.1 Cg_exo -74.96 123.74 8.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.363 2.042 . . . . 0.0 111.069 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.65 -61.23 1.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.008 0.432 . . . . 0.0 110.504 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -116.48 153.8 31.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.411 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.14 126.11 32.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 72' ' ' HIS . 26.7 t-80 -82.14 56.23 3.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.871 0.367 . . . . 0.0 111.613 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 69.75 -30.75 0.2 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.743 0.817 . . . . 0.0 112.559 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.414 ' H ' ' C ' ' A' ' 70' ' ' HIS . 86.5 t60 -70.25 99.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.525 . . . . 0.0 109.735 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -112.13 148.98 32.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.354 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.361 177.211 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.675 0.274 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.13 118.51 30.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.62 150.52 28.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.98 158.2 16.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.574 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -152.19 172.51 31.44 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 176.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.2 m -122.18 130.88 53.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.864 0.332 . . . . 0.0 110.196 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.866 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.5 mt -67.7 105.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.304 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -95.4 -36.29 11.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.886 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 31.7 m -144.87 136.97 25.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -145.59 126.02 14.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.042 0.448 . . . . 0.0 111.368 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -119.87 95.53 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.84 -41.0 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.96 -37.09 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.081 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.724 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 18.6 tptm -86.26 -30.4 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.02 5.59 65.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.542 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.724 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 84.1 m-85 -119.21 162.36 18.81 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.669 -0.313 . . . . 0.0 110.604 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.23 173.12 39.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.223 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.9 m-85 -131.05 131.41 44.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.866 HG12 ' HA ' ' A' ' 7' ' ' ILE . 82.2 mt -136.4 130.56 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.98 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -91.73 139.52 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.6 p-10 -115.87 -164.65 0.97 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.388 0.613 . . . . 0.0 111.88 -171.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -62.97 -32.28 73.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.566 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.25 -33.81 75.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 26.71 9.19 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.099 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t70 -135.15 177.53 7.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -96.07 139.89 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.106 0.479 . . . . 0.0 110.383 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 52.9 mtt-85 -118.2 138.99 51.94 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.47 119.54 25.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.556 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.817 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 66.3 m-85 -111.66 160.17 17.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.625 0.726 . . . . 0.0 112.099 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CD2' HG22 ' A' ' 32' ' ' ILE . 4.4 t60 -141.75 142.31 33.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.984 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -48.94 -34.39 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.698 HG22 ' CD2' ' A' ' 30' ' ' HIS . 18.4 tt -62.54 -25.38 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.565 0.697 . . . . 0.0 111.363 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.785 ' HG3' ' HA ' ' A' ' 60' ' ' TYR . 7.6 mptt -77.52 -22.48 51.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.241 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 23.9 t -93.8 134.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.606 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.03 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.675 HD22 HD12 ' A' ' 39' ' ' LEU . 14.8 p-10 -127.88 77.04 76.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.095 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 40' ' ' ILE . 59.9 Cg_endo -73.12 -23.47 18.12 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.9 2.4 . . . . 0.0 113.273 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.1 -29.11 68.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.459 0.647 . . . . 0.0 111.074 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.675 HD12 HD22 ' A' ' 36' ' ' ASN . 81.3 mt -92.8 4.97 52.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.36 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 7' ' ' ILE . 40.0 mt -69.93 110.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.974 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.58 158.09 25.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.986 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 144.71 33.44 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.148 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.43 11.02 8.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.517 0.675 . . . . 0.0 110.551 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.59 154.76 19.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.8 143.37 26.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.794 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.5 m -134.32 164.14 35.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.408 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.25 153.58 45.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -167.77 177.07 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 41.1 mt-10 -110.46 142.78 26.76 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.4 Cg_endo -84.97 142.47 8.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.214 2.609 . . . . 0.0 113.219 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 t -144.86 162.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -104.19 149.46 25.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.943 0.402 . . . . 0.0 110.73 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 6.3 t-20 -139.68 154.79 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -66.95 -31.35 71.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -82.4 -18.09 43.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.85 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.04 -163.26 31.33 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.648 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' ASP . 83.9 mt -73.05 140.53 47.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.069 0.435 . . . . 0.0 110.407 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.4 p -135.0 167.22 21.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.82 0.343 . . . . 0.0 110.691 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.95 159.31 44.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.785 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 43.2 p90 -143.87 -178.61 6.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 123.31 0.381 . . . . 0.0 110.005 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.29 39.4 30.19 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.701 0.626 . . . . 0.0 110.249 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -78.74 119.03 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.403 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.0 127.05 55.43 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.794 ' HA ' HG12 ' A' ' 46' ' ' VAL . 27.9 t -77.87 142.63 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.214 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.7 86.81 3.13 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.397 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 94.2 Cg_endo -84.41 168.67 11.42 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.726 2.284 . . . . 0.0 112.5 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.9 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -65.1 -65.89 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.573 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.815 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 1.5 tm-20 -162.41 105.56 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -145.91 121.06 10.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.157 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -63.95 146.6 53.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.61 177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -60.56 119.1 7.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -74.53 136.47 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.769 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -69.73 -40.68 76.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 C--O 1.242 0.695 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.492 169.029 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.687 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 10.2 tpt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.687 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -55.96 127.74 31.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 110.766 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -118.5 164.21 15.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.136 0.494 . . . . 0.0 111.199 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -115.01 152.76 31.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.468 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.22 -178.5 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.514 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -125.47 136.71 53.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.165 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.821 HD13 HG23 ' A' ' 40' ' ' ILE . 44.0 mt -77.11 115.63 19.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.263 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -104.28 -40.32 6.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.166 0.507 . . . . 0.0 111.431 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 m -136.97 114.77 11.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.451 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.702 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 75.9 t-105 -130.62 136.48 48.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.057 0.455 . . . . 0.0 111.493 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.35 97.12 5.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.702 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.1 tmtp? -67.75 -33.09 74.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 110.005 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.32 -35.7 81.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.034 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.927 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.5 mmpt? -88.9 -30.09 19.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.37 9.58 57.77 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 48.6 p90 -144.39 174.65 10.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.964 0.412 . . . . 0.0 111.026 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.66 -172.63 37.86 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.069 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -134.78 126.84 29.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.734 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 79.3 mt -123.64 131.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.887 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.57 119.84 31.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.506 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.98 177.42 7.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.491 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -81.2 -5.98 58.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.335 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.34 -35.03 18.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.234 0.54 . . . . 0.0 109.563 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.76 22.65 2.69 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.017 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -108.03 164.09 12.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.397 0.598 . . . . 0.0 110.485 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -116.89 115.62 25.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -111.11 148.66 32.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.712 -172.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -81.52 122.13 27.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.7 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 30.7 m-85 -111.72 154.85 24.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.531 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.576 ' ND1' HG22 ' A' ' 32' ' ' ILE . 17.4 t-80 -141.32 133.12 27.35 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.14 -29.7 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.576 HG22 ' ND1' ' A' ' 30' ' ' HIS . 19.1 tt -67.06 -29.33 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.276 0.56 . . . . 0.0 111.225 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -82.3 -4.32 56.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.204 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 40' ' ' ILE . 22.0 t -95.84 133.31 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.173 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.27 -42.78 22.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -125.43 73.88 68.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 40' ' ' ILE . 56.0 Cg_endo -70.65 -15.86 33.79 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.548 2.166 . . . . 0.0 112.262 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.93 -10.63 60.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.603 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 66' ' ' PRO . 95.6 mt -108.22 7.97 27.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.821 HG23 HD13 ' A' ' 7' ' ' ILE . 50.7 mt -78.67 114.75 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.39 0.614 . . . . 0.0 111.63 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 48.9 mtpt -124.29 167.78 13.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.59 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.99 135.25 34.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.49 21.56 2.28 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 0.0 109.795 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -98.81 146.58 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.413 177.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.62 29.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.197 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.701 HG21 HD13 ' A' ' 19' ' ' ILE . 23.6 m -136.56 156.0 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.7 p -121.71 135.18 54.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.761 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.59 179.98 7.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.613 0.244 . . . . 0.0 110.924 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.5 pt-20 -125.83 142.88 43.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 171.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_exo -74.41 145.4 33.86 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.059 2.506 . . . . 0.0 113.481 -174.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 58' ' ' SER . 9.0 t -139.17 156.95 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -113.63 127.26 55.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.431 0.634 . . . . 0.0 112.111 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -108.38 161.22 15.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.596 171.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -71.45 -13.43 61.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.099 0.476 . . . . 0.0 110.309 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.78 -19.95 25.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.108 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.08 -162.31 31.27 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.969 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -85.47 138.01 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 111.057 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 51' ' ' THR . 5.4 m -137.89 169.64 17.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.337 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -139.94 152.78 46.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.731 0.301 . . . . 0.0 110.679 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 1.6 p90 -139.67 -179.22 5.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.221 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.25 48.31 22.38 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.921 0.763 . . . . 0.0 110.041 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 24.9 t -75.9 112.67 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 39.6 mtmt -113.49 109.89 19.39 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.001 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.666 ' HA ' HG12 ' A' ' 46' ' ' VAL . 56.1 t -66.45 152.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.08 88.7 2.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 39' ' ' LEU . 35.9 Cg_endo -64.71 148.49 90.22 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.727 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.7 pt? -61.33 -25.16 66.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.214 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -148.68 -71.39 0.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.931 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -151.86 -56.65 0.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.479 . . . . 0.0 110.308 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -160.42 136.15 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -61.91 -38.2 87.49 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.192 -172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 73' ' ' HIS . 44.3 t-80 76.8 161.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.806 0.691 . . . . 0.0 111.339 169.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' HIS . 48.6 t-80 83.86 101.88 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.169 174.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 . . . . . 0 C--O 1.246 0.899 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.48 171.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.327 0.584 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -115.92 157.95 23.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.384 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -98.02 130.08 44.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.87 162.88 24.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.34 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -110.14 138.69 46.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.046 0.45 . . . . 0.0 110.134 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.863 HD13 HG23 ' A' ' 40' ' ' ILE . 53.0 mt -79.51 114.81 20.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.206 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -113.08 -55.45 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 111.04 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 m -104.51 124.51 49.4 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -160.06 126.79 4.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.98 102.13 10.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 2.5 tmtp? -73.83 -30.38 62.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.524 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.28 -42.06 94.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 0.0 110.672 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -90.38 -51.57 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 37.43 1.41 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.417 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 36.9 p90 -148.83 167.08 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.383 0.592 . . . . 0.0 110.819 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.53 -160.27 32.21 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.062 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.91 127.86 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.695 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.4 132.51 66.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.501 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -111.71 130.18 55.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 13.3 p-10 -91.85 -170.69 2.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.47 -9.0 19.69 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.105 0.478 . . . . 0.0 110.853 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -97.2 -44.85 6.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 -100.19 2.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.356 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -166.81 -160.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.49 135.93 36.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.555 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 63.2 mtt85 -117.75 156.73 27.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.692 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -79.86 117.48 20.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.101 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.695 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.1 m-85 -113.18 156.13 23.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.406 0.622 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 20.0 t-80 -148.89 138.23 21.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.931 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -49.19 -30.93 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' HG2' ' A' ' 33' ' ' LYS . 14.8 tt -61.94 -30.04 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 112.011 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.7 mmtt -93.69 10.26 33.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.739 HG11 HD11 ' A' ' 40' ' ' ILE . 21.7 t -108.73 132.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.751 0.31 . . . . 0.0 110.252 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.91 -23.92 33.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.435 ' HB2' HD12 ' A' ' 39' ' ' LEU . 23.0 p-10 -135.81 71.48 63.78 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 121.634 0.731 . . . . 0.0 110.149 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.42 -21.62 13.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.338 2.692 . . . . 0.0 114.34 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.4 -9.47 59.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.564 0.697 . . . . 0.0 110.107 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 36' ' ' ASN . 85.0 mt -93.45 -5.87 48.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.822 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.863 HG23 HD13 ' A' ' 7' ' ' ILE . 66.5 mt -71.28 111.42 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.085 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -137.48 157.1 47.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.668 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.681 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 14.8 tmtt? -59.95 136.1 57.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.963 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.681 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 26.8 t70 74.97 4.47 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.835 176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.65 156.41 22.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.26 138.26 36.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.0 m -132.42 164.51 34.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.392 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.8 p -127.87 140.56 51.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 12.6 p90 -151.68 162.96 40.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.492 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.6 mm-40 -94.9 142.84 25.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.37 142.93 16.99 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.377 2.051 . . . . 0.0 113.384 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.485 HG21 ' CE2' ' A' ' 60' ' ' TYR . 14.6 t -163.08 177.36 9.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.508 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -115.74 155.13 28.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.05 0.453 . . . . 0.0 111.102 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.658 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 14.3 t-20 -132.8 168.49 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.951 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -68.23 -38.75 82.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 15.8 ptpt -91.98 -1.66 57.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.879 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.87 -133.49 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.15 155.82 17.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.1 p -148.04 170.32 18.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.763 0.316 . . . . 0.0 111.016 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -135.4 151.06 50.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.256 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 51' ' ' THR . 24.2 m-85 -122.47 170.29 10.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.768 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.599 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 48.99 58.43 5.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.974 0.796 . . . . 0.0 110.879 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 34' ' ' VAL . 27.3 t -85.47 120.4 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.765 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -123.99 127.13 47.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.223 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.2 t -80.61 151.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.919 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.64 88.31 3.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.36 0.413 . . . . 0.0 110.443 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 39' ' ' LEU . 74.2 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.216 1.944 . . . . 0.0 111.949 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.457 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 11.8 ttt -138.98 177.18 8.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' H ' ' HG2' ' A' ' 3' ' ' MET . 4.3 p-10 -106.66 141.93 37.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 112.03 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -135.39 176.74 19.91 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -122.6 139.56 53.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.615 0.708 . . . . 0.0 110.721 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 19' ' ' ILE . 53.0 mt -76.46 107.86 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.285 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -97.88 -43.0 7.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.238 0.542 . . . . 0.0 111.037 -174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 m -132.09 121.9 24.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -139.42 129.83 25.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -107.62 92.35 4.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -59.44 -49.23 78.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.043 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.05 -45.38 90.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HG2' ' HE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -75.24 -39.65 59.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.762 -174.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.82 6.14 35.16 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.848 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.492 ' HE1' ' HG2' ' A' ' 14' ' ' LYS . 33.1 p90 -130.54 174.84 9.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.722 0.761 . . . . 0.0 110.836 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.39 -170.84 41.75 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.0 124.39 26.2 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.791 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.69 119.02 60.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.831 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 60.2 tttt -107.06 124.17 49.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.508 . . . . 0.0 110.823 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 p-10 -89.03 -176.18 5.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.884 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -107.73 5.27 26.54 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.214 0.53 . . . . 0.0 111.013 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.28 -49.86 5.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.68 -92.11 1.85 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.329 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -168.68 -168.53 0.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.669 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -74.62 135.84 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.554 0.693 . . . . 0.0 111.689 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -103.43 151.61 22.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.028 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -79.98 117.34 20.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 56.1 m-85 -111.09 155.64 22.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.631 0.729 . . . . 0.0 111.405 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.481 ' ND1' HG22 ' A' ' 32' ' ' ILE . 14.3 t-80 -139.83 131.77 27.74 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.965 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -46.87 -32.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' ND1' ' A' ' 30' ' ' HIS . 20.3 tt -62.7 -32.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.49 6.24 31.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 40' ' ' ILE . 33.6 t -91.79 133.42 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.91 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.25 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.566 HD22 HD12 ' A' ' 39' ' ' LEU . 22.2 p-10 -145.65 72.25 13.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.676 0.75 . . . . 0.0 110.124 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.568 ' HA ' HG13 ' A' ' 40' ' ' ILE . 92.8 Cg_endo -75.34 -9.69 20.39 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.146 2.564 . . . . 0.0 112.63 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.6 -9.98 59.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.566 HD12 HD22 ' A' ' 36' ' ' ASN . 90.4 mt -109.63 2.8 20.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.192 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 37' ' ' PRO . 55.4 mt -65.4 129.36 29.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.018 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 17.2 ptpt -143.33 166.02 25.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.275 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 12.9 tmtt? -80.08 144.9 32.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.674 0.273 . . . . 0.0 110.526 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 29.6 t70 67.27 27.88 8.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.696 0.76 . . . . 0.0 110.441 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -103.72 148.69 25.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.155 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.13 137.68 32.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 64' ' ' VAL . 26.8 m -133.29 155.56 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.405 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.4 p -113.13 133.81 54.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.93 175.7 13.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.85 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.0 mt-10 -115.72 140.81 26.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.789 174.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -82.05 133.94 7.97 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.957 2.438 . . . . 0.0 113.215 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -149.58 -175.18 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.045 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -124.21 146.48 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.118 0.485 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.435 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 15.8 t-20 -101.01 -64.68 1.03 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.724 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -174.02 -65.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.738 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.8 28.43 3.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.222 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.31 173.19 29.64 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.404 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.5 mt -81.13 146.01 30.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.73 0.3 . . . . 0.0 110.367 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.4 m -144.59 168.87 19.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.163 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.94 154.63 42.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.574 0.226 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -135.76 179.09 6.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.7 50.53 16.89 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.982 0.801 . . . . 0.0 110.22 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.11 113.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.078 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.23 114.66 28.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.914 ' HA ' HG12 ' A' ' 46' ' ' VAL . 45.9 t -71.13 131.36 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.847 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.04 86.98 4.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 0.0 110.671 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 122.435 2.09 . . . . 0.0 111.727 179.151 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 mtt -103.28 160.77 14.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.774 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -93.36 151.93 19.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.089 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -150.91 161.27 28.98 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.412 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -111.36 132.45 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.41 . . . . 0.0 110.289 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.85 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.3 mt -67.08 112.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.446 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HE2' ' A' ' 42' ' ' LYS . 3.2 m -101.07 -43.55 5.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -174.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -145.99 140.4 26.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.36 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -140.7 122.17 15.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 86.0 m-85 -110.54 88.82 2.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -55.85 -63.14 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.58 -7.48 59.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.114 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 23.7 tptm -85.22 -32.79 22.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' HIS . . . 103.71 -17.76 48.92 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.905 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -109.31 179.06 4.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.261 0.553 . . . . 0.0 111.657 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.55 171.82 44.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.289 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.38 128.4 41.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 7' ' ' ILE . 58.2 mt -133.11 128.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.124 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' ASP . 44.4 tptt -85.18 115.56 23.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.711 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.683 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.5 p-10 -92.61 -171.63 2.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -83.94 -36.84 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.704 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -89.04 -47.9 7.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -171.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.01 -101.69 2.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.08 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -163.4 -154.52 0.28 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.24 115.92 15.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.2 0.524 . . . . 0.0 110.101 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 43.7 mtt180 -100.17 152.39 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -80.24 118.56 22.02 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.78 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 8.9 m-85 -105.02 158.18 16.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.765 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.561 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.5 t-80 -140.4 126.09 19.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.71 -38.49 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.616 HG23 ' HG2' ' A' ' 33' ' ' LYS . 20.0 tt -59.74 -30.77 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.303 0.573 . . . . 0.0 111.839 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -96.11 11.74 33.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.349 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.509 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 21.8 t -97.85 127.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.22 61.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.447 . . . . 0.0 111.101 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -133.04 69.65 78.66 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.86 -17.66 32.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.672 2.248 . . . . 0.0 112.756 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.03 -28.88 65.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.257 0.551 . . . . 0.0 110.807 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' A' ' 66' ' ' PRO . 90.4 mt -88.56 3.12 51.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.289 -174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.838 HG23 HD13 ' A' ' 7' ' ' ILE . 42.2 mt -74.7 112.77 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.767 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.41 165.71 18.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.237 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 8' ' ' THR . 5.2 tptm -69.99 134.99 48.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.119 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 t70 69.03 16.94 8.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.963 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -84.04 159.94 21.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.31 139.39 33.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.4 m -131.95 162.8 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.681 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -126.55 134.44 50.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.857 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.683 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 19.0 p90 -149.06 174.6 12.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.813 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.684 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.0 mm-40 -96.17 142.03 23.98 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -81.86 134.73 8.52 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.221 2.614 . . . . 0.0 112.034 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 60' ' ' TYR . 13.3 t -158.58 174.07 15.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.0 0.428 . . . . 0.0 110.121 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -140.17 156.32 46.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.09 -73.51 0.64 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.067 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.66 -63.71 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.96 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -79.88 0.0 33.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.143 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.56 47.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.262 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.26 155.04 23.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 m -145.59 168.97 19.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.31 150.85 45.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.795 0.331 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.556 ' CE2' HG21 ' A' ' 51' ' ' THR . 29.6 m-85 -126.1 171.27 10.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.897 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.684 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 49.99 56.22 8.23 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.988 0.805 . . . . 0.0 110.93 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -73.43 106.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.778 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.09 106.08 16.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.009 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.724 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.2 t -68.83 147.44 12.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.022 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.4 t -109.28 87.12 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.361 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.1 Cg_endo . . . . . 0 N--CA 1.456 -0.715 0 C-N-CA 122.155 1.903 . . . . 0.0 111.813 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.774 0.321 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.8 mtm -98.73 145.79 26.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.6 p30 -108.22 161.8 14.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.286 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.71 159.72 23.29 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.798 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -108.44 133.62 52.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.756 HD13 HG23 ' A' ' 40' ' ' ILE . 47.0 mt -77.72 126.55 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.906 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -114.77 -53.09 2.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.059 0.457 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -118.44 124.52 47.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.924 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -138.6 125.29 20.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 89.3 m-85 -98.15 98.13 9.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.856 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -62.45 -36.64 83.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.26 -21.21 62.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 67.5 mmtt -102.42 -48.06 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.891 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.28 15.23 23.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.51 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 52.8 p90 -141.72 173.04 11.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.83 -166.99 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.476 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.8 129.78 30.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.4 mt -127.25 138.64 54.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.125 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -91.86 119.18 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.425 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -86.3 -173.34 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.389 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 44.0 mt-10 -79.18 -24.54 43.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.769 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -122.52 -44.14 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -169.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.58 -96.33 0.75 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.839 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -169.21 -157.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 130.09 38.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.503 0.592 . . . . 0.0 110.089 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 23.1 mtp85 -112.09 147.07 36.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.286 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.57 117.63 19.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 31.8 m-85 -111.22 150.41 29.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.902 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.438 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.0 t-160 -148.24 136.19 20.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.702 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.41 -34.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.698 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.8 tt -58.08 -34.71 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.698 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -100.74 15.38 28.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.415 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 40' ' ' ILE . 23.4 t -114.04 134.57 56.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.321 . . . . 0.0 110.28 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.31 60.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.16 78.13 53.47 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.619 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.76 -19.81 23.52 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.868 2.379 . . . . 0.0 113.956 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.56 -22.72 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -78.99 -11.45 60.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.452 0.644 . . . . 0.0 109.427 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 7' ' ' ILE . 56.8 mt -70.97 116.08 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.424 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -156.97 169.55 24.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.637 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 13.4 tmtt? -61.08 140.26 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 36.6 t70 76.29 4.14 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.115 0.884 . . . . 0.0 111.933 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -92.13 156.19 17.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.048 -0.407 . . . . 0.0 110.324 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.49 149.08 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.4 m -134.95 149.8 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.855 0.36 . . . . 0.0 110.893 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -109.63 138.03 46.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.061 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -161.48 -179.18 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.514 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 pt-20 -104.35 142.1 23.92 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.8 Cg_endo -86.88 137.05 4.48 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.113 2.542 . . . . 0.0 112.345 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 60' ' ' TYR . 6.2 t -159.23 169.38 24.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -109.96 155.8 21.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.724 0.297 . . . . 0.0 110.612 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 13.8 t-20 -132.53 157.75 43.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.612 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -78.59 8.87 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.792 0.329 . . . . 0.0 111.554 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -134.14 19.17 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 0.0 110.395 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.01 -147.38 19.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.427 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.59 152.28 20.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -144.5 167.67 21.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.672 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.04 153.41 37.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.583 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.603 ' CE2' HG21 ' A' ' 51' ' ' THR . 71.2 m-85 -130.23 168.29 17.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.44 55.79 8.88 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 124.058 0.849 . . . . 0.0 111.253 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 34' ' ' VAL . 23.4 t -82.75 117.49 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.168 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -122.37 119.86 32.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.9 t -68.62 142.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.03 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.4 86.4 5.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.472 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 C-N-CA 122.549 2.166 . . . . 0.0 112.204 -177.133 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 79.3 mtp -116.15 150.66 37.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.732 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -105.56 147.17 28.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.071 0.462 . . . . 0.0 110.715 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.29 161.01 26.48 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.694 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -105.6 138.38 41.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.72 105.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.717 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 p -107.53 -51.93 2.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.199 0.523 . . . . 0.0 110.524 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 20.5 m -100.81 118.83 37.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -151.0 113.32 4.6 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.924 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.584 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 99.4 m-85 -106.3 84.4 2.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.059 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 12.5 tmtt? -59.82 -30.75 69.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.164 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.62 -24.62 65.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.425 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.7 mptp? -104.4 -31.13 9.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.3 13.96 34.44 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.521 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -139.45 174.13 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.373 0.587 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.19 -162.54 31.44 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.069 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 97.7 m-85 -139.03 131.72 28.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 77.1 mt -119.09 122.07 68.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.004 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 26' ' ' ASN . 2.1 mmmp? -89.33 112.62 23.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.07 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.0 p-10 -96.65 -170.17 2.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.817 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.38 -32.09 72.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.059 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 27.1 t-20 -63.75 -31.09 72.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.385 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.75 10.32 47.08 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.667 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -107.68 168.18 9.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 17.1 p-10 -107.18 116.13 31.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.425 0.631 . . . . 0.0 110.561 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 39.6 mtt-85 -100.47 141.37 33.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.59 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -80.03 113.68 18.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 42.7 m-85 -105.62 153.64 21.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.672 0.748 . . . . 0.0 111.196 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -147.78 140.69 24.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.989 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.07 -18.36 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.676 HG23 ' HG2' ' A' ' 33' ' ' LYS . 7.6 tp -57.29 -39.89 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 111.701 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.676 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -92.06 3.28 55.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.769 -176.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -100.14 126.8 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.14 -30.37 21.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.339 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 HD12 ' A' ' 39' ' ' LEU . 13.0 p-10 -121.21 85.32 41.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.258 0.551 . . . . 0.0 111.343 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.77 -19.47 9.79 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.092 2.528 . . . . 0.0 113.733 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.79 -23.95 36.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.541 0.686 . . . . 0.0 109.926 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 36' ' ' ASN . 88.4 mt -86.95 -8.49 57.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.063 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.869 HD11 HG11 ' A' ' 34' ' ' VAL . 68.2 mt -65.19 107.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.377 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 73.7 mmtt -115.72 157.71 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -71.93 135.81 46.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 70.64 9.46 6.88 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.351 0.596 . . . . 0.0 111.16 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -82.27 166.96 19.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 110.639 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.18 145.19 36.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.452 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 64' ' ' VAL . 32.8 m -131.28 160.5 42.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.71 151.86 38.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.639 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 20.2 p90 -167.02 173.58 9.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.037 0.446 . . . . 0.0 111.477 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.2 mm-40 -104.96 141.12 21.9 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.266 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 21.4 Cg_endo -92.7 143.37 2.34 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.056 2.504 . . . . 0.0 113.508 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 t -152.02 151.06 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.389 174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 m -90.88 156.29 18.12 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.476 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 4.6 t-20 -136.11 173.87 11.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.49 -20.17 62.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -112.0 13.64 20.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.175 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.48 -155.75 21.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.987 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.5 mt -86.2 148.22 25.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.255 0.55 . . . . 0.0 110.687 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -145.44 169.17 18.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.731 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.24 154.37 43.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 49' ' ' GLU . 32.4 p90 -136.23 177.05 8.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.209 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.1 42.04 31.76 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.984 0.803 . . . . 0.0 110.419 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.7 t -75.06 112.69 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -116.84 125.31 51.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.556 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 46' ' ' VAL . 21.1 t -76.81 146.86 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.37 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.4 87.85 2.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 123.426 0.454 . . . . 0.0 110.434 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.3 Cg_endo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.582 2.188 . . . . 0.0 111.793 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -101.33 153.71 19.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.45 144.67 28.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.121 0.486 . . . . 0.0 110.451 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.3 162.76 28.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.699 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -111.03 134.05 52.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.08 0.467 . . . . 0.0 110.278 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 40' ' ' ILE . 57.0 mt -77.66 114.98 18.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.52 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 p -108.1 -42.57 4.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -130.28 122.89 28.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 74.3 t-105 -144.32 135.4 25.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.826 0.346 . . . . 0.0 110.329 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.64 86.42 2.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.536 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -60.63 -27.65 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.499 0.666 . . . . 0.0 110.009 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HE3' ' A' ' 14' ' ' LYS . 18.1 t70 -61.88 -34.03 75.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.357 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 30.9 mmtp -119.16 -21.76 7.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.98 12.28 50.24 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.821 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.411 ' HD2' ' HE1' ' A' ' 28' ' ' TYR . 25.5 m-85 -98.31 160.88 14.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -177.84 162.51 30.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.913 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -137.48 126.02 23.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.722 HD13 HG21 ' A' ' 46' ' ' VAL . 86.8 mt -120.99 129.99 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -93.9 120.88 34.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.4 p-10 -86.22 -173.67 4.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.983 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -91.1 -10.76 40.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.159 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.44 -42.91 28.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.46 44.81 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.75 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -136.2 162.18 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 0.0 110.542 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -117.86 127.11 53.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.538 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.77 146.29 50.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.235 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HD2' ' A' ' 16' ' ' PHE . 67.5 t80 -76.59 127.28 32.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 29.9 m-85 -112.97 154.7 26.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.808 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG22 ' A' ' 32' ' ' ILE . 10.5 t-80 -141.67 130.99 23.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.652 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -49.82 -34.12 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.62 HG23 ' HG2' ' A' ' 33' ' ' LYS . 19.2 tt -56.94 -34.22 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.9 mmtt -97.45 9.2 43.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.458 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.557 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 33.3 t -97.31 130.4 46.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.63 54.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.845 HD22 HD12 ' A' ' 39' ' ' LEU . 9.3 p-10 -132.73 79.42 64.14 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.272 0.558 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 68.9 Cg_endo -74.76 -22.34 15.49 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.02 2.48 . . . . 0.0 113.518 -173.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.17 -28.14 64.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 HD22 ' A' ' 36' ' ' ASN . 57.1 mt -82.63 -5.48 58.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.974 HG23 HD13 ' A' ' 7' ' ' ILE . 39.0 mt -72.25 112.62 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.625 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -133.79 174.76 10.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.772 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 1.7 tmtp? -70.53 140.96 51.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.536 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 33.1 t70 74.94 6.14 4.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.575 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.34 152.0 27.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.146 -0.346 . . . . 0.0 110.323 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.18 136.6 40.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 110.558 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.722 HG21 HD13 ' A' ' 19' ' ' ILE . 28.5 m -130.44 158.83 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.122 0.486 . . . . 0.0 111.046 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.6 p -118.31 135.4 54.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.378 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.465 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 16.8 p90 -143.69 164.9 29.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -173.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -98.17 142.23 24.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.591 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.55 142.89 21.12 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.292 1.994 . . . . 0.0 112.95 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 13.5 t -157.85 166.63 32.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.607 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -113.9 145.48 41.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.993 0.425 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.86 177.16 7.94 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.17 -25.76 58.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.053 0.454 . . . . 0.0 109.903 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.83 -14.41 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.939 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.01 -138.43 10.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.87 139.49 34.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -144.08 168.59 19.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.235 -174.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.92 149.13 44.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.865 0.364 . . . . 0.0 111.436 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 51' ' ' THR . 16.9 p90 -134.05 -177.61 4.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.133 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.43 42.2 32.02 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.743 0.652 . . . . 0.0 110.202 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -68.1 100.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.004 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.542 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 16.6 ttmm -108.28 116.42 31.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.635 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.7 t -70.88 148.49 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.133 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.2 t -104.64 87.94 2.0 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 93.2 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 C-N-CA 122.223 1.949 . . . . 0.0 111.956 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -113.83 149.22 35.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.348 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -101.46 152.12 21.13 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.943 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -151.6 177.06 29.73 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.23 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' ILE . 3.2 m -126.9 132.14 50.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.828 ' HA ' HG12 ' A' ' 19' ' ' ILE . 62.7 mt -65.0 106.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.506 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m -95.02 -37.38 11.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.86 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -150.96 125.06 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.878 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.648 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 74.6 t-105 -143.02 131.7 22.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.4 96.2 4.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.734 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.2 -41.78 89.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -69.57 -28.03 65.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.667 ' HG2' ' HD1' ' A' ' 16' ' ' PHE . 39.6 ttmt -87.69 -38.49 15.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.936 0.398 . . . . 0.0 110.41 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 106.34 -12.78 43.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.667 ' HD1' ' HG2' ' A' ' 14' ' ' LYS . 57.6 m-85 -96.6 163.42 13.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.902 0.382 . . . . 0.0 111.356 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.76 27.27 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.117 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -139.57 131.76 28.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.828 HG12 ' HA ' ' A' ' 7' ' ' ILE . 68.0 mt -136.92 125.11 33.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.862 0.363 . . . . 0.0 110.984 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 14.1 tmtt? -86.41 125.78 33.92 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.0 p-10 -97.1 -169.51 1.87 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.833 0.825 . . . . 0.0 112.853 -169.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -77.95 -30.23 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.287 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -74.09 -36.67 64.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.741 0.305 . . . . 0.0 110.41 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.17 41.05 0.45 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.488 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.41 163.51 32.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.159 0.48 . . . . 0.0 109.943 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -110.36 115.34 29.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -101.61 153.66 19.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.417 -170.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.892 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.8 m-85 -116.65 153.93 31.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.895 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.3 t-160 -136.4 133.76 37.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.648 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 12.4 p -47.23 -31.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.3 tt -67.72 -30.15 47.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.972 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.9 mmtt -97.7 15.31 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.67 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -94.29 130.77 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.38 48.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.975 0.417 . . . . 0.0 110.948 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.499 HD22 HD12 ' A' ' 39' ' ' LEU . 22.4 p-10 -135.21 79.22 50.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.518 0.675 . . . . 0.0 111.203 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HA ' HG13 ' A' ' 40' ' ' ILE . 86.0 Cg_endo -76.95 -11.1 18.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.859 2.373 . . . . 0.0 112.247 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.39 -18.97 61.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.803 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB3' ' HG3' ' A' ' 66' ' ' PRO . 78.7 mt -106.39 12.87 29.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 34' ' ' VAL . 40.9 mt -82.82 126.48 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.0 112.183 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -139.18 168.38 19.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 12.7 tmtt? -78.88 139.85 38.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 66.7 m-20 73.97 13.04 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.706 0.803 . . . . 0.0 111.709 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -82.57 156.72 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.594 0.235 . . . . 0.0 110.673 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.72 137.88 31.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 19' ' ' ILE . 28.6 m -136.04 160.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.801 ' HB ' ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -124.23 154.46 40.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 p90 -166.45 171.47 11.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.902 0.382 . . . . 0.0 111.542 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 26.3 mm-40 -101.17 143.33 26.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.128 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.55 148.56 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.25 1.966 . . . . 0.0 112.183 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -166.29 171.1 12.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -109.54 155.4 21.43 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.572 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 23.1 t-20 -131.17 162.46 29.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.663 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -58.94 -36.35 74.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.489 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.45 -48.7 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.706 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -141.27 3.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.119 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -86.1 149.16 25.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -151.01 169.78 20.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -135.42 151.1 50.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.556 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.1 172.23 7.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.565 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 50.01 49.5 20.21 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.946 0.778 . . . . 0.0 111.297 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.585 HG21 ' HD2' ' A' ' 29' ' ' PHE . 17.9 t -76.95 109.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.001 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.801 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -109.15 128.76 55.28 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 46' ' ' VAL . 28.5 t -84.93 143.93 10.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.398 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -114.3 85.12 10.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.654 ' HG3' ' HB3' ' A' ' 39' ' ' LEU . 87.0 Cg_endo . . . . . 0 N--CA 1.447 -1.242 0 C-N-CA 123.094 2.529 . . . . 0.0 112.208 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -109.53 177.29 4.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.895 0.379 . . . . 0.0 110.946 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.85 151.43 25.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.936 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.63 165.44 23.79 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.973 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -112.37 135.35 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.921 HD13 HG23 ' A' ' 40' ' ' ILE . 51.8 mt -82.29 121.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 p -106.89 -53.45 2.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.998 0.428 . . . . 0.0 111.228 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.1 m -124.55 127.32 47.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.078 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -142.09 135.53 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.986 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.49 102.56 9.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.03 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.649 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.85 -49.0 64.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.829 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -70.92 -46.46 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.57 19.57 9.71 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.8 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.68 170.73 15.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.924 0.862 . . . . 0.0 110.661 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.41 -170.52 41.33 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.267 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -133.25 131.81 40.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.755 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.6 mt -131.26 131.17 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -100.74 120.63 40.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.8 p30 -109.6 -164.84 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.144 0.497 . . . . 0.0 111.543 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.84 -10.25 59.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.128 -171.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.29 -28.05 69.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.326 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.95 8.02 55.86 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.195 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -129.77 163.78 25.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.612 ' H ' HD22 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -93.65 137.27 33.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 110.574 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' HB3' ' A' ' 57' ' ' LEU . 35.2 mtt85 -111.29 150.2 29.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.666 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -89.23 123.42 33.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.688 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.755 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 63.7 m-85 -116.74 155.64 28.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.315 0.579 . . . . 0.0 111.808 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.48 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-160 -136.49 135.17 38.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.666 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.96 -29.67 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.48 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.1 tt -63.76 -31.31 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.21 -9.01 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.667 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.872 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -91.17 134.29 30.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.261 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.36 -24.22 19.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.178 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.709 ' HB2' HG23 ' A' ' 64' ' ' VAL . 3.2 m-20 -122.38 65.49 23.13 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.849 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.04 -30.55 13.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.015 1.81 . . . . 0.0 113.656 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.13 -18.27 34.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.428 0.633 . . . . 0.0 110.152 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 87.4 mt -90.9 -8.68 48.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.921 HG23 HD13 ' A' ' 7' ' ' ILE . 54.3 mt -61.03 119.56 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.621 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -126.84 173.25 9.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -83.47 136.02 34.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 66.83 13.85 9.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.484 0.659 . . . . 0.0 111.001 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.13 156.4 17.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.671 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.7 137.65 39.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 64' ' ' VAL . 19.7 m -126.48 157.3 37.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.86 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 0.0 110.52 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.674 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 7.8 p90 -158.9 176.69 12.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.288 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.1 pm0 -111.47 143.36 28.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.1 Cg_exo -77.1 154.07 32.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.283 2.655 . . . . 0.0 113.507 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -166.89 179.4 5.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.036 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 57' ' ' LEU . 8.2 p -118.66 146.31 44.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.874 0.369 . . . . 0.0 110.447 175.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.568 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 2.3 t-20 -105.88 25.87 10.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 25.2 t-20 71.36 -56.18 0.64 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.833 -174.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.7 -39.04 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.099 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.24 -156.51 12.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.109 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 84.2 mt -84.82 134.77 34.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.959 0.409 . . . . 0.0 111.125 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 7.6 m -147.92 168.74 21.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.593 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -144.08 163.85 32.36 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.739 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.38 179.5 6.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.378 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.63 41.28 31.22 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 124.124 0.89 . . . . 0.0 110.508 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 48' ' ' PHE . 22.0 t -76.77 107.61 8.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.301 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -109.05 127.73 54.36 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.965 175.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 36' ' ' ASN . 82.3 t -65.78 149.95 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.695 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.51 86.02 1.29 Allowed Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 88.1 Cg_endo . . . . . 0 N--CA 1.447 -1.233 0 C-N-CA 122.806 2.337 . . . . 0.0 112.58 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.15 157.86 20.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.491 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -96.97 147.53 23.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.922 0.391 . . . . 0.0 110.054 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.714 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.86 165.49 28.05 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.762 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 m -120.37 135.0 55.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.089 0.471 . . . . 0.0 109.843 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.953 HD13 HG23 ' A' ' 40' ' ' ILE . 51.0 mt -76.58 117.24 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.585 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -101.47 -46.57 4.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 110.93 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -124.14 123.13 39.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -132.06 116.06 16.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.038 0.447 . . . . 0.0 110.695 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 81.1 m-85 -105.19 90.35 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.5 -38.97 82.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.722 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.99 -25.71 56.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.263 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 11' ' ' PHE . 41.0 mmtm -83.73 -38.2 21.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.39 45.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.921 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 54.8 p90 -144.13 176.61 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.809 0.337 . . . . 0.0 110.849 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.78 -168.41 29.87 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.297 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -138.29 130.65 28.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.1 mt -122.54 130.65 74.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 21' ' ' ASP . 13.3 tmtt? -104.58 118.09 35.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.6 p-10 -86.57 -178.78 6.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.943 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -93.39 -2.29 54.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.011 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -112.08 -54.06 2.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.819 0.343 . . . . 0.0 111.106 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.09 -99.16 2.07 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.194 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -158.85 -159.2 0.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.54 129.93 37.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.256 0.55 . . . . 0.0 110.621 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 69.1 mtt180 -108.32 151.6 25.76 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -77.95 124.42 27.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.063 0.459 . . . . 0.0 110.251 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 49.4 m-85 -120.51 148.0 44.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.496 0.665 . . . . 0.0 110.246 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -148.83 143.72 26.49 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.785 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' CB ' ' A' ' 37' ' ' PRO . 11.1 p -49.09 -25.52 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.731 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.6 tt -65.35 -33.61 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -106.7 -1.1 23.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 40' ' ' ILE . 46.4 t -99.25 126.29 52.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.41 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.81 74.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.592 HD22 ' HB ' ' A' ' 64' ' ' VAL . 37.1 m-20 -118.36 76.4 12.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.977 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' CB ' HG23 ' A' ' 31' ' ' VAL . 63.0 Cg_endo -75.77 -24.07 11.99 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.109 1.872 . . . . 0.0 112.439 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.92 -13.64 57.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.394 0.616 . . . . 0.0 110.594 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 79.9 mt -103.13 3.91 36.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.739 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.953 HG23 HD13 ' A' ' 7' ' ' ILE . 62.9 mt -72.47 115.88 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.4 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 30.8 mmtp -120.3 154.06 35.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.619 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -71.2 132.31 44.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.31 24.23 7.44 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.793 0.683 . . . . 0.0 111.647 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -95.67 157.98 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.969 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.85 139.7 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 111.09 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.4 m -137.6 166.5 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.187 0.518 . . . . 0.0 110.967 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.1 p -131.5 134.99 46.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.634 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 10.2 p90 -156.31 164.75 37.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.982 0.42 . . . . 0.0 111.475 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.65 144.09 29.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.631 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 147.23 32.35 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.763 2.309 . . . . 0.0 113.918 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.453 ' HB ' ' CD1' ' A' ' 60' ' ' TYR . 15.1 t -154.21 139.83 17.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.736 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 p -89.13 126.79 35.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.236 0.541 . . . . 0.0 111.528 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 14.2 t-20 -86.91 167.65 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.947 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.42 -34.54 61.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.556 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -99.96 -57.48 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.357 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.69 -148.22 4.8 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.488 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.73 140.87 30.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.007 0.432 . . . . 0.0 111.112 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -149.14 168.98 21.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.61 152.17 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 52.9 p90 -124.67 172.96 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.532 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . 45.81 52.12 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 124.347 1.029 . . . . 0.0 110.828 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' HD2' ' A' ' 29' ' ' PHE . 20.9 t -76.81 111.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.402 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -97.19 119.06 34.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 95.7 t -70.63 148.21 10.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.68 89.52 2.3 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 123.304 0.378 . . . . 0.0 110.936 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.512 0 C-N-CA 122.316 2.01 . . . . 0.0 111.908 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . . . . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.637 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -112.37 169.76 8.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.973 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.67 152.45 20.48 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.925 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 m -100.13 135.83 40.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.033 0.444 . . . . 0.0 110.705 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.794 HD13 HG23 ' A' ' 40' ' ' ILE . 55.2 mt -82.47 116.41 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.781 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -103.53 -51.35 3.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 30.2 m -119.52 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.466 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 58.9 t-105 -150.74 122.18 7.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 0.0 110.904 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -130.48 87.42 2.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.611 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.35 -37.82 78.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.21 -35.03 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.842 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HE2' ' HE1' ' A' ' 16' ' ' PHE . 54.0 mtpt -90.16 -14.48 33.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.627 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.01 -4.19 62.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.199 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' HIS . 53.5 p90 -132.75 173.58 11.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.643 0.721 . . . . 0.0 111.996 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.466 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -165.28 177.82 40.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.229 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 94.0 m-85 -139.07 130.18 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.768 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 85.4 mt -136.94 135.1 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.653 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.4 tmtp? -112.53 117.65 32.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.855 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.662 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.6 p-10 -97.84 174.96 6.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -94.89 2.01 55.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.35 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 3' ' ' MET . 7.2 t30 -105.88 -50.29 3.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.59 -87.99 2.03 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.359 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -171.24 -164.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 50.6 t-20 -82.23 122.69 28.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 43.8 mtt-85 -112.22 153.89 26.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.794 0.33 . . . . 0.0 111.041 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -80.12 121.34 25.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.768 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.1 m-85 -110.13 159.57 17.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.578 ' HB3' HG22 ' A' ' 32' ' ' ILE . 10.7 t-80 -148.54 147.03 28.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.14 -10.47 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 111.407 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 30' ' ' HIS . 8.9 tt -82.84 -19.49 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.565 0.698 . . . . 0.0 110.462 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 32' ' ' ILE . 12.3 mptt -103.14 -3.49 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.657 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG11 HD11 ' A' ' 40' ' ' ILE . 25.6 t -104.71 139.4 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.84 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.71 -31.34 19.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.318 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.8 HD22 HD12 ' A' ' 39' ' ' LEU . 21.7 p-10 -132.69 77.51 69.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.393 0.616 . . . . 0.0 110.65 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.2 -19.0 13.87 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.863 2.376 . . . . 0.0 113.817 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.31 -0.83 57.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.995 0.426 . . . . 0.0 111.053 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 HD22 ' A' ' 36' ' ' ASN . 69.6 mt -102.85 0.59 32.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.657 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.798 HD11 HG11 ' A' ' 34' ' ' VAL . 58.0 mt -80.96 109.11 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.805 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -117.67 155.62 29.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.3 tmtt? -74.42 141.51 45.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 59.3 m-20 75.48 19.82 2.05 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.522 0.729 . . . . 0.0 111.442 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -103.25 165.88 10.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.235 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.45 137.61 45.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.284 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 64' ' ' VAL . 18.3 m -128.35 164.27 30.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.104 0.478 . . . . 0.0 111.484 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 p -124.36 136.86 54.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.593 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 14.4 p90 -156.2 170.08 23.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.122 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 23.8 mm-40 -93.28 140.58 23.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -84.0 135.39 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.221 2.614 . . . . 0.0 113.1 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.6 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 11.9 t -151.48 -174.45 4.84 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.543 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 12.6 t -126.37 -177.9 4.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.228 0.537 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.616 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 7.7 t-20 -145.89 -170.99 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.8 -27.2 26.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.006 0.432 . . . . 0.0 109.963 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -108.38 1.74 21.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.067 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.8 31.83 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.482 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 71.4 mt -87.52 159.02 18.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.189 0.495 . . . . 0.0 110.518 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.616 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.5 m -147.69 169.01 20.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.205 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.19 151.01 47.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.6 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 26.9 p90 -133.0 170.66 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.399 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.73 47.8 23.89 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.152 0.907 . . . . 0.0 110.175 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.18 120.59 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.104 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 127.35 48.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.271 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.858 ' HA ' HG12 ' A' ' 46' ' ' VAL . 19.2 t -67.24 154.55 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.123 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.79 84.12 5.15 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 121.07 0.462 . . . . 0.0 111.29 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 58.2 Cg_endo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 123.35 2.7 . . . . 0.0 112.213 172.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.6 mtm -111.13 167.54 10.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.208 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -112.97 152.38 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.38 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.76 172.92 30.42 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.826 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -117.6 136.35 53.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 0.0 110.242 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 40' ' ' ILE . 46.8 mt -79.88 114.45 20.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.664 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 p -102.76 -43.3 5.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.179 0.514 . . . . 0.0 110.795 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.7 m -127.21 126.01 42.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.252 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -145.22 128.1 16.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.668 0.27 . . . . 0.0 111.039 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.61 98.16 5.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.3 176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.69 -37.31 86.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.95 -42.6 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.364 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 50.7 tptt -95.7 -49.82 5.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.618 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.47 13.48 12.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.952 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 74.6 m-85 -125.69 164.36 20.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.675 0.274 . . . . 0.0 110.328 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.35 170.47 41.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.86 129.04 37.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.1 mt -128.53 130.3 69.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.367 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -89.36 123.04 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.4 p30 -91.08 175.26 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.486 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -96.48 24.98 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.53 -48.88 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.514 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.18 -71.09 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.401 -0.905 . . . . 0.0 113.986 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.38 -154.3 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.027 0.414 . . . . 0.0 110.071 -170.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -88.03 152.93 21.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 53.1 mtt-85 -124.69 147.41 48.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -86.96 113.83 23.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.93 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 34.7 m-85 -105.48 150.13 25.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.657 0.741 . . . . 0.0 111.956 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' ND1' HG22 ' A' ' 32' ' ' ILE . 2.7 t-80 -128.45 130.61 47.83 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.084 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 37' ' ' PRO . 11.1 p -47.29 -31.95 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' ND1' ' A' ' 30' ' ' HIS . 13.5 tt -75.32 -21.41 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.58 -174.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.39 1.2 57.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.117 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 21.9 t -96.67 143.12 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.28 -42.81 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.368 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 39' ' ' LEU . 13.9 p-10 -127.69 75.67 77.69 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.189 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 91.8 Cg_endo -81.17 -17.29 9.29 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.959 2.439 . . . . 0.0 113.865 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -89.92 -8.76 51.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.474 0.654 . . . . 0.0 109.871 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 36' ' ' ASN . 87.3 mt -96.1 1.29 52.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.625 177.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 7' ' ' ILE . 51.1 mt -68.38 127.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.919 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -121.06 157.72 29.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.559 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -80.94 139.65 35.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.67 56.52 1.54 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.809 0.814 . . . . 0.0 109.276 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.6 36.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.18 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.96 140.12 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -134.88 162.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -127.5 139.84 52.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 9.7 p90 -156.47 170.63 21.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.414 . . . . 0.0 111.917 -172.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 62.5 mm-40 -85.4 142.56 37.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 5.5 Cg_exo -78.93 133.96 11.53 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.505 2.136 . . . . 0.0 111.287 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 60' ' ' TYR . 9.5 t -165.94 152.09 9.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -129.56 145.97 51.42 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.03 -69.85 0.78 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -175.33 -54.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.362 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.79 17.69 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.703 -175.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.49 171.76 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.333 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.84 155.93 37.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -148.03 169.14 20.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.803 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -148.92 143.14 26.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.468 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 51' ' ' THR . 22.8 m-85 -122.07 168.49 11.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.98 37.97 26.76 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.626 0.579 . . . . 0.0 110.79 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' HG13 ' A' ' 34' ' ' VAL . 18.4 t -67.86 114.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.158 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -115.95 117.85 31.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.587 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.9 t -79.98 146.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.487 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -111.56 86.24 6.69 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.2 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 C-N-CA 123.079 2.519 . . . . 0.0 111.852 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.28 153.81 17.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.1 p-10 -107.88 139.92 41.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 110.759 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.31 166.4 23.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.442 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 p -109.67 137.8 46.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.039 0.447 . . . . 0.0 111.315 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 HD13 HG12 ' A' ' 19' ' ' ILE . 21.5 mm -63.83 115.87 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.474 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.452 ' O ' ' HE3' ' A' ' 42' ' ' LYS . 29.3 p -110.59 -47.13 3.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.123 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -122.5 125.76 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.98 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -156.04 133.27 10.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.708 0.289 . . . . 0.0 110.578 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 86.4 m-85 -123.47 115.68 21.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.29 -51.87 61.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.966 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.43 -8.36 59.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 111.268 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 11' ' ' PHE . 70.2 mmtt -85.73 -39.88 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.863 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.13 9.21 65.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.045 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 41.1 p90 -135.47 169.13 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.043 0.422 . . . . 0.0 110.732 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.17 -170.93 41.73 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.112 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -136.58 134.91 37.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.629 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 90.8 mt -126.68 129.75 71.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.276 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -92.27 117.58 30.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.645 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 4.9 p-10 -102.43 -173.37 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 111.797 -173.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 40.9 mt-10 -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.073 -174.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -70.0 -25.62 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.981 0.419 . . . . 0.0 110.23 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.59 -18.49 9.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.568 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 -163.13 0.86 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.38 0.59 . . . . 0.0 110.13 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -121.62 147.91 45.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CZ ' HD13 ' A' ' 57' ' ' LEU . 8.2 mpt_? -111.52 146.89 36.5 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.202 170.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -85.68 120.83 27.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 53.9 m-85 -109.87 154.85 22.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.414 0.626 . . . . 0.0 111.672 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -144.8 134.86 23.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.093 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.39 -27.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.513 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -64.68 -25.72 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.606 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.5 mmtt -101.52 11.64 38.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.161 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 40' ' ' ILE . 61.1 t -97.95 127.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.077 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.82 -30.53 32.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.558 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.658 HD22 HD12 ' A' ' 39' ' ' LEU . 13.8 p-10 -142.06 81.4 14.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.177 0.513 . . . . 0.0 111.602 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.1 -19.04 23.31 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.739 2.293 . . . . 0.0 112.948 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.55 -23.31 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.352 0.596 . . . . 0.0 110.617 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.658 HD12 HD22 ' A' ' 36' ' ' ASN . 81.2 mt -101.89 9.68 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.091 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.712 HD11 HG11 ' A' ' 34' ' ' VAL . 51.2 mt -81.41 118.49 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.86 159.7 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 8' ' ' THR . 85.0 tttt -78.16 146.12 35.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 t70 72.42 3.76 4.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.56 156.32 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.222 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' GLY . . . -97.78 139.15 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 19' ' ' ILE . 32.9 m -128.53 148.6 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.224 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -110.86 134.6 52.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.012 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.6 p90 -147.79 167.45 24.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.956 0.408 . . . . 0.0 111.609 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 54.2 mm-40 -92.36 142.51 26.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.613 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -82.95 133.92 6.9 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.783 2.322 . . . . 0.0 112.301 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.3 t -152.96 161.38 42.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -101.64 147.61 26.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.291 0.567 . . . . 0.0 111.205 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -113.95 156.88 23.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.729 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -55.35 -33.72 63.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 111.461 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -101.8 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.596 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.0 -135.95 2.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.115 -172.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.45 HD13 ' CZ ' ' A' ' 27' ' ' ARG . 91.7 mt -102.59 151.33 22.46 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.696 0.284 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -145.55 167.49 22.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 111.003 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -140.93 148.89 41.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.553 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -117.84 170.97 8.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.206 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 46.95 53.72 10.13 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.095 0.872 . . . . 0.0 111.37 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 36.5 t -70.95 100.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.1 0.476 . . . . 0.0 110.234 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 34.3 ttmt -118.24 117.09 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.119 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.581 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 21.8 t -69.66 151.58 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.819 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.7 t -103.34 88.26 1.61 Allowed Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.1 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 123.329 2.686 . . . . 0.0 113.215 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -97.74 157.12 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.0 111.163 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.65 130.37 42.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.234 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.95 171.89 23.92 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.077 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -132.77 139.66 47.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.48 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.1 mt -76.85 106.01 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.079 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -95.69 -61.45 1.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.986 0.422 . . . . 0.0 110.603 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -98.76 118.22 35.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.337 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -140.68 127.36 20.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.878 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -116.87 89.77 3.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.352 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.1 -34.32 77.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.641 0.734 . . . . 0.0 110.092 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.39 -21.74 64.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.511 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.898 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.89 -45.7 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.225 -0.297 . . . . 0.0 111.302 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.29 1.3 20.39 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.555 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.565 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 56.0 p90 -140.4 175.57 9.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.09 0.445 . . . . 0.0 110.889 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.98 -161.32 26.41 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.115 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -137.37 129.72 29.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.092 0.473 . . . . 0.0 109.792 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.727 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.0 mt -116.66 131.07 70.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 13.9 tttp -106.07 130.67 53.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.83 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.9 p30 -92.76 175.92 6.63 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.74 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -100.76 16.97 23.25 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.535 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -114.84 -43.91 3.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.045 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.11 -80.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.09 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 11.8 t70 -161.23 -160.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 3.6 p-10 -99.24 154.21 18.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.35 163.64 20.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -178.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.76 128.7 34.27 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.727 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 58.5 m-85 -127.43 157.24 40.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.333 0.587 . . . . 0.0 111.193 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.565 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 54.7 t-80 -148.25 150.03 32.95 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.98 27.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.523 0.678 . . . . 0.0 112.793 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.446 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.8 tt -118.35 -32.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.514 -0.741 . . . . 0.0 110.902 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 32' ' ' ILE . 34.5 mmtp -95.21 5.27 52.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 110.902 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 36' ' ' ASN . 45.3 t -94.14 129.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.388 176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 -15.46 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 64' ' ' VAL . 5.4 m-20 -122.08 65.66 21.35 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.981 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 71.9 Cg_endo -75.3 -11.93 20.94 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.057 1.838 . . . . 0.0 111.772 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -84.57 -17.89 37.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.22 12.47 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.674 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.8 mt -75.19 134.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -161.18 170.62 19.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.168 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 8.3 tmtm? -74.69 137.88 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.758 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 7.5 t70 69.98 13.15 7.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.367 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.76 143.81 35.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.301 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 138.68 32.51 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 64' ' ' VAL . 20.5 m -138.4 163.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.23 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -128.02 134.23 49.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.215 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.71 172.36 16.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.31 141.73 24.99 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.74 160.27 6.27 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.815 2.343 . . . . 0.0 113.833 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.803 ' HB ' ' HE2' ' A' ' 60' ' ' TYR . 14.5 t -164.64 -179.46 5.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.747 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.456 ' C ' HD22 ' A' ' 53' ' ' ASN . 3.4 m -134.62 148.29 50.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.114 0.483 . . . . 0.0 110.052 175.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 52' ' ' THR . 0.9 OUTLIER -123.49 -179.91 4.51 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -72.25 -28.06 62.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.285 0.565 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 52.1 mmtt -74.39 -42.81 58.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.338 175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.88 -153.56 23.59 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.597 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD13 HH12 ' A' ' 27' ' ' ARG . 68.7 mt -73.54 134.49 43.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 5.5 m -143.65 167.87 21.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.944 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.56 160.9 40.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.942 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.803 ' HE2' ' HB ' ' A' ' 51' ' ' THR . 29.0 p90 -141.1 175.31 9.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.44 48.78 21.89 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.07 0.856 . . . . 0.0 110.706 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' HG13 ' A' ' 34' ' ' VAL . 14.5 t -83.6 111.84 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.317 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.14 126.76 51.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.827 0.346 . . . . 0.0 110.097 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 46' ' ' VAL . 81.7 t -70.26 144.26 13.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.257 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -110.64 85.28 4.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.736 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 9.9 Cg_endo . . . . . 0 N--CA 1.451 -1.007 0 C-N-CA 123.069 2.513 . . . . 0.0 111.705 174.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ttm -147.94 165.94 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.371 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.53 146.68 46.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.349 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.27 162.28 27.22 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.22 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' HG23 ' A' ' 19' ' ' ILE . 9.0 m -114.1 134.78 54.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.927 HD13 HG23 ' A' ' 40' ' ' ILE . 55.6 mt -73.81 121.14 24.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.704 -174.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -117.17 -56.1 2.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -117.65 122.73 44.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.042 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -140.79 114.37 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.944 0.402 . . . . 0.0 110.454 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 87.8 m-85 -89.61 83.18 6.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.844 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.54 -42.34 95.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.553 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -84.9 -47.8 9.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.343 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.91 8.91 8.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.314 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -138.35 172.51 12.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.316 0.558 . . . . 0.0 110.648 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.02 -171.22 38.21 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -137.37 129.35 29.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 66.1 mt -123.84 132.13 71.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.04 117.16 20.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.422 . . . . 0.0 110.617 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HB3' ' H ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -77.05 -168.52 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.93 0.871 . . . . 0.0 111.732 -174.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.59 -15.78 53.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.755 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.714 ' H ' ' HB3' ' A' ' 21' ' ' ASP . 46.9 m-80 -76.67 -14.63 59.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.644 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.44 -31.82 7.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.201 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.9 -175.55 2.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -109.46 147.94 32.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -171.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.631 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 49.3 mtt-85 -97.91 160.47 14.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.476 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.66 106.13 16.72 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 35.3 m-85 -96.97 154.94 17.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.282 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 32' ' ' ILE . 25.4 t-80 -149.12 133.48 17.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.561 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.68 -36.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.611 HG23 ' HG2' ' A' ' 33' ' ' LYS . 17.6 tt -61.26 -26.72 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.153 0.502 . . . . 0.0 111.939 -175.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.5 mmtt -104.88 9.16 34.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.384 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 40' ' ' ILE . 39.3 t -106.61 127.63 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.89 70.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.184 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -134.71 71.95 69.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.056 0.455 . . . . 0.0 111.427 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.39 -20.39 27.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.578 2.185 . . . . 0.0 112.657 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -80.88 -16.23 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.618 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.69 3.82 53.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.05 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.927 HG23 HD13 ' A' ' 7' ' ' ILE . 52.9 mt -73.9 110.07 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.381 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -117.64 -176.81 3.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.243 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -87.81 147.75 25.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.564 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.99 9.39 6.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.92 0.763 . . . . 0.0 111.104 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -90.3 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.48 151.88 20.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.342 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.2 m -129.94 164.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.433 0.635 . . . . 0.0 111.461 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -127.11 134.9 50.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.887 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.52 174.72 14.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.357 . . . . 0.0 111.667 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.82 142.01 23.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.257 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -86.81 138.88 5.31 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 167.79 27.8 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 131.86 41.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.22 24.14 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.51 -43.57 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.894 0.878 . . . . 0.0 111.811 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.92 -32.56 73.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.699 0.285 . . . . 0.0 110.777 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.74 -176.54 44.06 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.283 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.1 mt -79.09 138.16 37.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.435 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 2.0 p -151.13 169.05 22.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.122 0.487 . . . . 0.0 111.305 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HB2' ' HD2' ' A' ' 27' ' ' ARG . . . -143.35 148.41 36.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -131.79 175.11 9.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.76 32.63 22.4 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 124.016 0.822 . . . . 0.0 109.861 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.77 114.98 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.325 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -116.47 119.97 37.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' HG12 ' A' ' 46' ' ' VAL . 43.0 t -72.73 151.14 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.749 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.57 87.52 1.79 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.807 0.337 . . . . 0.0 110.235 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.3 Cg_endo . . . . . 0 N--CA 1.457 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 111.726 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.278 0.561 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 35.0 ttm -115.44 167.89 10.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.8 p-10 -127.93 141.18 51.61 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.056 0.455 . . . . 0.0 111.156 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -144.98 177.77 23.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.394 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 19' ' ' ILE . 6.6 m -122.92 135.27 54.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.8 0.333 . . . . 0.0 110.107 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.954 HD13 HG23 ' A' ' 40' ' ' ILE . 56.4 mt -74.28 122.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -114.27 -58.14 2.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 17.3 m -114.88 129.72 56.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.082 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.436 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 76.5 t-105 -152.89 130.14 11.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.42 97.47 5.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.87 -42.54 98.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.424 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.02 -43.64 70.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.764 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 16' ' ' PHE . 8.2 mmpt? -66.79 -39.77 87.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.82 -3.94 57.55 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.079 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.593 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 64.9 m-85 -95.48 156.81 16.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -163.51 157.31 29.45 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.0 m-85 -136.23 126.66 26.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 80.6 mt -134.07 133.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -102.95 129.02 49.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.5 p-10 -89.68 179.26 6.06 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.517 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.67 -8.53 58.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.75 -43.76 5.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.65 -98.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.103 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.2 -178.99 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.612 -0.346 . . . . 0.0 110.249 -164.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.91 122.87 20.74 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.322 0.582 . . . . 0.0 110.544 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -108.4 151.65 25.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.8 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -77.88 122.29 25.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.375 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 17.2 m-85 -112.55 153.21 27.86 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.318 0.58 . . . . 0.0 110.283 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 32' ' ' ILE . 3.7 t-80 -133.92 131.04 38.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.843 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 14.7 p -49.7 -26.72 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG22 ' ND1' ' A' ' 30' ' ' HIS . 12.3 tt -79.16 -20.37 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.459 0.647 . . . . 0.0 111.377 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' A' ' 32' ' ' ILE . 66.2 mmtt -102.69 10.77 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.013 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 34.6 t -101.66 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.643 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.11 -33.82 72.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.559 HD22 HD12 ' A' ' 39' ' ' LEU . 12.6 p-10 -141.75 74.63 22.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.076 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HA ' HG13 ' A' ' 40' ' ' ILE . 70.5 Cg_endo -75.02 -16.98 19.87 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.787 2.325 . . . . 0.0 112.983 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.28 -22.61 57.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.298 0.57 . . . . 0.0 110.434 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.559 HD12 HD22 ' A' ' 36' ' ' ASN . 92.3 mt -97.93 5.17 49.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.439 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 7' ' ' ILE . 33.0 mt -73.02 120.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.089 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -135.75 164.89 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.472 173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.616 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 2.4 tmtp? -68.98 142.53 54.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 30.6 t70 75.72 4.63 3.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.901 0.75 . . . . 0.0 111.38 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.38 147.29 29.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.14 -0.35 . . . . 0.0 110.233 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 140.67 29.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.614 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.6 m -132.28 151.15 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' MET . 11.5 p -118.91 135.23 54.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.804 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.564 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.4 p90 -154.1 173.18 16.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 0.0 111.76 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -99.83 142.89 25.45 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.635 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.29 143.99 12.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.468 2.112 . . . . 0.0 112.691 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 60' ' ' TYR . 11.6 t -165.12 176.46 8.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.292 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -113.35 143.75 43.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.146 0.498 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -100.89 16.7 24.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.753 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 73.59 -47.19 0.65 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -107.3 26.14 10.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.863 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.15 -171.21 34.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.951 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 145.78 25.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -148.03 169.98 18.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.811 0.339 . . . . 0.0 111.037 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.77 149.73 52.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.96 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 51' ' ' THR . 27.6 m-85 -114.37 172.37 7.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.96 41.27 26.91 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.973 0.795 . . . . 0.0 111.79 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 20.8 t -68.15 103.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.103 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -107.12 117.29 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.931 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 40' ' ' ILE . 22.3 t -87.67 140.17 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -176.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.23 88.44 2.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.108 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.573 -175.41 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.836 0.35 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.492 ' HE1' ' HB2' ' A' ' 22' ' ' GLU . 77.2 mtp -113.21 158.26 20.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 4.4 p-10 -106.11 140.47 39.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.232 0.539 . . . . 0.0 111.181 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.58 170.43 23.93 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.35 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -117.94 134.97 54.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.14 0.495 . . . . 0.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 40' ' ' ILE . 48.2 mt -77.79 120.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.391 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -107.74 -52.11 2.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 m -121.36 127.72 51.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.455 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -138.67 117.61 12.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.787 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 93.4 m-85 -90.76 88.37 7.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.3 -33.05 74.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.123 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.17 -31.66 72.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.79 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.787 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -92.46 -60.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.029 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.64 14.16 3.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.668 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.27 172.55 12.52 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.527 -0.396 . . . . 0.0 110.197 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.19 -163.27 24.91 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.505 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.55 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 85.2 m-85 -141.4 132.84 26.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 74.4 mt -130.87 139.43 51.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.301 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HE3' ' HA2' ' A' ' 24' ' ' GLY . 1.2 tmtp? -100.1 118.71 37.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.522 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 6.8 p-10 -102.22 -171.9 2.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.318 0.58 . . . . 0.0 111.288 -176.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 44.8 mt-10 -66.28 -23.34 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.449 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -70.53 -13.34 62.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.855 0.359 . . . . 0.0 110.992 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 20' ' ' LYS . . . 85.97 24.75 40.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.787 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -127.3 -177.47 4.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 18' ' ' PHE . 28.3 t-20 -127.54 120.67 28.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 51.0 mtt-85 -105.17 153.43 21.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.205 -172.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -80.44 115.97 20.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.739 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 23.9 m-85 -107.42 152.92 23.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.2 t-160 -150.47 138.45 20.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.231 -175.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.71 -31.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.1 tt -63.42 -27.63 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.051 0.453 . . . . 0.0 111.943 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.3 mmtt -102.28 7.25 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.502 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 40' ' ' ILE . 21.8 t -106.66 130.45 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.774 0.321 . . . . 0.0 110.198 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.07 -35.17 59.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -137.99 70.57 49.42 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.399 0.619 . . . . 0.0 111.026 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HA ' HG13 ' A' ' 40' ' ' ILE . 73.0 Cg_endo -74.16 -10.71 22.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.003 2.469 . . . . 0.0 112.236 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.37 -25.04 63.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.31 8.61 40.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.016 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 7' ' ' ILE . 43.8 mt -75.72 124.0 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.228 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.556 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 15.3 ptpt -144.63 163.74 33.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.158 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 1.4 tmtp? -72.73 140.56 47.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 35.1 t70 75.1 18.79 2.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.859 0.725 . . . . 0.0 110.89 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -100.93 149.38 23.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.23 137.5 32.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.237 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.9 m -132.6 147.59 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.874 0.369 . . . . 0.0 111.097 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.5 p -111.28 135.26 52.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.738 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 6.3 p90 -156.18 172.66 18.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 29.6 mm-40 -96.72 141.86 23.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_endo -89.02 136.38 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.847 2.365 . . . . 0.0 112.164 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.526 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 14.2 t -153.06 -177.0 6.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.036 0.446 . . . . 0.0 110.133 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -128.21 142.34 51.2 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 8.8 t-20 -105.8 170.05 8.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.54 -33.41 73.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.853 0.358 . . . . 0.0 110.732 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -119.56 26.76 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.82 176.17 22.71 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.687 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 57' ' ' LEU . 4.0 mp -79.28 143.7 35.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.834 0.317 . . . . 0.0 110.171 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p -151.76 170.22 20.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.222 0.534 . . . . 0.0 111.386 -172.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -136.7 148.51 47.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.162 175.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.526 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 29.6 p90 -130.3 177.38 7.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.71 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.1 35.5 26.4 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.004 0.815 . . . . 0.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . 26.1 t -67.46 112.24 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.356 -174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.57 117.22 30.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.504 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 46' ' ' VAL . 41.7 t -70.67 137.38 24.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.347 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.3 85.71 16.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.659 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 5.9 Cg_exo . . . . . 0 C--N 1.343 0.286 0 C-N-CA 123.276 2.65 . . . . 0.0 111.67 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.5 mtp -105.71 159.22 16.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.185 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.77 142.43 31.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.428 0.633 . . . . 0.0 111.12 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -138.46 167.39 25.02 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.046 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -110.64 137.87 47.76 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.135 0.493 . . . . 0.0 110.734 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 HG23 ' A' ' 40' ' ' ILE . 58.2 mt -79.19 117.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.714 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.5 p -108.68 -43.55 4.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.25 0.548 . . . . 0.0 111.227 -175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.5 m -136.55 122.14 19.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.766 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 71.0 t-105 -139.54 130.78 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.623 0.249 . . . . 0.0 110.58 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.54 90.59 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.96 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.631 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.6 tmtt? -67.08 -26.36 66.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.47 -20.72 36.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.081 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -97.07 -44.67 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.578 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.72 -2.82 10.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.511 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 40.0 p90 -148.42 177.89 9.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.568 0.684 . . . . 0.0 111.646 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.15 -164.05 28.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.242 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.93 131.25 42.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.1 mt -130.17 129.94 65.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -103.47 124.33 48.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.507 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 9.4 p-10 -95.34 -175.98 3.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.029 0.442 . . . . 0.0 110.687 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.2 -7.46 51.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.522 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . 5.7 t-20 -95.84 -58.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.682 0.277 . . . . 0.0 111.213 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.69 -92.19 2.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.678 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -164.33 -154.31 0.24 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -72.81 135.79 45.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 109.785 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 42.2 mtt180 -114.34 148.9 36.86 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.666 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -85.16 115.86 23.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 51.2 m-85 -109.94 161.8 15.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.71 138.52 24.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.63 -28.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -61.68 -26.85 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 111.794 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 32' ' ' ILE . 33.9 mmtp -99.93 7.39 44.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.589 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 40' ' ' ILE . 29.0 t -100.8 123.92 54.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.19 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.291 -176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.754 HD22 HD12 ' A' ' 39' ' ' LEU . 12.2 p-10 -134.27 78.25 58.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.359 0.6 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.18 -19.66 13.38 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.966 2.444 . . . . 0.0 114.195 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.54 -2.95 58.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.067 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.754 HD12 HD22 ' A' ' 36' ' ' ASN . 59.8 mt -99.08 -1.71 38.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.145 0.498 . . . . 0.0 109.855 174.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.702 HG23 HD13 ' A' ' 7' ' ' ILE . 52.7 mt -71.74 122.59 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.443 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.32 165.25 17.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.881 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -78.4 148.28 33.73 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.082 0.468 . . . . 0.0 111.613 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 61.52 26.73 16.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.172 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 165.01 11.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.702 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.51 138.83 39.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 111.141 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 64' ' ' VAL . 27.3 m -131.54 152.11 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -110.97 134.73 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.993 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 9.1 p90 -151.95 165.6 34.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.017 0.437 . . . . 0.0 111.469 -175.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.24 141.32 24.9 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -88.66 139.34 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.313 2.675 . . . . 0.0 113.488 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -150.55 173.82 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 151.7 48.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.96 0.41 . . . . 0.0 110.84 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.47 177.31 7.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -74.97 -11.5 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -95.18 -2.83 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.4 -140.41 12.26 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.794 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.31 144.57 27.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.213 0.53 . . . . 0.0 110.71 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -143.61 168.79 19.05 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.44 168.05 24.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.697 0.284 . . . . 0.0 111.291 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -148.72 -179.96 7.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.64 41.57 28.23 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.785 0.678 . . . . 0.0 110.521 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.6 t -70.23 101.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.364 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 19.4 ttmm -101.68 114.27 28.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.593 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.3 t -77.57 134.85 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.903 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.71 86.11 5.43 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 85.2 Cg_endo . . . . . 0 N--CA 1.451 -0.973 0 C-N-CA 123.053 2.502 . . . . 0.0 113.396 -174.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.429 ' HE3' ' HB3' ' A' ' 23' ' ' ASN . 60.7 mtp -115.34 154.18 29.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.549 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -118.08 139.96 50.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -146.5 176.58 25.34 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.869 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -116.6 140.13 49.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.3 mt -79.14 116.76 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.189 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -108.77 -63.27 1.36 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 m -102.91 129.05 49.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.29 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -147.03 135.01 21.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.759 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 89.2 m-85 -126.27 113.12 16.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.301 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -60.86 -64.07 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 -176.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.68 -17.02 61.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.336 -170.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 6.7 mmpt? -81.28 -35.62 30.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.944 173.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.26 15.16 62.84 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.266 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 43.9 p90 -145.34 175.39 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.478 -0.425 . . . . 0.0 110.605 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.63 -167.96 34.05 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.571 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.76 125.37 28.38 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.739 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.2 mt -120.85 129.2 75.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.865 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -107.45 126.49 52.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.216 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.631 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 5.0 p-10 -96.05 175.45 6.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.791 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -103.3 13.82 32.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB3' ' HE3' ' A' ' 3' ' ' MET . 8.2 t30 -107.09 -47.51 3.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.453 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.35 -83.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.34 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -169.15 -164.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -82.83 131.29 35.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -124.64 150.37 46.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 111.237 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -78.48 127.1 31.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.547 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.7 m-85 -120.62 156.56 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.656 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-80 -141.39 141.22 33.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.08 -31.26 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.627 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.2 tt -70.98 -21.26 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.672 0.749 . . . . 0.0 110.631 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.7 -11.52 59.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.058 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.868 HG11 HD11 ' A' ' 40' ' ' ILE . 23.3 t -91.11 138.44 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.31 -36.13 22.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.673 HD22 HD12 ' A' ' 39' ' ' LEU . 10.6 p-10 -129.25 85.35 59.71 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.772 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.7 -31.63 5.22 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.742 2.961 . . . . 0.0 112.692 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.93 -25.47 68.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.673 HD12 HD22 ' A' ' 36' ' ' ASN . 87.9 mt -95.77 5.25 51.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.612 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.868 HD11 HG11 ' A' ' 34' ' ' VAL . 36.2 mt -75.66 124.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.141 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 18.0 ptpt -143.68 164.57 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.165 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -78.92 151.42 31.72 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.27 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 71.68 4.04 4.89 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.432 1.083 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.485 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -85.09 158.45 20.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.757 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.17 136.0 39.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 64' ' ' VAL . 29.0 m -132.25 156.08 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -117.59 135.16 54.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.097 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.5 p90 -151.6 177.03 10.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.612 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -121.93 144.7 41.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.0 145.94 32.03 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.993 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -150.09 152.78 35.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -91.01 150.7 21.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.223 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 4.8 t-20 -127.15 159.18 35.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -70.35 -32.75 70.59 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.902 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 50.7 pttt -101.93 6.43 41.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -154.28 25.25 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.145 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.61 146.45 27.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.808 0.337 . . . . 0.0 110.461 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.9 p -145.07 169.41 18.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.09 0.471 . . . . 0.0 111.581 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -141.95 154.14 44.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.599 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -132.12 -175.93 3.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.21 50.52 18.84 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.005 0.816 . . . . 0.0 111.136 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -72.86 104.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.949 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -103.62 111.83 24.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.89 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HA ' HG12 ' A' ' 46' ' ' VAL . 59.0 t -72.58 142.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.881 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -105.13 88.42 2.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.1 Cg_exo . . . . . 0 N--CA 1.458 -0.616 0 C-N-CA 122.363 2.042 . . . . 0.0 111.069 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.62 150.52 28.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.98 158.2 16.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.574 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -152.19 172.51 31.44 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 176.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.2 m -122.18 130.88 53.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.864 0.332 . . . . 0.0 110.196 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.866 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.5 mt -67.7 105.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.304 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -95.4 -36.29 11.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.886 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 31.7 m -144.87 136.97 25.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -145.59 126.02 14.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.042 0.448 . . . . 0.0 111.368 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -119.87 95.53 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.84 -41.0 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.96 -37.09 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.081 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.724 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 18.6 tptm -86.26 -30.4 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 92.02 5.59 65.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.542 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.724 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 84.1 m-85 -119.21 162.36 18.81 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.669 -0.313 . . . . 0.0 110.604 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.23 173.12 39.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.223 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.9 m-85 -131.05 131.41 44.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.866 HG12 ' HA ' ' A' ' 7' ' ' ILE . 82.2 mt -136.4 130.56 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.98 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -91.73 139.52 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.6 p-10 -115.87 -164.65 0.97 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.388 0.613 . . . . 0.0 111.88 -171.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -62.97 -32.28 73.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.566 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.25 -33.81 75.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 26.71 9.19 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.099 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t70 -135.15 177.53 7.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' H ' HD22 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -96.07 139.89 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.106 0.479 . . . . 0.0 110.383 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 52.9 mtt-85 -118.2 138.99 51.94 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.47 119.54 25.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.556 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.817 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 66.3 m-85 -111.66 160.17 17.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.625 0.726 . . . . 0.0 112.099 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.496 ' ND1' HG22 ' A' ' 32' ' ' ILE . 15.6 t-160 -141.75 142.31 33.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.984 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -48.94 -34.39 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.496 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.4 tt -62.54 -25.38 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.565 0.697 . . . . 0.0 111.363 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.785 ' HG3' ' HA ' ' A' ' 60' ' ' TYR . 7.6 mptt -77.52 -22.48 51.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.241 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 23.9 t -93.8 134.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.606 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.03 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.675 HD22 HD12 ' A' ' 39' ' ' LEU . 14.8 p-10 -127.88 77.04 76.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.095 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 40' ' ' ILE . 59.9 Cg_endo -73.12 -23.47 18.12 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.9 2.4 . . . . 0.0 113.273 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.1 -29.11 68.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.459 0.647 . . . . 0.0 111.074 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.675 HD12 HD22 ' A' ' 36' ' ' ASN . 81.3 mt -92.8 4.97 52.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.36 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 7' ' ' ILE . 40.0 mt -69.93 110.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.974 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.58 158.09 25.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.986 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 144.71 33.44 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.148 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.43 11.02 8.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.517 0.675 . . . . 0.0 110.551 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.59 154.76 19.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.8 143.37 26.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.794 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.5 m -134.32 164.14 35.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.408 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.25 153.58 45.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -167.77 177.07 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 41.1 mt-10 -110.46 142.78 26.76 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.4 Cg_endo -84.97 142.47 8.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.214 2.609 . . . . 0.0 113.219 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 t -144.86 162.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -104.19 149.46 25.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.943 0.402 . . . . 0.0 110.73 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 6.3 t-20 -139.68 154.79 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -66.95 -31.35 71.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -82.4 -18.09 43.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.85 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.04 -163.26 31.33 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.648 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' ASP . 83.9 mt -73.05 140.53 47.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.069 0.435 . . . . 0.0 110.407 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.4 p -135.0 167.22 21.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.82 0.343 . . . . 0.0 110.691 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.95 159.31 44.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.785 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 43.2 p90 -143.87 -178.61 6.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 123.31 0.381 . . . . 0.0 110.005 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.29 39.4 30.19 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.701 0.626 . . . . 0.0 110.249 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -78.74 119.03 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.403 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.0 127.05 55.43 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.794 ' HA ' HG12 ' A' ' 46' ' ' VAL . 27.9 t -77.87 142.63 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.214 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.7 86.81 3.13 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.397 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 94.2 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 122.726 2.284 . . . . 0.0 112.5 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -118.5 164.21 15.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.136 0.494 . . . . 0.0 111.199 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -115.01 152.76 31.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.468 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.22 -178.5 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.514 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -125.47 136.71 53.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.165 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.821 HD13 HG23 ' A' ' 40' ' ' ILE . 44.0 mt -77.11 115.63 19.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.263 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -104.28 -40.32 6.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.166 0.507 . . . . 0.0 111.431 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 m -136.97 114.77 11.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.451 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.702 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 75.9 t-105 -130.62 136.48 48.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.057 0.455 . . . . 0.0 111.493 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.35 97.12 5.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.702 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.1 tmtp? -67.75 -33.09 74.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 110.005 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.32 -35.7 81.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.034 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.927 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.5 mmpt? -88.9 -30.09 19.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.37 9.58 57.77 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 48.6 p90 -144.39 174.65 10.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.964 0.412 . . . . 0.0 111.026 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.66 -172.63 37.86 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.069 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -134.78 126.84 29.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.734 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 79.3 mt -123.64 131.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.887 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.57 119.84 31.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.506 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.98 177.42 7.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.491 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -81.2 -5.98 58.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.335 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.34 -35.03 18.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.234 0.54 . . . . 0.0 109.563 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.76 22.65 2.69 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.017 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -108.03 164.09 12.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.397 0.598 . . . . 0.0 110.485 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -116.89 115.62 25.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -111.11 148.66 32.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.712 -172.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -81.52 122.13 27.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.7 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 30.7 m-85 -111.72 154.85 24.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.531 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.576 ' ND1' HG22 ' A' ' 32' ' ' ILE . 17.4 t-80 -141.32 133.12 27.35 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.14 -29.7 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.576 HG22 ' ND1' ' A' ' 30' ' ' HIS . 19.1 tt -67.06 -29.33 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.276 0.56 . . . . 0.0 111.225 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -82.3 -4.32 56.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.204 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 40' ' ' ILE . 22.0 t -95.84 133.31 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.173 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.27 -42.78 22.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -125.43 73.88 68.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 40' ' ' ILE . 56.0 Cg_endo -70.65 -15.86 33.79 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.548 2.166 . . . . 0.0 112.262 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.93 -10.63 60.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.603 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 66' ' ' PRO . 95.6 mt -108.22 7.97 27.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.821 HG23 HD13 ' A' ' 7' ' ' ILE . 50.7 mt -78.67 114.75 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.39 0.614 . . . . 0.0 111.63 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 48.9 mtpt -124.29 167.78 13.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.59 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.99 135.25 34.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.49 21.56 2.28 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 0.0 109.795 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -98.81 146.58 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.413 177.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.62 29.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.197 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.701 HG21 HD13 ' A' ' 19' ' ' ILE . 23.6 m -136.56 156.0 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.7 p -121.71 135.18 54.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.761 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.59 179.98 7.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.613 0.244 . . . . 0.0 110.924 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.5 pt-20 -125.83 142.88 43.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 171.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_exo -74.41 145.4 33.86 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.059 2.506 . . . . 0.0 113.481 -174.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 58' ' ' SER . 9.0 t -139.17 156.95 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -113.63 127.26 55.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.431 0.634 . . . . 0.0 112.111 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -108.38 161.22 15.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.596 171.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -71.45 -13.43 61.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.099 0.476 . . . . 0.0 110.309 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.78 -19.95 25.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.108 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.08 -162.31 31.27 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.969 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -85.47 138.01 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 111.057 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 51' ' ' THR . 5.4 m -137.89 169.64 17.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.337 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -139.94 152.78 46.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.731 0.301 . . . . 0.0 110.679 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 1.6 p90 -139.67 -179.22 5.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.221 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.25 48.31 22.38 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.921 0.763 . . . . 0.0 110.041 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 24.9 t -75.9 112.67 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 39.6 mtmt -113.49 109.89 19.39 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.001 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.666 ' HA ' HG12 ' A' ' 46' ' ' VAL . 56.1 t -66.45 152.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.08 88.7 2.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 39' ' ' LEU . 35.9 Cg_endo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.727 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . 68.9 113.54 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 124.035 0.835 . . . . 0.0 111.459 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -115.92 157.95 23.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.384 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -98.02 130.08 44.86 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.87 162.88 24.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.34 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 m -110.14 138.69 46.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.046 0.45 . . . . 0.0 110.134 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.863 HD13 HG23 ' A' ' 40' ' ' ILE . 53.0 mt -79.51 114.81 20.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.206 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -113.08 -55.45 2.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 111.04 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 m -104.51 124.51 49.4 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -160.06 126.79 4.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -111.98 102.13 10.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 2.5 tmtp? -73.83 -30.38 62.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.524 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.28 -42.06 94.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.079 0.466 . . . . 0.0 110.672 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -90.38 -51.57 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 37.43 1.41 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.417 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 36.9 p90 -148.83 167.08 26.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.383 0.592 . . . . 0.0 110.819 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.53 -160.27 32.21 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.062 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.91 127.86 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.695 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.4 132.51 66.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.501 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -111.71 130.18 55.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 13.3 p-10 -91.85 -170.69 2.64 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.47 -9.0 19.69 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.105 0.478 . . . . 0.0 110.853 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -97.2 -44.85 6.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 -100.19 2.64 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.356 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -166.81 -160.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.49 135.93 36.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.555 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 63.2 mtt85 -117.75 156.73 27.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.692 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -79.86 117.48 20.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.101 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.695 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.1 m-85 -113.18 156.13 23.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.406 0.622 . . . . 0.0 110.85 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 20.0 t-80 -148.89 138.23 21.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.931 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -49.19 -30.93 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG23 ' HG2' ' A' ' 33' ' ' LYS . 14.8 tt -61.94 -30.04 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 112.011 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.7 mmtt -93.69 10.26 33.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.739 HG11 HD11 ' A' ' 40' ' ' ILE . 21.7 t -108.73 132.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.751 0.31 . . . . 0.0 110.252 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.91 -23.92 33.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.435 ' HB2' HD12 ' A' ' 39' ' ' LEU . 23.0 p-10 -135.81 71.48 63.78 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 121.634 0.731 . . . . 0.0 110.149 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.42 -21.62 13.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.338 2.692 . . . . 0.0 114.34 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.4 -9.47 59.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.564 0.697 . . . . 0.0 110.107 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 36' ' ' ASN . 85.0 mt -93.45 -5.87 48.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.822 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.863 HG23 HD13 ' A' ' 7' ' ' ILE . 66.5 mt -71.28 111.42 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.085 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -137.48 157.1 47.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.668 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.681 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 14.8 tmtt? -59.95 136.1 57.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.963 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.681 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 26.8 t70 74.97 4.47 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.835 176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.65 156.41 22.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.26 138.26 36.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.0 m -132.42 164.51 34.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.392 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.8 p -127.87 140.56 51.95 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 12.6 p90 -151.68 162.96 40.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.492 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.6 mm-40 -94.9 142.84 25.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.37 142.93 16.99 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.377 2.051 . . . . 0.0 113.384 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.485 HG21 ' CE2' ' A' ' 60' ' ' TYR . 14.6 t -163.08 177.36 9.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.508 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -115.74 155.13 28.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.05 0.453 . . . . 0.0 111.102 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.658 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 14.3 t-20 -132.8 168.49 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.951 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -68.23 -38.75 82.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 15.8 ptpt -91.98 -1.66 57.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.879 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.87 -133.49 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.56 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.15 155.82 17.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.1 p -148.04 170.32 18.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.763 0.316 . . . . 0.0 111.016 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -135.4 151.06 50.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.256 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 51' ' ' THR . 24.2 m-85 -122.47 170.29 10.13 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.768 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.599 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 48.99 58.43 5.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.974 0.796 . . . . 0.0 110.879 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 34' ' ' VAL . 27.3 t -85.47 120.4 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.765 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -123.99 127.13 47.47 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.223 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.2 t -80.61 151.43 4.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.919 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.64 88.31 3.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 123.36 0.413 . . . . 0.0 110.443 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 39' ' ' LEU . 74.2 Cg_endo -75.31 143.76 28.49 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.216 1.944 . . . . 0.0 111.949 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.0 -7.97 59.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.62 163.32 35.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -125.0 89.59 3.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.028 0.442 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -109.13 144.44 37.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.285 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -77.42 133.86 38.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.092 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -134.57 92.98 2.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.437 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -160.61 137.72 9.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.953 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.76 177.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.56 126.59 33.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.239 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.457 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 11.8 ttt -138.98 177.18 8.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' H ' ' HG2' ' A' ' 3' ' ' MET . 4.3 p-10 -106.66 141.93 37.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 112.03 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -135.39 176.74 19.91 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -122.6 139.56 53.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.615 0.708 . . . . 0.0 110.721 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 19' ' ' ILE . 53.0 mt -76.46 107.86 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.285 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -97.88 -43.0 7.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.238 0.542 . . . . 0.0 111.037 -174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 m -132.09 121.9 24.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -139.42 129.83 25.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.818 0.342 . . . . 0.0 110.482 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -107.62 92.35 4.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -59.44 -49.23 78.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.043 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.05 -45.38 90.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HG2' ' HE1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -75.24 -39.65 59.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.762 -174.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.82 6.14 35.16 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.848 174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.492 ' HE1' ' HG2' ' A' ' 14' ' ' LYS . 33.1 p90 -130.54 174.84 9.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.722 0.761 . . . . 0.0 110.836 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.39 -170.84 41.75 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.0 124.39 26.2 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.791 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 88.1 mt -117.69 119.02 60.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.831 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 26' ' ' ASN . 60.2 tttt -107.06 124.17 49.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.508 . . . . 0.0 110.823 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 p-10 -89.03 -176.18 5.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.884 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -107.73 5.27 26.54 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.214 0.53 . . . . 0.0 111.013 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.28 -49.86 5.52 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.68 -92.11 1.85 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.329 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -168.68 -168.53 0.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.669 ' HB3' ' HB2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -74.62 135.84 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.554 0.693 . . . . 0.0 111.689 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -103.43 151.61 22.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.028 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -79.98 117.34 20.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 56.1 m-85 -111.09 155.64 22.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.631 0.729 . . . . 0.0 111.405 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.481 ' ND1' HG22 ' A' ' 32' ' ' ILE . 14.3 t-80 -139.83 131.77 27.74 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.965 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -46.87 -32.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' ND1' ' A' ' 30' ' ' HIS . 20.3 tt -62.7 -32.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.49 6.24 31.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 40' ' ' ILE . 33.6 t -91.79 133.42 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.91 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.25 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.566 HD22 HD12 ' A' ' 39' ' ' LEU . 22.2 p-10 -145.65 72.25 13.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.676 0.75 . . . . 0.0 110.124 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.568 ' HA ' HG13 ' A' ' 40' ' ' ILE . 92.8 Cg_endo -75.34 -9.69 20.39 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.146 2.564 . . . . 0.0 112.63 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.6 -9.98 59.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.566 HD12 HD22 ' A' ' 36' ' ' ASN . 90.4 mt -109.63 2.8 20.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.192 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 37' ' ' PRO . 55.4 mt -65.4 129.36 29.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.018 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 17.2 ptpt -143.33 166.02 25.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.275 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 12.9 tmtt? -80.08 144.9 32.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.674 0.273 . . . . 0.0 110.526 -177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 29.6 t70 67.27 27.88 8.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.696 0.76 . . . . 0.0 110.441 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -103.72 148.69 25.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.155 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.13 137.68 32.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' A' ' 64' ' ' VAL . 26.8 m -133.29 155.56 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.405 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.4 p -113.13 133.81 54.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.93 175.7 13.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.85 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 39.0 mt-10 -115.72 140.81 26.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.789 174.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -82.05 133.94 7.97 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.957 2.438 . . . . 0.0 113.215 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -149.58 -175.18 4.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.045 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -124.21 146.48 48.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.118 0.485 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.435 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 15.8 t-20 -101.01 -64.68 1.03 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.724 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -174.02 -65.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.738 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.8 28.43 3.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.222 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.31 173.19 29.64 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.404 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 98.5 mt -81.13 146.01 30.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.73 0.3 . . . . 0.0 110.367 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.4 m -144.59 168.87 19.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.163 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.94 154.63 42.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.574 0.226 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -135.76 179.09 6.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.7 50.53 16.89 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.982 0.801 . . . . 0.0 110.22 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.11 113.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.078 -174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.23 114.66 28.28 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.914 ' HA ' HG12 ' A' ' 46' ' ' VAL . 45.9 t -71.13 131.36 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.847 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -109.04 86.98 4.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 0.0 110.671 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.79 157.85 27.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.435 2.09 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.0 mt -91.61 16.5 10.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.222 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 64.87 1.04 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.4 m80 42.86 -99.22 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.533 0.733 . . . . 0.0 112.587 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.6 m80 61.4 26.21 16.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -71.86 -25.12 61.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 172.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -106.81 101.25 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.523 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -114.42 -7.58 12.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.45 0.643 . . . . 0.0 109.335 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.4 p80 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.926 175.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.87 116.61 14.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.984 0.421 . . . . 0.0 110.854 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 mtt -103.28 160.77 14.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.774 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -93.36 151.93 19.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.089 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -150.91 161.27 28.98 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.412 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.3 m -111.36 132.45 54.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.41 . . . . 0.0 110.289 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.85 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.3 mt -67.08 112.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.446 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HE2' ' A' ' 42' ' ' LYS . 3.2 m -101.07 -43.55 5.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -174.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -145.99 140.4 26.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.36 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -140.7 122.17 15.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 86.0 m-85 -110.54 88.82 2.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -55.85 -63.14 1.27 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.58 -7.48 59.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.114 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 23.7 tptm -85.22 -32.79 22.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' HIS . . . 103.71 -17.76 48.92 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.905 176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -109.31 179.06 4.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.261 0.553 . . . . 0.0 111.657 -174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.55 171.82 44.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.289 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -130.38 128.4 41.32 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 7' ' ' ILE . 58.2 mt -133.11 128.65 56.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.124 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' ASP . 44.4 tptt -85.18 115.56 23.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.711 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.683 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.5 p-10 -92.61 -171.63 2.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -83.94 -36.84 22.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.704 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -89.04 -47.9 7.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -171.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.01 -101.69 2.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.08 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -163.4 -154.52 0.28 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.24 115.92 15.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.2 0.524 . . . . 0.0 110.101 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.441 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 43.7 mtt180 -100.17 152.39 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -80.24 118.56 22.02 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.217 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.78 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 8.9 m-85 -105.02 158.18 16.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.765 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.561 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.5 t-80 -140.4 126.09 19.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.71 -38.49 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.616 HG23 ' HG2' ' A' ' 33' ' ' LYS . 20.0 tt -59.74 -30.77 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.303 0.573 . . . . 0.0 111.839 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -96.11 11.74 33.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.349 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 21.8 t -97.85 127.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.22 61.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.447 . . . . 0.0 111.101 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -133.04 69.65 78.66 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.161 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.86 -17.66 32.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.672 2.248 . . . . 0.0 112.756 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.03 -28.88 65.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.257 0.551 . . . . 0.0 110.807 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' A' ' 66' ' ' PRO . 90.4 mt -88.56 3.12 51.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.289 -174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.838 HG23 HD13 ' A' ' 7' ' ' ILE . 42.2 mt -74.7 112.77 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.767 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -126.41 165.71 18.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.237 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 8' ' ' THR . 5.2 tptm -69.99 134.99 48.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.119 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 t70 69.03 16.94 8.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.963 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -84.04 159.94 21.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.31 139.39 33.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 64' ' ' VAL . 34.4 m -131.95 162.8 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.681 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -126.55 134.44 50.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.857 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.683 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 19.0 p90 -149.06 174.6 12.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.813 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.684 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 10.0 mm-40 -96.17 142.03 23.98 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.7 Cg_exo -81.86 134.73 8.52 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.221 2.614 . . . . 0.0 112.034 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.556 HG21 ' CE2' ' A' ' 60' ' ' TYR . 13.3 t -158.58 174.07 15.64 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.0 0.428 . . . . 0.0 110.121 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.4 m -140.17 156.32 46.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.09 -73.51 0.64 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.067 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.66 -63.71 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.96 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -79.88 0.0 33.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.143 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.56 47.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.262 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.1 mt -83.26 155.04 23.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 m -145.59 168.97 19.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.31 150.85 45.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.795 0.331 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.556 ' CE2' HG21 ' A' ' 51' ' ' THR . 29.6 m-85 -126.1 171.27 10.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.897 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.684 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 49.99 56.22 8.23 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.988 0.805 . . . . 0.0 110.93 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -73.43 106.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.778 -175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.09 106.08 16.13 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.009 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.724 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.2 t -68.83 147.44 12.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.022 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.4 t -109.28 87.12 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.361 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.1 Cg_endo -79.12 139.48 15.06 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.155 1.903 . . . . 0.0 111.813 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.4 pt? -92.73 -9.49 40.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.349 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.19 122.94 49.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -83.71 -40.33 19.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.991 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -88.06 129.8 35.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -146.08 135.85 23.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.213 0.53 . . . . 0.0 111.691 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -170.54 161.81 7.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -84.61 112.2 20.22 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.8 m80 . . . . . 0 C--O 1.25 1.126 0 O-C-N 123.989 0.806 . . . . 0.0 111.4 177.117 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.73 -178.23 0.22 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.703 0.627 . . . . 0.0 110.531 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.8 mtm -98.73 145.79 26.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.6 p30 -108.22 161.8 14.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.286 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.71 159.72 23.29 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.798 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -108.44 133.62 52.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.756 HD13 HG23 ' A' ' 40' ' ' ILE . 47.0 mt -77.72 126.55 38.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.906 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -114.77 -53.09 2.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.059 0.457 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.0 m -118.44 124.52 47.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.924 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -138.6 125.29 20.85 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 89.3 m-85 -98.15 98.13 9.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.856 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -62.45 -36.64 83.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.26 -21.21 62.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 67.5 mmtt -102.42 -48.06 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.891 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.28 15.23 23.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.51 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 52.8 p90 -141.72 173.04 11.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -172.83 -166.99 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.476 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.8 129.78 30.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.4 mt -127.25 138.64 54.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.125 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -91.86 119.18 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.425 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -86.3 -173.34 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.389 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 44.0 mt-10 -79.18 -24.54 43.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.769 -172.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -122.52 -44.14 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -169.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.58 -96.33 0.75 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.839 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -169.21 -157.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -171.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.37 130.09 38.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.503 0.592 . . . . 0.0 110.089 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 23.1 mtp85 -112.09 147.07 36.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.286 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.57 117.63 19.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 31.8 m-85 -111.22 150.41 29.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.902 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.0 t-160 -148.24 136.19 20.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.702 -174.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.41 -34.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.698 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.8 tt -58.08 -34.71 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.698 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -100.74 15.38 28.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.415 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 40' ' ' ILE . 23.4 t -114.04 134.57 56.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.321 . . . . 0.0 110.28 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.31 60.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -135.16 78.13 53.47 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.619 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.76 -19.81 23.52 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.868 2.379 . . . . 0.0 113.956 -171.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.56 -22.72 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.045 0.45 . . . . 0.0 110.623 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -78.99 -11.45 60.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.452 0.644 . . . . 0.0 109.427 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 7' ' ' ILE . 56.8 mt -70.97 116.08 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.424 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -156.97 169.55 24.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.637 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 13.4 tmtt? -61.08 140.26 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 36.6 t70 76.29 4.14 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.115 0.884 . . . . 0.0 111.933 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -92.13 156.19 17.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.048 -0.407 . . . . 0.0 110.324 174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.49 149.08 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.4 m -134.95 149.8 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.855 0.36 . . . . 0.0 110.893 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -109.63 138.03 46.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.061 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -161.48 -179.18 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.514 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 pt-20 -104.35 142.1 23.92 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.8 Cg_endo -86.88 137.05 4.48 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.113 2.542 . . . . 0.0 112.345 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' CE2' ' A' ' 60' ' ' TYR . 6.2 t -159.23 169.38 24.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -109.96 155.8 21.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.724 0.297 . . . . 0.0 110.612 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 13.8 t-20 -132.53 157.75 43.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.612 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -78.59 8.87 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.792 0.329 . . . . 0.0 111.554 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -134.14 19.17 3.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 0.0 110.395 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.01 -147.38 19.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.427 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.59 152.28 20.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -144.5 167.67 21.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.672 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.04 153.41 37.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.583 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.603 ' CE2' HG21 ' A' ' 51' ' ' THR . 71.2 m-85 -130.23 168.29 17.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.44 55.79 8.88 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 124.058 0.849 . . . . 0.0 111.253 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 34' ' ' VAL . 23.4 t -82.75 117.49 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.168 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -122.37 119.86 32.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 46' ' ' VAL . 61.9 t -68.62 142.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.03 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.4 86.4 5.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.472 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.586 ' HB2' HD12 ' A' ' 67' ' ' LEU . 92.3 Cg_endo -83.13 174.15 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.549 2.166 . . . . 0.0 112.204 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 66' ' ' PRO . 6.5 mp 59.35 24.81 13.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.292 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -55.83 -54.74 40.87 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -119.04 147.15 44.42 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 164.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -71.8 144.61 49.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.045 0.45 . . . . 0.0 111.057 -174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -101.05 -46.86 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.469 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 61.61 -93.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.99 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 179.52 -67.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.4 t60 . . . . . 0 C--O 1.245 0.853 0 CA-C-N 113.945 -1.479 . . . . 0.0 107.493 168.693 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 49.6 ttm . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.79 114.35 21.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 23' ' ' ASN . 79.3 mtp -116.15 150.66 37.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.732 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -105.56 147.17 28.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.071 0.462 . . . . 0.0 110.715 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.29 161.01 26.48 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.694 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -105.6 138.38 41.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.72 105.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.717 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 p -107.53 -51.93 2.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.199 0.523 . . . . 0.0 110.524 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 20.5 m -100.81 118.83 37.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -151.0 113.32 4.6 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.924 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.584 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 99.4 m-85 -106.3 84.4 2.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.059 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 12' ' ' LYS . 12.5 tmtt? -59.82 -30.75 69.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.164 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.62 -24.62 65.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.425 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.7 mptp? -104.4 -31.13 9.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.3 13.96 34.44 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.521 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -139.45 174.13 10.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.373 0.587 . . . . 0.0 111.041 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 176.19 -162.54 31.44 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.069 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 97.7 m-85 -139.03 131.72 28.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.703 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 77.1 mt -119.09 122.07 68.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.004 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 26' ' ' ASN . 2.1 mmmp? -89.33 112.62 23.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.07 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.639 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.0 p-10 -96.65 -170.17 2.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.817 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.38 -32.09 72.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.059 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 27.1 t-20 -63.75 -31.09 72.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.385 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.75 10.32 47.08 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.667 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -107.68 168.18 9.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 17.1 p-10 -107.18 116.13 31.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.425 0.631 . . . . 0.0 110.561 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 39.6 mtt-85 -100.47 141.37 33.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.59 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -80.03 113.68 18.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.703 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 42.7 m-85 -105.62 153.64 21.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.672 0.748 . . . . 0.0 111.196 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -147.78 140.69 24.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.989 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.07 -18.36 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.676 HG23 ' HG2' ' A' ' 33' ' ' LYS . 7.6 tp -57.29 -39.89 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 111.701 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.676 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.2 mmtt -92.06 3.28 55.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.769 -176.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -100.14 126.8 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.14 -30.37 21.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.339 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 HD12 ' A' ' 39' ' ' LEU . 13.0 p-10 -121.21 85.32 41.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.258 0.551 . . . . 0.0 111.343 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.77 -19.47 9.79 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.092 2.528 . . . . 0.0 113.733 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.79 -23.95 36.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.541 0.686 . . . . 0.0 109.926 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 36' ' ' ASN . 88.4 mt -86.95 -8.49 57.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.063 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.869 HD11 HG11 ' A' ' 34' ' ' VAL . 68.2 mt -65.19 107.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.377 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 73.7 mmtt -115.72 157.71 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -71.93 135.81 46.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 70.64 9.46 6.88 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.351 0.596 . . . . 0.0 111.16 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -82.27 166.96 19.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 110.639 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.18 145.19 36.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.452 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 64' ' ' VAL . 32.8 m -131.28 160.5 42.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.71 151.86 38.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.639 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 20.2 p90 -167.02 173.58 9.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.037 0.446 . . . . 0.0 111.477 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.2 mm-40 -104.96 141.12 21.9 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.266 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 21.4 Cg_endo -92.7 143.37 2.34 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.056 2.504 . . . . 0.0 113.508 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 t -152.02 151.06 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.389 174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 m -90.88 156.29 18.12 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.476 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 4.6 t-20 -136.11 173.87 11.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.49 -20.17 62.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -112.0 13.64 20.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.175 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.48 -155.75 21.51 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.987 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.5 mt -86.2 148.22 25.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.255 0.55 . . . . 0.0 110.687 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -145.44 169.17 18.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.731 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.24 154.37 43.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 49' ' ' GLU . 32.4 p90 -136.23 177.05 8.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.209 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.1 42.04 31.76 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.984 0.803 . . . . 0.0 110.419 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.7 t -75.06 112.69 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -116.84 125.31 51.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.556 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 46' ' ' VAL . 21.1 t -76.81 146.86 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.37 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -106.4 87.85 2.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 O-C-N 123.426 0.454 . . . . 0.0 110.434 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 39' ' ' LEU . 71.3 Cg_endo -72.67 172.23 15.62 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.582 2.188 . . . . 0.0 111.793 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.7 mt 70.2 -54.41 0.62 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.406 0.682 . . . . 0.0 111.945 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.6 -52.66 54.29 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.032 0.533 . . . . 0.0 109.87 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -122.15 86.59 2.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 109.599 171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -96.02 141.61 29.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.93 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -141.65 149.25 40.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.979 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -132.75 160.97 35.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.278 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -90.72 110.58 21.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.912 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.353 -176.834 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.01 17.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.344 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.1 mtp -101.33 153.71 19.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.45 144.67 28.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.121 0.486 . . . . 0.0 110.451 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.3 162.76 28.19 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.699 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 m -111.03 134.05 52.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.08 0.467 . . . . 0.0 110.278 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 40' ' ' ILE . 57.0 mt -77.66 114.98 18.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.52 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 p -108.1 -42.57 4.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -130.28 122.89 28.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 74.3 t-105 -144.32 135.4 25.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.826 0.346 . . . . 0.0 110.329 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.64 86.42 2.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.536 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -60.63 -27.65 67.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.499 0.666 . . . . 0.0 110.009 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' OD2' ' HE3' ' A' ' 14' ' ' LYS . 18.1 t70 -61.88 -34.03 75.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.357 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HE3' ' OD2' ' A' ' 13' ' ' ASP . 30.9 mmtp -119.16 -21.76 7.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.98 12.28 50.24 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.821 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.411 ' HD2' ' HE1' ' A' ' 28' ' ' TYR . 25.5 m-85 -98.31 160.88 14.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -177.84 162.51 30.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.913 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -137.48 126.02 23.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.722 HD13 HG21 ' A' ' 46' ' ' VAL . 86.8 mt -120.99 129.99 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -93.9 120.88 34.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.4 p-10 -86.22 -173.67 4.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.184 0.516 . . . . 0.0 110.983 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -91.1 -10.76 40.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.159 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.44 -42.91 28.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.46 44.81 0.28 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.75 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -136.2 162.18 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 0.0 110.542 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -117.86 127.11 53.55 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.538 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.77 146.29 50.64 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.235 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HD2' ' A' ' 16' ' ' PHE . 67.5 t80 -76.59 127.28 32.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.699 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 29.9 m-85 -112.97 154.7 26.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.808 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.491 ' ND1' HG22 ' A' ' 32' ' ' ILE . 10.5 t-80 -141.67 130.99 23.58 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.652 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -49.82 -34.12 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.62 HG23 ' HG2' ' A' ' 33' ' ' LYS . 19.2 tt -56.94 -34.22 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.9 mmtt -97.45 9.2 43.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.458 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.557 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 33.3 t -97.31 130.4 46.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.34 -45.63 54.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.845 HD22 HD12 ' A' ' 39' ' ' LEU . 9.3 p-10 -132.73 79.42 64.14 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.272 0.558 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 68.9 Cg_endo -74.76 -22.34 15.49 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.02 2.48 . . . . 0.0 113.518 -173.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.17 -28.14 64.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 HD22 ' A' ' 36' ' ' ASN . 57.1 mt -82.63 -5.48 58.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.306 0.574 . . . . 0.0 110.071 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.974 HG23 HD13 ' A' ' 7' ' ' ILE . 39.0 mt -72.25 112.62 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.625 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -133.79 174.76 10.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.772 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 1.7 tmtp? -70.53 140.96 51.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.536 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 33.1 t70 74.94 6.14 4.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.575 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.34 152.0 27.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.146 -0.346 . . . . 0.0 110.323 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.18 136.6 40.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.9 0.381 . . . . 0.0 110.558 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.722 HG21 HD13 ' A' ' 19' ' ' ILE . 28.5 m -130.44 158.83 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.122 0.486 . . . . 0.0 111.046 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.6 p -118.31 135.4 54.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.378 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.465 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 16.8 p90 -143.69 164.9 29.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -173.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -98.17 142.23 24.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.591 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.55 142.89 21.12 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.292 1.994 . . . . 0.0 112.95 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 13.5 t -157.85 166.63 32.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.607 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -113.9 145.48 41.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.993 0.425 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.86 177.16 7.94 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.17 -25.76 58.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.053 0.454 . . . . 0.0 109.903 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -74.83 -14.41 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.939 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.01 -138.43 10.17 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.87 139.49 34.67 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -144.08 168.59 19.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.235 -174.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.92 149.13 44.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.865 0.364 . . . . 0.0 111.436 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 51' ' ' THR . 16.9 p90 -134.05 -177.61 4.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.133 177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.43 42.2 32.02 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.743 0.652 . . . . 0.0 110.202 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.4 t -68.1 100.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.004 -174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.542 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 16.6 ttmm -108.28 116.42 31.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.635 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.7 t -70.88 148.49 10.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.133 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.2 t -104.64 87.94 2.0 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 93.2 Cg_endo -82.3 145.06 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.223 1.949 . . . . 0.0 111.956 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.3 pt? -60.23 -24.13 64.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.695 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -162.69 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -131.06 -54.86 1.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.904 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t60 70.37 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 O-C-N 124.193 0.933 . . . . 0.0 110.313 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -64.35 134.7 55.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 0.0 111.124 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.1 135.52 38.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -170.99 151.36 3.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 110.887 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.589 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.8 114.35 4.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -113.83 149.22 35.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.348 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -101.46 152.12 21.13 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.943 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -151.6 177.06 29.73 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.23 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' ILE . 3.2 m -126.9 132.14 50.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.828 ' HA ' HG12 ' A' ' 19' ' ' ILE . 62.7 mt -65.0 106.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.506 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 m -95.02 -37.38 11.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.86 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -150.96 125.06 9.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.878 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.648 ' HH2' ' HA ' ' A' ' 31' ' ' VAL . 74.6 t-105 -143.02 131.7 22.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.4 96.2 4.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.734 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.2 -41.78 89.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -69.57 -28.03 65.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.667 ' HG2' ' HD1' ' A' ' 16' ' ' PHE . 39.6 ttmt -87.69 -38.49 15.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.936 0.398 . . . . 0.0 110.41 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 106.34 -12.78 43.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.526 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.667 ' HD1' ' HG2' ' A' ' 14' ' ' LYS . 57.6 m-85 -96.6 163.42 13.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.902 0.382 . . . . 0.0 111.356 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.63 155.76 27.27 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.117 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -139.57 131.76 28.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.828 HG12 ' HA ' ' A' ' 7' ' ' ILE . 68.0 mt -136.92 125.11 33.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.862 0.363 . . . . 0.0 110.984 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 14.1 tmtt? -86.41 125.78 33.92 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.0 p-10 -97.1 -169.51 1.87 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.833 0.825 . . . . 0.0 112.853 -169.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -77.95 -30.23 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.287 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -74.09 -36.67 64.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.741 0.305 . . . . 0.0 110.41 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.17 41.05 0.45 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.488 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.41 163.51 32.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.159 0.48 . . . . 0.0 109.943 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -110.36 115.34 29.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -101.61 153.66 19.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.417 -170.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.892 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.8 m-85 -116.65 153.93 31.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.895 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.3 t-160 -136.4 133.76 37.06 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.648 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 12.4 p -47.23 -31.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.566 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.3 tt -67.72 -30.15 47.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.972 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.9 mmtt -97.7 15.31 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.67 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -94.29 130.77 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -43.38 48.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.975 0.417 . . . . 0.0 110.948 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.499 HD22 HD12 ' A' ' 39' ' ' LEU . 22.4 p-10 -135.21 79.22 50.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.518 0.675 . . . . 0.0 111.203 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HA ' HG13 ' A' ' 40' ' ' ILE . 86.0 Cg_endo -76.95 -11.1 18.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.859 2.373 . . . . 0.0 112.247 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.39 -18.97 61.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.803 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB3' ' HG3' ' A' ' 66' ' ' PRO . 78.7 mt -106.39 12.87 29.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.061 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 34' ' ' VAL . 40.9 mt -82.82 126.48 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.0 112.183 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -139.18 168.38 19.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 12.7 tmtt? -78.88 139.85 38.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 66.7 m-20 73.97 13.04 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.706 0.803 . . . . 0.0 111.709 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -82.57 156.72 23.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.594 0.235 . . . . 0.0 110.673 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.72 137.88 31.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 19' ' ' ILE . 28.6 m -136.04 160.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.801 ' HB ' ' HD3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -124.23 154.46 40.13 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 p90 -166.45 171.47 11.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.902 0.382 . . . . 0.0 111.542 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 26.3 mm-40 -101.17 143.33 26.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.128 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.55 148.56 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.25 1.966 . . . . 0.0 112.183 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -166.29 171.1 12.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -109.54 155.4 21.43 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.572 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 23.1 t-20 -131.17 162.46 29.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.663 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -58.94 -36.35 74.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.489 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.45 -48.7 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.706 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.13 -141.27 3.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.119 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.5 mt -86.1 149.16 25.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 p -151.01 169.78 20.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -135.42 151.1 50.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.556 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -120.1 172.23 7.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.565 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . . . 50.01 49.5 20.21 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.946 0.778 . . . . 0.0 111.297 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.585 HG21 ' HD2' ' A' ' 29' ' ' PHE . 17.9 t -76.95 109.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.001 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.801 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 0.0 OUTLIER -109.15 128.76 55.28 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 46' ' ' VAL . 28.5 t -84.93 143.93 10.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.398 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.1 t -114.3 85.12 10.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.654 ' HG3' ' HB3' ' A' ' 39' ' ' LEU . 87.0 Cg_endo -96.93 164.12 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.094 2.529 . . . . 0.0 112.208 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.804 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.3 pt? -91.23 3.09 55.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.17 0.509 . . . . 0.0 109.989 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 70' ' ' HIS . 12.3 tp10 -90.22 -88.46 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.543 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.418 ' H ' ' HB3' ' A' ' 68' ' ' GLU . 2.6 t60 55.8 28.12 11.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.655 0.74 . . . . 0.0 109.134 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.521 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 29.8 t-80 -120.82 13.25 11.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.573 -169.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 70' ' ' HIS . 34.0 m80 70.83 152.36 0.11 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.839 -175.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -132.71 127.65 35.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.108 0.48 . . . . 0.0 109.877 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -83.77 102.38 12.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.902 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.589 -177.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.771 0.32 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.58 124.02 49.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.077 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -109.53 177.29 4.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.895 0.379 . . . . 0.0 110.946 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.85 151.43 25.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.936 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.63 165.44 23.79 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.973 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.3 m -112.37 135.35 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.921 HD13 HG23 ' A' ' 40' ' ' ILE . 51.8 mt -82.29 121.43 35.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.531 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 p -106.89 -53.45 2.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.998 0.428 . . . . 0.0 111.228 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.1 m -124.55 127.32 47.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.078 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -142.09 135.53 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.986 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.49 102.56 9.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.03 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.649 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.85 -49.0 64.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.829 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -70.92 -46.46 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.57 19.57 9.71 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.8 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -137.68 170.73 15.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.924 0.862 . . . . 0.0 110.661 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.41 -170.52 41.33 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.267 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -133.25 131.81 40.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.755 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.6 mt -131.26 131.17 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -100.74 120.63 40.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.674 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.8 p30 -109.6 -164.84 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.144 0.497 . . . . 0.0 111.543 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.84 -10.25 59.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.128 -171.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.29 -28.05 69.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.326 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.95 8.02 55.86 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.195 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -129.77 163.78 25.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.612 ' H ' HD22 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -93.65 137.27 33.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 110.574 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' HB3' ' A' ' 57' ' ' LEU . 35.2 mtt85 -111.29 150.2 29.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.666 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -89.23 123.42 33.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.688 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.755 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 63.7 m-85 -116.74 155.64 28.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.315 0.579 . . . . 0.0 111.808 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.48 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-160 -136.49 135.17 38.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.666 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.96 -29.67 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.1 tt -63.76 -31.31 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.21 -9.01 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.667 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.872 HG11 HD11 ' A' ' 40' ' ' ILE . 39.6 t -91.17 134.29 30.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.261 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.36 -24.22 19.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.178 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.709 ' HB2' HG23 ' A' ' 64' ' ' VAL . 3.2 m-20 -122.38 65.49 23.13 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.849 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.04 -30.55 13.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.015 1.81 . . . . 0.0 113.656 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.13 -18.27 34.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.428 0.633 . . . . 0.0 110.152 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 87.4 mt -90.9 -8.68 48.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.209 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.921 HG23 HD13 ' A' ' 7' ' ' ILE . 54.3 mt -61.03 119.56 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.621 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -126.84 173.25 9.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -83.47 136.02 34.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.4 t70 66.83 13.85 9.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.484 0.659 . . . . 0.0 111.001 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.13 156.4 17.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.671 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.7 137.65 39.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 64' ' ' VAL . 19.7 m -126.48 157.3 37.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.86 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 0.0 110.52 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.674 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 7.8 p90 -158.9 176.69 12.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.288 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 2.1 pm0 -111.47 143.36 28.35 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.1 Cg_exo -77.1 154.07 32.61 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.283 2.655 . . . . 0.0 113.507 -173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -166.89 179.4 5.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.036 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 57' ' ' LEU . 8.2 p -118.66 146.31 44.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.874 0.369 . . . . 0.0 110.447 175.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.568 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 2.3 t-20 -105.88 25.87 10.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 25.2 t-20 71.36 -56.18 0.64 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.833 -174.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.7 -39.04 92.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.099 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.24 -156.51 12.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.109 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 84.2 mt -84.82 134.77 34.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.959 0.409 . . . . 0.0 111.125 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 7.6 m -147.92 168.74 21.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.593 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -144.08 163.85 32.36 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.739 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.38 179.5 6.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.378 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.63 41.28 31.22 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 124.124 0.89 . . . . 0.0 110.508 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 48' ' ' PHE . 22.0 t -76.77 107.61 8.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.301 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -109.05 127.73 54.36 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.965 175.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 36' ' ' ASN . 82.3 t -65.78 149.95 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.695 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.51 86.02 1.29 Allowed Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 88.1 Cg_endo -92.94 159.55 2.7 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.806 2.337 . . . . 0.0 112.58 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -90.49 -26.97 19.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.624 ' HG2' ' H ' ' A' ' 70' ' ' HIS . 31.0 tt0 -135.73 128.73 31.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.941 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -68.29 -19.22 64.68 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.455 0.169 . . . . 0.0 111.044 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.624 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 54.3 m-70 65.91 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.956 0.785 . . . . 0.0 111.176 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -57.35 105.84 0.27 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.123 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.76 139.39 30.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 -173.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -84.39 -74.62 0.38 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.0 m170 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.326 171.492 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.09 129.16 38.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.246 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.15 157.86 20.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.491 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -96.97 147.53 23.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.922 0.391 . . . . 0.0 110.054 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.714 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -145.86 165.49 28.05 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.762 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 m -120.37 135.0 55.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.089 0.471 . . . . 0.0 109.843 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.953 HD13 HG23 ' A' ' 40' ' ' ILE . 51.0 mt -76.58 117.24 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.585 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -101.47 -46.57 4.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 110.93 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 m -124.14 123.13 39.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -132.06 116.06 16.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.038 0.447 . . . . 0.0 110.695 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 81.1 m-85 -105.19 90.35 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.5 -38.97 82.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.722 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.99 -25.71 56.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.263 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 11' ' ' PHE . 41.0 mmtm -83.73 -38.2 21.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.059 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.39 45.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.921 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 54.8 p90 -144.13 176.61 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.809 0.337 . . . . 0.0 110.849 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.78 -168.41 29.87 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.297 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -138.29 130.65 28.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.1 mt -122.54 130.65 74.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.311 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 21' ' ' ASP . 13.3 tmtt? -104.58 118.09 35.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 6.6 p-10 -86.57 -178.78 6.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.943 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -93.39 -2.29 54.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.011 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -112.08 -54.06 2.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.819 0.343 . . . . 0.0 111.106 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.09 -99.16 2.07 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.194 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -158.85 -159.2 0.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.54 129.93 37.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.256 0.55 . . . . 0.0 110.621 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 69.1 mtt180 -108.32 151.6 25.76 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -77.95 124.42 27.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.063 0.459 . . . . 0.0 110.251 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 49.4 m-85 -120.51 148.0 44.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.496 0.665 . . . . 0.0 110.246 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -148.83 143.72 26.49 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.785 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' CB ' ' A' ' 37' ' ' PRO . 11.1 p -49.09 -25.52 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.731 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.6 tt -65.35 -33.61 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.731 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.6 mmtt -106.7 -1.1 23.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 40' ' ' ILE . 46.4 t -99.25 126.29 52.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.41 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.81 74.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.592 HD22 ' HB ' ' A' ' 64' ' ' VAL . 37.1 m-20 -118.36 76.4 12.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.977 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' CB ' HG23 ' A' ' 31' ' ' VAL . 63.0 Cg_endo -75.77 -24.07 11.99 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.109 1.872 . . . . 0.0 112.439 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.92 -13.64 57.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.394 0.616 . . . . 0.0 110.594 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 36' ' ' ASN . 79.9 mt -103.13 3.91 36.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.739 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.953 HG23 HD13 ' A' ' 7' ' ' ILE . 62.9 mt -72.47 115.88 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.4 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 30.8 mmtp -120.3 154.06 35.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.619 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -71.2 132.31 44.81 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.31 24.23 7.44 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.793 0.683 . . . . 0.0 111.647 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -95.67 157.98 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.969 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.85 139.7 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 0.0 111.09 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.4 m -137.6 166.5 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.187 0.518 . . . . 0.0 110.967 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.1 p -131.5 134.99 46.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.634 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 10.2 p90 -156.31 164.75 37.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.982 0.42 . . . . 0.0 111.475 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.65 144.09 29.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.631 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 147.23 32.35 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.763 2.309 . . . . 0.0 113.918 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.453 ' HB ' ' CD1' ' A' ' 60' ' ' TYR . 15.1 t -154.21 139.83 17.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.736 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 p -89.13 126.79 35.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.236 0.541 . . . . 0.0 111.528 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 14.2 t-20 -86.91 167.65 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.947 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.42 -34.54 61.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.556 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -99.96 -57.48 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.357 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.69 -148.22 4.8 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.488 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.73 140.87 30.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.007 0.432 . . . . 0.0 111.112 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.7 p -149.14 168.98 21.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -138.61 152.17 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.106 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 52.9 p90 -124.67 172.96 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.532 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . 45.81 52.12 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 124.347 1.029 . . . . 0.0 110.828 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' HD2' ' A' ' 29' ' ' PHE . 20.9 t -76.81 111.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.402 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -97.19 119.06 34.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.749 ' HA ' HG12 ' A' ' 46' ' ' VAL . 95.7 t -70.63 148.21 10.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.68 89.52 2.3 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 123.304 0.378 . . . . 0.0 110.936 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 56.0 Cg_endo -69.29 135.04 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.316 2.01 . . . . 0.0 111.908 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.93 -21.73 40.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.179 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.1 133.7 39.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.858 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -90.95 124.13 34.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 71' ' ' HIS . 28.0 t60 -127.42 -24.8 3.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' HIS . 13.8 m-70 67.01 -167.57 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -134.85 -34.54 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.139 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -133.15 -69.52 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.681 174.522 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.561 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 23.4 ttt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.935 0.398 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . . . -70.14 117.48 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.442 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.637 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -112.37 169.76 8.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.973 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -133.67 152.45 20.48 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.925 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 m -100.13 135.83 40.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.033 0.444 . . . . 0.0 110.705 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.794 HD13 HG23 ' A' ' 40' ' ' ILE . 55.2 mt -82.47 116.41 26.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.781 -177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -103.53 -51.35 3.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.829 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 30.2 m -119.52 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.322 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.466 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 58.9 t-105 -150.74 122.18 7.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 0.0 110.904 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -130.48 87.42 2.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.611 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.35 -37.82 78.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.21 -35.03 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.842 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HE2' ' HE1' ' A' ' 16' ' ' PHE . 54.0 mtpt -90.16 -14.48 33.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.627 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.01 -4.19 62.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.199 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' HIS . 53.5 p90 -132.75 173.58 11.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.643 0.721 . . . . 0.0 111.996 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.466 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -165.28 177.82 40.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.229 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 94.0 m-85 -139.07 130.18 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.768 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 85.4 mt -136.94 135.1 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.653 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.4 tmtp? -112.53 117.65 32.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.855 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.662 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 7.6 p-10 -97.84 174.96 6.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 110.965 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -94.89 2.01 55.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.35 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 3' ' ' MET . 7.2 t30 -105.88 -50.29 3.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.898 0.38 . . . . 0.0 110.543 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.59 -87.99 2.03 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.359 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -171.24 -164.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 50.6 t-20 -82.23 122.69 28.24 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 43.8 mtt-85 -112.22 153.89 26.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.794 0.33 . . . . 0.0 111.041 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -80.12 121.34 25.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.768 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 19.1 m-85 -110.13 159.57 17.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.578 ' HB3' HG22 ' A' ' 32' ' ' ILE . 10.7 t-80 -148.54 147.03 28.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.14 -10.47 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.361 0.6 . . . . 0.0 111.407 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 30' ' ' HIS . 8.9 tt -82.84 -19.49 10.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.565 0.698 . . . . 0.0 110.462 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 32' ' ' ILE . 12.3 mptt -103.14 -3.49 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.657 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG11 HD11 ' A' ' 40' ' ' ILE . 25.6 t -104.71 139.4 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.84 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.71 -31.34 19.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.318 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.8 HD22 HD12 ' A' ' 39' ' ' LEU . 21.7 p-10 -132.69 77.51 69.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.393 0.616 . . . . 0.0 110.65 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.2 -19.0 13.87 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.863 2.376 . . . . 0.0 113.817 -172.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.31 -0.83 57.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.995 0.426 . . . . 0.0 111.053 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 HD22 ' A' ' 36' ' ' ASN . 69.6 mt -102.85 0.59 32.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.657 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.798 HD11 HG11 ' A' ' 34' ' ' VAL . 58.0 mt -80.96 109.11 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.805 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -117.67 155.62 29.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.3 tmtt? -74.42 141.51 45.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 59.3 m-20 75.48 19.82 2.05 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.522 0.729 . . . . 0.0 111.442 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -103.25 165.88 10.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.235 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.45 137.61 45.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.284 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 64' ' ' VAL . 18.3 m -128.35 164.27 30.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.104 0.478 . . . . 0.0 111.484 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 p -124.36 136.86 54.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.593 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 14.4 p90 -156.2 170.08 23.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.122 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 2' ' ' ALA . 23.8 mm-40 -93.28 140.58 23.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 3.7 Cg_exo -84.0 135.39 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.221 2.614 . . . . 0.0 113.1 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.6 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 11.9 t -151.48 -174.45 4.84 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.543 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 12.6 t -126.37 -177.9 4.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.228 0.537 . . . . 0.0 110.79 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.616 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 7.7 t-20 -145.89 -170.99 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.8 -27.2 26.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.006 0.432 . . . . 0.0 109.963 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -108.38 1.74 21.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.067 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.8 31.83 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.482 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 71.4 mt -87.52 159.02 18.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.189 0.495 . . . . 0.0 110.518 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.616 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 6.5 m -147.69 169.01 20.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.205 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.19 151.01 47.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.6 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 26.9 p90 -133.0 170.66 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.399 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.73 47.8 23.89 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.152 0.907 . . . . 0.0 110.175 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.18 120.59 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.104 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 127.35 48.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.271 174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.858 ' HA ' HG12 ' A' ' 46' ' ' VAL . 19.2 t -67.24 154.55 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.123 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.79 84.12 5.15 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 121.07 0.462 . . . . 0.0 111.29 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 58.2 Cg_endo -100.95 146.53 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 123.35 2.7 . . . . 0.0 112.213 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.784 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.3 pt? -96.33 52.71 1.27 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.857 0.837 . . . . 0.0 110.283 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -147.4 120.42 8.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.297 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -91.97 123.9 35.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.188 0.518 . . . . 0.0 111.704 -174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -86.47 105.06 16.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -49.52 134.38 19.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.012 0.435 . . . . 0.0 110.925 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -106.18 146.42 30.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.179 -168.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -120.88 -33.31 3.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 164.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 . . . . . 0 C--O 1.245 0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.729 173.885 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.69 129.94 43.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 112.062 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.6 mtm -111.13 167.54 10.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.208 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -112.97 152.38 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.38 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.76 172.92 30.42 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.826 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -117.6 136.35 53.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 0.0 110.242 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 40' ' ' ILE . 46.8 mt -79.88 114.45 20.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.664 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 p -102.76 -43.3 5.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.179 0.514 . . . . 0.0 110.795 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.7 m -127.21 126.01 42.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.252 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -145.22 128.1 16.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.668 0.27 . . . . 0.0 111.039 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.61 98.16 5.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.3 176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.69 -37.31 86.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.95 -42.6 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.364 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 50.7 tptt -95.7 -49.82 5.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.618 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.47 13.48 12.99 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.952 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 74.6 m-85 -125.69 164.36 20.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.675 0.274 . . . . 0.0 110.328 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.35 170.47 41.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.86 129.04 37.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.1 mt -128.53 130.3 69.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.367 -176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -89.36 123.04 33.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 3.4 p30 -91.08 175.26 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.486 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -96.48 24.98 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.53 -48.88 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.514 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.18 -71.09 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.401 -0.905 . . . . 0.0 113.986 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -156.38 -154.3 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.027 0.414 . . . . 0.0 110.071 -170.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -88.03 152.93 21.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 53.1 mtt-85 -124.69 147.41 48.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -86.96 113.83 23.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.93 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.704 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 34.7 m-85 -105.48 150.13 25.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.657 0.741 . . . . 0.0 111.956 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' ND1' HG22 ' A' ' 32' ' ' ILE . 2.7 t-80 -128.45 130.61 47.83 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.084 177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 37' ' ' PRO . 11.1 p -47.29 -31.95 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' ND1' ' A' ' 30' ' ' HIS . 13.5 tt -75.32 -21.41 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.58 -174.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.39 1.2 57.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.117 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 37' ' ' PRO . 21.9 t -96.67 143.12 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.28 -42.81 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.368 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 39' ' ' LEU . 13.9 p-10 -127.69 75.67 77.69 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.189 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 91.8 Cg_endo -81.17 -17.29 9.29 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.959 2.439 . . . . 0.0 113.865 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -89.92 -8.76 51.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.474 0.654 . . . . 0.0 109.871 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 36' ' ' ASN . 87.3 mt -96.1 1.29 52.35 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.625 177.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.72 HG23 HD13 ' A' ' 7' ' ' ILE . 51.1 mt -68.38 127.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.919 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -121.06 157.72 29.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.559 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -80.94 139.65 35.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.67 56.52 1.54 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.809 0.814 . . . . 0.0 109.276 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.6 36.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.18 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.96 140.12 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.787 0.327 . . . . 0.0 110.703 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -134.88 162.09 39.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.0 p -127.5 139.84 52.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 9.7 p90 -156.47 170.63 21.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.414 . . . . 0.0 111.917 -172.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 62.5 mm-40 -85.4 142.56 37.85 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 5.5 Cg_exo -78.93 133.96 11.53 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.505 2.136 . . . . 0.0 111.287 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 60' ' ' TYR . 9.5 t -165.94 152.09 9.27 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 m -129.56 145.97 51.42 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.03 -69.85 0.78 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -175.33 -54.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.362 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.79 17.69 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.703 -175.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.49 171.76 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.333 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.84 155.93 37.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -148.03 169.14 20.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.803 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -148.92 143.14 26.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.468 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 51' ' ' THR . 22.8 m-85 -122.07 168.49 11.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.98 37.97 26.76 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.626 0.579 . . . . 0.0 110.79 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' HG13 ' A' ' 34' ' ' VAL . 18.4 t -67.86 114.83 5.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.158 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -115.95 117.85 31.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.587 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 46' ' ' VAL . 20.9 t -79.98 146.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.487 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -111.56 86.24 6.69 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.314 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.2 Cg_endo -85.53 131.33 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.079 2.519 . . . . 0.0 111.852 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.3 pt? -86.03 70.59 10.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.809 0.814 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -126.99 134.02 50.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.7 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -96.72 125.51 41.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.992 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -80.36 70.24 6.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.581 0.705 . . . . 0.0 109.667 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -139.37 130.93 27.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.266 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.78 127.85 30.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -107.15 -13.99 15.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.775 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.3 t60 . . . . . 0 C--O 1.246 0.896 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.346 177.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.956 0.407 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.13 114.43 23.73 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.28 153.81 17.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.1 p-10 -107.88 139.92 41.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 110.759 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -132.31 166.4 23.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.442 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 p -109.67 137.8 46.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.039 0.447 . . . . 0.0 111.315 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 HD13 HG12 ' A' ' 19' ' ' ILE . 21.5 mm -63.83 115.87 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.474 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.452 ' O ' ' HE3' ' A' ' 42' ' ' LYS . 29.3 p -110.59 -47.13 3.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.123 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -122.5 125.76 46.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.98 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -156.04 133.27 10.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.708 0.289 . . . . 0.0 110.578 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . 86.4 m-85 -123.47 115.68 21.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.29 -51.87 61.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.966 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.43 -8.36 59.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 111.268 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.664 ' HB2' ' HB2' ' A' ' 11' ' ' PHE . 70.2 mmtt -85.73 -39.88 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.863 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.13 9.21 65.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.045 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 41.1 p90 -135.47 169.13 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.043 0.422 . . . . 0.0 110.732 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.17 -170.93 41.73 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.112 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -136.58 134.91 37.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.629 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 90.8 mt -126.68 129.75 71.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.276 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -92.27 117.58 30.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.645 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 4.9 p-10 -102.43 -173.37 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 111.797 -173.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 4' ' ' ASN . 40.9 mt-10 -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.073 -174.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -70.0 -25.62 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.981 0.419 . . . . 0.0 110.23 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.59 -18.49 9.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.568 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 -163.13 0.86 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.38 0.59 . . . . 0.0 110.13 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -121.62 147.91 45.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.263 0.554 . . . . 0.0 110.915 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CZ ' HD13 ' A' ' 57' ' ' LEU . 8.2 mpt_? -111.52 146.89 36.5 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.202 170.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -85.68 120.83 27.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 53.9 m-85 -109.87 154.85 22.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.414 0.626 . . . . 0.0 111.672 -176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -144.8 134.86 23.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.093 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.39 -27.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.513 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -64.68 -25.72 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.606 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 32' ' ' ILE . 73.5 mmtt -101.52 11.64 38.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.161 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HD11 ' A' ' 40' ' ' ILE . 61.1 t -97.95 127.35 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.077 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.82 -30.53 32.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.558 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.658 HD22 HD12 ' A' ' 39' ' ' LEU . 13.8 p-10 -142.06 81.4 14.38 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.177 0.513 . . . . 0.0 111.602 -177.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.1 -19.04 23.31 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.739 2.293 . . . . 0.0 112.948 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.55 -23.31 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.352 0.596 . . . . 0.0 110.617 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.658 HD12 HD22 ' A' ' 36' ' ' ASN . 81.2 mt -101.89 9.68 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.091 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.712 HD11 HG11 ' A' ' 34' ' ' VAL . 51.2 mt -81.41 118.49 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.261 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.86 159.7 34.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 8' ' ' THR . 85.0 tttt -78.16 146.12 35.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 42' ' ' LYS . 33.8 t70 72.42 3.76 4.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.56 156.32 19.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.222 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' GLY . . . -97.78 139.15 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 19' ' ' ILE . 32.9 m -128.53 148.6 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.224 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 p -110.86 134.6 52.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.012 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.645 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.6 p90 -147.79 167.45 24.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.956 0.408 . . . . 0.0 111.609 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 54.2 mm-40 -92.36 142.51 26.11 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.613 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -82.95 133.92 6.9 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.783 2.322 . . . . 0.0 112.301 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.3 t -152.96 161.38 42.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -101.64 147.61 26.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.291 0.567 . . . . 0.0 111.205 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -113.95 156.88 23.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.729 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -55.35 -33.72 63.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 111.461 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -101.8 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.596 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.0 -135.95 2.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.115 -172.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.45 HD13 ' CZ ' ' A' ' 27' ' ' ARG . 91.7 mt -102.59 151.33 22.46 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.696 0.284 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -145.55 167.49 22.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 111.003 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 48' ' ' PHE . . . -140.93 148.89 41.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.553 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -117.84 170.97 8.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.206 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 46.95 53.72 10.13 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 124.095 0.872 . . . . 0.0 111.37 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 36.5 t -70.95 100.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.1 0.476 . . . . 0.0 110.234 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 34.3 ttmt -118.24 117.09 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.119 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.581 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 21.8 t -69.66 151.58 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.819 -177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.7 t -103.34 88.26 1.61 Allowed Pre-proline 0 C--O 1.235 0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.1 Cg_endo -81.93 140.09 11.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.329 2.686 . . . . 0.0 113.215 -170.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.1 pt? -84.56 -12.07 54.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.803 174.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.555 ' HG3' ' H ' ' A' ' 70' ' ' HIS . 11.9 tp10 -108.98 151.95 25.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.429 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 82.9 m-70 -80.72 -15.9 55.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.555 ' H ' ' HG3' ' A' ' 68' ' ' GLU . 81.6 t60 72.85 -70.56 0.16 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.389 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 54.4 m80 66.03 163.19 0.16 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.034 0.533 . . . . 0.0 110.693 -174.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 m170 59.65 -164.0 0.22 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.089 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -114.72 -59.08 2.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.301 177.126 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HG2' ' A' ' 1' ' ' MET . 47.7 ttm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.204 0.526 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.77 114.18 28.01 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -97.74 157.12 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.0 111.163 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.65 130.37 42.55 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.234 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -140.95 171.89 23.92 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.077 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 m -132.77 139.66 47.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.48 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.1 mt -76.85 106.01 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.079 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 p -95.69 -61.45 1.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.986 0.422 . . . . 0.0 110.603 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -98.76 118.22 35.01 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.337 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -140.68 127.36 20.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.878 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -116.87 89.77 3.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.352 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.1 -34.32 77.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.641 0.734 . . . . 0.0 110.092 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.39 -21.74 64.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.511 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.898 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -101.89 -45.7 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.225 -0.297 . . . . 0.0 111.302 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.29 1.3 20.39 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.555 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.565 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 56.0 p90 -140.4 175.57 9.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.09 0.445 . . . . 0.0 110.889 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.98 -161.32 26.41 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.115 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -137.37 129.72 29.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.092 0.473 . . . . 0.0 109.792 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.727 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 84.0 mt -116.66 131.07 70.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 13.9 tttp -106.07 130.67 53.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.83 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.9 p30 -92.76 175.92 6.63 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.74 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -100.76 16.97 23.25 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.535 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -114.84 -43.91 3.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.045 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.11 -80.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.09 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 26' ' ' ASN . 11.8 t70 -161.23 -160.91 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 3.6 p-10 -99.24 154.21 18.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.143 0.497 . . . . 0.0 110.268 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.35 163.64 20.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -178.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.76 128.7 34.27 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.727 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 58.5 m-85 -127.43 157.24 40.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.333 0.587 . . . . 0.0 111.193 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.565 ' HD2' ' HB3' ' A' ' 16' ' ' PHE . 54.7 t-80 -148.25 150.03 32.95 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.98 27.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.523 0.678 . . . . 0.0 112.793 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.446 HG23 ' HG2' ' A' ' 33' ' ' LYS . 15.8 tt -118.35 -32.33 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 121.514 -0.741 . . . . 0.0 110.902 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG2' HG23 ' A' ' 32' ' ' ILE . 34.5 mmtp -95.21 5.27 52.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.287 0.565 . . . . 0.0 110.902 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 36' ' ' ASN . 45.3 t -94.14 129.1 44.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.388 176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.33 -15.46 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' HB2' HG23 ' A' ' 64' ' ' VAL . 5.4 m-20 -122.08 65.66 21.35 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.981 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 40' ' ' ILE . 71.9 Cg_endo -75.3 -11.93 20.94 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.057 1.838 . . . . 0.0 111.772 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -84.57 -17.89 37.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.22 12.47 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.674 -172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.8 mt -75.19 134.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.8 0.333 . . . . 0.0 111.193 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -161.18 170.62 19.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.168 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 8.3 tmtm? -74.69 137.88 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.758 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 7.5 t70 69.98 13.15 7.9 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.367 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.76 143.81 35.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.301 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.69 138.68 32.51 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 64' ' ' VAL . 20.5 m -138.4 163.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.23 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -128.02 134.23 49.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.215 174.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -151.71 172.36 16.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.948 0.404 . . . . 0.0 111.101 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.31 141.73 24.99 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.74 160.27 6.27 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.815 2.343 . . . . 0.0 113.833 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.803 ' HB ' ' HE2' ' A' ' 60' ' ' TYR . 14.5 t -164.64 -179.46 5.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.747 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.456 ' C ' HD22 ' A' ' 53' ' ' ASN . 3.4 m -134.62 148.29 50.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.114 0.483 . . . . 0.0 110.052 175.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 52' ' ' THR . 0.9 OUTLIER -123.49 -179.91 4.51 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -72.25 -28.06 62.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.285 0.565 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 52.1 mmtt -74.39 -42.81 58.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.338 175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.88 -153.56 23.59 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.597 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD13 HH12 ' A' ' 27' ' ' ARG . 68.7 mt -73.54 134.49 43.81 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.833 0.349 . . . . 0.0 110.749 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 5.5 m -143.65 167.87 21.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.944 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -144.56 160.9 40.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.942 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.803 ' HE2' ' HB ' ' A' ' 51' ' ' THR . 29.0 p90 -141.1 175.31 9.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 52.44 48.78 21.89 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.07 0.856 . . . . 0.0 110.706 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' HB ' HG13 ' A' ' 34' ' ' VAL . 14.5 t -83.6 111.84 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.317 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.14 126.76 51.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.827 0.346 . . . . 0.0 110.097 175.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 46' ' ' VAL . 81.7 t -70.26 144.26 13.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.257 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -110.64 85.28 4.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.736 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 9.9 Cg_endo -91.48 136.85 1.92 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.069 2.513 . . . . 0.0 111.705 174.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.62 17.5 3.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.256 0.55 . . . . 0.0 110.698 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -103.4 -69.45 0.8 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.027 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 63.38 83.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.886 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -140.03 -71.47 0.38 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.083 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 64.02 104.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.754 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -74.75 160.85 30.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -134.16 153.16 52.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.747 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.1 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.614 173.331 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.38 -163.59 0.26 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.529 0.518 . . . . 0.0 109.833 -173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ttm -147.94 165.94 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.371 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.53 146.68 46.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.349 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.27 162.28 27.22 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.22 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' HG23 ' A' ' 19' ' ' ILE . 9.0 m -114.1 134.78 54.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.927 HD13 HG23 ' A' ' 40' ' ' ILE . 55.6 mt -73.81 121.14 24.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.704 -174.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -117.17 -56.1 2.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -117.65 122.73 44.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.042 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -140.79 114.37 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.944 0.402 . . . . 0.0 110.454 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 87.8 m-85 -89.61 83.18 6.28 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.844 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.54 -42.34 95.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.553 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -84.9 -47.8 9.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.343 -176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.91 8.91 8.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.314 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -138.35 172.51 12.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.316 0.558 . . . . 0.0 110.648 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.02 -171.22 38.21 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -137.37 129.35 29.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.772 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 66.1 mt -123.84 132.13 71.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.04 117.16 20.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.422 . . . . 0.0 110.617 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.714 ' HB3' ' H ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -77.05 -168.52 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.93 0.871 . . . . 0.0 111.732 -174.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.59 -15.78 53.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.755 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.714 ' H ' ' HB3' ' A' ' 21' ' ' ASP . 46.9 m-80 -76.67 -14.63 59.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.644 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.44 -31.82 7.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.201 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.9 -175.55 2.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -109.46 147.94 32.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -171.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.631 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 49.3 mtt-85 -97.91 160.47 14.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.476 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.66 106.13 16.72 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.772 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 35.3 m-85 -96.97 154.94 17.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.282 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 32' ' ' ILE . 25.4 t-80 -149.12 133.48 17.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.561 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.68 -36.15 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.611 HG23 ' HG2' ' A' ' 33' ' ' LYS . 17.6 tt -61.26 -26.72 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.153 0.502 . . . . 0.0 111.939 -175.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' A' ' 32' ' ' ILE . 74.5 mmtt -104.88 9.16 34.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.384 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 40' ' ' ILE . 39.3 t -106.61 127.63 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.89 70.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.184 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -134.71 71.95 69.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.056 0.455 . . . . 0.0 111.427 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.39 -20.39 27.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.578 2.185 . . . . 0.0 112.657 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -80.88 -16.23 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.397 0.618 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.69 3.82 53.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.05 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.927 HG23 HD13 ' A' ' 7' ' ' ILE . 52.9 mt -73.9 110.07 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.381 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -117.64 -176.81 3.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.243 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -87.81 147.75 25.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.564 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.99 9.39 6.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.92 0.763 . . . . 0.0 111.104 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -90.3 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.48 151.88 20.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.342 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 64' ' ' VAL . 31.2 m -129.94 164.13 33.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.433 0.635 . . . . 0.0 111.461 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -127.11 134.9 50.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.887 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.52 174.72 14.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.357 . . . . 0.0 111.667 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.82 142.01 23.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.257 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -86.81 138.88 5.31 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 167.79 27.8 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 131.86 41.15 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -97.22 24.14 6.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.304 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.51 -43.57 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.894 0.878 . . . . 0.0 111.811 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.92 -32.56 73.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.699 0.285 . . . . 0.0 110.777 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.74 -176.54 44.06 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.283 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.1 mt -79.09 138.16 37.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.435 ' HA ' ' HB3' ' A' ' 27' ' ' ARG . 2.0 p -151.13 169.05 22.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.122 0.487 . . . . 0.0 111.305 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HB2' ' HD2' ' A' ' 27' ' ' ARG . . . -143.35 148.41 36.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.877 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -131.79 175.11 9.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.76 32.63 22.4 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 124.016 0.822 . . . . 0.0 109.861 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.77 114.98 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.325 -173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -116.47 119.97 37.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' HG12 ' A' ' 46' ' ' VAL . 43.0 t -72.73 151.14 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.749 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.57 87.52 1.79 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.807 0.337 . . . . 0.0 110.235 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 1.3 Cg_endo -82.26 131.86 6.86 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 111.726 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.29 -70.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.232 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 128.14 21.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -146.74 70.03 1.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.383 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -56.18 124.07 16.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.434 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -71.4 121.09 17.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.875 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.48 85.18 7.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -99.27 37.31 1.58 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.545 0.688 . . . . 0.0 109.603 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.933 -178.304 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.4 114.23 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 123.866 0.729 . . . . 0.0 111.635 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' THR . 35.0 ttm -115.44 167.89 10.47 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.8 p-10 -127.93 141.18 51.61 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.056 0.455 . . . . 0.0 111.156 -175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -144.98 177.77 23.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.394 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 19' ' ' ILE . 6.6 m -122.92 135.27 54.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.8 0.333 . . . . 0.0 110.107 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.954 HD13 HG23 ' A' ' 40' ' ' ILE . 56.4 mt -74.28 122.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -176.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -114.27 -58.14 2.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 17.3 m -114.88 129.72 56.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.082 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.436 ' HE3' ' HA3' ' A' ' 17' ' ' GLY . 76.5 t-105 -152.89 130.14 11.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.42 97.47 5.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.87 -42.54 98.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.424 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.02 -43.64 70.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.764 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 16' ' ' PHE . 8.2 mmpt? -66.79 -39.77 87.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.82 -3.94 57.55 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.079 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.593 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 64.9 m-85 -95.48 156.81 16.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.436 ' HA3' ' HE3' ' A' ' 10' ' ' TRP . . . -163.51 157.31 29.45 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.0 m-85 -136.23 126.66 26.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 80.6 mt -134.07 133.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -102.95 129.02 49.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 7.5 p-10 -89.68 179.26 6.06 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.517 176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.67 -8.53 58.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.75 -43.76 5.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.65 -98.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.103 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.2 -178.99 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.612 -0.346 . . . . 0.0 110.249 -164.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.91 122.87 20.74 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.322 0.582 . . . . 0.0 110.544 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -108.4 151.65 25.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.8 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -77.88 122.29 25.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.375 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 17.2 m-85 -112.55 153.21 27.86 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.318 0.58 . . . . 0.0 110.283 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 32' ' ' ILE . 3.7 t-80 -133.92 131.04 38.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.843 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' HH2' ' A' ' 10' ' ' TRP . 14.7 p -49.7 -26.72 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG22 ' ND1' ' A' ' 30' ' ' HIS . 12.3 tt -79.16 -20.37 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.459 0.647 . . . . 0.0 111.377 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG2' HG23 ' A' ' 32' ' ' ILE . 66.2 mmtt -102.69 10.77 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.013 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 40' ' ' ILE . 34.6 t -101.66 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.643 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.11 -33.82 72.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.559 HD22 HD12 ' A' ' 39' ' ' LEU . 12.6 p-10 -141.75 74.63 22.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.076 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HA ' HG13 ' A' ' 40' ' ' ILE . 70.5 Cg_endo -75.02 -16.98 19.87 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.787 2.325 . . . . 0.0 112.983 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.28 -22.61 57.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.298 0.57 . . . . 0.0 110.434 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.559 HD12 HD22 ' A' ' 36' ' ' ASN . 92.3 mt -97.93 5.17 49.22 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.439 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 7' ' ' ILE . 33.0 mt -73.02 120.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.089 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -135.75 164.89 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.472 173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.616 ' HD3' ' N ' ' A' ' 43' ' ' ASP . 2.4 tmtp? -68.98 142.53 54.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 30.6 t70 75.72 4.63 3.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.901 0.75 . . . . 0.0 111.38 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' HD12 ' A' ' 7' ' ' ILE . . . -81.38 147.29 29.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.14 -0.35 . . . . 0.0 110.233 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.62 140.67 29.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.614 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.6 m -132.28 151.15 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' MET . 11.5 p -118.91 135.23 54.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.804 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.564 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.4 p90 -154.1 173.18 16.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 0.0 111.76 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -99.83 142.89 25.45 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.635 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.29 143.99 12.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.468 2.112 . . . . 0.0 112.691 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 60' ' ' TYR . 11.6 t -165.12 176.46 8.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.292 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -113.35 143.75 43.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.146 0.498 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -100.89 16.7 24.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.753 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 73.59 -47.19 0.65 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.684 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -107.3 26.14 10.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.863 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.15 -171.21 34.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.951 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 145.78 25.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 p -148.03 169.98 18.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.811 0.339 . . . . 0.0 111.037 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.77 149.73 52.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.96 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 51' ' ' THR . 27.6 m-85 -114.37 172.37 7.06 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.273 174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.96 41.27 26.91 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.973 0.795 . . . . 0.0 111.79 174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 20.8 t -68.15 103.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.103 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 34.3 ttmt -107.12 117.29 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.931 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 40' ' ' ILE . 22.3 t -87.67 140.17 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -176.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.23 88.44 2.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.108 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.92 162.17 39.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.573 -175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.3 pt? -68.17 -25.57 65.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.009 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -162.39 151.19 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -85.86 80.79 8.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.239 0.542 . . . . 0.0 109.668 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -79.13 136.02 37.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.387 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -78.45 134.11 37.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.384 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -136.89 97.89 3.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -112.59 -3.64 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.53 172.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.79 124.26 21.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.492 ' HE1' ' HB2' ' A' ' 22' ' ' GLU . 77.2 mtp -113.21 158.26 20.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 4.4 p-10 -106.11 140.47 39.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.232 0.539 . . . . 0.0 111.181 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.58 170.43 23.93 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.35 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -117.94 134.97 54.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.14 0.495 . . . . 0.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 40' ' ' ILE . 48.2 mt -77.79 120.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.391 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -107.74 -52.11 2.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.778 0.323 . . . . 0.0 110.924 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 m -121.36 127.72 51.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.455 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -138.67 117.61 12.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.99 0.424 . . . . 0.0 110.148 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.787 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . 93.4 m-85 -90.76 88.37 7.05 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.3 -33.05 74.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.123 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.17 -31.66 72.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.79 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.787 ' HD3' ' HB3' ' A' ' 11' ' ' PHE . 3.9 mptp? -92.46 -60.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.029 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.64 14.16 3.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.668 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.27 172.55 12.52 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.527 -0.396 . . . . 0.0 110.197 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.19 -163.27 24.91 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.505 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.55 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 85.2 m-85 -141.4 132.84 26.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.764 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 74.4 mt -130.87 139.43 51.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.301 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HE3' ' HA2' ' A' ' 24' ' ' GLY . 1.2 tmtp? -100.1 118.71 37.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.522 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 6.8 p-10 -102.22 -171.9 2.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.318 0.58 . . . . 0.0 111.288 -176.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HB2' ' HE1' ' A' ' 3' ' ' MET . 44.8 mt-10 -66.28 -23.34 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.449 -174.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -70.53 -13.34 62.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.855 0.359 . . . . 0.0 110.992 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 20' ' ' LYS . . . 85.97 24.75 40.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.787 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -127.3 -177.47 4.08 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' A' ' 18' ' ' PHE . 28.3 t-20 -127.54 120.67 28.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 51.0 mtt-85 -105.17 153.43 21.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.205 -172.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -80.44 115.97 20.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.739 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 23.9 m-85 -107.42 152.92 23.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' ND1' HG22 ' A' ' 32' ' ' ILE . 12.2 t-160 -150.47 138.45 20.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.231 -175.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.71 -31.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 33' ' ' LYS . 18.1 tt -63.42 -27.63 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.051 0.453 . . . . 0.0 111.943 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 32' ' ' ILE . 75.3 mmtt -102.28 7.25 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.502 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 40' ' ' ILE . 21.8 t -106.66 130.45 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.774 0.321 . . . . 0.0 110.198 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.07 -35.17 59.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -137.99 70.57 49.42 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.399 0.619 . . . . 0.0 111.026 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HA ' HG13 ' A' ' 40' ' ' ILE . 73.0 Cg_endo -74.16 -10.71 22.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.003 2.469 . . . . 0.0 112.236 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.37 -25.04 63.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.31 8.61 40.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.016 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.853 HG23 HD13 ' A' ' 7' ' ' ILE . 43.8 mt -75.72 124.0 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.228 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.556 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 15.3 ptpt -144.63 163.74 33.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.158 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' HB2' ' A' ' 43' ' ' ASP . 1.4 tmtp? -72.73 140.56 47.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.557 ' HB2' ' HD3' ' A' ' 42' ' ' LYS . 35.1 t70 75.1 18.79 2.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.859 0.725 . . . . 0.0 110.89 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -100.93 149.38 23.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.23 137.5 32.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.237 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 64' ' ' VAL . 15.9 m -132.6 147.59 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.874 0.369 . . . . 0.0 111.097 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.5 p -111.28 135.26 52.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.738 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 6.3 p90 -156.18 172.66 18.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 29.6 mm-40 -96.72 141.86 23.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_endo -89.02 136.38 2.96 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.847 2.365 . . . . 0.0 112.164 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.526 ' HB ' ' HE1' ' A' ' 60' ' ' TYR . 14.2 t -153.06 -177.0 6.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.036 0.446 . . . . 0.0 110.133 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -128.21 142.34 51.2 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 8.8 t-20 -105.8 170.05 8.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.54 -33.41 73.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.853 0.358 . . . . 0.0 110.732 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -119.56 26.76 9.17 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.82 176.17 22.71 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.687 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 57' ' ' LEU . 4.0 mp -79.28 143.7 35.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.834 0.317 . . . . 0.0 110.171 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p -151.76 170.22 20.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.222 0.534 . . . . 0.0 111.386 -172.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -136.7 148.51 47.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.162 175.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.526 ' HE1' ' HB ' ' A' ' 51' ' ' THR . 29.6 p90 -130.3 177.38 7.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.71 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.1 35.5 26.4 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.004 0.815 . . . . 0.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . 26.1 t -67.46 112.24 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.356 -174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.57 117.22 30.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.504 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 46' ' ' VAL . 41.7 t -70.67 137.38 24.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.347 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.3 85.71 16.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.659 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 5.9 Cg_exo -79.56 -169.99 0.91 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.276 2.65 . . . . 0.0 111.67 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.08 -33.14 72.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.487 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 69' ' ' HIS . 27.2 tt0 -137.54 168.57 19.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 35.8 t-80 -66.39 -23.42 66.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.698 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 66.73 102.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.88 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -66.94 107.58 2.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.376 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.23 157.05 16.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.867 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -81.25 124.07 29.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.366 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.142 175.666 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.49 114.85 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.255 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.5 mtp -105.71 159.22 16.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.185 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.77 142.43 31.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.428 0.633 . . . . 0.0 111.12 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -138.46 167.39 25.02 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.046 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -110.64 137.87 47.76 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.135 0.493 . . . . 0.0 110.734 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.702 HD13 HG23 ' A' ' 40' ' ' ILE . 58.2 mt -79.19 117.78 25.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.714 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.5 p -108.68 -43.55 4.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.25 0.548 . . . . 0.0 111.227 -175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.5 m -136.55 122.14 19.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.766 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 71.0 t-105 -139.54 130.78 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.623 0.249 . . . . 0.0 110.58 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.54 90.59 3.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.96 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.631 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.6 tmtt? -67.08 -26.36 66.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.354 0.597 . . . . 0.0 109.825 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.47 -20.72 36.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.081 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -97.07 -44.67 6.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.578 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.72 -2.82 10.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.511 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 29' ' ' PHE . 40.0 p90 -148.42 177.89 9.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.568 0.684 . . . . 0.0 111.646 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.15 -164.05 28.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.242 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.93 131.25 42.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.794 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 86.1 mt -130.17 129.94 65.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -103.47 124.33 48.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.91 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.507 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 9.4 p-10 -95.34 -175.98 3.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.029 0.442 . . . . 0.0 110.687 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.2 -7.46 51.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.522 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . 5.7 t-20 -95.84 -58.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.682 0.277 . . . . 0.0 111.213 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.69 -92.19 2.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.678 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -164.33 -154.31 0.24 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -72.81 135.79 45.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 109.785 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 42.2 mtt180 -114.34 148.9 36.86 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.666 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -85.16 115.86 23.19 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.794 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 51.2 m-85 -109.94 161.8 15.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -146.71 138.52 24.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.63 -28.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 ' HG2' ' A' ' 33' ' ' LYS . 16.2 tt -61.68 -26.85 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 111.794 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 32' ' ' ILE . 33.9 mmtp -99.93 7.39 44.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.589 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 40' ' ' ILE . 29.0 t -100.8 123.92 54.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.82 -39.19 69.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.291 -176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.754 HD22 HD12 ' A' ' 39' ' ' LEU . 12.2 p-10 -134.27 78.25 58.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.359 0.6 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.18 -19.66 13.38 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.966 2.444 . . . . 0.0 114.195 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.54 -2.95 58.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.067 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.754 HD12 HD22 ' A' ' 36' ' ' ASN . 59.8 mt -99.08 -1.71 38.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.145 0.498 . . . . 0.0 109.855 174.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.702 HG23 HD13 ' A' ' 7' ' ' ILE . 52.7 mt -71.74 122.59 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.443 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.32 165.25 17.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.881 171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -78.4 148.28 33.73 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.082 0.468 . . . . 0.0 111.613 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 61.52 26.73 16.4 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.172 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 165.01 11.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.702 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.51 138.83 39.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 111.141 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 64' ' ' VAL . 27.3 m -131.54 152.11 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -110.97 134.73 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.993 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 9.1 p90 -151.95 165.6 34.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.017 0.437 . . . . 0.0 111.469 -175.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.24 141.32 24.9 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -88.66 139.34 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.313 2.675 . . . . 0.0 113.488 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -150.55 173.82 13.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 151.7 48.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.96 0.41 . . . . 0.0 110.84 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.47 177.31 7.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.703 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -74.97 -11.5 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -95.18 -2.83 48.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.4 -140.41 12.26 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.794 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.31 144.57 27.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.213 0.53 . . . . 0.0 110.71 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -143.61 168.79 19.05 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.44 168.05 24.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.697 0.284 . . . . 0.0 111.291 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -148.72 -179.96 7.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.64 41.57 28.23 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.785 0.678 . . . . 0.0 110.521 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.6 t -70.23 101.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.364 -174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 19.4 ttmm -101.68 114.27 28.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.593 175.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 46' ' ' VAL . 50.3 t -77.57 134.85 27.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.903 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.71 86.11 5.43 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 85.2 Cg_endo -93.37 -169.27 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.053 2.502 . . . . 0.0 113.396 -174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.07 84.97 2.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.287 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -51.19 125.78 14.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.021 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -128.83 128.97 44.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 171.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -59.93 133.52 56.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.722 -171.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.86 135.71 41.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.125 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -74.93 135.88 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.986 0.422 . . . . 0.0 110.706 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -115.65 67.33 0.7 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.73 0.776 . . . . 0.0 110.438 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 33.3 m80 . . . . . 0 C--O 1.247 0.96 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.912 176.709 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.08 16.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.096 0.474 . . . . 0.0 110.808 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.429 ' HE3' ' HB3' ' A' ' 23' ' ' ASN . 60.7 mtp -115.34 154.18 29.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.549 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -118.08 139.96 50.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -146.5 176.58 25.34 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.869 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -116.6 140.13 49.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HA ' HG12 ' A' ' 19' ' ' ILE . 52.3 mt -79.14 116.76 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.189 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -108.77 -63.27 1.36 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 m -102.91 129.05 49.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.29 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -147.03 135.01 21.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.759 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' A' ' 14' ' ' LYS . 89.2 m-85 -126.27 113.12 16.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.301 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -60.86 -64.07 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 -176.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.68 -17.02 61.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.336 -170.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 6.7 mmpt? -81.28 -35.62 30.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.944 173.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.26 15.16 62.84 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.266 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 43.9 p90 -145.34 175.39 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.478 -0.425 . . . . 0.0 110.605 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.63 -167.96 34.05 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.571 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.76 125.37 28.38 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.739 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 89.2 mt -120.85 129.2 75.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.865 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -107.45 126.49 52.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.216 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.631 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 5.0 p-10 -96.05 175.45 6.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.791 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -103.3 13.82 32.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB3' ' HE3' ' A' ' 3' ' ' MET . 8.2 t30 -107.09 -47.51 3.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.453 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.35 -83.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.34 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -169.15 -164.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -82.83 131.29 35.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -124.64 150.37 46.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 111.237 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -78.48 127.1 31.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.547 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 33.7 m-85 -120.62 156.56 31.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.656 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 32' ' ' ILE . 11.4 t-80 -141.39 141.22 33.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.08 -31.26 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.627 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.2 tt -70.98 -21.26 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.672 0.749 . . . . 0.0 110.631 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.7 -11.52 59.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.058 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.868 HG11 HD11 ' A' ' 40' ' ' ILE . 23.3 t -91.11 138.44 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.31 -36.13 22.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.673 HD22 HD12 ' A' ' 39' ' ' LEU . 10.6 p-10 -129.25 85.35 59.71 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.772 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.7 -31.63 5.22 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.742 2.961 . . . . 0.0 112.692 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.93 -25.47 68.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.673 HD12 HD22 ' A' ' 36' ' ' ASN . 87.9 mt -95.77 5.25 51.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.612 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.868 HD11 HG11 ' A' ' 34' ' ' VAL . 36.2 mt -75.66 124.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.141 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HG3' ' HB2' ' A' ' 44' ' ' ALA . 18.0 ptpt -143.68 164.57 30.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.165 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -78.92 151.42 31.72 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.27 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 71.68 4.04 4.89 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.432 1.083 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.485 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . . . -85.09 158.45 20.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.757 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.17 136.0 39.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 64' ' ' VAL . 29.0 m -132.25 156.08 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -117.59 135.16 54.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.097 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.631 ' HZ ' ' HB3' ' A' ' 21' ' ' ASP . 18.5 p90 -151.6 177.03 10.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.612 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -121.93 144.7 41.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.0 145.94 32.03 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.993 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -150.09 152.78 35.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -91.01 150.7 21.34 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.223 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 4.8 t-20 -127.15 159.18 35.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -70.35 -32.75 70.59 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.902 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 53' ' ' ASN . 50.7 pttt -101.93 6.43 41.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -154.28 25.25 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.145 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.61 146.45 27.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.808 0.337 . . . . 0.0 110.461 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.9 p -145.07 169.41 18.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.09 0.471 . . . . 0.0 111.581 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -141.95 154.14 44.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.599 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -132.12 -175.93 3.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 51.21 50.52 18.84 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.005 0.816 . . . . 0.0 111.136 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -72.86 104.6 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.949 -175.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -103.62 111.83 24.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.89 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HA ' HG12 ' A' ' 46' ' ' VAL . 59.0 t -72.58 142.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.881 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -105.13 88.42 2.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 3.1 Cg_exo -74.96 123.74 8.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.363 2.042 . . . . 0.0 111.069 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.65 -61.23 1.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.008 0.432 . . . . 0.0 110.504 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -116.48 153.8 31.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.411 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.14 126.11 32.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 72' ' ' HIS . 26.7 t-80 -82.14 56.23 3.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.871 0.367 . . . . 0.0 111.613 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 69.75 -30.75 0.2 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.743 0.817 . . . . 0.0 112.559 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.414 ' H ' ' C ' ' A' ' 70' ' ' HIS . 86.5 t60 -70.25 99.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.525 . . . . 0.0 109.735 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -112.13 148.98 32.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.354 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.361 177.211 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.675 0.274 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.13 118.51 30.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp -110.62 150.52 28.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.98 158.2 16.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.574 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 21' ' ' ASP . . . -152.19 172.51 31.44 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 176.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.2 m -122.18 130.88 53.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.864 0.332 . . . . 0.0 110.196 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.866 ' HA ' HG12 ' A' ' 19' ' ' ILE . 66.5 mt -67.7 105.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.08 0.467 . . . . 0.0 110.304 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -95.4 -36.29 11.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.886 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 31.7 m -144.87 136.97 25.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -145.59 126.02 14.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.042 0.448 . . . . 0.0 111.368 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -119.87 95.53 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -62.84 -41.0 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.96 -37.09 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.081 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.724 ' HG3' ' HD2' ' A' ' 16' ' ' PHE . 18.6 tptm -86.26 -30.4 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' O ' ' HD2' ' A' ' 30' ' ' HIS . . . 92.02 5.59 65.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.542 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.724 ' HD2' ' HG3' ' A' ' 14' ' ' LYS . 84.1 m-85 -119.21 162.36 18.81 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.669 -0.313 . . . . 0.0 110.604 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -163.23 173.12 39.35 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.223 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 9' ' ' THR . 96.9 m-85 -131.05 131.41 44.25 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.866 HG12 ' HA ' ' A' ' 7' ' ' ILE . 82.2 mt -136.4 130.56 47.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.98 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -91.73 139.52 30.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 12.6 p-10 -115.87 -164.65 0.97 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.388 0.613 . . . . 0.0 111.88 -171.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -62.97 -32.28 73.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.566 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.25 -33.81 75.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 26.71 9.19 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.099 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t70 -135.15 177.53 7.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' H ' HD22 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -96.07 139.89 31.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.106 0.479 . . . . 0.0 110.383 179.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 52.9 mtt-85 -118.2 138.99 51.94 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.47 119.54 25.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.556 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.817 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 66.3 m-85 -111.66 160.17 17.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.625 0.726 . . . . 0.0 112.099 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.496 ' ND1' HG22 ' A' ' 32' ' ' ILE . 15.6 t-160 -141.75 142.31 33.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.984 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -48.94 -34.39 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.496 HG22 ' ND1' ' A' ' 30' ' ' HIS . 18.4 tt -62.54 -25.38 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.565 0.697 . . . . 0.0 111.363 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.785 ' HG3' ' HA ' ' A' ' 60' ' ' TYR . 7.6 mptt -77.52 -22.48 51.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.241 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 23.9 t -93.8 134.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.606 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.01 -33.03 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.675 HD22 HD12 ' A' ' 39' ' ' LEU . 14.8 p-10 -127.88 77.04 76.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.095 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 40' ' ' ILE . 59.9 Cg_endo -73.12 -23.47 18.12 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.9 2.4 . . . . 0.0 113.273 -176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.1 -29.11 68.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.459 0.647 . . . . 0.0 111.074 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.675 HD12 HD22 ' A' ' 36' ' ' ASN . 81.3 mt -92.8 4.97 52.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.36 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 7' ' ' ILE . 40.0 mt -69.93 110.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.974 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.58 158.09 25.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.986 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 144.71 33.44 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.148 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.43 11.02 8.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.517 0.675 . . . . 0.0 110.551 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.59 154.76 19.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.418 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.8 143.37 26.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.794 HG12 ' HA ' ' A' ' 64' ' ' VAL . 28.5 m -134.32 164.14 35.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.408 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.25 153.58 45.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -167.77 177.07 5.96 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 41.1 mt-10 -110.46 142.78 26.76 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 3.4 Cg_endo -84.97 142.47 8.86 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.214 2.609 . . . . 0.0 113.219 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.7 t -144.86 162.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m -104.19 149.46 25.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.943 0.402 . . . . 0.0 110.73 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 6.3 t-20 -139.68 154.79 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -66.95 -31.35 71.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.182 0.515 . . . . 0.0 110.185 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -82.4 -18.09 43.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.85 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.04 -163.26 31.33 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.648 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' ASP . 83.9 mt -73.05 140.53 47.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.069 0.435 . . . . 0.0 110.407 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 53' ' ' ASN . 1.4 p -135.0 167.22 21.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.82 0.343 . . . . 0.0 110.691 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 29' ' ' PHE . . . -149.95 159.31 44.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.785 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 43.2 p90 -143.87 -178.61 6.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 123.31 0.381 . . . . 0.0 110.005 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 56.29 39.4 30.19 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.701 0.626 . . . . 0.0 110.249 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 21.9 t -78.74 119.03 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.403 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.481 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.0 127.05 55.43 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.794 ' HA ' HG12 ' A' ' 46' ' ' VAL . 27.9 t -77.87 142.63 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.214 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.7 86.81 3.13 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.397 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 64' ' ' VAL . 94.2 Cg_endo -84.41 168.67 11.42 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.726 2.284 . . . . 0.0 112.5 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.9 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -65.1 -65.89 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.573 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.815 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 1.5 tm-20 -162.41 105.56 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -145.91 121.06 10.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.157 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -63.95 146.6 53.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.61 177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -60.56 119.1 7.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -74.53 136.47 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.769 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -69.73 -40.68 76.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 C--O 1.242 0.695 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.492 169.029 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.687 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 10.2 tpt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.687 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -55.96 127.74 31.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 110.766 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -118.5 164.21 15.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.136 0.494 . . . . 0.0 111.199 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -115.01 152.76 31.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.468 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.22 -178.5 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.514 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.7 m -125.47 136.71 53.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.865 0.364 . . . . 0.0 110.165 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.821 HD13 HG23 ' A' ' 40' ' ' ILE . 44.0 mt -77.11 115.63 19.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.263 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -104.28 -40.32 6.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.166 0.507 . . . . 0.0 111.431 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.5 m -136.97 114.77 11.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.451 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.702 ' HE1' ' HG2' ' A' ' 12' ' ' LYS . 75.9 t-105 -130.62 136.48 48.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.057 0.455 . . . . 0.0 111.493 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.35 97.12 5.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.702 ' HG2' ' HE1' ' A' ' 10' ' ' TRP . 6.1 tmtp? -67.75 -33.09 74.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 110.005 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.32 -35.7 81.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.034 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.927 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 8.5 mmpt? -88.9 -30.09 19.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.37 9.58 57.77 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 14' ' ' LYS . 48.6 p90 -144.39 174.65 10.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.964 0.412 . . . . 0.0 111.026 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.66 -172.63 37.86 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.069 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -134.78 126.84 29.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.734 ' HB ' ' CE1' ' A' ' 29' ' ' PHE . 79.3 mt -123.64 131.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.887 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.57 119.84 31.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.506 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -76.98 177.42 7.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.491 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -81.2 -5.98 58.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.335 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.34 -35.03 18.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.234 0.54 . . . . 0.0 109.563 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.76 22.65 2.69 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.017 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -108.03 164.09 12.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.397 0.598 . . . . 0.0 110.485 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -116.89 115.62 25.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -111.11 148.66 32.21 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.712 -172.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -81.52 122.13 27.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.7 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE1' ' HB ' ' A' ' 19' ' ' ILE . 30.7 m-85 -111.72 154.85 24.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.531 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.576 ' ND1' HG22 ' A' ' 32' ' ' ILE . 17.4 t-80 -141.32 133.12 27.35 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -50.14 -29.7 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.576 HG22 ' ND1' ' A' ' 30' ' ' HIS . 19.1 tt -67.06 -29.33 45.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.276 0.56 . . . . 0.0 111.225 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -82.3 -4.32 56.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.204 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 40' ' ' ILE . 22.0 t -95.84 133.31 37.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.173 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.27 -42.78 22.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.881 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -125.43 73.88 68.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 40' ' ' ILE . 56.0 Cg_endo -70.65 -15.86 33.79 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.548 2.166 . . . . 0.0 112.262 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.93 -10.63 60.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.603 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 66' ' ' PRO . 95.6 mt -108.22 7.97 27.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.821 HG23 HD13 ' A' ' 7' ' ' ILE . 50.7 mt -78.67 114.75 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.39 0.614 . . . . 0.0 111.63 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 48.9 mtpt -124.29 167.78 13.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.59 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.99 135.25 34.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.49 21.56 2.28 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 0.0 109.795 -174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 41' ' ' LYS . . . -98.81 146.58 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.413 177.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.62 29.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.197 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.701 HG21 HD13 ' A' ' 19' ' ' ILE . 23.6 m -136.56 156.0 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.7 p -121.71 135.18 54.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.761 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.59 179.98 7.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.613 0.244 . . . . 0.0 110.924 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.5 pt-20 -125.83 142.88 43.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 171.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 8.1 Cg_exo -74.41 145.4 33.86 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 123.059 2.506 . . . . 0.0 113.481 -174.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 58' ' ' SER . 9.0 t -139.17 156.95 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -113.63 127.26 55.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.431 0.634 . . . . 0.0 112.111 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -108.38 161.22 15.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.596 171.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -71.45 -13.43 61.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.099 0.476 . . . . 0.0 110.309 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.78 -19.95 25.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.108 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.08 -162.31 31.27 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.969 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.8 mt -85.47 138.01 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 111.057 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 51' ' ' THR . 5.4 m -137.89 169.64 17.43 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.337 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . . . -139.94 152.78 46.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.731 0.301 . . . . 0.0 110.679 176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' A' ' 51' ' ' THR . 1.6 p90 -139.67 -179.22 5.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.221 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.25 48.31 22.38 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.921 0.763 . . . . 0.0 110.041 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 34' ' ' VAL . 24.9 t -75.9 112.67 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -173.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 39.6 mtmt -113.49 109.89 19.39 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.001 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.666 ' HA ' HG12 ' A' ' 46' ' ' VAL . 56.1 t -66.45 152.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.08 88.7 2.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 39' ' ' LEU . 35.9 Cg_endo -64.71 148.49 90.22 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.597 2.198 . . . . 0.0 112.727 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.7 pt? -61.33 -25.16 66.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.214 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -148.68 -71.39 0.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.931 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -151.86 -56.65 0.14 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.479 . . . . 0.0 110.308 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -160.42 136.15 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -61.91 -38.2 87.49 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.192 -172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 73' ' ' HIS . 44.3 t-80 76.8 161.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.806 0.691 . . . . 0.0 111.339 169.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' HIS . 48.6 t-80 83.86 101.88 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.169 174.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 . . . . . 0 C--O 1.246 0.899 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.48 171.699 . . . . . . . . 0 0 . 1 stop_ save_